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Preface 
Photo: CEC. 
W ith the 'Europe against cancer' programme the European Com-munity has reinforced its human dimension - a new dimension for 
the Community in many respects - and drawn closer to the citizens of 
our 12 countries. 
One European in four is stricken by this terrible disease at some stage. 
However, it is a proven fact that many cancers can be avoided, and 
many cured if detected sufficiently early. This is the essential message 
of the 'Europe against Cancer' programme, which aims to reduce the 
trend of deaths from cancer by 15% between now and the year 2000. 
The programme covers four areas: cancer prevention, training of health 
personnel, information of the public and health education in schools, 
and medical research. 
By pooling their efforts and working more closely together, Europeans 
can hope to advance further and faster in all these areas. Tangible 
results have already been achieved, as this special edition of Social 
Europe clearly demonstrates. 
Vasso Papandreou 
Member of the Commission 
of the European Communities 
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Europe against cancer: a new concept 
W hen the Heads of State or Government of the European Community approved the launch of a European programme against cancer at the Milan European 
Council in June 1985, they were breaking new ground. Up until then actions at 
Community level in this field had been limited to two tasks: 
D the development of norms for the protection of the population against ionizing 
radiation and chemical carcinogens; 
D the avoidance of occupational cancers, originally in the iron and steel industries, 
subsequently in all the other sectors. 
But even taken together, these actions confronted the origins of only 10% of the 
mortality from cancer despite the fact that over 75% of cancers are linked to external 
factors which can be overcome at individual, national or Community level. 
From now on, with the Europe against cancer programme, the European Community 
can act in new areas such as disease prevention, information of the public, health 
education (especially in schools) and the training of health personnel. But the 
innovative character of the programme is not just a question of the areas covered. It 
also inspires the chosen strategy, which has three key elements: 
D the partnership approach, which enables the programme to bring together all the 
national actors involved in the campaign against cancer, and to regroup them in 
European committees and working parties, both scientific and non-scientific; 
D the European Code against cancer, which presents 10 rules for a healthy lifestyle; 
D the importance of maintaining a long-term vision because the objective of the 
programme is cited for the year 2000 and the campaign is a long-term affair. 
This concept is new but fertile. It amounts simply to saying that the European 
Community can and should be concerned with its citizens, on the one hand by 
allocating a part of its budget to financing European actions against cancer, and on the 
other hand by taking account of the 'cancer dimension' in the traditional areas of its 
competence such as research, protection of the population against ionizing radiation 
and protection of workers. 
The European Commission has succeeded in having a number of proposals adopted 
by the Council of Ministers of the European Community, not only in the field of 
cancer but also concerned with other illnesses (cardiovascular diseases, pulmonary 
diseases, etc.). These texts are included as annexes to this volume. 
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Foreword 
EUROPE 
AGAINST CANCER 
This edition of Social Europe reflects the innovatory character of the Europe against 
cancer programme. We read the contributions from cancer experts, directors of 
cancer leagues, general practitioners and educationalists, and from officials and 
experts at the Commission. All these partners are contributing to the special character 
of the programme and to bringing the European Community closer to the concerns of 
its citizens. 
Jean Degimbe 
Director-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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What is the problem? 
Before a problem can be solved, it must be identified. In these 
articles, the principal causes of cancer are reviewed, with analysis 
of possible means of prevention. The current epidemiological 
situation concerning certain cancers in the Community is illustrated 
by maps of mortality and the apparently mundane but vital task of 
registering cancers explained. 
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Prevention of cancer 
Prospects for the near future? 
An alternative title for the present article could read 'Promotion of a healthy life'. Our 
global aim is encouraging the development of a general environment conducive to the 
well-being of populations. Such a goal should be seen in a much wider context, taking 
into account not only the economic aspects of health and disease, but also the 
philosophical and moral issues by which the attainment of good health allows human 
beings to aspire to a better, more equitable and socially fair world. 
Cancer: responsible for a quarter 
of the mortality in the Community 
Although we do not live in the land of Utopia, and, 
consequently, the well-known goal for the world's 
population set by the World Health Organization 
(WHO) of 'Health for all by the year 2000' may be 
unattainable in its entirety, having such an ambitious 
slogan has undoubtedly allowed considerable progress 
to be made in a shorter time-scale than it would 
otherwise have been. 
With regard to cancer, more limited goals have been 
set by various national and international bodies, most 
of these also aimed at the somewhat mystical figure of 
the year 2000. The target of the European Regional 
Office of the World Health Organization is a reduction 
of at least 15% in cancer mortality in people under 65 
in Europe. 
At the present time, cancer represents around a 
quarter of the overall mortality in most EC countries. 
But this figure, as high as it might be, only alludes to a 
small proportion of the total amount of human, social 
and financial costs linked to cancer. This explains the 
need to try to prevent at least some of these cancers 
from taking place. 
A rational approach to prevention would require 
knowledge of cause and subsequently removal of that 
cause. In reality, this is neither sufficient nor even 
necessary. As the classical historical example of the 
termination of the cholera epidemic in London in 1854 
by removal of the handle of a water pump clearly 
shows, even years before the agent responsible for 
cholera had been isolated, prevention was possible. On 
the other hand, some causal agents, even if known, 
cannot be removed from our environment. This applies 
to external factors, such as solar radiation or, even 
more importantly, internal determinants of disease 
such as the genetic background of an individual or the 
hormonal milieu. 
With this proviso in mind, prevention is often sepa-
rated into two components: primary prevention aiming 
at preventing the occurrence of cancer, mainly through 
removal of identified risk factors and secondary pre-
vention, the goal of which is to diagnose cancer at a 
very early stage or preferably to be able to recognize 
disease at a precancerous phase. This last type of 
prevention is referred to as screening. 
Primary prevention: 
attainable and desirable goals 
Primary prevention requires some knowledge of cause 
or at least strong indication of risk factors and. in fact, 
tentative removal of suspicious exposures and subse-
quent reduction in disease occurrence often helps in 
identifying causes. 
Eliminate tobacco from 
our environment 
In the domain of cancer, the best example of possible 
and necessary effective primary prevention is the 
removal of tobacco from our environment. Tobacco is 
in fact a remarkable product because of the number of 
diseases to which it can reliably be linked as a causal 
agent or, at least, as a factor which is partially 
responsible for the occurrence of disease. In this 
respect, tobacco is almost unique, perhaps only rivalled 
by alcohol, which is also responsible for many diseases. 
As early as the 17th century, those in medicine or in 
government had seen the need to combat smoking, but 
unfortunately, economic constraints prevailed, and it 
was felt more profitable to tax tobacco rather than to 
ban it. Therefore, we are faced today with a myriad of 
tobacco-related ailments and their considerable human 
and financial costs. 
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Tobacco is the best known and most widely used 
carcinogen, and its use is responsible for: 
D the vast majority of cancers of the lung, trachea and 
bronchus; 
D a considerable proportion of cancers of the bladder 
and of the renal pelvis; 
D a considerable proportion of cancers of the oral 
cavity, lip, pharynx, larynx and oesophagus, with an 
added large proportion of risk attributable to 
alcohol consumption; , 
D a considerable proportion of cancers of the pancreas 
and possibly of renal adenocarcinoma. 
The causal link between lung cancer and cigarette 
smoking was established as early as 1950, based on 
epidemiological studies of very high quality. Since that 
time, hundreds of investigations have been carried out 
in various populations and countries, and they have 
repeatedly confirmed the earlier findings. It seems 
almost inconceivable that almost 40 years later govern-
ments still accept the sale of sources of deadly smoke 
and subjects still maintain and initiate the habit of 
smoking, especially when one considers, on the one 
hand, the repeated oral assertions of concern for the 
public's health made by governments and, on the 
other, the fear of cancer in the general population. The 
very low survival rate of lung cancer and the suffering 
experienced by cancer patients should be an additional 
very valid deterrent against the maintenance and 
dissemination of the habit, but obviously, this informa-
tion is somehow removed or ignored in the individual's 
conscience. 
In addition, cancer is not the only disease associated 
with tobacco use. The increased risk of cardiovascular 
diseases has also been clearly demonstrated. Smokers 
have higher rates of coronary heart disease, including 
myocardial infarction and chronic heart disease, 
peripheral vascular diseases and cerebrovascular dis-
eases. Special note should be taken of the specific risk 
of cardiocerebrovascular diseases among women who 
smoke and use oral contraceptives. 
The present action plan also 
offers help to smokers who 
want to give up. 
Photo:© Tome&Janry/ 
Dupuis, Belgium. 
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Another group of diseases which have been associated 
with smoking are chronic obstructive lung diseases, 
such as emphysema and chronic bronchitis. Still other 
diseases could be cited: pneumonia, tuberculosis, pep-
tic ulcers. 
It would therefore seem reasonable to eliminate 
tobacco from our world, but no country has yet taken 
such a drastic decision. At least, every effort should be 
made to advance in the right direction by trying to 
make cigarettes and other tobacco products less afford-
able through taxes, by bringing into force and effec-
tively implementing restrictive legislation such as a 
complete ban on tobacco advertising, a restriction of 
sales to minors and of smoking in public places and, 
most important of all, by promoting effective health 
education for adolescents and children as well as for the 
general population. 
Alcohol: moderate consumption 
Recommendations for a healthy life style should also 
address the issue of alcohol. Whereas there is no safe 
level for cigarette smoking and no such thing as a safe 
tobacco product, arguments can be put forward for 
alcohol to be consumed in moderation. A dose of 
approximately one glass of wine per day presents no 
measurable health risk and may even slightly reduce 
cardiovascular mortality. But increased amounts of 
alcohol lead to increased risk of disease. In particular, 
alcohol is a recognized carcinogen for cancers of the 
oral cavity, pharynx, larynx, oesophagus and liver. For 
most of these cancer sites, the combined effects of 
drinking alcohol and smoking greatly increase risk. If 
one also takes into account the other diseases linked 
with excessive drinking as well as the accidents and 
violence it causes, it is clear that the public health 
message should stress in no uncertain terms the impor-
tance of moderating one's intake and preferably this 
should be done in quantitative terms. 
Eat fresh fruit and vegetables several 
times a day 
This method of presenting quantitative information is 
even more relevant for diet. Once again, the public 
message needs to be clear, simple, yet to the point and 
easy to implement. One cannot and should not give 
advice which is only concerned with cancer prevention. 
But in order to avoid obesity and its ensuing diseases 
and, more specifically, to reduce cardiovascular risk, a 
diet rich in fresh fruit, vegetables and cereals and poor 
in fat, particularly of animal origin, is to be recom-
mended. To put it simply, everyone should eat fruit 
and vegetables several times a day. The problem of 
tolerable fat intake is more complex given the numer-
ous sources of such compounds and their various types 
which carry differing risks or benefits. In general, a 
person's total caloric intake should be such that no 
excess weight should occur. This caloric intake should 
of course be adjusted according to one's requirements, 
which in turn are linked to the usual level of physical 
exercise. Total intake of fat should be reduced, and 
preference should be given to vegetable fat. Finally, it 
is advisable to vary the types of foods consumed. 
The importance of personal lifestyle 
Personal habits and ways of life account for a large 
proportion of all cancers. In contrast, only a limited 
number of cancers may reliably be linked to specific 
carcinogens present in the general environment. The 
effects of air pollution or background radiation on 
health are extremely difficult to quantify precisely. The 
same can also be said of potential risks linked to the 
presence of contaminants, such as pesticide residue in 
food. 
Prevent the development of 
occupational cancers 
Of special note is the issue of occupational exposures to 
known or suspected carcinogens. Although the number 
of subjects exposed is low and. therefore, the impact of 
removing these carcinogens from the work environ-
ment is small in terms of population cancer incidence, 
these compounds represent a substantial threat to the 
workers involved, and every effort should be made to 
reduce exposure and, if possible, to replace these 
products by other less dangerous substances. The work 
force needs to be adequately informed of possible risks 
and an efficient control should be maintained to 
prevent the emission of hazardous chemicals in the 
production chain. 
Avoid excessive exposure to the sun 
One other factor, the exposure to which can be 
controlled by the individual, is solar irradiation. Sun-
light is necessary for life, but excessive exposure to it, 
in particular for some fair-skinned individuals, may 
lead to malignant melanoma of the skin. Avoiding 
sunburn, especially during childhood, is relatively easy. 
An important point is to convince women (and men!) 
that havinu fair skin is as attractive as having a dark 
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suntan. Although UV machines are controlled (but 
certainly not in all instances) for the type of UV rays 
emitted, it is difficult to justify their use apart from 
wanting to appear fashionable. 
In the future, it may be possible to control some other 
risk factors for cancer. Already today, immunization 
against hepatitis Β is being carried out and it is 
expected not only to prevent the occurrence of viral 
hepatitis, but also to reduce the risk of primary liver 
cancer. In Europe, the majority of cancers most 
commonly encountered, with the exception of cervical 
cancer, are not known to be linked to viruses or 
parasites. Control of genetic factors is not yet possible, 
although some screening could be foreseen in the near 
future to identify individuals at particularly high risk 
who could benefit from a specific surveillance. 
For two cancer sites, cancer of the cervix and breast 
cancer, there is agreement on the efficacy of screening. 
The carrying out of cervical smears at regular intervals, 
starting at a young age, has been consistently linked 
with a decrease in mortality from cervical cancer as well 
as with some reduction in incidence through treatment 
of precancerous lesions and carcinoma in situ. Screen­
ing for breast cancer by mammography has also been 
shown to reduce mortality by 20 to 40%, at least among 
women over 50 years of age. 
The case for colon cancer, although less clear, certainly 
warrants considerable attention, whereas some screen­
ing programmes, lung cancer for example, cannot be 
justified as the savings (if any) in major expense are 
minimal. 
Secondary prevention: 
screening for cancer can have 
a positive impact 
Knowledge of the aetiology of most common cancers is 
still quite limited. Fortunately, even though the causes 
of cancer are not fully understood, an impact on cancer 
occurrence and/or mortality through early detection is 
possible. 
Most identified carcinogens 
are man-made substances 
Of the 59 agents classified as carcinogenic to humans 
(for which there is sufficient evidence of carcinogeni­
city, according to the definitions of the International 
Agency for Research on Cancer - IARC), the large 
majority are man-made industrial chemicals, industrial 
exposure and medical drugs. Therefore, among the 
recognized human carcinogenic agents, only a few (or 
Information is an essential 
element of cancer prevention. 
Photo: CEC 
SOCIAL EUROPE 1/91 13 
Chapter 1 
at least exposure to them) go back more than a century 
and a half: ionizing and non-ionizing radiation, anatox-
ins, certain combustion products and possibly certain 
viruses for instance. As far as we know, the situation 
would therefore indicate that the industrial exploitation 
of natural resources, of which asbestos and tobacco are 
two different and conspicuous examples, and the 
synthesis of new chemicals have indeed generated new 
hazards and new carcinogens which have been added to 
the older ones. Since cancer is a much older disease 
than the industrial revolution, we must assume that 
there are causes we have not yet identified which are 
responsible for a rather consistent fraction of the total 
cancer cases. 
An important challenge 
for the 21st century 
At the dawn of the 21st century, we are facing a 
considerable challenge. Our knowledge of cancer cau-
sation is still limited, particularly with regard to some 
of the most common cancers (such as breast, ovary, 
colon, prostate and gastric cancer), and it would 
therefore appear logical to concentrate our efforts on 
trying to discover their aetiology. In a logical world, 
this information could then be used in prevention by 
the removal from our environment of avoidable causes 
of disease. 
Unfortunately, knowledge is not enough and even 
when some causes of cancer, particularly tobacco use, 
have been identified beyond any doubt, experience 
shows that it may take as long as 20 or 30 years before 
sufficient energy is devoted to the fight against smo-
king. 
A smoke-free generation by the year 2000 should be 
our most important goal. Children born today should 
be the object of all our concerted efforts to provide a 
smoke-free environment by not being exposed to 
passive smoking and by not becoming smokers them-
selves. It is also important to protect the developing 
world from becoming the next victims of the tobacco 
industry. Faced with a diminishing market in the 
Western world, marketing strategies are now being 
implemented in the Third World, leading to a 1 to 2% 
increase in annual tobacco sales in developing coun-
tries. 
In order to succeed, we need to take action in a number 
of fields: education, information, health, taxation, 
economics, agriculture, politics and legislation. The 
issues of education and information are of paramount 
importance. We need to find the best ways of commu-
nicating health information effectively, in order not 
only to increase awareness of the problem, but also to 
motivate subjects to modify their behaviour. If adverti-
sing succeeds in changing consumers' choices, why has 
public health information failed to make an impact on 
people's habits? Part of the answer may be financial 
constraints, but it may also be that we lack creative 
imagination and that the exhortation to lead a healthier 
life must contain not only a physical but also a moral 
component. 
Dr Annie J. Sasco 
Dr Lorenzo Tomatis, Director 
International Agency for 
Research on Cancer (IARC) 
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The role of cancer registration 
The incidence of cancer varies between different parts of Europe, suggesting that 
factors associated with place of residence are important determinants of cancer risk. 
That is the reason why epidemiology, the scientific study of the distribution and 
determinants of a disease, is and will be playing a central role in the 'Europe against 
cancer' programme. Cancer registration as the presupposition of cancer epidemiology 
is the organized effort to collect, verify and tabulate, employ and disseminate 
information on the incidence of malignant neoplasms (in a defined geographical area). 
So, cancer registries are epidemiological institutions which deal with cancer registration 
and will nearly always conduct research in analytical and descriptive epidemiology. 
Cancer registration is an essential component of any rational programme of cancer 
control. It has proved estimating the size of the public health problem posed by cancer, 
examining the causes of cancer, evaluating survival of cancer patients and the benefits 
of cancer treatment, and planning of cancer treatment services. The ultimate goal of 
any cancer control programme is the reduction of cancer incidence. This comprises 
primary prevention aspects, and the monitoring of trends in cancer incidence thus 
becomes an integral part of a cancer control programme. To assess and control the 
impact of malignant disease on the community with the emphasis on epidemiology and 
public health, population-based cancer registries are needed. This type of cancer 
registry records all new cases in a defined population. 
Cancer registration reveals 
the scale of the problem 
The enumeration of cancer cases in a defined popula-
tion serves to assess the dimension of the cancer 
problem in terms of the number of new cases and the 
comutation of incidence rates, i.e. the number of new 
cases per 100 000 population per year. The incidence of 
cancer varies with age, and differences between the 
sexes are often apparent (e.g. a 3 to 4 times higher 
incidence of lung cancer in men). There are wide 
variations in incidence between populations both 
among and within countries (e.g. differences between 
regions, occupational groups, socio-economic classes, 
and religious groups). Increasing trends are seen for 
several sites (e.g. lung cancer, skin melanoma), while 
others are decreasing in many countries (e.g. stomach 
cancer, cancer of the uterine cervix). Such differences 
in incidence between populations have led to the 
recognition that the risk of cancer development is 
determined by exogenous factors related to lifestyle 
(smoking, alcohol consumption, diet, exposure to UV 
radiation), to the occupational environment, and to the 
general environment. Thus, cancer would be to a large 
extent avoidable. 
Another important role of the cancer registry lies in the 
possibility to link cancer registry records with other 
data files. The cancer registry has thus served as an 
end-point in numerous cohort studies to evaluate risks 
associated with occupational exposure, drug taking, 
smoking, diet, etc. Similarly, the cancer registry 
facilitates the conducting of intervention trials such as 
the study of the possibly cancer-preventive action of 
beta-carotene and tocopherol supplementation in 
heavy smokers. Cancer registries may also serve as a 
source of cancer cases for investigations — case-control 
studies for instance — where exposures are compared 
among patients with cancer and persons without cancer 
in order to identify characteristics of individuals who 
have developed a malignant disease. 
The cancer registry's data may be used for the planning 
and establishment of cancer treatment and care 
facilities directed towards various types of cancer. 
Geographic differences as well as time trends, includ-
ing the projection of future incidence roles, may be 
useful for such purposes. 
When the cancer registry follows up individual patients 
for their remaining life-time, and collects information 
on the date and cause of death, it may contribute to the 
evaluation of patient care and health-care planning, by 
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According to epidemiological data, one in four Europeans is 
currently affected by cancer and, if the present trend 
continues, the figure will increase to one European in three by 
the year 2000. 
Photo: CEC. 
monitoring population-based survival rates. This sup-
plements the more detailed information that is often 
available from specialized hospitals. If true differences 
are found, diagnostic and treatment facilities may be 
directed to parts of the population with less favourable 
survival expectancy. 
Finally, registries have played a crucial role in demon-
strating the effect which cancer screening programmes 
have had in lowering cancer incidence, by comparing 
incidence trends between areas where such screening 
has been practised with different intensity, e.g. Finland 
versus Norway and different Scandinavian countries. 
Examination of asymptomatic persons to detect cancer 
at an early stage is becoming increasingly important in 
the control of certain malignant diseases. 
Cancer registration within 
the European Community 
began in 1929 
Continuous registration of cancer morbidity in Europe 
started in 1929 when the first population-based cancer 
registry was set up in Hamburg, Germany. Its main 
goal was to collect information on cancer patients in 
order to facilitate follow-up. The next two registries 
were opened in the United States in Connecticut in 
1936, and in the State of New York (excluding New 
York City) in 1940. The first registry to cover a whole 
nation was the Danish Cancer Registry set up in 1942. 
Cancer deaths in Europe (1986) 
Country 
Belgium 
Denmark 
FR of Germany 
Greece 
Spain1 
France 
Ireland 
Italy2 
Luxembourg 
Netherlands 
Portugal 
United Kingdom 
European Community 
Total 
deaths 
112 791 
57 777 
701 832 
91 783 
299 409 
546 926 
33 704 
547 436 
4 014 
125 307 
95 828 
660 735 
3 277 542 
Cancer deaths 
Total 
27 220 
14 946 
163 038 
18 365 
65 810 
133 008 
6 886 
133 770 
938 
33 966 
16 241 
156 858 
771 046 
Lung 
(men) 
5 780 
2 220 
21 310 
3 682 
9 771 
17 393 
1 118 
23 597 
190 
7 536 
1 600 
28 627 
122 824 
Breast 
(women) 
2 400 
1290 
14 165 
1 193 
4 231 
9 530 
571 
9 953 
77 
3 040 
1231 
15 245 
62 926 
Based on WHO figures. 
' 1984. 
2 1985. 
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Today, population-based cancer registries covering all 
or part of the national populations exist in all countries 
of the European Community except Greece and Lux-
embourg. A recent survey showed that there are 62 
cancer registries in the European Community which 
attempt to record neoplasms in general in their respec-
tive territories. An additional 20 registries collect data 
sets restricted either to children, or to a single site, or 
to a group of cancer. The only country in the Commun-
ity where cancer is a reportable disease is Denmark. In 
all other European countries, cancer registration is 
based on voluntary agreement. 
Not all cancer registries function at the optimal level, 
and only 27 registries (12 from the United Kingdom) 
from the Community have reported their data in the 
monograph Cancer incidence in five continents pub-
lished by the International Agency for Research on 
Cancer (IARC) in Lyons, France. The IARC, founded 
in 1968, assembles the results of all important cancer 
registries from all continents. In Europe, at least two 
regional or language group associations exist: The 
Nordic Association of Cancer Registries, and the 
Group for the Epidemiology and Registration of 
Cancer in Latin-Language Countries. 
In all European countries, apart from the problems of 
completeness and validity, the issues of confidentiality 
and professional secrecy have proven the major issue in 
the registration of cancer. In some countries of the 
European Community, this is the most important 
hindrance to making full use of the information con-
tained in population-based cancer registries. 
There is no doubt that cancer registries support the 
principle that all data concerning individuals with 
cancer should be strictly confidential. On the other 
hand, full respect for the confidentiality of such data 
need not prevent the safe, efficient and useful opera-
tion of cancer registries, as experience over many years 
has amply demonstrated in all parts of the world. No 
breach of confidentiality has ever been reported from 
any cancer registry. Cancer registries thus have clear 
definitions of which information must be handled as 
confidential, what measures must be taken for the 
security of data within the registry and for the protec-
tion of the reporting physician, how the surveillance 
and periodic review of data security procedures is 
effected and what is required of a written application 
for data release and the necessary mechanisms for the 
protection of any such release. 
Most cancer registries operate a code of confidentiality 
for individual cancer data and have developed approp-
riate mechanisms for ensuring adherence to it. In this 
way, data on individuals whose cancer is reported to 
the registry do not reach unauthorized third parties. 
Proportion of European cancer deaths attributable to various factors 
These attempted estimates are largely based on the work of Higginson and Muir (1979) for Birmingham in 
the United Kingdom, of Doll and Peto (1981) for the United States and of Tubiana (1985) for France. They 
incorporate many uncertain factors and should, in any case, be adapted to differing national situations. 
Factors 
Tobacco 
Alcohol 
Diet 
Occupation 
Infection 
Geophysics2 
Best 
estimate 
(in %) 
30 
41 
30? 
4 
3? 
3 
Range of 
estimates 
(in%) 
25-35 
2-5 
10-50 
2-8 
1-10 
2-4 
Estimated 
annual number 
of deaths 
220 000 
30 000 
220 000? 
30 000 
22 000? 
22 000 
' Could be higher, certainly extremely variable by country (e.g. 10 % in France). 
3 Radioactivity and solar rays. 
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Chapter 1 
Developing cancer registration 
in the Member States 
The 'Europe against cancer' programme provides a 
basis for the strengthening of cancer registration in 
Europe through improvements in ongoing registration 
schemes, improvement in the comparability of data, 
and support for the establishment of cancer registration 
systems in countries or regions where none exist. 
Following careful consideration of the current state of 
cancer registration in the EC during the first half of 
1989, the 'Europe against cancer' programme sup-
ported a proposal to strengthen cancer registration in 
the Community Member States through the establish-
ment of a network of European cancer registries. The 
programme will be jointly managed by the Danish 
Cancer Registry and the IARC. The overall objective is 
to improve comparability of cancer registry data and 
extend cancer registration within the European Com-
munity with the aim of creating a solid basis for the 
continuous monitoring of the burden of cancer in the 
Community, and of enhancing the use of cancer 
incidence information for research and planning. 
Dr Ole Møller Jensen and Prof. E. Grundmann 
Members of the Committee 
of Cancer Experts of the 
'Europe against cancer' programme 
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Maps of mortality for certain cancers 
Produced by the IARC for the 'Europe against cancer' programme 
Deaths from lung cancer in men 
Deaths from cancer of the oesophagus in men 
Deaths from stomach cancer in women 
Deaths from malignant melanomas in men 
Deaths from breast cancer in women 
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Deaths from lung cancer 
In men 
Number of deaths 
per 100 000 
population 
(age-standardized, 1970s) 
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The regions hardest hit today 
(Great Britain, Benelux, Germany, 
Northern Italy) are those in which 
tobacco consumption was particu-
larly high fifteen or twenty years 
ago: this is the delay usually, 
observed between exposure to 
tobacco smoke and the appearance 
of lung cancer. 
Conclusion: 
do not smoke. 
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Deaths from cancer of the 
oesophagus In men 
Number of deaths 
per 100 000 
population 
(age-standardized, 1970s) 
High alcohol consumption, 
aggravated by smoking, explains the 
record of mortality in western France. 
Conclusion: 
moderate your consumption 
of alcoholic drinks. 
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Deaths from stomach cancer 
In women 
Number of deaths 
per 100 000 
population 
(age-standardized, 1970s) 
>20 
1 7 - 20 
14-17 
11 -14 
8 - 1 1 
5 - 8 
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Mortality is particularly high in Cen-
tral-Northern Italy and Portugal. A 
diet too low in fresh fruit and veg-
etables is probably a risk factor. 
Conclusion: 
eat fresh fruit and vegetables often. 
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Deaths from malignant 
melanomas in men 
Number of deaths 
per 100 000 
population 
(age-standardized, 1970s) 
Skin cancers claim most victims in 
the countries of Northern Europe 
(Denmark, Germany, England). 
Among fair-skinned people, a major 
risk factor is intermittent but 
excessive exposure to the sun. 
Conclusion: 
avoid excessive 
exposure to the sun. 
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Deaths from breast cancer 
in women 
Number of deaths 
per 100 000 
population 
(age-standardized, 1970s) 
>30 
2 6 - 3 0 
2 2 - 2 6 
1 8 - 2 2 
1 4 - 1 8 
1 0 - 1 4 
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Mortality is particularly high in 
Northern Europe (Denmark, United 
Kingdom, Ireland, Netherlands). 
Among the reasons given are 
excessive weight and a diet too rich 
in animal fats. However, these 
hypotheses need to be confirmed. 
Conclusion: 
avoid being overweight. 
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CHAPTER 2 
The European Community's response 
These three articles present in a nutshell the essential features of the 
'Europe against cancer' programme. Professor Tubiana explains 
how the predominantly scientific and medically oriented group of 
cancer experts came to identify the key features of the programme 
(information, education, training, tobacco control, screening and 
research) as priorities, and produced the European Code against 
cancer. This is discussed more fully in the second article. Finally, 
progress and achievements are evaluated and the future directions 
of the 'Europe against cancer' programme identified. 
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The advantages of a European programme 
from a cancer expert's point of view 
When the principle of a European action against cancer was decided in Milan in June 
1985 at the meeting of the Heads of State or Government of the 12 countries of the 
Community, European cancer experts asked themselves at first what useful effect such 
an action could have, in addition to the national programmes and the major 
international operations such as those sponsored by the World Health Organization 
(WHO) and the International Union Against Cancer (UICC). Nevertheless, it quickly 
became apparent that a European action could have three specific advantages, namely: 
D to exploit the prestige of a 'European' label to increase the effectiveness of actions 
which could only be undertaken at a national level; 
D to take advantage of the experience and help of experts from all the Community 
countries. The European dimension considerably increased the ability of each 
country not only in research but also in applying new methods of diagnosis and 
treatment; 
D to promote legislative or regulatory measures at a time when more and more 
decisions were being taken at European level for subsequent implementation at 
national level. 
A few examples quickly illustrate the benefit that Europeans have received from these three aspects 
of the action against cancer. 
The European Code against cancer and its 10 com-
mandments have been promoted in all the European 
media and distributed widely by all the organizations 
against cancer in the Twelve. This result was only 
possible because the cancer experts of the European 
Community were able to agree on a text which, for this 
reason, has had a major impact on public opinion. 
Moreover, a whole series of actions around the Code 
have taken place which could not have been 
implemented without experience gained in one or 
another of the Member States. One of the most 
promising is health education in schools: informing 
children from the age of 5-7 through to the end of their 
adolescence of the strengths and weaknesses of the 
human body and what they need to do to maintain a 
healthy development. 
There is no doubt that all these elements are the best 
way to bring home to everyone what is necessary to 
achieve and maintain good health and thus to take 
responsibility for establishing a healthy lifestyle 
through the years to come. This could have happened 
independently in each country but the mutual support 
and cooperation between European countries has 
played a decisive part in this undertaking; thanks to 
these contacts those countries less experienced in this 
field have been able to take advantage of the others. 
This positive result of European cooperation has been 
even more apparent in the case of screening for 
cancers. An important decision of the Council of 
Health Ministers was to organize mass screening cam-
paigns for breast and cervical cancer, at the request of 
the Committee of Cancer Experts. Its implementation 
was only possible, however, because certain countries 
which had launched pilot exercises had an experience 
in the field which enabled the difficulties and rewards 
of these projects to be assessed. This experience 
allowed the other countries to move forward to mass 
screening more rapidly. 
Alongside information to the general public, training of 
health professionals, especially generai practitioners, 
has been an important aim of the programme, much 
appreciated by European doctors. 
In the field of research, Community cooperation is still 
more fruitful in broadening the national dimension and 
providing young doctors and scientists with the possi-
bility of training in other European centres. More and 
more, the cooperation between cancer specialists and 
hospitals in every country is improving the effective-
ness of clinical research and speeding up the evaluation 
of new methods of treatment. Large programmes can 
be developed which would be too costly for a single 
country. 
Even the differences between countries have enriched 
the programme. Research on the role of dietary factors 
in the development of cancer has benefited from the 
differences between northern European and Mediter-
ranean countries; we can thus hope to understand why 
certain cancers are much more frequent in some 
countries than in others. 
Significant progress has been made in the campaigns 
aeainst tobacco and alcohol abuse, which are the causes 
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The European Community's response 
In January 1986, the European Commission created a committee, bringing together the leading cancer experts, which was 
charged with the development of an action plan against cancer. 
Photo: CEC. 
of many cancers. On the legal front, Europe plays a 
crucial role. Important decisions restricting tobacco 
have already been taken: harmonization of labelling on 
cigarette packets; the banning of high-tar cigarettes; 
the banning of tobacco advertising on television; and 
the banning of smoking in public places. Unquestion-
ably, such measures could not have been taken so 
quickly without the European impetus. 
These examples show the advantages of a European 
action against cancer — still the second highest cause of 
death and the principal cause of death in the 35 to 65 
age group. Moreover, the more successful the actions 
against other diseases the more the death toll from 
cancer mounts. The primary goal of the European 
action is to reduce the number of deaths from cancer by 
at least 15% at the beginning of the 21st century, 
compared with the situation which would have been the 
case without the action. This highly ambitious objective 
requires willing and energetic support at all levels. 
The campaign against tobacco, screening of certain 
cancers, better training for health professionals, better 
public information, coordination of therapeutic 
research in European hospitals and checks on the 
quality of treatment are all major elements of such a 
strategy. Success will need the perseverance of all the 
partners and increased awareness of all Europeans. 
Without a European action against cancer this could 
not possibly be achieved. 
Prof. Maurice Tubiana 
Chairman of the Committee of Cancer Experts 
of the 'Europe against cancer' programme 
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The European Code 
A basic tool 
Cancer is not a death sentence. Many cancers can be avoided, more can be cured if 
detected early. Outcome does not depend solely on the doctor, but also, and especially, 
on the patient. These are the essential messages of the European Code against cancer. 
The first objective of the cancer experts, when they met at the invitation of the Heads of 
State or Government of the European Community, was to prepare a short document 
explaining how each of us can, on the one hand, reduce the risk of being affected by a 
cancer in our lives, and on the other, increase the chance of being cured if we do 
develop one. 
A document of this type, to be useful, should be based on a complete awareness of the 
causes and development of cancers: exhaustive preparation was therefore necessary, 
involving epidemiologists, statisticians and clinicians. 
The document starts with prevention. Taking all cancers concerning men and women of all ages 
together, one third are due to tobacco. Given that a 
third of adults smoke, this indicates that the risk of 
cancer is much greater among smokers than among 
non-smokers. For example, cancers of the lung and the 
larynx are, respectively, 20 and 10 times more frequent 
among smokers than among non-smokers. The first 
recommendation, and the most important therefore, 
deals with tobacco: do not smoke and do not smoke in 
the presence of others because tobacco is poisonous for 
them, especially for children. 
Alcohol, while a less potent carcinogen, is also impli-
cated in a significant number of cancers, especially 
those of the mouth, throat and oesophagus. None the 
less, in contrast to tobacco, where even one cigarette 
per day is already damaging to health, there is no 
evidence for a toxic effect on men of a consumption of 
alcohol equivalent to a third of a litre of wine per day. 
The recommendation is therefore: moderate your con-
sumption of alcohol. 
Prolonged sunbathing, especially by fair and red-
headed people whose skin is more fragile, can provoke 
skin cancers, of which certain types, melanomas, are 
very serious. Excessive exposure to sun should there-
fore be avoided by fair-skinned people, light clothes 
worn as protection and sun protection creams used. 
These recommendations are especially important for 
children who should not be allowed to play in direct 
sunshine for long periods without precautions. 
Finally, it is difficult to avoid the presence of carcino-
gens, especially chemical products, in our environ-
ment. For example, the combustion of coal, oil and 
wood releases powerful carcinogens; it is out of the 
question to ban their use. But risks can be substantially 
reduced if industries and workers follow the safety 
procedures which have been developed to achieve the 
maximum security. 
If the first four commandments show how we can 
protect ourselves against the carcinogens present in our 
environment, the fifth and sixth show how we can 
increase the resources of our own organism and so 
reduce our risk. A number of studies undertaken in 
Japan, America and Europe have established the role 
of diet in the prevalence of cancers. 
Certain foods have a beneficial effect. In particular, 
people who eat fresh (including deep-frozen) fruit and 
vegetables at every meal are less affected by cancer 
than those of the same age and sex with different diets. 
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Similarly, but with less certainty, a number of studies 
show a protective effect from fibre-rich foods such as 
cereals. The positive effect of fruit and vegetables can 
easily be accounted for by the number of vitamins, 
especially A, C and E, they contain. As they probably 
include other useful elements, they should not be 
replaced by vitamin pills. The favourable effect of 
fibres is probably due to the fact that they accelerate 
the passage of food through the intestinal system. 
There is a correlation between a diet rich in fat, 
especially of animal origin (from meat, whole milk, 
creamy cheeses), and an increased risk of colo-rectal 
cancers, cancers of the breast and prostate. The exact 
mechanisms are still under research and the object of 
many discussions. Since, in addition, a reduction in 
animal fat reduces the risk of cardiovascular diseases it 
seemed legitimate to recommend it. As the standard of 
living in the Western world has risen and the consump-
tion of meat and dairy products has increased at the 
expense of cereals, fat has come to supply 45 % or 
more of the calorific intake. This proportion should be 
diminished, if possible back to 30 % ; this would require 
a marked change in our habits, for example increasing 
our consumption of cereals, fish, and low-fat milk 
products. 
Finally, statistics demonstrate that certain cancers, 
such as of the breast, uterus and prostate, are more 
frequent among people whose weight is higher than 
average. The campaign against obesity is therefore part 
of the campaign against cancer. 
A cancer diagnosed and treated at its outset will be 
managed and cured more easily. Experience shows that 
an informed public will consult medical help earlier and 
thus improve the therapeutic outcome. This is true for 
all cancers, but especially for cancers of the skin, 
digestive tract, uro-genitary organs, and the respiratory 
tract. In all these cases swelling or bleeding are warning 
signs which should not be neglected and which should 
lead to a medical consultation. 
Finally, simple tests exist for two frequent cancers, 
those of the cervix and breast. Screening can detect 
precancerous or cancerous lesions at a stage where they 
can be easily cured. Every three years, all women 
between 25 and 70 should undergo a cervical smear and 
those between 50 and 70 a mammography. These two 
completely painless tests, if carried out under correct 
conditions on all eligible women, could save the lives of 
30 000 women in Europe every year. 
All of us need to work together to spread these 
commandments, to follow them and to encourage 
others to do so. Through these means we could save 
more than 100 000 Europeans from dying of cancer 
each year. 
Prof. Maurice Tubiana 
Chairman of the Committee of Cancer Experts 
of the 'Europe against cancer' programme 
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European Code against cancer 
ι f the 'Ten European Commandments' are followed, there will be a significant reduction in the number of deaths from cancer in the European Community, already predicted to reach 15% by the year 2000. 
Committee of Cancer Experts of the European Community 
CERTAIN 
CANCERS MAY 
BE AVOIDED: 
1 
2 
3 
Do not smoke. Smokers, stop as quickly as possible and do not 
smoke in the presence of others. 
Moderate your consumption of alcoholic drinks, beers, wines or 
spirits. 
Avoid excessive exposure to the sun. 
Follow health and safety instructions at work concerning pro­
duction, handling or use of any substance which may cause 
cancer. 
YOUR GENERAL HEALTH WILL BENEFIT FROM THE FOLLOWING 
COMMANDMENTS WHICH MAY ALSO REDUCE THE RISKS OF SOME CANCERS 
MORE 
CANCERS WILL 
BE CURED IF 
DETECTED: 
5 
6 
7 
Frequently eat fresh fruit and vegetables, and cereals with a high 
fibre content. 
Avoid becoming overweight and limit your intake of fatty foods. 
See a doctor if you notice a lump, or observe a change in a mole, 
or abnormal bleeding. 
8 See a doctor if you have persistent problems, such as a persistent cough, a persistent hoarseness, a change in bowel habits or an unexplained weight loss. 
9 
10 
FOR WOMEN 
Have a cervical smear regularly. 
Check your breasts regularly, and, if possible, undergo mam­
mography at regular intervals above the age of 50. 
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Europe against cancer 
Achievements and prospects 
The 'Europe against cancer' programme has now been running for four years. The first 
three constituted the first plan of action 1987-89. The fourth marked the launch of the 
second plan of action which will run to 1994. It is instructive to draw on the experience 
gained so as to place the prospects for the next four years in perspective. 
1987-89: 
Highly satisfactory progress 
Between 1987 and 1989 significant progress was 
recorded in each of the programme's areas, namely 
cancer prevention, health information and education, 
training of health personnel and cancer research. 
governmental organizations (anti-cancer and anti-
tobacco associations, general practitioners, cancer 
experts, producers of medical TV programmes) as well 
as the Ministries of Health and Education, and was 
designed to make the general public and schoolchildren 
more aware of the European Code against cancer. The 
Year culminated on 9 January 1990 with the first ever 
Eurovision broadcast on a serious scientific subject. 
Remarkable results in the campaign 
against tobacco 
In the area of prevention remarkable results were 
obtained, particularly in the campaign against smoking, 
which is responsible for almost a third of cancer deaths. 
A number of proposals for Community legislation were 
drafted by the Commission and discussed by the 
European Parliament and the Council of Ministers of 
the European Community. Some proposals were 
adopted during this first plan of action, namely a 
resolution on banning smoking in places open to the 
public (adopted on 16 May 1989), and a Directive on 
harmonization of the labelling of tobacco products 
(adopted on 13 November 1989). This Directive obliges 
Member States to modify their legislation on the 
labelling of tobacco products by 1 January 1992, so as 
to inform smokers more clearly of the indisputable 
risks which smoking entails, by printing unambiguous 
medical warnings such as 'Smoking causes cancer' or 
'Smoking causes heart disease' in large legible letters 
on one of the two largest surfaces of every cigarette 
packet. A second Directive which imposes limits on the 
maximum tar levels in cigarettes (15 mg by the end of 
1992, 12 mg by the end of 1997) was adopted by the 
Council of Ministers on 17 May 1990. 
1989: The European Year 
of Information on Cancer 
In the field of information and health education, the 
main achievement during the first action plan 1987-89 
was of course the 'European Year of Information on 
Cancer' in 1989. This involved the participation of non-
Training in the best centres of Europe 
With regard to the training of health personnel, the 
representatives of all the parties concerned agreed on a 
series of recommendations concerning cancer training 
for doctors, dentists and nurses. In addition, around 
100 doctors and nurses were given the opportunity to 
receive further training in cancer screening and treat-
ment at the best centres in Europe. 
Research: a broader 
European dimension 
Finally, cancer research took on a broader European 
dimension with the promotion of exchanges between 
research workers (50 grants awarded each year) and 
the coordination of clinical and basic research. 
Research was also initiated into promising new 
radiotherapy techniques involving neutron capture or 
light ions. 
1990-94: The second plan 
of action: continuation and 
extension of the programme 
Building on the satisfactory results achieved so far, the 
European Community will extend its campaign over 
the next five years, on the basis of the decision adopted 
at the Council of Health Ministers of 17 May 1990. ' 
This decision covers the following fields. 
OJ L 137. 30.5.1990. p. 31. 
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Improved knowledge of the links 
between diet and cancer 
The Community will pursue with undiminished vigour 
its legislative activities in the fight against si jking. 
Thus certain Directives will seek to reinforce the 
existing controls. Particular importance will b«. given to 
studies and pilot actions concerning the links between 
nutrition and cancer, given that diet could be respons-
ible for a third of cancer deaths. Prospective studies 
will allow large population samples across the Com-
munity to be monitored for many years. The diversity 
of diets in the Member States should enable clearer 
links to be established between certain foods and 
cancer of the breast or digestive system. 
Progress on screening 
The 'Europe against cancer' programme will also assist 
common progress in the field of screening with the 
establishment of pilot networks for breast and cervical 
screening. The European Week of 1991 will be focused 
on screening and early detection, particularly of the 
'female' cancers. In addition, completion of the evalua-
tion studies of colo-rectal screening by 1994 will allow 
conclusions to be drawn by national and regional health 
authorities on this topic. 
Accent on health education in schools 
The 'Europe against cancer' programme will continue 
to promote public awareness of the 10 European 
commandments for cancer prevention. In particular it 
will build on the experience of the European Year of 
Information on Cancer 1989 and on the support offered 
by the associations and leagues. The second action plan 
will place special emphasis on health education in 
schools based on the conclusions of the studies and the 
European conferences conducted so far. In this context 
the European Conference held in Dublin in February 
1990 allowed the creation of a strategy which should be 
progressively applied across the Member States. 
The success of the 'Europe 
against cancer' programme, 
since its launch in 1986, is 
due both to national actions 
and the cooperation between 
the various partners at 
European level. 
Photo: CEC. 
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Pilot schemes for training 
Special efforts will be made to encourage implementa-
tion of the recommendations produced during the first 
action plan, and at the beginning of the second, 
especially in the so-called 'consensus conferences' for 
general practitioners, nurses and dentists. 
Also, on the basis of the experience acquired from 1988 
to 1990, financial support will be forthcoming for 
further training initiatives for doctors and nurses. 
Finally, the first results of the joint medical research 
actions undertaken since 1987 should find practical 
applications in the course of the next five years notably 
in the form of pilot installations for treating patients by 
improved radiotherapy. 
The objective: to reduce mortality 
by the year 2000 
We should first note the conditions which have facili-
tated this significant success in the campaign against 
cancer. The importance of a motivating objective — to 
reduce mortality from cancer by 15% by the year 2000 
(i.e. to reduce the number of deaths from the expected 
1 million to 850 000) — is fundamental. Secondly, the 
European Commission has adopted a partnership 
strategy to ensure the inclusion of all the national 
bodies involved in the campaign against cancer. These 
have been brought together at European level and 
form: 
D the Committee of Cancer Experts (the safeguard of 
the scientific content of the programme); 
D the senior officials concerned in the Ministries of 
Health, Education and Research, without whom the 
programme could not be effective; 
D the organizations against cancer and the anti-
tobacco organizations of the European Community, 
the 'advance battalions' of the programme; 
D the representatives of the general practitioners who 
play a central role in the early detection and 
systematic screening of cancer; 
D the producers of medical TV programmes, thanks to 
whom the messages about cancer prevention have 
been widely broadcast. 
While it is too early to detect a possible modifying of 
the rising trend of mortality from cancer it is apparent 
that the partners of the programme are now convinced 
of the value of a common effort at European level 
(which was far from being the case at the beginning of 
the programme). Their wholehearted support is a fact 
which has allowed the European Community to make 
significant advances in a field of wide concern to so 
many citizens. 
Michel Richonnier 
Head of 'Programme of action against cancer' Unit 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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CHAPTER 3 
Attacking the causes 
The Commission of the European Communities has undertaken 
many actions which have as their principal or secondary effect the 
protection of citizens of the Community from cancer. Some of these 
are presented in this section, beginning with the question of tobacco 
use. 
Tobacco is linked to a third of all deaths from cancer. This stark 
fact obliges any serious cancer prevention programme to make 
every effort to reduce smoking prevalence and consumption, and 
the Committee of Cancer Experts has placed the campaign against 
tobacco at the head of its priorities and of the Code. The report by 
Jacques-René Rabier on smoking in the European Community 
shows that prevalence is beginning to decline. The article by 
Stylianos Christopoulos shows the range of actions undertaken 
under the 'Europe against cancer' banner, both by the decision-
making bodies of the Community and by the partners in the 
Member States. 
Three other types of action against the causes of cancer are 
discussed here: the improvement of nutrition practices, which 
requires collaboration between many services of the Commission as 
well as across the Community; the protection of workers from 
industrial carcinogens and the laborious but vital work of classi-
fying chemical substances according to their toxicity, including 
carcinogenicity. 
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The campaign against tobacco in Europe 
The first priority of the programme 
Every year, some 450 000 people are killed by tobacco — 230 000 of them by cancer — 
in the European Community.1 That is why the campaign against tobacco was one of 
the first priorities of the Europe against cancer programme. This involves not just 
legislative measures but a large-scale campaign of public awareness and also specific 
measures towards strategic groups such as general practitioners and teachers. 
All these actions were preceded and will be followed by sample surveys of the target 
groups.' Some of the principal results are presented below. 
One in three Europeans 
admits to smoking 
A little over a third (36%) of Europeans aged 15 and 
over call themselves smokers.3 Three countries have 
more than 40%: Denmark (45%), Greece (43%) and 
the Netherlands (42%). The country with the lowest 
prevalence is Portugal with 'only' (28%) smokers. 
It might at first sight seem surprising that Denmark, 
with the highest-priced cigarettes in the Community, 
should have the highest smoking rate. There is no real 
contradiction, however, because when the price of a 
packet of cigarettes is compared with some indicator of 
the standard of living, such as GDP per head, mea-
sured in purchasing power standards, the relative price 
is 30% less in Denmark than, say, Ireland. In Portugal, 
on the other hand, the low prevalence rate can be 
explained by the fact that women, traditionally non-
smokers, are still less likely to smoke than men. 
In fact any study of smoking habits, or attempt to 
predict their change, must take account of the sex and 
age differences observed.4 In general terms women 
smoke less than men, but this is becoming less and less 
true. In Denmark, for example, they have quite caught 
up, so to speak. For men the highest rates of smoking 
are in the 25 to 54 age group, while for women they are 
in the 15 to 39 age group. 
When age and sex are considered together, it can be 
seen that in the countries where women's socio-cultural 
status has advanced faster or further compared to men 
(Denmark, Netherlands, Luxembourg) young women 
(15 to 24) already have higher smoking rates than men 
of the same age. In countries such as Greece, and even 
more so Portugal, young women still smoke less than 
men but it unfortunately would not be surprising if 
prevalence among women rises sharply with the newer 
generations and as a side effect of a more modern 
status. 
Giving up 
The risks of smoking are well known. Three-quarters of 
Europeans, when asked, think that the recommenda-
tion 'Don't smoke' is 'very important'. This attitude is 
of course largely shared by general practitioners and 
teachers. Better still, nearly 60% of smokers in the 
genera] public agree that it is 'very important' that they 
should not smoke. 
The smoker's world seems to be riddled with contradic-
tions: 
D one smoker in three says he/she wants to stop, and 
more than one in four to cut down; these rates are 
even higher among GPs;5 
D six smokers in ten claim to have tried to stop at least 
once. 
Putting these responses together, we can draw the 
following conclusions about the 94 million smokers 
(out of 260 million people of 15 and over) in the 
European Community: 
D 25%, or around 23 million, have tried, and still 
want, to stop; 
' According to available epidemiological data and statistics from the 
WHO. 
2 Four surveys have been conducted of the general public, in spring 
1987, spring 1988, autumn 1988 and spring 1989. 12 000 people 
aged 15 and up were questioned in each survey. GPs were surveyed 
in early autumn 1989 (N = 2314) and teachers in January/February 
1989 (N = 2750). All these surveys were conducted by specialized 
organizations collaborating under the name of 'European Omnibus 
Surveys' and coordinated by 'Faits et Opinions' (Paris). 
3 According to the aggregated results of the four surveys of the 
general public. 
4 The 'normal' trend is considered to be that which would result from 
the free play of market forces without any attempt to promote a 
health message. 
• Teachers were not asked this question. 
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D 35%, or 33 million, have tried, and half of these 
would like to cut down, the other half are happy as 
they are; 
D the rest, 40% or around 37 million, can be consi-
dered as the hard-core or confirmed nicotine ad-
dicts. 
Actions against smoking must be coordinated and 
evaluated with care, whether generalized, for example 
legal measures, or specific towards the most influential 
role models, in this case GPs and teachers. 
These groups are not yet free of the weed. Across the 
Community, the proportion of GPs who smoke is much 
the same as that of the general public (36%). So far as 
we can tell (the question was not put in quite the same 
way) teachers have a significantly lower rate (21%).6 
But note the very low rate among doctors (and 
teachers) in the United Kingdom, the remarkable 
result of 40 years of consistent campaigning since the 
publication of the epidemiological research of Doll and 
Hill.7 
The surveys into these two professions allow us to 
identify the most effective types of anti-smoking 
actions to initiate or develop. 
General practitioners warn their 
patients against smoking 
Nearly all doctors questioned agree with the recom-
mendation 'Do not smoke'. But they realize that it is a 
hard rule for the general public to follow. 
How do they present it to their patients? Rather too 
discreetly, at least in some countries, it would seem. 
Nearly nine GPs out of ten say that they 'very often' 
warn their patients of the dangers of smoking if the 
patient has symptoms linked to smoking. Rather fewer 
(75%) do so when the patient himself raises the 
question. It falls to less than half (48%) — and even 
lower in Denmark and the Netherlands (26% and 20% 
respectively) — if the patient is a smoker without 
tobacco-related symptoms who does not bring the 
subject up. 
Strictly speaking, we should take account of the differences in 
demographic structure between doctors, teachers and the general 
public. 
7 'Smoking and carcinoma of the lung', British Medical Journal, 
1950. 
90% of lung cancers are 
linked to smoking. Moreover, 
smoking increases the risk of 
cancer for all tissues in 
contact with the smoke: lips, 
mouth, oesophagus, 
kidneys... 
Photo: CEC. 
Fíeht asainst smokin 
SOCIAL EUROPE 1/91 37 
Chapter 3 
Teachers warn their pupils 
Teachers are also quite convinced of the importance of 
the smoking point of the European Code. How is the 
question dealt with in the classroom? Eight out of ten 
primary and nine out of ten secondary teachers, across 
the Community, claim to warn their pupils about 
tobacco. 
Is this positive attitude of teachers supported by school 
rules such as the prohibition of smoking by pupils in 
schools? The situation seems to vary greatly from one 
country to another; prohibition is the rule in Ireland, 
Greece, Portugal and the United Kingdom; restric-
tions, such as no smoking in the actual classroom, in 
Spain and Denmark. In Denmark and the Netherlands 
the head of school is apparently given the power to 
permit smoking in specified areas. 
This brief review of the surveys which have been 
conducted under the aegis of the Europe against cancer 
programme shows that there is still much to be done 
before one of the most dangerous habits affecting 
citizens of the European Community — smoking — can 
be eliminated. 
The battle is far from won, but at least it has been 
engaged. 
Jacques-René Rabier 
Special Adviser to the 
Commission of the European Communities 
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A comprehensive and varied approach 
In the framework of the first action plan of the 'Europe against cancer' programme, the 
Commission identified 14 measures to reduce the adverse impact of tobacco on health. 
The proposed legislation on tobacco has so far included five proposals for Directives: 
harmonization of indirect taxation on tobacco products, harmonization of the health 
warnings on tobacco packaging; limiting the tar yield of cigarettes to 15 mg by 1992 
and 12 mg by 1997; restricting tobacco advertising (including a ban on indirect 
advertising) and the strengthening of the health warnings with the ban of moist snuff. 
Moreover, in 1989 the Council and the Ministers for Health meeting within the Council 
adopted a resolution based on a draft recommendation of the European Commission 
concerning smoking in public places. Last but not least, Eurostat has, since July 1989, 
published a monthly price index excluding tobacco. 
Taxation: a proposal that combines 
harmonization and flexibility 
In respect of the harmonization of taxes, no progress 
has been noted yet. The wide variety of prices and the 
wide variety of taxation systems make the harmoniza­
tion process very difficult. 
The Commission has therefore adopted a modified 
proposal which takes account of these difficulties while 
preserving the objective of eventual harmonization. 
According to this proposal: 
D on 1 January 1993 each Member State will be 
required to apply rates higher than, or equal to, the 
minimum rates set for each product category (in the 
Member States as a whole, the approach will allow 
fiscal health to be maintained or increased). This 
flexibility must under no circumstances jeopardize 
the fundamental principle of abolition of customs 
and tax frontiers by 1 January 1993; 
D after 1 January 1993, the initial flexibility must 
gradually give way to a movement towards target 
rates compatible with essential public health 
requirements. To this end, the target rates have 
been significantly increased compared to those 
proposed in 1987. 
A price index excluding tobacco 
by Eurostat 
Since July 1989, a price index excluding tobacco has 
been published monthly by the Statistical Office of the 
European Communities. 
In general, the difference between including or exclud­
ing tobacco from the price index is negligible. 
Comparison between index including tobacco 
and index excluding tobacco 
Position 1990 (base 1985 = 100) 
Β 
DK 
D 
GR 
E 
F 
IRL 
I 
L 
NL 
Ρ 
UK 
EUR 12 
General index 
including tobacco 
products 
109.4 
119.7 
106.2 
201.4 
134.0 
114.6 
116.7 
129.2 
107.6 
102.8 
164.4 
127.1 
120.2 
without tobacco 
products 
109.2 
119.9 
106.0 
199.9 
134.0 
114.4 
116.3 
128.8 
107.4 
102.3 
164.5 
127.2 
120.0 
Source: Eurostat. 
Smoking in public places: 
non-smokers have priority 
This measure has been adopted as a resolution of the 
Council and of the Ministers for Health of the Member 
States meeting within the Council.1 It identifies a series 
of public places where smoking should not be allowed. 
In order to allow enforcement of such a measure, 
special provision is made for clearly defined areas to be 
reserved for smokers in those establishments. The 
measure also asks Member States to ensure that in case 
of conflict, in areas other than those reserved for 
OJ C 189.26.7.1989, p. 1. 
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smokers, the right to health for non-smokers prevails 
over the right of smokers to smoke. 
Member States must inform the European Commission 
every two years of actions taken in response to this 
resolution. 
The labelling Directive 
The Council of Ministers of 13 November 1989 adopted 
the first directive on tobacco prevention: Directive 
89/622/EEC on the labelling of tobacco products.2 
This Directive is aimed at the harmonization of 
national provisions on the labelling of tobacco products 
which, at present, are likely to constitute obstacles to 
trade incompatible with the establishment and func-
tioning of the single internal market. In accordance 
with Article 100a of the EEC Treaty the Directive 
takes as a base a high level of protection in the fields of 
health and consumer protection. 
The main lines laid down in the EC Directive are the 
following: 
D all units of packaging of tobacco products must carry 
on one of the largest surfaces the following general 
message 'Smoking seriously damages health'; 
D for cigarette packets, the other largest surface must 
carry specific alternating messages chosen from a list 
drawn up by each Member State on the basis of the 
list of health warnings set out in the annex. These 
national lists must include the following warnings: 
'Smoking causes cancer', 'Smoking causes heart 
disease'; 
D the tar and nicotine yield of cigarettes must be 
indicated on the side of the packet. 
OJ L359, 8.12.1989. p. 1. 
The European Community 
has adopted a Directive 
limiting the tar content of 
cigarettes. 
Photo: CEC. 
Legislation 
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Directive limiting the tar yield 
in cigarettes to a maximum of 15 mg 
by the end of 1992 
As adopted by the Council of Ministers of 17 May 
1990,3 this Directive provides for a maximum tar level 
of 15 mg per cigarette by the end of 1992 and 12 mg by 
the end of 1997. Special transitional measures delaying 
the implementation in Greece were also approved. 
While there is no such thing as, a 'safe' or 'healthy' 
cigarette there is convincing evidence that reducing the 
tar content of cigarettes can help to reduce their 
poisonous effects. 
Proposal for a Directive limiting 
the advertising of tobacco products 
On 30 March 1989, the Commission presented a 
proposal4 covering the advertising of tobacco products 
in the press and by means of bills and posters to the 
Council of Ministers. 
The main items of the proposal were the following: 
D the limitation of the content of the advertising 
message; 
D incorporation of warnings in tobacco advertising 
inserts concerning the health risks of the product; 
D ban on indirect advertising; 
D ban of all kinds of advertising in youth publications. 
The European Parliament, in its plenary session in 
March 1990, adopted a more radical position: it called 
for a total ban of direct and indirect advertising, as is 
already the case in France, Italy and Portugal. The 
Commission adopted a modified proposal on 19 April 
1990.5 
The Council of Ministers of 17 May and 3 December 
1990 did not manage to reach a common position. 
In 1991 the European Commission will examine the 
possibility of adopting a proposal for a Directive to 
completely harmonize the various national regulations 
concerning advertising of tobacco products. 
Proposal for an amendment 
of Directive 89/622/EEC concerning 
the labelling of tobacco products 
When adopting the first labelling Directive 89/622/EEC 
in November 1989, the Member States asked the 
Commission to warn consumers more effectively by 
completing labelling by specific warnings on all tobacco 
products and not only cigarettes, as soon as technically 
possible. 
Consequently, on 14 November 1990, the Commission 
presented to the Council a proposal for a Directive6 
amending Directive 89/622/EEC concerning the label-
ling of tobacco products. 
The main amendments: 
D all tobacco products are to carry, in addition to the 
general ('Tobacco seriously damages health'), a 
specific health warning; 
D packs of rolling tobacco are now to carry the same 
health warnings as cigarettes; 
D packs of cigars, cigarillos, pipe tobacco and other 
smoking tobacco products are to carry the same 
health warnings as cigarettes except those referring 
to heart diseases; 
D smokeless tobacco products (mainly traditional 
chewing tobacco) are to carry the general health 
warning 'Tobacco seriously damages health' plus the 
specific warning 'can cause cancer'; 
D a new optional warning has been added: 'Smoking 
causes addiction'. 
Oral moist snuff products present a special case which 
justifies real prevention. Therefore the Commission 
proposes to ban moist snuff in the EC by 1 July 1992. 
Some key elements of the 
campaign against tobacco 
It always takes a combination of the approach chosen, 
of the means devoted, of time and of human factors to 
tackle a problem successfully. However, at this stage, 
some elements which play a central role in the general 
approach have been identified. 
Smoking prevention as part of the 
'Europe against cancer' programme 
According to the World Health Organization and the 
Committee of Cancer Experts of the 'Europe against 
cancer' programme, tobacco is the single most impor-
3 OJ L 137.30.5.1990, p. 36. 
4 OJ C 124, 19.5.1990, p. 5. 
5 O J C 116, 11.5.1990, p. 7. 
" OJ C 29. 5.2.1991. p. 5. 
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tant avoidable epidemic in the world. The fact that the 
smoking prevention policy of the European Commu-
nity was a part of a major integrated programme, the 
'Europe against cancer' programme, contributed to the 
credibility of the anti-smoking measures proposed. The 
first commandment of the European Code on cancer 
prevention is 'Don't smoke'. This way, this message 
passed to several million European citizens during the 
European Year of Information on Cancer. 
Continuous monitoring of 
the smoking habits and attitudes 
of European citizens 
From the beginning of the programme, smoking habits 
of European citizens have been systematically moni-
tored through regular opinion surveys. Five such opin-
ion surveys have been conducted in the framework of 
the Eurobarometer survey between 1987 and 1990. 
All those surveys were conducted under similar condi-
tions on the basis of a sample of about 12 000 people. 
On the basis of those surveys, there are about 90 
million smokers in the European Community (35% of 
the population above 16 years of age). 
The same surveys showed that almost three out of four 
Europeans were in favour of banning tobacco advertis-
ing and smoking in public places. 
One measure for every 
tobacco prevention issue 
Moreover, the measures proposed by the Commission 
of the European Communities on the legislation level 
were individually presented and not concentrated in a 
sole proposal. This enabled the Commission to identify 
every possible sphere of specific EC competence when 
dealing with tobacco prevention issues. 
This approach contributed to simplifying the examina-
tion of each measure in the Council of Ministers and 
the European Parliament. Finally, it also helps in 
maintaining public interest alive when tackling each 
specific aspect of the tobacco prevention issue. 
Smoking prevention and reconversion 
of tobacco production 
Apart from anti-smoking measures, there is a need to 
assist reconversion of the tobacco-growing sector of the 
European Community as proposed in action No 9 of 
the first 'Europe against cancer' programme. 
The Directive on maximum tar yield in cigarettes has 
revealed that certain of the tobacco varieties produced 
in the EC are particularly damaging to health. Recon-
version towards other crops and/or reorientation 
towards other more marketable and less toxic varieties 
must therefore be started. 
Conversion of tobacco 
plantations to other crops or 
less toxic varieties of tobacco 
must be encouraged. 
Photo: CEC 
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Public awareness The newsletter issued by BASP has rapidly gained a 
very good reputation for the quality of its information. 
The 'Europe against cancer' programme also deals with Finally, the relationship built up with the major Euro-
information and public awareness in the fight against p e a n organizations for smoking prevention which hold 
tobacco. To this end, the European Commission crea- regular meetings in different European countries is 
ted a European Bureau for Action on Smoking Preven- v e r y important in the promotion of the European 
tion (BASP) entrusted with the contact with all Euro- Commission proposals. Moreover, the European Com-
pean organizations for smoking prevention. It also miss¡on maintains close contact with the WHO with 
helps with studies in relation to tobacco prevention and w h o m ¡ t organized the first European Conference on 
various issues raised at the different stages of examina- smoking policies in Madrid in November 1988. 
tion of the European Commission proposals. 
Stylianos Christopoulos 
Head of Sector 
'Programme of action against cancer' Unit 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
SOCIAL EUROPE 1/91 43 
Actions for a healthy diet 
Eating habits, including the consumption of alcoholic drinks, play an important role in 
the development, and also the prevention, of a number of cancers of the digestive tract 
and of breast cancer, it is estimated that nutritional factors could be at the origin of 
more than one third of deaths from cancer. Faced with this evidence, it was clear that 
proposals for actions in the area of nutrition should be incorporated in the 'Europe 
against cancer' programme. 
Nutritional recommendations 
for the prevention of cancer 
adapted to each category 
of actor concerned 
Despite the lack of certainty which characterizes pre-
sent knowledge on the links between diet and cancer, 
the Committee of Cancer Experts nevertheless judged 
it appropriate to formulate two recommendations on 
diet together with a preceding general warning: 
'Your general health will benefit from the following 
two recommendations which may also reduce the risks 
of some cancers: 
D frequently eat fresh fruit and vegetables and cereals 
with a high fibre content; 
D avoid being overweight and limit consumption of 
fatty foods.' 
The dissemination of these two recommendations was 
undertaken by the governmental and non-governmen-
tal partners of the programme in each of the Member 
States, in the majority of cases, with the financial 
support of the European Commission. 
Euro-Santé opinion polls have evaluated the degree of 
awareness of the European Code against cancer and its 
application. The application of the first nutritional 
recommendation 'Frequently eat fresh fruit and vege-
tables' appears to be more widely spread among the 
general public than the awareness of following a very 
important rule of cancer prevention. 
In fact, almost one European in three (28%) claims to 
eat fresh fruit and vegetables regularly without how-
ever being aware that this is an essential element of 
cancer prevention. As far as differences between 
countries are concerned, there seems to be a general 
uniformity in the application of this rule, with the 
exception of Germany. 
The second nutritional recommendation is, however, 
only considered as 'very important' by a little less than 
one European in two, on average, and large variations 
can be observed between countries (67% in Portugal 
and 39% in France). However, two thirds of Euro-
peans claim to avoid being overweight. Again, the 
application of the recommendation is more widely 
spread than the importance attached to it. 
Improved public information would permit a better 
understanding of the link between the avoidance of 
being overweight and the prevention of cancer. 
Avoidance of being overweight is a conscious concern 
of as many as 77% of Greeks and as few as 54% of 
Germans. 
Numerous studies on 
'diet and cancer' 
Several studies have been financed within the 
framework of the first action plan 1987-89 with a view 
to improving the level of knowledge on the possible 
links between diet and cancer: 
D feasibility phase of a prospective study on the links 
between nutrition, health and cancer; 
D prospective study on the anti-promoting role of 
selenium; 
D feasibility phase of a case-control study on the links 
between nutrition, lifestyle and the incidence of 
breast and colon cancer in the European Commu-
nity; 
D case-control study of patients with adenomatous 
polyps or cancer of the colon; 
D case-control study of the link between lifestyle, 
especially diet, and cancers of the pancreas and bile 
ducts; 
D case-control study on nutrition, alcohol consump-
tion and breast cancer; 
D case-control study of nutrition and precancerous 
intestinal lesions; 
D intervention study on the anti-promoting role of 
calcium. 
An evaluation of the first results of these studies has 
been drafted in the form of a scientific report for the 
programme and is available on request. 
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It is now accepted that certain 
eating habits increase the 
risk of developing certain 
types of cancer. 
Photo: CEC. 
Information campaigns 
on diet launched 
All programme partners in the 12 Member States have 
adapted their existing public information campaigns to 
take account of the European recommendations on 
cancer prevention concerning diet and the results of the 
epidemiological studies available, and new brochures 
have been published. 
During the European Year of Information on Cancer a 
number of actions involving the free distribution of 
fresh fruit and vegetables were organized through the 
intermediary of the non-governmental associations: 
among others, in Italy during the European Week 
against Cancer in May 1988 and in Luxembourg and 
Denmark during the European Week of October 1989. 
Finally, several colloquia were organized. 
The second action plan 1990-94 intends to finance a 
larger number of quality studies whose results will 
make it possible to clarify the guiding principles of 
nutritional recommendations. 
In general, we can conclude that the experience of the 
dissemination of nutritional messages in the framework 
of a vast information campaign undertaken by the 
'Europe against cancer' programme has been conclu-
sive. The dissemination of such messages, contained 
within the European Code, with the added comment 
that their application would be beneficial for health in 
general, constitutes a good model for increasing the 
primary awareness of the general public. 
Myriam Wilpart 
Consultant to the 'Europe against cancer' programme 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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The first step in chemicals control 
The European Community took an early initiative in the field of legislation for 
chemicals. In 1967 the Council of the European Communities adopted a first Directive' 
in order to approximate the laws, regulations and administrative provisions in the 
Member States relating to the classification, packaging and labelling of dangerous 
substances — Directive 67/548/EEC. This Directive has been amended six times over 
subsequent years. The sixth amendment is the version that is in force today. It was 
adopted in 1979 (Directive 79/831 /EEC).' A common position on a seventh 
amendment has recently been adopted by the Council. 
The objectives of this Directive are twofold: 
D first, the protection of man and the environment, and 
D second, the elimination of technical barriers to trade. 
1 500 chemicals classified 
The objective of classification is to identify all the 
physico-chemical and toxicological properties of the 
substances which may constitute a risk during normal 
handling or use. 
All dangerous substances must be labelled when they 
are marketed. Annex I of the sixth amendment con-
tains some l 500 chemicals which have been classified 
and labelled at Community level. All dangerous sub-
stances not yet contained in Annex I must be provision-
ally labelled by the manufacturer or the importer. 
The toxicological properties of the substance that must 
be considered for classification and labelling include a 
wide range of effects, including acute and chronic 
toxicity, corrosivity, irritation, sensitization, car-
cinogenicity, mutagenicity and teratogenicity. 
Criteria for the classification and labelling of chemical 
substances are shown in Annex VI of the sixth amend-
ment. 
Three categories of classification 
of carcinogenic substances 
The criteria in the labelling guide for carcinogenic 
substances are shown below. 
'For the purpose of classification and labelling, and 
having regard to the current state of knowledge, such 
substances are divided into three categories: 
Category 1 
Substances known to be carcinogenic to man. There is 
sufficient evidence to establish a causal association 
between human exposure to a substance and the 
development of cancer. 
Category 2 
Substances which should be regarded as if they are 
carcinogenic to man. There is sufficient evidence to 
provide a strong presumption that human exposure to a 
substance may result in the development of cancer, 
generally on the basis of: 
D appropriate long-term animal studies, 
D other relevant information. 
Category 3 
Substances which cause concern for man owing to 
possible carcinogenic effects but in respect of which the 
available information is not adequate for making a 
satisfactory assessment. There is some evidence from 
appropriate animal studies, but this is insufficient to 
place the substance in category 2. 
The following symbols and specific risk phrases apply. 
Categories 1 and 2 
T; R 45 — May cause cancer 
However, for substances and preparations which pre-
sent a carcinogenic risk only when inhaled, for example 
as dust, vapour or fumes (other routes of exposure, e.g. 
swallowing or contact with the skin do not present any 
carcinogenic risk), the following symbol and specific 
risk phrase should be used: 
T; R 49 — May cause cancer by inhalation 
1 OJ 196. 16.8.1967. p. 1 
: OJ L259. 15.10.1979. p. 10. 
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R 45 - May cause cancer. 
Toxic 
The phrase 'may cause cancer by inhalation' will be 
introduced into national legislation in 1991 for the first 
time, to indicate a special subcategory of carcinogens 
that only cause cancer by inhalation. 
Category 3 
Xn; R 40 — Possible risk of irreversible effects 
The labelling guide also includes comments regarding 
the categorization of carcinogenic substances: 
'The placing of a substance into category 1 is done on 
the basis of epidemiological data; placing into 
categories 2 and 3 is based primarily on animal 
experiments.' 
For classification as a category 2 carcinogen, either 
results in two animal species should be available or 
clear positive evidence in one species, together with 
supporting evidence such as genotoxicity data, 
metabolic or biochemical studies, induction of benign 
tumours, structural relationship with other known 
carcinogens, or data from epidemiological studies sug-
gesting an association. 
Category 3 actually comprises 2 subcategories: 
D substances which are well investigated but for which 
the evidence of a tumour-inducing effect is insuffi-
cient for classification in category 2. Additional 
experiments would not be expected to yield further 
relevant information with respect to classification; 
D substances which are insufficiently investigated. The 
available data are inadequate, but they raise con-
cern for man. This classification is provisional; 
further experiments are necessary before a final 
decision can be made. 
For distinction between categories 2 and 3 the argu-
ments listed below which reduce the significance of 
experimental tumour induction in view of possible 
human exposure are relevant. These arguments, espe-
cially in combination, would lead in most cases to 
classification in category 3, even though tumours have 
been induced in animals: 
D carcinogenic effects only at very high dose level 
exceeding the 'maximal tolerated dose'. The maxi-
mal tolerated dose is characterized by toxic effects 
which, although not yet reducing lifespan, go along 
with physical changes such as about 10% retardation 
in weight gain; 
D appearance of tumours, especially at high dose 
levels, only in particular organs of certain species 
known to be susceptible to a high spontaneous 
tumour formation; 
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D appearance of tumours, only at the site of applica­
tion, in very sensitive test systems (e.g. 
intraperitoneal or subcutaneous application of cer­
tain locally active compounds), if the particular 
target is not relevant to man; 
D lack of genotoxicity in short-term tests in vivo and in 
vitro; 
D existence of a secondary mechanism of action with 
the implication of a practical threshold above a 
certain dose level (e.g. hormonal effects on target 
organs or on mechanisms of physiological regula­
tion, chronic stimulation of cell proliferation); 
D existence of a species-specific mechanism of tumour 
formation (e.g. by specific metabolic pathways) 
irrelevant for man. 
For a distinction between category 3 and no classifica­
tion arguments are relevant which exclude a concern 
for man. 
Π a substance should not be classified in any of the 
categories if the mechanism of experimental tumour 
formation is clearly identified, with good evidence 
that this process cannot be extrapolated to man; 
D if the only available tumour data are liver tumours 
in certain sensitive strains of mice, without any 
other supplementary evidence, the substance may 
not be classified in any of the categories; 
D particular attention should be paid to cases where 
the only available tumour data are the occurrence of 
neoplasms at sites and in strains where they are well 
known to occur spontaneously with a high inci­
dence. 
These criteria and comments have been developed by 
the Commission's Working Group on Dangerous Sub­
stances with the advice of the Commission's Group of 
Specialized Experts in the field of carcinogenicity. 
The criteria and comments are used when the Commis­
sion and the Member States are preparing proposals for 
the classification and labelling of substances for inclu­
sion in Annex I. 
At the beginning of 1991, a total of 14 entries in Annex 
I were category 1 carcinogens, 56 entries category 2 
carcinogens and 38 entries category 3 carcinogens — a 
total of 108 entries. 
It should be noted that some of these entries are for 
groups of substances (e.g. benzidine salts) so the actual 
number of individual substances in Annex I classified 
as carcinogens is larger. 
Carcinogens not included 
in Annex I 
As with all other dangerous substances carcinogens are 
required to be classified and labelled even if they are 
not included specifically in Annex I. 
If a manufacturer or his representative has information 
available which indicates that a substance should be 
classified and labelled as a carcinogen, he or his 
representative shall provisionally label the substance in 
accordance with these criteria. 
He shall also submit as soon as possible a document 
summarizing all relevant information to one Member 
State in which the substance is placed on the market. 
This summary document should include a bibliography 
containing all relevant references, including any rele­
vant unpublished data. 
Furthermore, a manufacturer or his representative who 
has new data which are relevant to the classification 
and labelling of a substance as a carcinogen shall 
submit these data as soon as possible to one Member 
State in which the substance is placed on the market. 
Further work on the classification 
and labelling of carcinogens 
The Commission's Working Group is still discussing 
the classification and labelling of potential carcinogens. 
Proposals will be put forward in 1991 for Commission 
directives for the classification of a large number of 
metals and their salts, pesticides and other industrial 
chemicals. 
The number of new entries in Annex I for carcinogenic 
substances is expected to be even greater in 1991 than 
in 1990. 
Hazard identification — 
Risk management 
The classification of a dangerous substance is based on 
its intrinsic properties, independent of the use to which 
the substance might be put, or of the quantities 
produced or the patterns of exposure. 
This is only the first step in making people aware of the 
dangerous properties of a particular substance and to 
warn the user or consumer by means of a label. It is the 
starting point for downstream legislation and risk 
management that might follow after undertaking a 
detailed risk evaluation which has to take into account 
other parameters such as use, quantities, exposure, etc. 
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Examples of possible downstream legislation are: D measures to protect the different compartments of 
D ban or restriction of marketing and use of a sub- t h e environment, i.e. the aquatic environment, air, 
stance; soil; 
D measures to protect people at work (in particular 
maximum concentrations in the air of the work- □ finally, measures concerning the safe disposal of the 
place); substance or products containing the substance. 
Goffredo Del Bino 
Head of 'Environmental control of products, 
industrial installations and biotechnology' Unit 
Directorate-General for Environment, 
Nuclear Safety and Civil Protection 
Commission of the European Communities 
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Protection of workers from the risks 
related to exposure to carcinogens 
// has for a long time been recognized in the industrialized countries that occupational 
cancer is a serious problem in the context of worker protection. Estimates vary, but it 
appears that between 2 and 8% of all deaths due to cancer might have an occupational 
origin. Because of the need to prevent and monitor the risk, the Member States of the 
European Community have introduced into their legislation regulations concerning 
either agents in general or specific agents. 
However, while the purpose of the legislation in each country is the same there are 
considerable differences in scope and in the importance attached to individual aspects. 
Most of the regulations take into account data from the cancer registers kept in a 
number of countries and epidemiological studies carried out throughout the world; 
other important sources of information are the international organizations such as the 
International Labour Office, the World Health Organization and the International 
Agency for Research on Cancer (IARC) in Lyons. 
The first Directive adopted in 1959 
Because of the differences in legislation the European 
Community decided to use Council Directives for 
harmonization purposes and these, once adopted, must 
be incorporated into national legislation. 
The first Directive in this area was adopted in 1959 and 
covered ionizing radiation; the basic standards ensure 
the protection of workers and the prevention of radia-
tion-induced diseases. These standards are com-
plemented and updated at regular intervals. 
Three European Community action programmes on 
health and safety at work were adopted between 1978 
and 1987. These programmes provide a basis for 
Community policy and have given rise to a number of 
major measures to protect workers. Many of the 
measures introduced cover hazardous substances in 
general but some relate specifically to carcinogenic 
substances at work. 
A vital part of the first programme was the adoption by 
the Council on 27 November 1980 of a Directive1 on 
the protection of workers from the risks related to 
exposure to chemical, physical and biological agents at 
work. This Directive asks Member States to take short-
and long-term measures and also provides for the 
adoption by the Council of individual directives laying 
down the limit value(s) and other rules governing 
specific listed agents, some of which arc regarded as 
occupational carcinogens. 
By virtue of this Directive, the Council adopted two 
Directives on carcinogenic agents — asbestos in 1983 
and four aromatic amines in 1988. 
In fact, before the 1980 Directive, the Commission had 
reacted quickly to the publication of studies on the 
links between vinyl chloride monomer and angiosar-
comas by adopting the first Directive to cover the 
monitoring of worker exposure to a carcinogenic chem-
ical substance in 1978. 
New impulse from the adoption 
of the 'Europe against cancer' 
programme 
New impetus came from the resolution of the Council 
and the representatives of the Governments of the 
Member States meeting within the Council on the 
proposed European Community programme of action 
against cancer and the proposed plan of action for the 
1987-89 'Europe against cancer' programme submitted 
by the Commission to the Council. 
. . . and the entry into force of 
the Single European Act 
In the mean time the Single European Act had been 
signed by the 12 Member States in The Hague and the 
Treaties thus amended to increase unity within the 
European Community. 
The keystone for development will be the creation in 
1992 of the internal market. This is central to the 
OJ 1. 327. 3.12.1980, p. 8 (published in Social Europe 2/90). 
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strategy for relaunching the 'construction of Europe'. 
However, this process must include a social dimension 
with the physical and mental well-being of workers as 
one of the main priorities. A new article in the Treaty, 
Article 118a, describes the main means of achieving the 
objectives: 
D Member States shall set as their objective the 
conditions for protecting workers, while maintain-
ing the improvements made. The Directives must 
therefore lay down minimum' requirements for 
gradual implementation; 
D the provisions shall not prevent any Member State 
from maintaining or introducing more stringent 
measures; 
D the directives shall avoid imposing administrative 
and financial constraints on small and medium-sized 
undertakings. 
A new Directive adopted in 1990 
In order to make rapid progress in the prevention of 
occupational cancer it is felt that the best policy now is 
to establish a new kind of general directive rather than 
directives on individual agents but to use the content of 
these as a basis, the aim being to harmonize conditions 
in the Member States while at the same time making 
progress. 
The aim of the new Directive (90/394/EEC) adopted by 
the Council on 28 June 1990,1 is therefore to eliminate 
the differences between the legislations of the Member 
States and represents a guarantee of better protection 
for workers by improving working methods, working 
conditions, information and human behaviour. 
Article 1 states that the aim of the Directive is to 
protect workers against risks to their health arising 
from exposure to carcinogens at work. 
Article 2 defines the term 'carcinogen'. Council Direc-
tives 67/548/EEC and 88/379/EEC on the approxima-
tion of the laws, regulations and administrative provi-
sions of the Member States relating to the classifica-
tion, packaging and labelling of dangerous substances 
and preparations automatically apply with amendments 
to take account of technical progress. 
Once a substance or preparation has been classified by 
risk phrase 'R 45' ('may cause cancer'), workers 
OJ L 196, 26.7.1990, p. 1 (published in Social Europe 2/90). 
The European Community 
plays a vital role in the 
promotion of a better 
protection of workers from 
carcinogenic substances. 
Photo: CEC. 
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The directive specifies that 
protective clothing and 
individual equipment must be 
worn as long as the normal 
exposure persists. 
Photo: INRS. 
exposed must be protected by the provisions of this 
Directive. There are at the moment 52 chemical agents 
classified in this way. 'Carcinogen' also covers the 
substances, preparations or processes listed in Annex I, 
which consists at present of four articles. 
Article 3 describes the scope of the Directive. In the 
case of any activity likely to involve a risk of exposure, 
the nature, degree and duration of workers' exposure 
must be determined in order to lay down the measures 
to be taken. Articles 4 and 5 describe the measures to 
be taken to avoid or reduce exposure. The employer is 
required, in the first instance, to replace the car-
cinogenic agent or at least to use it in a sealed 
environment; in every case he must apply a series of 
preventive measures. Article 6 specifies the informa-
tion which the employer must keep available for the 
responsible authorities of the Member States. 
Abnormal exposure to carcinogens may be unforeseen, 
accidental or a result of activities involving an increase 
in exposure. The Directive obliges the employer to 
take all necessary measures for the protection of the 
workers involved and lays down the technical and 
personal protection measures to be implemented. 
Other articles in the Directive restrict access to places 
where activities involving carcinogenic agents take 
place and describe the measures to be taken to provide 
workers with washing and toilet facilities, including 
showers and facilities for the storage of street clothes 
and working clothes and personal protective equip-
ment. 
Workers must receive adequate information and regu-
lar training concerning the potential risks to health, 
hygiene requirements, the use of protective equipment 
and procedures to follow in the event of an incident. 
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Article 12 stipulates that measures shall be taken to 
ensure that workers can check that the Directive is 
being properly applied and that they receive informa-
tion on the potential risks to health from abnormal 
exposure. The employer is obliged to keep a list of the 
workers exposed, to which the worker has access. 
Article 13 establishes that consultation and participa-
tion of workers shall take place in accordance with 
Directive 89/391/EEC on the introduction of measures 
to encourage improvements in the safety and health of 
workers at work. Article 14 sets out the requirements 
regarding health surveillance of workers and refers to 
the practical recommendations given in Annex II. 
Article 15 requires that the health records and the list 
of workers exposed be kept for at least 40 years 
following the end of exposure. 
Article 16 allows the Council by means of a Directive 
on a proposal of the Commission, to specify exposure 
limit values for all carcinogenic agents where that is 
possible and, if necessary, other related arrangements; 
this to be on the basis of the scientific and technical 
information available. Annex III will contain these 
values. 
Article 17 explains the procedure for amending 
Annexes I and II. 
Article 18 asks the national authorities to provide the 
Commission with the analyses made of data on notified 
cases of occupational cancer. 
Article 19 sets out the time limits and methods for 
implementing this Directive in the Member States. The 
Directive will enter into force on 31 December 1992 at 
the latest in each Member State. 
The Commission hopes that this Directive will be a 
milestone in the protection of workers from the risk, of 
which they are often unaware, of contracting cancer as 
a result of exposure at work. 
Clearly the Commission's efforts will not stop here. 
Epidemiological research and data assessment must be 
a continuous process if the welfare of all workers is to 
be maintained. Every effort must be made to achieve 
this objective. 
Ronald Haigh 
Head of Industrial medicine and hygiene Unit 
and 
Dr Giorgio Aresini 
Principal Administrator 
Industrial medicine and hygiene 
Health and Safety Directorate 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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The advantages of screening 
There is no doubt at all that early detection of cancer saves lives. 
There are a number of approaches to improving early detection. It 
is clear that a high level of awareness of symptoms and risks is 
necessary among medical personnel, and this need is met by the 
training section of the programme. It is also vitally important that 
individuals are alerted to the possible significance of certain danger 
signs, and these are covered in points 7 and 8 of the European Code 
against cancer. Thirdly, for specific cancers techniques exist that 
permit identification and diagnosis before any symptoms appear. 
Screening consists of the application of this approach: some of the 
considerations that determine whether it is useful are discussed in 
the article by Professor De Waard. The two areas where it is 
considered of proven utility, cervical screening and breast screen-
ing, are the subject of points 9 and 10 of the European Code and 
the development of pilot programmes implementing European 
networks is described by Alain Vanvossel. The point of view of the 
'consumer' is important in this area and the report on a recent 12-
country survey provides original and unique data on this. 
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In the fight against cancer several approaches are being followed. In the first place 
efforts are made to understand the causative factors of this disease by means of basic 
laboratory research and epidemiological analysis. The rationale will be clear: 
understanding causation is the key to preventive measures. 
The difficulty is, however, that cancer is a group of diseases each of which apparently 
has its own causes. For example, smoking has to do with a number of cancers, mainly 
those of the upper respiratory tract, but not with such frequent cancers as cancer of the 
breast and of the large bowel. 
Objective: to detect cancer at the 
earliest possible stage 
For clinical doctors the fight is mainly concerned with 
diagnosis and treatment of cancers which present 
themselves through symptoms like persistent cough, 
loss of blood or abnormal growth in the skin. Experi-
ence has taught them that — statistically speaking — 
chances of cure are better if the cancer is still localized 
in one organ; dissemination to other organs (metasta-
sis) seriously worsens prognosis. 
Naturally, emphasis has been put on the possibility of 
early detection of cancer by means of systematic 
investigation of persons with and without symptoms. 
Empirical knowledge confirms the theoretical notion 
that cancer found in persons without symptoms is on 
average in an earlier stage of its development than in 
persons with symptoms, thereby leading to better 
prognosis. 
Systematic investigation of whole populations irrespec-
tive of symptoms is called screening. Screening has to 
make use of one or more screening tests which will 
distinguish those who (probably) have the disease from 
the majority who (again: probably) do not have the 
disease. The properties of a good screening test are 
given by its sensitivity (namely, the ability to identify 
those who have the disease under scrutiny) and 
specificity (namely, the ability to identify those who do 
not have the disease). It will be clear that the usefulness 
of a screening test depends not only on these charac-
teristics but also on its practical applicability and its 
cost. 
Screening programmes are large undertakings and they 
should not be started before serious consideration of 
their pros and cons. Since even the best test is not 
100% specific there will always be persons who will 
turn out 'positive', namely suspected of having the 
disease at screening but in whom further examination 
does not reveal the suspected cancer. The 'predictive 
value' of a positive screening test depends not only on 
its quality (defined by its sensitivity and specificity) but 
also on the prevalence of the disease in the screened 
population. Since the prevalence of any kind of cancer 
in a free-living population is usually low (in the order of 
magnitude of a few cases per 1 000 persons) there will 
always be a substantial proportion of so-called 
'positives' who will go through the anxiety of false 
alarm. The issue is whether the benefits of screening 
will outweigh the anxiety and the cost brought about by 
the programme. 
Screening programmes 
for three types of cancer 
At present there are three sites of cancer for which 
screening programmes in Europe are ongoing or in an 
experimental phase: cancer of the uterine cervix, 
cancer of the breast and cancer of the large bowel 
(colo-rectal cancer). 
Screening for cancer of the uterine cervix has a history 
which dates back to 1943 when G. N. Papanicolaou 
(born in Greece but working in the United States) 
discovered that loose cells exfoliated from the surface 
of the 'mouth' of the uterus (an easily accessible site) 
may reveal the presence of cancer. This was a some-
what revolutionary idea since the doctrine had always 
been that cancer can be diagnosed only by studying 
whole tissue blocks. The concept emerged that cyto ( = 
cell) diagnosis can be used as a screening test for the 
existence of cancer to be confirmed by histo (= tissue) 
diagnosis. 
Europe was not very quick in appreciating the potential 
of the 'Papanicolaou' test as a tool in the fight against 
cancer outside the hospital setting. Still, the test fulfills 
all the criteria for good screening: in qualified hands it 
has good sensitivity and specificity, and taking a Pap 
smear is a quick and harmless procedure. Moreover, it 
is able to detect very early stages of the disease. 
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The 'Europe against cancer' 
programme supports projects 
for the screening of cervical 
and breast cancer. 
Photo: CEC. 
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In the late 1960s (more than 15 years after such 
initiatives in North America) systematic campaigns 
were launched. The Nordic countries excelled in their 
programmes and it is largely through their efforts that 
the scientific world has become convinced of the public 
health merits of this screening tool. 
Interestingly, there is no formal proof of its efficacy in 
bringing down mortality from cervical cancer. Such 
proof should have come from experimental design 
called the 'randomized controlled trial'. However, by 
the time that epidemiologists considered such research 
the Pap test had gained so much foothold already in 
clinical practice that it would be impossible to withhold 
it from the control group in an experimental study. 
Screening for cervical cancer is not yet commonplace in 
all EC countries. Sufficient knowledge on the 'state of 
the art' is available and it is mainly a matter of health 
education and public health organizations to control 
this disease. Since this type of cancer is not very 
frequent in some European countries (unlike the 
situation in the Third World) health authorities may 
differ in their priorities of cancer control. 
Screening for cancer of the breast 
Screening for cancer of the breast differs in many 
respects from screening for cancer of the uterine cervix. 
Here again the original research was undertaken in the 
United States. The screening test is mammography, 
namely an X-ray picture of the female breast. Cancer 
can be spotted by looking carefully at small densities 
and micro-calcifications. The test is neither simple nor 
cheap; its sensitivity and specificity are reasonably 
good in experienced hands, but one does not detect 
cancer in stages as early as is the case in cervical cancer 
screening. This is probably one of the reasons that 
proof of the efficacy of screening in terms of better 
prognosis is limited to cancers detected after age 50 
(which seem to grow slower than those occurring 
before that age). 
Although Americans took the lead in breast cancer 
screening with a randomized controlled trial conducted 
in New York and published from 1971 onwards, they 
lost their 'yellow jersey' by a series of mistakes and 
unhappy events which will not be elaborated upon 
here. Europe took over with projects in Sweden, the 
United Kingdom, the Netherlands and Italy. In par-
ticular, the Swedes undertook a major research effort 
in setting up large randomized trials which by the mid-
1980s have led to the conclusion that breast cancer 
mortality could be lowered by about 30%. 
Recently doubt has been expressed whether such 
outcome could be equalled in other regions of Europe. 
In order to understand the scientific debate it is 
necessary to explain which kind of evidence is at the 
core of it. Basically, one can compare the mortality 
rates due to breast cancer between those who have 
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been screened and those who have not. This has been 
done in a relative sense by means of so-called 'case-
control' studies in the Netherlands and Italy. The 
results point to a 50% reduction in mortality among the 
screened population compared to the unscreened. 
However, persons who decide not to take part in a 
screening programme certainly are some self-selected 
group from those invited (less health-conscious?) and it 
could be that such 'confounding' characteristics are 
(partly) responsible for the difference. 
In order to avoid wrong conclusions based on selection 
bias, statisticians prefer to compare those invited for 
screening with those not invited (depending on the 
outcome of a lottery, the so-called randomization). It 
will be clear that the difference between groups so 
designed will be 'diluted' because of the fate of the non-
participants in the group invited to be screened. Thus, 
the impact of a screening programme depends very 
much on the percentage of participants after invitation. 
Moreover, it depends on the level of specific preventive 
care already provided to the target population as a 
whole (in this case: mammography). Differences in the 
outcome of various projects can be partly explained in 
this way. 
Even a 50% reduction in mortality from breast cancer 
in those aged 50 and over is less than desirable. 
However, breast cancer is such a prevalent disease 
(about 60 000 deaths annually) in Europe of the 
Twelve that even a limited relative decrease amounts to 
a great many lives saved. 
In addition to gains in mortality there is the important 
aspect of a better quality of life since early diagnosis 
allows a shift to less radical surgical procedures. 
Screening for cancer of the large bowel (which consists 
of the colon and the rectum) is still in an experimental 
phase. The prevalence of this disease in both males and 
females (resulting in about 100 000 deaths per annum 
in the EC countries) is such that a decision on its 
applicability would be very welcome. 
The problem is that the available screening test, 
namely the biochemical detection of traces of blood in 
the stools, is far from specific. Thus, a fairly large 
proportion of screened persons will have to be investi-
gated further by means of specialized methods (roent-
genology, endoscopy) and the predictive value of a 
'positive' test will be fairly low. 
Those who fear 'medicalization' of health policy have a 
case here. Further research on the perspective of 
primary prevention through studies on a probable role 
of nutrition in the causation of this kind of cancer is 
without any doubt a priority. If primary prevention 
were possible there would be no need for expensive 
screening programmes. 
Prof. Frits de Waard 
Preventicon, University of Utrecht 
The Netherlands 
For cancer of the colon and 
rectum, widespread 
European studies are 
presently underway to 
evaluate the effectiveness of 
screening through detection 
of blood in the stool. 
Photo: CEC. 
Screening and detection <ä> 
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Given that it is at present impossible to eliminate all carcinogens, and that primary 
prevention will always have a limited impact, systematic screening must have a role to 
play in reducing mortality from cancer. The 'Europe against cancer' programme seeks 
to promote this screening, and also to alert the public to the importance of early 
detection. The last two points of the European Code against cancer highlight this: 
D 9th recommendation: 'Have a cervical smear regularly'. 
D 10th recommendation: 'Check your breasts regularly and, if possible, undergo 
mammography at regular intervals above the age of 50'. 
Breast cancer screening: 
a first European network 
established in 1989 
In order to implement a systematic breast screening 
programme a pilot network has been established since 
1989. Each of the pilot projects is required to follow a 
large group of women, inviting them to take part by 
individualized letters with automatic follow-up. These 
measures to ensure a high participation rate are com-
plemented by other quality criteria to maximize the 
effectiveness of the programmes. 
In four regions, Ilia in Greece, Navarre in Spain, 
Oporto in Portugal, and Limburg in Belgium, this 
screening is undertaken by mobile or semi-mobile 
mammography units. This system allows good coverage 
of rural and remote areas and encourages participation 
by relevant local actors (local authorities, general 
practitioners, socio-cultural organizations, etc.). In 
Dublin (Ireland) a mixed system combining a mobile 
unit with a fixed screening centre has been adopted 
while in Bas-Rhin (France) the screening is performed 
by independent radiologists with centralized coordina-
tion of the results and follow-up. In 1991 Florence 
(Italy) and Copenhagen (Denmark) joined the network 
with similar projects. 
There are many advantages in collaboration in this kind 
of network. On the one hand daily improvements in the 
technique of screening can be made, developing an 
experience indispensable for establishing a generalized 
network. On the other hand, comparing the results 
allows more precise evaluation, from all points of view 
(medical, epidemiological and economic) and hence a 
levelling upwards of screening practice. 
The first evaluation meeting was held in Coimbra, 
Portugal, in 1990 when the network had been running 
for a year. It could already be shown that an adequate 
participation rate could be achieved when all the local 
partners were involved. The need to improve quality 
control became apparent as did the overwhelming 
importance of social and cultural factors and the need 
to vary the approach accordingly. The 1991 evaluation 
exercise on an enlarged network will allow confirma-
tion of factors leading to success. 
In addition to action in the field the 'Europe against 
cancer' programme has supported complementary 
training in screening. This training leads to a high 
degree of reliability in the taking and reading of 
mammograms and improvement in project evaluation. 
Training sessions have been organized in Utrecht, 
Florence and Strasbourg. 
Finally, an economic evaluation of systematic screening 
of breast and cervical cancers has been commissioned1 
in order to provide decision-makers at national or 
regional level with the tools necessary to prepare a 
medical-economic dossier for cancer screening pro-
grammes. 
The Commission of the European Communities is 
convinced that this programme, which integrates public 
awareness (using the European Code), effective action 
at the level of the individual citizen by the pilot 
networks, training of concerned health personnel and 
ongoing evaluation, will impel the decision-makers to 
take the steps necessary to implement mass screening. 
Towards a comparable network for 
cervical cancer screening 
A comparable network for cervical screening would be 
very desirable. However, the fact that many projects 
already exist and that the financial implications would 
be considerable mean that the programme has had to 
postpone the launch of such a network. None the less, 
the criteria for quality control of such a network have 
been developed and could form the basis for establish-
ing a network in the near future. In the meantime the 
programme is supporting projects which analyse the 
factors influencing the participation rate and others 
testing alternative screening methods such as cervico-
graphy. 
For other cancers there are many uncertainties restrict-
ing the advantages of systematic screening campaigns. 
Report on lhe economic evaluation of systematic screening of breast 
and cervical cancers (Lancry, Fagnani et al., DG XII. Comac-
HSR). 
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The best candidate seems to be colo-rectal cancer, 
using detection of blood in the faeces, but caution is 
still necessary. For this reason the 'Europe against 
cancer' programme has not supported any of the many 
proposals made in this field. 
On the other hand, certain studies which are designed 
to evaluate the results of the faecal occult test have 
been supported. These studies on the effectiveness of 
screening, undertaken by experts of world renown in 
the United Kingdom, Germany and France should 
demonstrate whether the test is a reliable screen and 
also whether an acceptable participation rate can be 
achieved, the factors influencing this. 
The first useful results will arrive at the end of 1991 and 
a new strategy to promote this technique might perhaps 
be launched in 1992. 
For other cancers such as malignant melanoma and 
cancer of the prostate the programme has only sup-
ported isolated initiatives in order to increase our 
knowledge in this area, and it would be premature to 
embark on large-scale campaigns. 
It is clear that the organization of screening campaigns 
is the responsibility of Member States. However, these 
actions show that even with a very limited budget the 
'Europe against cancer' programme can stimulate the 
relevant partners to develop effective screening prac-
tices. The Commission will therefore continue, during 
the second action plan, to examine with the Member 
States how a systematic screening policy can be im-
plemented. 
To highlight this, and to keep the public informed, 
screening and early detection has been adopted as the 
theme for the European Week against cancer in 
October 1991. This will ensure that all those con-
cerned, especially the women of Europe, will be 
motivated to participate in these campaigns which 
could save so many lives. 
Dr Alain Vanvossel 
Administrator 
'Programme of action against cancer' Unit 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
A European network of pilot projects for the screening of breast cancer by mammography is now in place. 
PAiofo: CEC 
PILOT PROJECTS 
<0^$ 
DUBLIN 
NAVARRA 
FLANDERS 
STRASBOURG 
CENTRAL 
REGION " T | 
Screening and detection 
60 SOCIAL EUROPE 1 91 
The European women's point of view 
The European Code against cancer contains 10 'commandments', of which eight apply 
both to men and women and two exclusively to women: 'Have a cervical smear 
regularly', 'Check your breasts regularly and, if possible, undergo mammography at 
regular intervals over the age of 50'. 
T his survey1 reveals the importance which European women attach to these recommendations, their 
awareness of them and their compliance with them. 
Women agree on the importance 
of the recommendations 
for women 
Only 4% of European women believe it is not impor-
tant to have a cervical smear regularly and check their 
breasts regularly. Seven out of 10 consider it very 
important. The proportions have remained stable over 
the years (the same questions were asked in autumn 
1988 and spring 1989). 
Question: 
Here are two recommendations for women. For each of 
them, please tell me if you think it is very important, 
fairly important or not important at all in lessening the 
risks of cancer? 
(%) 
Have a cervical 
smear regularly 
Very important 
Fairly important 
Not important 
No reply 
Total 
Check your 
breasts regularly 
Very important 
Fairly important 
Not important 
No reply 
Total 
Autumn 
1988 
71 
19 
3 
7 
100 
71 
20 
3 
6 
100 
Spring 
1989 
74 
18 
3 
5 
100 
76 
17 
3 
4 
100 
Feb.-
March 
1990 
68 
19 
4 
9 
100 
70 
20 
4 
6 
100 
There has been a slight fall in the numbers replying 
'very important' in almost all countries compared with 
1989. The launching of the anti-cancer campaign at the 
start of 1989 increased women's awareness of the 
importance of these two recommendations; in the 
meantime, this increased awareness has dropped 
slightly, with fewer replying 'very important' and more 
replying 'fairly important'. By and large, however, 
women continue to agree that these two command-
ments are very important (68% and 70% respectively). 
We know that women also attach great importance to 
the other eight recommendations in the Code, which 
apply to both sexes. Women rank the 'cervical smear' 
and 'breast checking' recommendations fourth in order 
of importance, after the recommendation to see a 
doctor for a lump, a change in a mole, etc. (86%) or for 
persistent cough, hoarseness, etc. (82%) and the 
recommendation not to smoke (77%). 
The cervical smear: a considerable 
difference between generations 
The series of questions asked in February-March 1990 
was an exact repetition of the questions asked in spring 
1988, and the two sets of replies can thus be compared. 
Question: 
Let us talk about the cervical smear. Do you know what 
it is, and if so, have you ever had it done? 
(%) 
Does not know what it is 
Knows, but has never 
had it done 
Knows, and has had it done 
No reply 
Total 
Spring 
1988 
18 
32 
48 
2 
100 
Feb.-March 
1990 
13 
30 
56 
1 
100 
The number of women who do not know about the 
cervical smear has thus fallen, and the number of 
women who have had one has increased substantially. 
This trend applies to most Member States, particularly 
those where cervical smears were relatively uncommon 
two years ago. 
1 Extracted from a survey conducted for the 'Europe against cancer' 
programme in early 1990 by European Omnibus Surveys. 
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In decreasing order of 
positive replies 
in 1990 
France 
United Kingdom 
Denmark 
Germany 
Luxembourg 
Belgium 
Netherlands 
Ireland 
Italy 
Greece 
Spain 
Portugal 
Community overall 
Have had a cervical smear 
Spring 
1988 
% 
70 
67 
62 
47 
63 
43 
55 
45 
40 
30 
12 
6 
48 
Feb.-March 
1990 
% 
69 
69 
66 
62 
60 
57 
56 
55 
51 
34 
26 
20 
56 
Table 1 
Experience of cervical smear, 
by age 
(February-March 1990) 
Community overall 
Reminder 
spring 1988 
Overall 
56 
(48) 
% of women who have 
had a cervical 
smear, by age 
Age 
15-24 
27 
(25) 
Age 
25-39 
70 
(63) 
Age 
40-54 
71 
(59) 
Age 
55 or 
over 
49 
(41) 
The percentage of women having had a cervical smear 
has increased in all age groups. As could be expected, 
in all countries it is the women between 25 and 54 who 
are most likely to have had a cervical smear (see 
Table 1). 
The countries can be divided into three groups, accord-
ing to the numbers of women between 25 and 54 who 
have already had a cervical smear: 
D United Kingdom, France, Denmark, Belgium, Ger-
many, Ireland, Netherlands (seven or more women 
out of 10); 
D Italy, Greece (five to seven women out of 10); 
D Spain and Portugal (two to three women out of 10). 
In the 15-24 age group, almost five women out of 10 
have had a cervical smear in the United Kingdom, 
France, Denmark and Belgium, compared with 
Photo: CEE 
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Screening is often carried out 
using mobile or semi-mobile 
units. 
Photo: CEC. 
approximately two out of 10 in Germany, Ireland and 
the Netherlands, and even fewer in the countries of 
southern Europe, i.e. Greece, Italy, Spain and Por-
tugal. 
Age at which first cervical smear taken 
Question: 
At what age did you first have a cervical smear? 
Before age 25 
Age 25-34 
Age 35-44 
Age 45 or over 
Total 
% having had 
a cervical smear 
Spring 
1988 
33 
27 
19 
21 
100 
Feb.-March 
1990 
31 
27 
20 
22 
100 
The differences between generations are considerable, 
as expected. The younger the women, the more likely 
they are to have started having cervical smears early. 
For example, 40% of women aged 25-39 had their first 
cervical smear by the age of 24 whereas this is true of 
only 8% of women in the 40-54 age group and a mere 
1% of women in the over-55 age group. 
Frequency of cervical smears 
The same question was put in this survey as was put in 
1988. 
Question: 
How often do you have a cervical smear done? 
Every year 
Every 2 or 3 years 
Every 4 or 5 years 
Less often 
No reply 
Total 
% having had 
a cervical smear 
Spring 
1988 
35 
25 
10 
17 
13 
100 
Feb.-March 
1990 
37 
27 
9 
16 
11 
100 
The frequency of smears can be seen to have increased 
slightly (at least every two or three years: 60% in 1988, 
64% in 1990). 
At the same time as this increase in frequency, 
however, there has also been an increase in the 
numbers of women having cervical smears done. 
Cancer experts recommend that women have their first 
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cervical smear as soon as they become sexually active, 
with follow-ups at least every three years. 
How does this recommendation tally with the actual 
situation in each country? 
to check their breasts regularly (70%) and the numbers 
who actually do so regularly (27%). 
The table below presents the combined results to the 
two questions, calculated in percentages on the basis of 
the total number of women interviewed. 
Belgium 
Denmark 
Germany 
Greece 
Spain 
France 
Ireland 
Italy 
Luxembourg 
Netherlands 
Portugal 
United Kingdom 
Community overall 
% of women having a smear 
at least ever 
Women aged 15 
or over 
41 
45 
51 
19 
17 
55 
28 
33 
58 
39 
12 
39 
38 
r three years 
Women who have 
had a smear 
72 
67 
78 
55 
61 
78 
51 
64 
86 
63 
59 
58 
68 
Breast checks: a quarter of women 
do it regularly 
70% of European women, when shown the list of 10 
recommendations in the European Code against 
cancer, rate regular breast checking as 'very impor-
tant'. The survey yields additional information on the 
practice of breast checking and mammography. 
Question: 
Do you ever feel your breasts to see if there is anything 
unusual? 
Regularly 
From time to time 
Practically never 
No reply 
Total 
Feb.-March 
1990 
% 
27 
38 
30 
5 
100 
Check their breasts: 
Regularly 
From time to time 
Never, 
or unknown 
No reply 
Total 
(%) 
State that checking breasts 
Very 
important 
24 
28 
16 
2 
70 
regularly is: 
Fairly 
important 
2 
9 
8 
1 
20 
Not 
important 
or no 
reply 
1 
1 
6 
? 
10 
27 
38 
30 
5 
100 
The table shows that only a minority of women actually 
practice what they preach with regard to breast check-
ing: only 24% say that the recommendation "Check 
your breasts regularly' is very important and actually 
do so regularly. 
Mammography: 
awareness is increasing 
Question: 
Let us talk now about mammography. Do you know 
what it is, and if yes, have you ever had it done? 
Does not know what it is 
Knows, but has never 
had it done 
Knows, and has had it done 
No reply 
Total 
Spring 
1988 
% 
23 
56 
19 
2 
100 
Feb.-March 
1990 
% 
19 
55 
24 
2 
100 
There is therefore a considerable difference between 
the numbers of women who say that it is very important 
The same phenomenon applies to mammography as 
applies to the cervical smear: there is progressively less 
ignorance about it and more women are having it done. 
The increase is most marked in Spain and Portugal, 
followed by the countries of northern Europe: the 
United Kingdom, the Netherlands and Denmark. 
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In decreasing order of 
positive replies in 1990 
Germany 
France 
Luxembourg 
Belgium 
Spain 
Italy 
Portugal 
Denmark 
Netherlands 
United Kingdom 
Greece 
Ireland 
Community overall 
Have had a 
mammography 
% 
Spring 
1988 
29 
24 
33 
26 
12 
21 
9 
17 
12 
8 
10 
5 
19 
Feb.-March 
1990 
32 
31 
30 
25 
23 
22 
22 
21 
18 
14 
9 
6 
24 
In all countries mammographies are most common in 
the 40-54 age group (See Table 2). 
Table 2 
Experience of mammography, 
by age 
(February-March 1990) 
Community 
overall 
Reminder 
spring 1988 
Overall 
24 
(19) 
% of women who have 
had a mammography, 
by age 
Age 
15-24 
8 
(5) 
Age 
25-39 
21 
(18) 
Age 
40-54 
39 
(28) 
Age 
55 or 
over 
24 
(21) 
Slightly more women are ignorant about mammogra-
phy than about the cervical smear (the European 
averages are 21% and 13% respectively). 
However, the countries where ignorance is highest are 
by no means the same: the Netherlands leads the field 
(41% do not know what mammography is), followed 
by Belgium (40%), the United Kingdom (37%) and 
Ireland (38%). 
Looking more particularly at the age group which 
should, in principle, be most concerned (55 or over), it 
is noticeable that in all the abovementioned countries 
40% or more of women in this age group do not know 
what a mammography is. (See Table 3 below). 
Table 3 
Ignorance 
concerning mammography, 
by country and age 
Belgium 
Denmark 
Germany 
Greece 
Spain 
France 
Ireland 
Italy 
Luxembourg 
Netherlands 
Portugal 
United Kingdom 
Community 
overall 
Overall 
40 
21 
16 
14 
23 
14 
38 
8 
12 
41 
16 
37 
21 
% of women who do not 
know what it is, by age 
Age 
15-24 
39 
41 
34 
13 
20 
27 
55 
12 
Age 
25-39 
27 
10 
13 
1 
16 
10 
30 
7 
Age 
40-54 
41 
18 
13 
6 
22 
7 
25 
5 
Sample too smal 
71 
16 
53 
32 
34 
5 
29 
16 
22 
16 
27 
15 
Age 
55 or over 
54 
21 
13 
31 
31 
15 
44 
10 
I 
43 
24 
41 
24 
Age at which first mammography done 
Question: 
' ' what age did you first have a mammography? At 
Before age 25 
Age 25-34 
Age 35-44 
Age 45-54 
Age 55 and over 
Don ' t r emember 
Total 
% having had a 
mammography 
Spring 
1988 
14 
20 
27 
18 
12 
9 
100 
Feb.-March 
1990 
18 
23 
24 
18 
11 
6 
100 
Over half of all women with experience of mammogra-
phy have had one done before the age of 45; the 1990 
survey confirms the 1988 findings. 
It is particularly important to study the variations in 
responses according to the ages of the women inter-
viewed. 
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Table 4 
Age at which women had a mammography for the first time 
(February-March 1990) 
First mammography at age 
19 or under 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65 or over 
No reply 
Total 
Overall 
% 
1 
3 
2 
3 
2 
4 
2 
2 
1 
1 
1 
2 
24 
C* 
1 
4 
6 
9 
11 
15 
17 
19 
20 
21 
22 
-
24 
Based on respondent's present age 
25 
% 
3 
6 
6 
4 
1 
-
-
-
-
-
1 
21 
39 
C* 
3 
9 
15 
19 
20 
-
-
-
-
-
-
21 
40-54 
% 
-
2 
3 
7 
6 
10 
5 
3 
-
3 
39 
C* 
-
2 
5 
12 
18 
28 
33 
36 
-
-
39 
55 or, over 
% 
— 
-
-
1 
1 
4 
3 
5 
4 
2 
2 
2 
24 
C* 
_ 
-
-
1 
2 
6 
9 
14 
18 
22 
-
-
24 
All figures are calculated on the basis of the total number of women interviewed in the generation indicated at the 
head of each column. 
C* equals cumulative score. The cumulative score is calculated as follows: under 'Overall', for example, 1% of 
women had their first mammography at age 19 or under, and 3% at age 20-24; the total percentage of women who 
have had their first mammography by age 24 is therefore 1% + 3%, i.e. 4%. 
Cancer can be more easily 
cured it detected in time. 
Photo: CEC. 
LiJkäJ etectíon <S> 
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Most of the women aged 40-54 who have had a 
mammography (28 out of 36) have had it done before 
age 45. In contrast, most women of 55 or over who 
have had one (16 out of 22) did not have their first one 
until after age 45 (see Table 4). 
Frequency of mammographies 
Question: 
How often do you have a mammography done? 
Every year 
Every 2 or 3 years 
Every 4 or 5 years 
Less often 
No reply 
Total 
% having had a 
mammography 
Spring 
1988 
20 
20 
9 
41 
10 
100 
Feb.-March 
1990 
24 
23 
7 
35 
10 
100 
It would appear from the results that the frequency of 
mammographies is increasing. 
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Europe against cancer — Examples of action 
on information, health education and training 
The following three sections present an overview of a number of 
different policies and actions in the context of the 'Europe against 
cancer' programme. 
At the start the accent was very much on the European Year of 
Information on Cancer and on the various collaborations with 
television companies and these are fully described in that section. 
Also of prime importance, however, has been the support given to 
the programme by the organizations against cancer of the Com-
munity, and indeed beyond. Their role is described by the 
Chairman of the European Cancer Leagues and amplified by the 
report from a typical league, the Italian one. 
Once the first push of information was achieved, the accent shifted 
to health education, especially in schools, and the programme has 
been instrumental in developing, in close collaboration with other 
parts of the Commission and with national authorities, a strategy to 
achieve an effective form of health education available to all the 
children in the Community. The cornerstone of this strategy is the 
set of recommendations established at the first European Confer-
ence on Health Education and Cancer Prevention in Schools held 
in Dublin in February 1990 and reprinted here in full. 
Finally, it is apparent that the health professions themselves need to 
be supported by the best possible initial and in-service training in 
this field, and the approaches to achieving this are described, with 
particular attention paid to the key role played by general 
practitioners. 
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An overview 
The European Year of Information on Cancer, included in the first plan of action, 
which took place in 1989, was intended by all concerned with the campaign against 
cancer to be a high point of the programme and a test bed for future actions. It certainly 
was the high point so far, both in terms of the scope of themes covered and in terms of 
the number of actions launched on both European and national scales. However, it 
was also an important trial for future approaches, in the sense that the efforts to spread 
the message to the general public exposed the limits of this kind of approach and 
pointed the way to more effective actions on the future, especially the need to refine 
selection of the target groups for the messages. 
Information directed towards 
the general public 
Among the most important information actions, we 
should mention those actions aimed at increasing 
public awareness, those which took place simultane-
ously in all Member States, those which had a particu-
lar impact in one or more countries and finally national 
initiatives with a European dimension which took place 
throughout the year. 
Among these actions aimed at increasing public aware-
ness figure in particular: 
Press conferences: 
D in January 1989 to launch the European Year in 
each of the 12 capital cities. It should be noted that 
in the UK the Prime Minister in person launched the 
European Year; 
D at the beginning of October 1989 to present the 
programme of activities for the 'European Week 
against Cancer'. 
Press releases on the results of the European opinion 
polls: 
D in January 1989 on Europeans and the European 
Code against cancer in order to evaluate public 
awareness of the code and of the programme; 
D in June 1989 on general practitioners and the 
European Code which made possible an evaluation 
of the level of awareness and of application of the 
Code among general practitioners; 
D in September 1989 on teachers and the European 
Code which gave interesting indications as to the 
behaviour of teachers concerning cancer. 
D European television programmes which were broad-
cast between May and December 1989 and a 
'Eurovision against cancer' programme broadcast 
on Tuesday 9 January 1990. These European televi-
sion programmes (content, target groups, evalua-
tion of results) are discussed in more detail in the 
article 'TV Europe against cancer'. They have, 
moreover, been complemented by other TV and 
radio programmes and spots produced on the initia-
tive of national actors; 
D European mobile exhibitions which were organized 
during the month of October, in trains (France, 
Spain) in buses (Belgium, Italy, Portugal), in sta-
tions or in tents (Belgium, Denmark, Germany); 
D a European week against cancer from 9 to 15 
October took place in all member countries and 
included a programme of actions and events (open 
door days, sporting events, exhibitions, distribution 
of the European Code and brochures); 
D the distribution, by the leagues and associations, of 
the European Code, January and October 1989; 
D the organization of sporting events open to the 
general public (marathons, athletic events, cycling 
rallies, etc.) to promote the European Code and its 
principal messages (May 1989). 
Events with a European dimension 
Among these events, the following should be men-
tioned in particular: 
D the European colloquium on spreading the message 
of cancer prevention held in Lisbon from 24 to 27 
February 1989; 
D the European conference on health education and 
cancer prevention in schools (from the point of view 
of the leagues and associations) which was held in 
Viterbo, Italy, from 5 to 7 April 1989; 
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A large number of information 
campaigns and exhibitions 
were organized across 
Europe in order to make 
millions of Europeans more 
aware of how cancers can be 
avoided. 
Photo: CEC. 
D the European conference on the treatment and 
prevention of cancer. Aimed at 100 medical journal-
ists from the 12 countries of the European Com-
munity, it was held in Venice from 11 to 12 May 
1989; 
D the presentation of the programme of activities of 
the European Year to the President and Members 
of the European Parliament, Strasbourg, 24 May 
1989; 
D the ninth meeting in London (25 and 26 May 1989) 
of the Committee of Cancer Experts who were 
received by the Prime Minister; 
D participation of two 'Europe against cancer' cars, 
with European staff, in the 'Tour de France' (with 
stages in Belgium and in Luxembourg). 
D the tenth meeting in Copenhagen (10 and 11 Octo-
ber 1989) of the Committee of Cancer Experts who 
were received by the Prime Minister. 
Numerous national activities having a European 
dimension were organized throughout the year. 
Important actions in the field of 
health education in schools 
Although the emphasis was put on information and 
prevention during the European Year, several impor-
tant actions were carried out in the field of health 
education. 
European level conferences to 
establish a coherent approach 
A European conference was held (in April) in Viterbo, 
Italy with the aim of laying the foundations for a 
coherent approach by leagues and associations to 
health education. This action was followed up and 
developed with those responsible for health education 
during the European conference on health education 
and cancer prevention in schools which was held in 
Dublin (7-9 February 1990). This latter conference, 
prepared in collaboration with the Ministers for Health 
and for Education, has identified a number of positive 
conclusions with a view to the development of a health 
education policy for schools. 
National initiatives supported 
by the Commission 
The year 1989 has also been the occasion for a certain 
number of national initiatives supported by the Euro-
pean Commission: the elaboration of education packs 
for teachers, conferences and colloquia aimed at 
teachers, the distribution of brochures in schools, the 
presentation of health education films. 
Among the most important actions which received the 
support of the European Commission in 1989, the 
following should be particularly noted: 
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D the training of teachers in Portugal, started in 1988 
and continued in 1989, to increase awareness of the 
European Code against cancer and to familiarize 
them with the UICC training manual, specially 
adapted for use in Portugal (Portuguese League 
against Cancer); 
□ development, in 1989, of a manual for teachers in 
the UK 'Cancer in perspective: an awareness course 
for educators' (Cancer Education Coordinating 
Group) complementing the manual of the UICC; 
D distribution, in 1989, of educational material in 
primary schools in Denmark (Danish Association 
against Cancer), in France (French Committee for 
Health Education), in Luxembourg (League against 
Cancer in Luxembourg and Ministry of Health); 
D distribution, during 1989, of educational material 
and packs for teachers and students of secondary 
schools in Belgium (Belgian Organization against 
Cancer), in Spain (Ministry of Education), in the 
Netherlands (Dutch Association against Cancer), in 
Denmark (Danish Association against Cancer); 
D organization of special awareness sessions among 
secondary school children in Portugal (Ministry of 
Health in collaboration with the Ministry of Educa­
tion); 
D organization of poster competitions on some of the 
European commandments for a healthy way of life 
in different primary schools in Spain (Spanish 
Association against Cancer in collaboration with the 
Ministries of Health and Education), in Luxem­
bourg (League against Cancer in Luxembourg), in 
Greece (Greek Association against Cancer) and in 
different secondary schools in Portugal (Portuguese 
League against Cancer and Ministry of Education). 
European audiovisual material — 
more than 30 000 videocassettes 
In addition, in 1989 the European Commission 
financed 3 600 000 brochures, some 6 000 000 copies of 
the European Code and the printing of approximately 
100 000 sets of 6 posters representing maps of cancer 
mortality in Europe and the European Code against 
cancer; it also circulated approximately 30 000 videos 
with health education programmes that had already 
been broadcast to the public in 1988 (see Annex IV). 
These materials, available in the nine languages of the 
European Community, were widely distributed in 
schools by the Associations against Cancer or by the 
Ministries of Health and Education of the 12 Member 
States. 
Increased participation 
of all the partners 
The European Year has been characterized by an 
active participation of the leagues and associations of 
the various countries, although the situation is different 
from country to country and depending on the associa­
tion. Without them the dissemination of the messages 
of the European Code would not have had the same 
impact. Moreover, the collaboration started in 1988 
between associations on both national and European 
level was continued and reinforced, as is shown by the 
large number of actions carried out by several associa­
tions working together. 
The financial support of the European Community 
made possible the financing of numerous programmes 
presented by national actors and the contribution of 
considerable support material (brochures, video films, 
various promotional 'gadgets'). 
Régis Malbois 
Adviser 
David Sweet 
Administrator 
Commission of the European Communities 
Europe against cancer programme 
Directorate-General for Employment. 
Industrial Relations and Social Affairs 
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The first action plan 1987-89 of the 'Europe against cancer' programme has not only 
had the effect that the EC Commission has made the Member States adopt this 
important common action plan against cancer, but it has also contributed to increasing 
the efforts among the European leagues in the fight against cancer. On this background 
1 warmly support the continuation of the programme in the years 1990-94. 
As president of the Association of European Cancer Leagues whose members also 
include cancer leagues from countries which are not members of the European 
Communities, I am particularly pleased to see that also the cancer leagues of these 
countries have been inspired by the action plan — it is for example worth noting that 
several countries outside the EC are now working on the basis of the European Code 
against cancer. 
However, it is important to emphasize the fact that the fight against cancer is not only a 
personal matter but also a public matter. 
Education and information of the citizens are of course of utmost importance — but if 
we are to attain the goal set in the action plan — that is to reduce the number of deaths 
from cancer by 15% by the year 2000, directives must be adopted and implemented in 
the fields mentioned in the action plan at a much faster rate than has so far been the 
case. 
I n the tobacco field, it is of a vital importance to adopt directives on, for instance, a total ban on the 
advertising of tobacco products, on the tar content of 
cigarettes and on the introduction of smoke-free areas. 
Furthermore, it is highly important that the Commis-
sion takes initiatives in the nutrition field, especially 
with a view to protecting the consumers against sub-
stances in food which may cause cancer. 
It is equally important to stress the necessity of the 
Commission giving higher priority to the labelling of 
chemical substances which are suspected of causing 
cancer. 
Moreover, the Commission must take the necessary 
steps to ensure that all women in the individual 
Member States are offered screening for cervical 
cancer and breast cancer based on the existing recom-
mendations. 
The 'Europe against cancer' programme has provided a 
welcome opportunity for the European Cancer Lea-
gues to deal with their responsibility to influence the 
public authorities to convert results of cancer research 
into practical policy. Accordingly, the Association of 
the Cancer Leagues (ECL) consisting of 27 European 
cancer leagues has decided to play a more active 
political role in questions of importance in the fight 
against cancer. 
The ECL has reached a consensus on how to deal with 
three major problems i.e. screening for cervical cancer 
and breast cancer and the labelling of carcinogenic 
substances. 
D in relation to cervix cancer the leagues recognized 
the need for nationwide organized screening for 
cervix cancer as a proven method to reduce cancer 
morbidity and mortality. 
Conditions for the implementation are well-trained 
screening health professionals, quality control of 
their performance, especially of the Pap smear, 
agreement on intervals and ages of women to be 
screened. Continuous scientific evaluation of the 
programme is needed; 
D nationwide mammographie screening was 
wholeheartedly supported by all leagues. Studies 
made in many countries in the last decade have 
shown that the potential reduction in mortality and 
in morbidity due to breast cancer is considerable in 
screening programmes using mammography among 
women over 50 years of age. 
The ECL supports the continuation of the existing 
Community programme and recommends that well-
organized screening programmes are implemented 
as fast as possible in all countries. 
Requirements for the achievements of this goal are 
well-trained personnel and facilities. Continuous 
scientific evaluation of the programme is needed. 
Moreover, in both programmes quality public infor-
mation is needed to motivate the target population 
to participate, including personal invitations; 
D the presence of carcinogenic substances in the 
environment was recognized by the leagues as an 
important worldwide problem. Their contribution 
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All partners of the 'Europe 
against cancer' programme 
participate in the European-
wide information campaign. 
Photo: CEC. 
Information 
to cancer mortality is not clearly identified in all 
cases at the moment. The growing problem forces 
the leagues to take action. More research is needed 
and the existing knowledge must be converted into a 
practical policy for cancer leagues enabling them to 
act as governmental policy influencing organiza-
tions. 
In the case of well-identified problems they have to 
increase the awareness of the general public on 
carcinogenic substances and should cooperate with 
relevant bodies to put pressure on public authorities 
on local, national and international level. 
The cancer diseases and accordingly the fight against 
cancer know no frontiers. A condition for success is 
international cooperation, and the establishment of the 
'Europe against cancer' programme is a vital contribu-
tion in this respect. 
As for the national cancer leagues the 'Europe against 
cancer' programme has so far led to intensified efforts 
on the national level. These efforts in the fight against 
cancer will no doubt be strengthened considerably 
during the second action plan with even closer coopera-
tion, on the basis of the programme, between the 
cancer leagues of Europe. 
Ole Bang 
Managing Director, Danish Cancer Society 
President, Association of European Cancer Leagues 
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As the 'Europe against cancer' programme commences its second action plan, I believe 
that there is a need to emphasize the positive aspects of the initiatives taken by the 
European leagues and associations against cancer and the considerable results 
obtained. 
The work which has been developed in common, and this is one of the most important 
results, has enabled us to develop within ourselves a genuine European awareness, not 
in an abstract sense but in full consciousness of the fact that via the convergence of the 
activities and the experiences of the different Community countries it is possible to 
establish with greater conviction and greater prospects of victory our struggle against 
such a grave disease. 
As a result, we do not feel that we are involved in sectoral interests or problems, but 
rather that we are participating directly and consciously in a programme and playing 
an active part in Community life. 
T he leagues and associations against cancer are established in and operate in all the Community 
countries. They probably represent more than 10 
million European citizens. Each of them has its own 
national characteristics and style, but all of them have 
been campaigning against cancer for many years in the 
area of public information, research and assistance to 
victims. 
In the course of the implementation of the 'Europe 
against cancer' programme the leagues and associations 
have played a particularly important role in relation to 
a wide range of measures: 
D the anti-smoking campaign; 
D information on appropriate nutrition; 
D promotion of early screening and diagnosis; 
D health education; 
D the training of health care staff. 
We should particularly like to emphasize the measures 
developed in relation to the anti-smoking campaign. 
Smoking today is a major social problem. 
The number of dead as a result of smoking in the 
countries of the European Communities amounts to 
about half a million people per year, 30% of them 
dying of cancer, 25% of heart disease and 45% as a 
result of respiratory disease. The role of tar as a cause 
of lung cancer has been known for many years and has 
been publicized by the World Health Organization and 
the International Agency for Cancer Research. The 
incidence of lung cancer has been increasing steadily in 
all the Community countries and in recent years it has 
also begun affecting women aged under 40. As a 
consequence of these developments and in order to 
face up to this serious problem the 'Europe against 
cancer' programme has launched measures to combat 
smoking. 
A delegation of the leagues and associations involved 
met a number of members of the European Parliament 
responsible for reporting on the Community Directives 
concerning the requirement to label tobacco products 
and indicate the maximum tar yield in cigarettes. 
It is with great satisfaction that the representatives of 
the European leagues and associations against cancer 
and the committees concerned with the campaign 
against smoking learned that the Council of Health 
Ministers of the 12 Member States which met in 
Brussels on 13 November 1989 approved the Directives 
on labelling tobacco products and on maximum tar 
yields as presented by the Commission and approved 
by the European Parliament. 
We all know that the European Community institu-
tions, from the Council through the Commission to the 
European Parliament are strongly committed to imple-
menting the Single Act and realizing the economic and 
social integration of Europe. 
In the face of such an important subject as the struggle 
against cancer which is one of the most widespread 
diseases of the European population we have to 
continue stressing the urgency of health care as an 
essential component of the process of constructing a 
united Europe. 
One of the priority aims of such a union is the 
improvement in the quality of life of all the citizens of 
Europe. 
I should also like to thank the President of the 
European Parliament Lord Plumb, who in May 1989 
was kind enough to grant an audience to the represen-
tatives of the leagues and associations against cancer. 
On the occasion of this meeting we reaffirmed our 
commitment to the European programme by suppor-
ting and developing our activities. 
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The Italian league against cancer is one of the first to have 
used mobile exhibitions to reach the general public directly. 
The leagues and associations have placed at the dis­
posal of the Community efforts in this area their 
information and action systems by offering their active 
collaboration in all measures to combat cancer. 
We were also very pleased to note that the Council has 
adopted the new action programme for 1990­94 pre­
sented by the Commission. 
The new plan will devote particular attention to staff 
training and also to prevention and improved nutrition. 
Where smoking is concerned, the programme sets out 
to define specific priorities and underscores in particu­
lar the need to cut smoking among young people and 
women. 
In brief, the new plan will improve awareness of the 
causes of cancer and the possibilities of prevention and 
treatment. The Italian League against Cancer will 
participate in the programme by developing its own 
measures, on the one hand by highlighting the risks run 
by those people who do not organize their lives in an 
appropriate way and on the other by calling for specific 
legal measures to safeguard public health. 
If practical prevention measures against cancer are to 
be realized there is a need to guarantee: 
D the effective participation of the public in the 
various initiatives realized in this connection via 
health education programmes; 
D the appropriate training and continuing training of 
medical and non­medical staff; 
D the availability of structures suitable for providing 
appropriate prevention; 
D the provision of legislative standards in relation to 
specific forms of action. 
The Italian League against Cancer offers all its support 
for the advancement of the European programme in 
the conviction that the necessary final objective is the 
preservation and improvement of human health above 
and beyond all technical and economic considerations. 
Maria Grazia Lanfranco 
Lega Italiana per la Lotta contro i Tumori 
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A successful collaboration 
No information policy can afford to neglect the audiovisual medium, a fact which was 
not lost on the 'Europe against cancer' programme which clearly perceived from the 
word go the need to base its 'information' platform on the production of films and 
videos for mass communication aimed at the general public. It was therefore decided at 
the outset to secure whenever possible the cooperation of the television channels of the 
Member States of the European Community. 
A European group of TV producers 
The approach was sound but fraught with obstacles, 
witness the socio-cultural and economic diversity of 
these countries and particularly the traditional 'jour­
nalistic' independence encountered in the world of 
television. As we shall see, however, even deep-rooted 
attitudes can be overcome and a seemingly daunting 
task turned into a wonderful example of solidarity and 
sense of collective responsibility. 
The first step was to set up the Group of Producers of 
Medical and Scientific Programmes of European Tele­
vision Channels. Most of the major EEC television 
companies were told in 1987 of the launching of the 
'Europe against cancer' programme and were invited to 
take part in the work of this group by appointing a 
representative to it, either the person responsible for 
scientific and medical programmes or, alternatively, 
the person responsible for documentaries or current 
affairs. This group has since then held around a dozen 
meetings in Brussels and has been the catalyst at 
European level for a vast audiovisual campaign to get 
the relevant messages through to a very broad public. 
The first European Week 
against Cancer (May 1988) 
A number of invitations to tender were sent out in mid-
1987 for the production of programmes to be shown by 
the European TV network during the European Week 
against Cancer (1-7 May 1988). 
The following programmes were produced as a result: 
D 'Lifestyles and cancer in Europe'. This 40-minute 
programme was entrusted to the BBC and directed 
by John Groom. The aim of the film was to make 
the public aware of the relationship between life­
style (smoking habits, eating patterns, excessive 
exposure to the sun, etc.) and the prevention of 
cancer; 
D 'Man and cancer'. Based on an original script by 
David Filkin (BBC), this 30-minute programme was 
produced jointly in London by the BBC (UK), the 
RTBF (B), the BRT (Β), the TVE (E) and the NOS 
(NL). Filmed in front of the public, this production 
uses large-scale models of cells, graphics and anima­
tion techniques to explain what cancer is, how it is 
triggered and how it can be avoided. The pro­
gramme sets out the 10 'commandments' of the 
European Code against cancer; 
D 'Euro-Jim against crab-cancer'. This is a four-
minute cartoon intended to make children aware of 
the five cancer prevention rules connected with 
lifestyle ('Don't smoke', 'Beware of alcohol!', 
'Avoid being overweight', 'Sun, yes but ...', 'Eat 
fresh fruit and vegetables'), was produced by AAA 
(Paris) and Final Cut (Brussels). 
These three programmes were made available free of 
charge by the Commission to all the EEC television 
channels for showing during the European Week. 
The results were on the whole very encouraging both as 
regards the number of broadcasts and as regards 
viewing figures and reception. 'Lifestyles and cancer in 
Europe', for instance, was shown by 11 channels and, 
in particular, was watched by around six million 
viewers in Germany (see annex for summary table). 
The audiovisual approach: 
A significant feature 
of the European Year 
of Information on Cancer (1989) 
In order to give a 'general public' slant to the launch of 
the 'European Cancer Information Year' (1989), pre­
paration of a 12-minute film on the content of the 
'Europe against cancer' programme was started at the 
end of 1988. 
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European television 
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informing the general public 
and promoting a healthier 
way of life. 
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As a follow-up to the TV showing, the four program­
mes produced in 1987 and 1988 ('Lifestyles and cancer 
in Europe', 'Man and cancer', 'Euro-Jim against crab-
cancer' and 'Europe against cancer') were adapted into 
the nine Community languages, reproduced on 30 000 
'general public' cassettes and distributed throughout 
the 12 EEC countries by the Community press and 
information offices, public relations agencies and gov­
ernmental and non-governmental organizations 
involved in the fight against cancer. 
In order to build up the corpus of audiovisual material 
for the European Year of Information on Cancer 
(1989); the 'Europe against cancer' programme sent 
out a fresh invitation to tender in June 1988 for the 
production of television programmes. 
In October 1988 it was decided to produce the follow­
ing programmes: 
D 'Vom Krebs geheilt' (Production: Dr H. Mohl — 
ZDF); 
D 'Cancers professionnels en Europe' (Production: 
Marie-Anne Mengeot and Salvatore Nay — RTBF); 
D 'Free generation' (Production: Stratecom SA); 
D 'Bronzer sans griller' (Production: Stratecom SA); 
D 'Can you treat cancer?' (Production: Yorkshire 
TV); 
D 'A very European cancer' (Production: Yorkshire 
TV); 
D 'Living with cancer' (Production: Yorkshire TV); 
D 'Eurovision against cancer' (Production: RTBF in 
association with other TV channels). 
With the exception of 'Eurovision against cancer', 
which will be dealt with separately, these programmes 
were all produced in the first half of 1989 and widely 
shown via the EEC television networks. 
The 52-minute 'Vom Krebs geheilt' programme, aimed 
at convincing the general public of the success of early 
detection drives, is based on accounts by cancer 
sufferers from different Member States of how they 
were cured. 
'Occupational cancer in Europe' goes back over the 
discovery of the first cases of occupational cancer, 
describes the present situation and reports on the 
efforts being made internationally, particularly by the 
European Community, to protect workers effectively. 
'Bronzer sans griller' ('Tan, don't burn') is a 26-minute 
programme on skin cancers, with special emphasis on 
malignant melanoma. This film goes into the somewhat 
chequered relationship between man and the sun and 
stresses the dangers of excessive exposure. 
'Free generation': this 26-minute programme is aimed 
at warning the 12-18 year-old group of the dangers of 
tobacco smoking. The film is presented by Ray Cokes 
(the MTV star presenter) against a backdrop familiar 
to this generation, i.e. rock music, cinema, advertising, 
adventure, etc. It exposes the tobacco industry's adver-
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tising strategy: sponsoring sporting or cultural events, 
fashion, rock concerts, etc. 
It features interviews with celebrities who do not or no 
longer smoke, the message being in the programme's 
slogan: 'Smoking is out!' 
'Can you treat cancer?' is a programme based on three 
subjects: 
D the state-of-the-art techniques used in radiotherapy; 
D the most recent methods of cancer treatment: bone 
marrow transplants, monoclonal antibodies, inter-
feron and interleukine; 
D early detection techniques. 
'A very European cancer' is devoted to breast cancer in 
women. It is tackled in three parts: an interview with 
Daniela, an Italian lady cured of breast cancer, detec-
tion methods and the difficulties encountered in this 
context, and the causes of breast cancer. 
'Living with cancer' hinges on the socio-psychological 
aspects of cancer and offers three reports: 
D an interview with Jessie Hunt, a 74-year old English 
lady who has suffered from cancer for the last 23 
years and who thinks that cancer ought to be 
considered in the same way as any other illness; 
the work carried out in a clinic in the Black Forest in 
Germany where children suffering from cancer are 
treated in the company of their families with a view 
to their reintegration into normal life; 
Michel, from France, tells of how he was turned 
down for a job with the French PTT because he had 
suffered from cancer as a child. 
D 
D 
This kind of discrimination is now prohibited by law 
in France. 
In parallel with these other programmes, 'Europe 
against cancer' asked the Leicestershire Health Educa-
tion Video Unit headed by Professor Ralph Rosenthal 
to produce a video on 'Prevention and early detection 
of cancer'. 
A brief introduction on the actual nature of the illness 
starts this programme which then goes into the 
methods of prevention and early detection of the 
following types of cancers: lung cancer, cancer of the 
colon, skin cancer, breast cancer, cervical cancer and 
cancer of the testes. It ends with a reminder of the 10 
commandments of the European Code against cancer. 
This film won the first prize for cancer films at the 
Parma International Scientific and Medical Film Festi-
val (Italy — 1989). Following this award, the pro-
gramme has been distributed on video in all the 
Member States of the Community and also in the USA, 
Canada and Australia. In addition, the USSR's No 1 
television channel has acquired the broadcasting rights 
for this film. 
'Eurovision against cancer' — 
January 1990: 
bringing the European Year 
to an end 
The European Cancer Information Year closed with an 
ambitious media event: 'Eurovision against cancer', 
which also marked the start of the 1990-2000 decade of 
fight against cancer. 
This programme, prepared over a two-year period and 
coordinated by the RTBF, the instigator of the project 
represented by Mrs Françoise Wolff and Mr Jean-
Michel Briou, is a unique technical achievement and 
reflects a tremendous solidarity between the members 
of the group of European TV channels. It brought 
together 11 channels from nine Community countries: 
RTBF/Télé21 and BRT 2 (Belgium), Antenne 2 
(France), ET2 (Greece), TV2 (Denmark), TVE 
(Spain), ZDF/3SAT (RFA), RAI UNO (Italy), RTP 
(Portugal), RTE (Ireland) and TV5. 
On 9 January 1990, these channels, with the exception 
of the Irish television channel which withdrew at the 
last minute, showed an information programme pro-
duced jointly with the support of the Commission of the 
European Communities on four major cancer preven-
tion themes: tobacco, alcohol, eating habits and sys-
tematic detection. 
The principle of the programme was simple enough. 
Each participating TV channel undertook to produce a 
4-5 minute spot on one of the four major themes 
mentioned above. These spots were then pooled, 
adapted into the nine Community languages and made 
available to each participant. On the evening the 
programme was shown, each participant organized a 
studio set around guests who were then given the 
possibility of duplex linkups for live discussion with 
foreign panels. We thus had the Greek putting live 
questions to the Belgian panels on the tobacco theme, 
the Belgian panels putting questions directly to the 
Danish panels on detection, etc. 
Italy and Germany, however, opted for national panels 
involving no exchanges with foreign sets. 
This programme can be considered a major success. On 
a country-by-country basis the results recorded are 
eloquent: 
D Denmark: Shown at 9 p.m. on 9 January. 
Viewing audience of 12% with peaks of 16% 
Appreciation: 4.07 on a scale of 0 to 5. 
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D France: Shown at 10 p.m. on 9 January. 
Viewing audience of 6% (i.e. 1 171 600 house-
holds), a remarkable score in a country where there 
is fierce competition. 
France-Soir rating: 9/10 
D Spain: Shown at 3 p.m. on 9 January. 
Viewing audience: 3.1% 
D Portugal: Shown at 9 p.m. on 9 January. 
Viewing audience: 35% 
D Belgium: BRT2 shown at 9 p.m. on 9 January. 
Viewing audience: 3% 
RTBF shown at 9 p.m. on 9 January. 
Viewing audience: 2.8% 
D Greece: Shown at 9 p.m. on 9 January. 
Viewing audience: 15% 
D Germany: Shown at 8.30 p.m. on 9 January on 
3SAT. 
Audience viewing figures unavailable. 
D Italy: Shown at 11.40 p.m. on 9 January. 
Viewing audience: 13.58%. 
It should be added that the RTBF French version of 
'Eurovision against cancer' was shown by TV5-Europe 
on 9 January 1990 and by TV5-Canada on 12 February 
1990. 
In the context of this report, it should be stressed that 
the European Committee of Cancer Experts chaired by 
Professor Maurice Tubiana was closely involved in the 
scientific scrutiny of the various audiovisual produc-
tions of the 'Europe against cancer' programme. 
Audiovisual productions in 1990 
1. In December 1990 a second edition of videocasset-
tes was made available for health education pur-
poses to all those involved in the nine-language 
programme of the Community. This new cassette 
contains four films ('Europe against cancer' in an 
updated version, 'Euro-Jim against crab-cancer', 
'Free generation' and 'Prevention and early detec-
tion of cancer'. 
2. The 'Europe against cancer' programme co-
financed with the various associations and leagues 
against cancer in the Member States of the Com-
munity (plus Finland, Sweden and Norway) a major 
documentary entitled 'Smoking'. It was produced by 
the Danish company 'Angel Film Aps' and directed 
by the Swede Dan Sail. 
This documentary was made available to all TV 
channels throughout the European Community for 
showing during the 'European Week against 
Cancer' in October 1990. 
An abridged 20-minute version of this film was pro-
duced at the end of 1990 and made available to all those 
involved in the 'Europe against cancer' programme. 
A positive response from the critics 
There was some reason to suppose that an audiovisual 
campaign on cancer might well fall flat in view of the 
somewhat forbidding nature of the subject and the 
natural propensity of the public to shy away from such 
deep and potentially disturbing issues. 
The results prove otherwise and show that, indeed, 
there is a public demand for reliable information on 
health education in general and particularly on cancer. 
So let us leave the last word to the journalists in their 
role as commentators and critics. 
France-Soir's report (11 January 1990) on 'Eurovision 
against cancer' stated: 'At last! How incredible, if not 
simply ridiculous, it has been to see Eurovision, ever 
since it started up, putting everything into futile 
ventures of the song contest type. The serious, adult 
Europe came of age on Tuesday ...', while the 'La 
Croix' issued on the same day carried an article by 
Jacques-Yves Bellay, who wrote: 'I always shudder at 
the thought of big medical shows, in cases illness itself 
becomes (...) the means to an end which is merely to 
entertain or to provide an opportunity for the advertis-
ers to cash in. Fortunately Eurovision against cancer 
(...) will not have been debased in this way. Tactfully 
steered by Jean-Daniel Flaysakier, the programme 
succeeded in involving 10 European television channels 
(...). This was television carrying out real journalism'. 
Lastly, Jacques Ponein had this to say in the 5 May 1988 
edition of Le Soir, 'There is no doubt that information 
is important to health, but it is an instrument whose 
effectiveness can be very variable and its effects not 
particularly incisive in the short-term. Take tobacco for 
example: (...) the repeated campaigns of the last few 
years have undoubtedly created a psychological climate 
in which smokers no longer feel comfortable. And in 
the developed countries (i.e. where there is a consistent 
flow of information) consumption of tobacco is falling 
2% every year...'. 
His article is entitled 'There is some considerable sense 
of achievement at the Commission of the European 
Communities: TV for Europe is here. Thanks to 
cancer...'. 
Jean-Pol Ferbus 
TV producer and consultant to the 
'Europe against cancer' programme 
Directorate-General for Employment. 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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Health education is now acknowledged to be a vitally important element in the central 
fight against ill health and disease. Through education we can provide young people 
with the means of overcoming many dangers to health, enabling them to acquire 
knowledge, positive attitudes and decision-making skills essential for the adoption of 
healthy lifestyles in a modern society. There is ample experience and much research 
evidence to show that the seeds of our health-related behaviour (our lifestyles) are sown 
in our early years. It is evident therefore that both primary and secondary schools can 
provide major opportunities for systematic and directly influential health education, 
ideally in partnership with families and community initiatives. It is not surprising 
therefore that there has been renewed interest in the development of effective 
programmes of school health education and promotion throughout Europe, an interest 
accelerated by anxieties over drug abuse, the spread of AIDS and the increasing 
carnage caused by cancer and heart disease. 
While this modern movement in European school health education goes well beyond 
the confines of the European Communities itself it is none the less true to say that the 
EC is playing a major role in its development. Other international organizations such 
as the European Office of the World Health Organization and the Council of Europe 
have also played prominent roles and, over the past six years, there have been several 
joint initiatives by these three organizations. Coordination between them is important 
because of the opportunity to conserve and rationalize scarce resources and, as 
important, to agree upon and pursue a joint policy for school health education in 
Europe. 
The purpose of school health 
education: to promote a 
healthy lifestyle 
We have come to understand, through a mixture of 
research evidence and experience, that the health of an 
individual is dependent upon a complex interaction 
between at least four important factors: 
D genetic inheritance; 
D the physical and social environments in which we 
live; 
D health­related behaviour (lifestyle); 
D the quality of the available health services. 
While there is little that we can presently do to alter the 
genetic predisposition of individuals there is however a 
great deal we can do to improve positively the other 
three factors. 
The main objective of school health education in 
Europe has become the promotion of healthy lifestyles 
amongst children and young people, but we have 
learned how difficult this can be in the absence of a 
supportive physical and social milieu. We now know 
that, to be effective, classroom teaching and learning 
must also be reflected by what pupils learn implicitly 
from the school milieu and, as far as possible, by what 
they observe and learn at home and in the surrounding 
community. 
This knowledge has helped us to construct the concept 
of 'the health­promoting school' as the main objective 
of our work. In its simplest sense the health­promoting 
school can be represented as the dynamic interaction 
between three main strands of learning and support. 
• What children learn in the classroom — through the 
health education curriculum. 
• What children learn from being in a school commu­
nity — through its ethos, its culture and traditions, its 
regard for human relationships and dignity — all of 
which should support and expand what is taught in the 
classroom. 
' Classroom ■ 
The 
health­
promoting 
school 
School 
milieu 
Family/ 
local 
environment 
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against cancer' campaign by 
designing posters. 
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Health education 
• What children learn from local environment — 
through living in families and exchanges with other 
influential individuals and groups; through the 
activities of health-related services such as doctors, 
nurses and hospitals and through public health cam-
paigns. 
The successful health-promoting school is one which is 
able to coordinate all these learning opportunities to 
the best possible advantage, to focus all these 
influences towards promoting the health of both pupils 
and teachers. Each of us can reflect upon how schools 
that are well known to us could improve their capacity 
for promoting health by small changes to their policies 
and management or by better liaison and coordination 
without of school agencies. 
In many instances where there is excellent learning and 
teaching in the classroom related to, for example 
tobacco or nutrition, the messages and influences are 
undone by bad experiences in school canteens or by 
lack of coherent smoking policies. Children learn from 
example and good role models, not from rhetoric. 
Promoting health — 
the challenges 
School health education in Europe faces many 
challenges such as: 
D where is it to be placed in the school programme? 
Most European countries have rejected it as a 
separate subject and insist that it is best integrated 
with other subjects. 
D how best is it to be coordinated across the cur-
riculum? If health education is to be integrated with 
other subjects (science, language, civics, etc.), how 
can we avoid boring repetition and how can we 
decide upon priorities? 
D what kind of teaching methods are most successful? 
Health education must be concerned to help pupils 
make decisions about their own lifestyles and this 
involves a participative process within which the key 
elements are the acquisition of knowledge and the 
skills through which the knowledge may be 
implemented into their day-to-day lives. 
Without doubt however, the most significant challenge 
facing school health education in Europe is that of 
teacher training. The pre- and in-service training of 
teachers in health education has been identified consis-
tently as a key issue by conferences, symposia and 
working parties on European school health education 
over the past six or seven years. Few countries provide 
room for health education in the pre-service training of 
teachers and there is need for good models to be 
developed and shared. If, during their routine training, 
health education is neglected, then it is difficult later to 
convince teachers (or schools) that it is an important 
part of the school programme. While many countries 
do provide some in-service education for teachers most 
agree that this is inadequate to provide a firm founda-
tion for the development of school health education 
82 SOCIAL EUROPE 1-91 
Europe against cancer - Examples of action on information, health education and training 
programmes. Without teachers who understand the 
importance of the major health issues and how they 
might be managed within schools, school health educa-
tion will continue to be viewed with suspicion and the 
health-promoting school will remain a dream. It is good 
to see therefore, that positive actions have recently 
taken place or are planned for the near future under 
the auspices of one or other of the three main 
organizations with an interest in promoting school 
health education. 
Planning for the future: promoting 
school health education 
One of the most important events ever held to promote 
the interest of school health education in Europe was 
the conference 'Health education and cancer preven-
tion in schools' organized for the Commission of the 
European Communities by Europe against cancer in 
Dublin in February 1990. 
Out of the work of three major working groups arose 
recommendations which will help to stimulate and 
revitalize school health education in the 12 Member 
States of the EC and will no doubt provide a lead for 
the rest of Europe. 
The recommendations will be implemented through 
three working groups comprised of representatives 
from each of the Member States, representing the 
interests of primary schools, secondary schools and 
teacher training respectively. The proposed work of the 
groups is outlined briefly here. 
Primary schools 
O To produce a teachers' school guide 'Promoting 
healthy lifestyles amongst primary schools in 
Europe' by the end of 1991; 
D to produce a training module to accompany the 
guide by the end of 1991. 
Secondary schools 
D To produce a teachers' coordinators' guide 'Pro-
moting healthy lifestyles of young people in secon-
dary schools' by the end of 1991; 
D to produce a training module to accompany the 
guide by the end of 1991. 
Teacher training 
D To plan and organize two five-day training work-
shops for teachers and teacher trainers in each of the 
next five years. 
Because training has been given such a high priority, a 
Summer School in School Health Education was held 
at the University of Southampton, United Kingdom, 
from 9 to 21 July 1990, which was financed jointly by 
the European Office of the World Health Organization 
and the Commission of the European Communities. 
Twenty-five countries were represented, including two 
participants from each of the Member States of the EC 
and two from most Eastern European countries. As a 
result of the Summer School, it will now be possible to 
call upon a reservoir of potential trainers from across 
Europe to help staff future training events. 
The Summer School has also helped to create an even 
stronger network of European colleagues which will no 
doubt be enlarged further over the next few years. The 
Southampton event proved to be such an unqualified 
success that there are plans to repeat the Summer 
School in 1991. An additional training workshop is also 
planned on nutrition education for August 1991 which 
will be held in Schleswig-Holstein, Germany, accom-
modating up to three participants from each of the 12 
Member States of the European Community. 
In addition to the training and other events outlined 
above, the 'Europe against cancer' programme of the 
European Community intends to stimulate school 
health education activities even further by offering 
sponsorship for selected school-based projects in the 12 
Member States. The projects accepted for sponsorship 
will need to be based upon the promotion of healthy 
lifestyles amongst pupils in both primary and secondary 
schools and must include those aspects related to the 
prevention of cancers such as tobacco and nutrition 
education. Submissions of projects have already been 
made by most countries and it is expected that go-
ahead for those selected will be made early in 1991. 
An Association for European 
School Health Education? 
European school health education is, relatively speak-
ing, in its infancy and recent comparative studies show 
how uneven its development is. Most experienced 
school health educators voice the opinion that its 
interests could be best served by the creation of a 
School Health Education Association for Europe 
(SHEAE). 
At present there is no one single organization devoted 
specifically and totally to the development of school 
health education in Europe. There are organizations 
set up to consider single issues such as tobacco smoking 
or nutrition or community health education. There is as 
yet, however, no forum for the discussion and develop-
ment specifically of school health education in its 
entirety. 
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While school health education shares basic principles 
and ideas with community health education,, it has 
nevertheless developed guiding principles of its own 
which are uniquely related to schools — for example 
the health-promoting school, the spiral curriculum, 
starting from where children are, integration, coordina-
tion, etc. 
Where countries have introduced a school health 
education association, school health education has 
prospered and developed — such as in the United 
States of America, Canada and Australia. Associations 
typically encourage research and development and the 
exchange of ideas in school health education in three 
ways: 
By stimulating activities in the regions which in the 
case of Europe would be in each of the European 
countries. 
By stimulating international exchanges through 
international conferences — which could be held 
annually or every two years in different countries on a 
rotating basis — south, north, east and west. 
By producing a six-monthly or quarterly newsletter 
or magazine School health education in Europe contain-
ing recent research and/or developments from across 
Europe and other continents. 
No other association or organization would be in any 
way threatened or intimidated by the creation of a 
European Association of School Health Education, the 
membership could be a new clientele — the 200 000 
primary and 60 000 secondary schools of the European 
Communities together with those from all the other 
European States. The task of such an Association 
would be to ensure that every one of its schools was as 
health-promoting of its staff and pupils as it possibly 
can be. A goal which I am sure every parent, teacher, 
pupil or citizen would share. 
Trevor Williams 
Consultant, 'Europe against cancer' programme 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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The contribution of the European Community 
to health education 
Deprived of direct competence in the field of public health or general education, the 
European Community has nevertheless succeeded, with the 'Europe against cancer' 
programme, in promoting significant actions in the field of health education. 
The importance of the European 
Code as a guide to a healthy life 
One of the first tasks the Committee of Cancer Experts 
took on, in 1987 and 1988, was the devising of a 
'European Code against cancer'. These 10 recommen-
dations which result from the latest research are based 
on two statements: on the one hand, a healthy way of 
life (tobacco, alcohol, nutrition, etc.) is beneficial to 
health in general and allows us to avoid certain cancers 
as well as other diseases; on the other hand, awareness 
of one's body enables us to detect certain cancers early, 
therefore making it possible to cure them. 
These 10 commandments are aimed at adults and 
adolescents. For primary school children and young 
adolescents at secondary school level, only those com-
mandments concerning a healthy way of life are 
appropriate. 
This 'European Code against cancer' was approved 
during the second half of 1987 by the non-governmen-
tal organizations against cancer and by the Ministers 
for Health. It was formally transmitted to Heads of 
States and/or Governments, during the European 
Council of Copenhagen in December 1987, in order to 
achieve maximum publicity in 1989, the 'European 
Year of Information on Cancer'. 
On the basis of the recommendations of the European 
group of senior officials for health education which met 
six times from 1987 to 1989 the 'Europe against cancer' 
programme pursued the following strategy: to directly 
emphasize the healthy way of life (by adding the 
'awareness of one's body' dimension for adolescents) 
and to indirectly promote positive benefits for cancer 
prevention. As for the opportunity to approach the 
disease as such, this was left to the appreciation of the 
different partners of the programme in the Member 
States. So, in southern Europe, the word 'cancer' very 
often remains taboo, which is not the case any more in 
northern Europe. 
Since the launch of the first action plan a number of 
actions in the field of health education have taken place 
at both European and national level. These include 
conferences, training seminars and working groups. 
With the second action plan 1990-94 of the 'Europe 
against cancer' programme, these awareness campaigns 
for children and adults promoting a healthier way of 
life and an awareness of one's body will increase during 
the next five years. 
The programme contributes 
to the improvement of the daily 
environment of children 
In order to attain its principal goal of promoting the 
adoption of a healthy lifestyle among children, health 
education cannot limit itself to classrooms or school 
programmes. What is the use of a message denouncing 
the bad effects of tobacco if teachers freely smoke in 
schools, if bills around schools show advertisement in 
favour of tobacco, or if periodicals for youngsters 
contain advertisements for tobacco? 
Unfortunately, this type of advertising is still very 
common in newspapers, periodicals and billboards of 
several Member States. This situation is particularly 
prejudicial for young people who are, in fact, the main 
target of tobacco dealers. In some cases, advertise-
ments filter into periodicals for young people. Fortu-
nately, some Member States forbid such practices. 
However, young people of these Member States are 
not totally protected from such harmful influences. 
Indeed, newspapers, periodicals and magazines circu-
late more and more in the European Community. 
Moreover, in different countries, learning a new lan-
guage is not done any more with the help of works from 
Goethe, Victor Hugo or Shakespeare, but with magazi-
nes for the general public. That is why, in June 1989, 
the European Commission took on the harmonization 
of the existing dispositions in the Member States 
concerning advertisements in favour of tobacco pro-
ducts by means of bills and posters. 
This European legislation can only facilitate the task of 
teachers by avoiding that messages spread in class-
rooms be contradicted in the children's daily environ-
ment. Moreover, this European action in favour of a 
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role in this long-term action. 
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helps them through the 
organization of training 
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healthier way of life is also reinforced by the 'informa­
tion of the general public' section of the 'Europe 
against cancer' programme. 
With the 'Europe against cancer' programme, the 
European Community, under the banner of the 'Citi­
zens' Europe', succeeded for the first time in its 
history, in making a significant contribution to health 
education in schools. In some respects, this interven­
tion is decisive, notably in the domain of the fight 
against tobacco. This breakthrough, launched in 1987. 
is being enlarged and built on during the second plan of 
action 1990-94 of the 'Europe against cancer' pro­
gramme. 
Michel Richonnier 
Head of Programme of action against cancer Unit 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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From Viterbo to Dublin 
A strategy unfolds 
Health education in schools was not born in Viterbo during the Conference which was 
organized by the Italian League against Cancer from 5 to 7 April 1989 under the 
auspices of the Commission and the 'Europe against cancer' programme. Several 
conferences on the subject had already been held beforehand organized by the 
Commission or other international organizations such as the World Health Organiza-
tion or the Council of Europe. Certain countries had already begun to implement 
certain principles of health education in schools. But for the most part this entailed 
conferences and seminars aimed at specialists or initiatives taken by officials in 
Ministries either inside or outside of the direction defined by the public authorities. 
T he main accomplishment of the Viterbo confer-ence, whose theme was the role of health educa-
tion in the prevention of cancer, was undoubtedly that 
it assembled for the first time representatives from a 
variety of backgrounds: associations and leagues 
against cancer, teachers, people and organizations 
working in the field of health education as well as 
doctors, dentists, nurses and those working in the fight 
against tobacco. Together they tried to make an 
inventory of current experience and methodologies and 
to sketch an outline of how associations and leagues 
could contribute to the process of health education. 
With the distance necessary to judge the significance of 
such an event, it can be seen today that the final 
recommendations made by the group of associations 
and leagues of the Community at the end of this 
conference, served as a starting point to a strategy 
which would later be defined on Dublin. 
D an exchange of information on national experiences 
which would allow an objective assessment of suc-
cesses and failures in each country; 
D the establishment of a database on what is available 
on health education in each country from informa-
tion to teacher training in health education. There is 
a wealth of such documentation but it is often 
scattered and deserves to be better known; 
D the development of precise concrete and practical 
recommendations for those responsible for health 
education in the Member States. 
The outcome of the conference corresponded closely 
with its proposed objectives and justified the hopes of 
the Commission and the national ministries. The actual 
recommendations approved by the national Ministers 
for Education accepted: 
D the extent and content of a policy on health educa-
tion; 
The Dublin conference: 
the beginning of a real strategy 
The European conference, held in Dublin from 7 to 9 
February 1990 was on the same theme as that of 
Viterbo and in the framework of the 'Europe against 
cancer' programme. It gathered together individuals, 
organizations, institutions and associations working in 
health education including those with experience in 
particular areas essential to health education - healthy 
lifestyle, tobacco, nutrition teacher training. 
The objectives of the conference were essentially to 
promote a positive and dynamic approach to health 
education in every country. Three particular objectives 
had been specified: 
D the essential role of the primary teacher in aware-
ness and respect for the human body and its 
protection from nuisance; 
D the role of second-level teachers in teaching about 
healthy lifestyle through studying particular diseases 
especially cancer; 
D the definition of methodology for teacher training in 
health education. 
The proposition regarding the content and the 
methodology of health education as well as the training 
of teachers were sent to those responsible for health 
education policy. Working groups were established at 
the European level to study each of these three 
propositions. 
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In February 1990, the 
Community took the initiative 
of organizing, in Dublin, a 
European conference on 
health education in schools. 
This was a follow-up to the 
meeting of European 
organizations against cancer 
in Viterbo, in 1989. 
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Moreover to assure the success of the conference it was 
decided that its final conclusions would be discussed at 
national conferences which would be attended by those 
responsible for health education nationally. Such con-
ferences have already been held in some countries and 
are being planned in others. 
To conclude, while the Viterbo conference was the 
start of a common reflection on health education, that 
in Dublin defined and implemented a real strategy on 
which in the future those working a health education at 
either European or national level can build. 
Régis Malbois 
Adviser, Programme of action against cancer Unit 
Directorate-General for Employment, 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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Oncology in the medical curriculum 
The fight against cancer is a fight against a complex phenomenon the causes of which 
are still largely unknown. For this reason, research is one of the essential elements of 
oncology, that branch, of medicine which deals with the diagnosis and treatment of 
tumours. 
A nother and fundamental pillar in the fight against cancer is the training of health professionals. The 
need for training has become permanent and pressing 
in recent years for three main reasons: 
D the first is that, according to the latest estimates, up 
to 20% of cancer deaths are due to late diagnosis or 
inadequate treatment. In fact, in Europe it has been 
shown that approximately 45% of cancer patients 
are curable, signifying that 35% of our defeats can 
be imputed to the intrinsic biological aggressiveness 
of the disease. Therefore, to achieve a reduction in 
this figure, our means of attack lies in experimental 
research in the laboratories, where scientists are 
constantly trying to understand the mechanism of 
cellular transformation into malignancy. Further-
more, in view of the need of improving the majority 
of European health systems, a reduction in the 
number of cancer deaths will require us to invest 
increasingly in education and training; 
D the second reason lies in the fact that the teaching of 
oncology is a difficult task owing to the need for so-
called interdisciplinarity, meaning integration of 
diverse specialities and backgrounds, whereas in the 
past there was a rigid separation of the roles of 
medical disciplines (in so far as gastric cancer simply 
had to undergo surgery and leukaemia was cured 
exclusively by drugs). One of the major achieve-
ments of modern oncology is, in fact, this multidisci-
plinary approach to the cancer patient: mutilation of 
limbs for sarcomas has been drastically reduced by 
combining less extensive surgery with more 
chemotherapy; the breast preserving treatment of 
breast cancer has been made possible by a synergis-
tic combination of limited surgery with 
radiotherapy; 
D the third reason which makes training so important 
in oncology is the rapid development of technology 
in this field. New methodologies, such as the use of 
laser in cancer treatment or nuclear magnetic reso-
nance in tumour diagnosis, are not yet included in 
the curricula of most medical faculties. Nevertheless 
the oncologist finds himself obliged to employ these 
new techniques, imposed on him by the reality of 
technological development, immediately. 
Unfortunately, a standardized system of control of 
training and updating for health professionals is sadly 
lacking in Europe. 
In the United States, medical training is both checked 
periodically by the American Medical Association and 
encouraged by the government by way of fiscal benefits 
for the doctors who attend selected congresses and 
educational meetings with the purpose of bringing 
themselves up-to-date (credit hours of training). There 
are no rules of a similar kind in most of the member 
countries in Europe. A solution should be found, 
because it is not possible to rely exclusively on the good 
will and the humanist tradition and culture of our 
doctors. 
At undergraduate level, there is a need for a cur-
riculum which will include oncology for all European 
medical students; a proposal was prepared by the 
European Commission at a Consensus Conference in 
Bonn in 1988 and some of the member countries have 
already implemented it. It guarantees at least 75 hours 
of coordinated teaching of oncology for all medical 
students including a compulsory examination at the 
end. At postgraduate level, a crucial role in the fight 
against cancer is played by the general practitioner who 
must then be well trained in educating his patient (anti-
smoking campaigns, etc.), in being a skilled early 
detector of tumours, in assisting his patients with 
cancer during treatment and in the cases where pain 
control and terminal care are needed. 
Specialists who are not oncologists can also contribute 
enormously and, consequently, need to be continually 
updated at least in their specific fields of action 
(dentists for oral cavity tumours, gynaecologists, 
haematologists, etc.). Oncologists, too, need to make 
an effort in this direction: it has been estimated, for 
example, that three relevant papers on breast cancer 
are published every week in medical journals. All this 
concerns cancer nurses as well, and it is more and more 
frequently being suggested that a specialization be 
recognized in order to encourage these crucial profes-
sionals, both economically and in terms of their status 
within the medical community. 
As in other important fields of our social life, the 
European Community can play an extremely important 
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role in improving cancer education and training by 
recommending an advance curriculum in oncology to 
all medical schools, by harmonizing oncological 
specializations among the member countries, by sug-
gesting incentives for the permanent education of 
doctors and nurses and by activating mechanisms of 
'training the trainers' to spread the knowledge of 
cancer prevention and management. 
Dr Alberto Costa 
Director, European School of Oncology 
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Using advisory committees to promote cancer training 
Training as a whole for certain health professions is regulated within the European 
Community by directives: there are separate ones for each profession concerned.1 
Their basic purpose is to facilitate the free movement for purposes of employment of 
Community citizens holding the qualifications referred to in the directives. They do this 
by listing the professional diplomas recognized at Community level and by setting the 
criteria to be met in the training leading up to the award of those diplomas within 
Member States. 
W hen the directives were under discussion, it was recognized by the Council and the Commission 
that ongoing advice would be needed on the effective 
implementation of the directives and on any changes 
needed to them to reflect developments in professional 
training, both basic and post-basic. At the same time 
that it adopted the successive directives the Council 
therefore also adopted decisions setting up training 
advisory committees, responsible for helping the Com-
mission to ensure comparably high standards of train-
ing throughout the Community. Each committee has 72 
members, nominated by the Member States and drawn 
from the professions at large. There are three groups of 
members — the practising profession, the teachers and 
the competent authorities. The advisory committees 
are the authoritative sources of advice to the Commis-
sion on training for the health professions. The Com-
mission provides the secretariat for the committees. 
With the launch of the 'Europe against cancer' pro-
gramme's plan of action, it was natural that the 
Commission should request the advisory committees 
for doctors, nurses and dentists for their views on the 
present state of the art in training in cancer and for 
their recommendations as to improvements that were 
desirable and feasible in such training. 
The committees had at their disposal the general advice 
given in this field by the committee of national cancer 
experts, but the Commission looked to the three 
advisory committees for a much more detailed assess-
ment, one upon which specific future action in training 
could be built. The advisory committees were asked to 
report on all levels and forms of training - basic, 
specialist, continuing professional education, and 
teaching technology. 
All three advisory committees had to work within a 
tight timetable, but they finished their task by the end 
of 1988 and the reports and recommendations on 
training in cancer for their respective professions are 
now public.2 
In addition, as part of this work there was a conference 
held in Bonn in May 1988 upon undergraduate training 
in cancer and the Royal Marsden Hospital, London, 
did a review of the training of nurses in cancer. There is 
insufficient space here to present in detail the recom-
mendations of the committees, but copies of their full 
reports can be obtained on request from the Commis-
sion (Directorate-General for the Internal Market and 
Industrial Affairs). There were certain key conclusions 
common to all reports, however, and these merit 
attention. 
One was the emphasis placed on prevention and early 
detection in the fight against cancer, and the conse-
quential need to improve the skills of health personnel 
in these areas of their professional training. Prevention 
on the one hand, and early detection and treatment on 
the other, help to avoid the need for more extensive 
and distressing late treatment of cancer. They are also 
the most cost-effective approach to pacient care. 
Improving the capabilities 
of GPs and dentists 
Allied with this conclusion in all three reports was the 
emphasis placed upon the role in prevention and early 
detection of the front-line professionals, those in 
routine frequent contact with patients. The committees 
felt that the training in cancer of such health personnel 
justified particular attention in the future. Especially in 
mind here were general medical practitioners and 
general dental practitioners. In short, the family doctor 
and family dentist. 
The committees felt that, in general, there was need for 
better coordination in the teaching of cancer within and 
between training institutions. 
Doctors, nurses, midwives, dentists, pharmacists and veterina-
rians. 
Doctors: Doc III/D/890/3/88; nurses: Doc III/D/248/3/88; dentists: 
Doc III/D/886/3/88. 
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Given the speed of development in knowledge and 
technology, the skills of health professionals in cancer 
can rapidly become out of date. This is especially true 
of practitioners who work mainly by themselves, away 
from health institutions. The three advisory commit-
tees therefore stressed the importance of well-con-
structed schemes of continuing professional education, 
readily available to health personnel working in all 
types of settings. The committees found that, on the 
whole, the arrangements at present made for continu-
ing professional training in cancer were deficient in a 
number of ways. 
Lastly, all three committees considered that the Com-
munity could play a valuable role in cross-fertilization 
of ideas and experience in the field of teaching techno-
logy in cancer. 
As regards the future, the Commission made it clear to 
the committees from the beginning that it was not 
looking for a single one-off exercise but that it was 
seeking recommendations for continued action in the 
field of training. The Commission's proposals for such 
further action are to be found in its action programme 
for 1990-94. The new programme proposes that the 
budget provision for action on training should be 
considerably increased from the figure in the 1987-89 
programme. 
A double approach: 
the Commission 
and national authorities 
The approach to be taken over the next four years falls 
into two broad areas. There are the initiatives that the 
Commission proposes to take under its own responsi-
bility and direct funding. 
Some of these initiatives are already well under way, 
such as those on the curriculum and teaching material 
for general practitioner training in cancer. Work is also 
in hand on developing agreed core curricula for train-
ing in cancer for nurses and dentists. 
The other broad area is the initiatives that could and 
should be taken directly by national authorities, gov-
ernmental or professional, to give a practical follow-up 
to the recommendations of the three advisory commit-
tees; with a view to trying to stimulate such initiatives 
the Commission took the unusual step of making the 
work of the three advisory committees the subject of a 
formal recommendation of its own.3 Recommendation 
89/601/EEC of 8 November 1989 is addressed to the 
OJ L346, 27.11.1989. 
Thanks to the programme, 
students of the health 
professions should have a 
minimum training in 
oncology. 
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Member States, and it requests that they, their compe-
tent authorities and their establishments responsible 
for professional training should ensure that the recom-
mendations of the committees are widely distributed, 
discussed and implemented. The recommendation also 
forewarns that the Commission will in due course 
review the practical outcome of the committees' recom-
mendations in the Member States. 
The work of the advisory committees in cancer is, of 
course, by no means at an end. They are not consti-
tuted in such a way as to enable them to undertake the 
detailed activity which is already in hand or which will 
begin as the 1990-94 programme gathers speed, 
although individual members of the committees will be 
drawn into this detailed work by virtue of the particular 
expertise that they can provide. The committees as a 
whole will be kept informed about the implementation 
of the 1990-94 programme, and they will be free to 
offer their advice about it. They will have a particular 
interest in the relationship between specific ideas for 
training in cancer and the curricula as a whole for the 
professions for which they are responsible. All cur-
ricula are already overcrowded: increasing the 
emphasis given to one area of study — in this case 
cancer — runs the risk of creating imbalances else-
where in a curriculum. 
Involvement in cancer has been, and will remain, an 
unusual experience for the advisory committees. The 
directives under which they function state the criteria 
for training in fairly broad terms only. Moreover, 
where indiviudal areas of study are mentioned it is in 
terms of disciplines and not of diseases. In the case of 
cancer, the committees were requested for the first 
time to study in depth the training for a specific disease 
and, in doing so, to consider the prevention and 
treatment of that disease. Cancer was also a new 
venture for the committees in that their involvement 
was not directed towards issues affecting freedom of 
movement but towards the intrinsic nature of training 
in cancer and its appropriateness in equipping health-
care personnel to meet the needs of patients. 
Sidney Allman 
Principal Administrator 
Unit for freedom of establishment 
and freedom to provide services 
Directorate-General for the Internal Market 
and Industrial Affairs 
Commission of the European Communities 
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The role of the general practitioner 
'In the campaign against cancer, general practitioners are in the front line. The 
spontaneous trust which is placed in them and their continuous contacts with their 
patients make family doctors a cornerstone of any policy of prevention, of systematic 
check-ups and of early detection of cancer'. With these words the committee of leading 
cancer experts introduced their comments on the training needs of general practitioners 
to fully engage them in the 'Europe against cancer' programme. 
A key role 
for the general practitioner 
The role of the general practitioner involves him in the 
health care of the population from birth until death. In 
consequence, he is in contact with his patients on 
average at least three times a year. Thus he is in a 
unique position to advise his patients, not only about 
the life-style issues in relation to cancer but also 
concerning appropriate screening examinations, some 
of which he can carry out himself. Furthermore, 
because of his continuing contact with his patients over 
long periods of their lives he is aware of their personal 
and family history and is in a position to identify those 
individuals who are particularly 'at risk' of developing a 
cancer and who merit special screening counselling. 
As the physician responsible for the care of the patient 
at home he is involved not only in the early diagnosis of 
cancer but also the care of the patient with cancer when 
he is at home. If the patient is living at home during 
treatment the general practitioner will be involved in 
the management of the side-effects of treatment and, 
increasingly, will be involved in the treatment itself 
(chemotherapy, immunotherapy or hormone therapy). 
Certainly he has an essential role in caring for the 
patient after treatment, in rehabilitation as well as 
during periods of remission. The family physician has 
always played an essential role in terminal care of his 
patients and this role is particularly important in the 
case of patients with cancer. Not only does this require 
his particular skills in terminal care but also the use of 
measures available to alleviate the symptoms associ-
ated with an incurable cancer. 
In order to fulfil all of these functions the general 
practitioner requires specific postgraduate training, 
analogous to that of specialists. This has been recog-
nized by the European Community in the Directive on 
specific training of general practitioners (Directive 86/ 
457/EEC). This Directive, whose first provisions 
became operative on 1 January 1990, requires Member 
States to set up specific postgraduate training program-
mes for those intending to become general practition-
ers and offers the opportunity to incorporate in these 
programmes appropriate training in prevention, early 
detection and treatment of cancers. This training is 
theoretical and practical, incorporating not only infor-
mation about the frequency of cancers and their early 
detection but also the real possibilities available for 
treatment. Because of his special relationship with 
patients on a continuing basis over many years, the 
general practitioner is the best person to break down 
the taboo which inhibits frank and open discussion of 
cancer, still commonly regarded as a dreaded disease. 
The fact that certain cancers can now be cured, can be 
treated and by adjustment of life-styles avoided or the 
risk substantially reduced, is a message which the 
family physician can convey on an opportunistic basis 
during consultations. 
In certain areas the family doctor has quite specific 
contributions to make. 
Smoking 
As tobacco plays such an important part in the develop-
ment of many diseases, not only cancers, the general 
practitioner is best placed to influence smoking habits 
in the population. He not only has the opportunity to 
enquire about smoking practices in the context of many 
consultations, but also to influence his patients by his 
own example. 
Alcohol 
The important role of alcohol in certain diseases 
presents a possibility for the general practitioner to 
advise his patients concerning their use of alcohol. This 
is particularly relevant to the development of cancer 
when it is combined with smoking. 
Diet 
This aspect of the individual life-style is one frequently 
discussed in the context of many diseases. The general 
practitioner with his special knowledge of the patient 
and of his family is able to advise his individual patients 
concerning dietary factors relevant to certain cancers. 
Early diagnosis 
This is a particularly important part of the role of the 
general practitioner as he is likely to be the first person 
to be presented with any abnormal symptom or anxiety 
of a patient concerning his health. 
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Whether these symptoms are related to a cancer or not, 
the consultation presents either the opportunity to 
diagnose a cancer at the time of consultation or to 
advise and, if the patient is willing, carry out or arrange 
appropriate screening procedures, e.g. cervical screen-
ing, or instruction in breast self-examination. 
Actions 
by the European Community 
The advisory committees on medical, dental and nurs-
ing training considered the training of health personnel 
in the matter of cancer and the Commission has 
commended their recommendations to Member 
States.1 In the recommendations on medical training 
the vital role of general practitioners was recognized 
and specific training in screening methods, counselling, 
appropriate methods of treatment, rehabilitation and 
terminal care called for. The importance of teaching of 
these subjects in continuing medical education was also 
stressed. 
In order to seek the best method of implementing this 
and to engage general practitioners as actors in the 
'Europe against cancer' programme, a group of rep-
resentatives of general practitioners was established. 
As a result general practitioners have been involved in 
various ways during the European Weeks against 
Cancer. The group is examining the appropriate cancer 
core-content of specific training programmes for 
intending general practitioners and will be making 
1 OJ L346, 27.11.1989. 
recommendations on continuing medical education 
programmes. 
Unfortunately in some Member States the number of 
family doctors smoking remains high whereas in others 
huge reductions in the number of doctors smoking have 
been achieved. The representatives of general prac-
titioners are promoting 'no smoking' practices in all 
their organizations and are examining the best ways in 
which they can use the successful methods of reducing 
smoking amongst doctors in the UK. 
There is wide variation between Member States in the 
degrees to which general practitioners carry out cervi-
cal screening or are trained to carry out this procedure. 
Recommendations for pilot projects in those Members 
States where there is no training have been made. 
Following the extension of the training programmes to 
include treatment, palliative medicine will constitute a 
particularly important sector to be included in both 
specific and continuing education programmes. 
In the course of the action plan 1990-94 firm founda-
tions will be established to ensure that general prac-
titioners as key actors in the programme have the 
opportunity to be adequately trained to carry out their 
essential role in education, prevention, early diagnosis 
and the treatment of cancer. 
Dr Alan Rowe 
Consultant to the 
'Europe against cancer' programme 
Directorate-General for Employment, 
Industrial Relations und Social Affairs 
Commission of the European Communities 
General practitioners, key 
actors in the programme, 
must receive adequate 
training. 
Photo: CEC. 
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Research 
One of the earliest actions of the 'Europe against cancer' pro-
gramme was to include a cancer chapter in the programme for 
scientific research of the European Community. Professor Bleehen 
here describes the range of actions undertaken or coordinated at 
Community level while Dr Vermorken concentrates on the major 
projects in radiation treatment led and largely financed at Com-
munity level. Finally, demonstrating that European cooperation 
can take many forms, Professor Veronesi describes the develop-
ment and achievements of the European Organization for Research 
and Treatment of Cancer (EORTC). 
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During the first action plan 1987-89, the 'Europe against cancer' programme had its 
highest public visibility in the areas of prevention and education. This is, of course, as 
it should be. However, we should not assume that it is being slow to implement activity 
in aspects of research. 
During the early meetings of the cancer experts, decisions were very clearly made as to 
the research priorities. The four categories of endeavour that were identified were those 
of fellowships, clinical orientated research, epidemiological research and basic 
laboratory research. 
It was unanimously agreed that there should be a priority order established as it was not 
possible, within the available funding, to implement large-scale programmes in all 
areas. Indeed, in terms of scientific feasibility, it clearly is not desirable to attempt to do 
too many things at once in this new venture. We therefore allocated certain defined 
priorities which have been implemented over the period. 
In addition, of course, many actions relating to cancer research were already being 
implemented from previous programmes at the time when the 'Europe against cancer' 
programme was commenced. 
Some of these will be continuing in terms of concerted actions and new ones will also be 
initiated as a result of further applications following an advertisement inviting more 
requests. 
Fellowship programme 
widely appreciated 
The fellowship programme was allocated the equiva-
lent of 50 man-years of fellowships. It was decided that 
these should be allocated in two ways. They could be 
fellowships awarded to one individual for a whole year, 
with the possibility of renewal for a second year. These 
would permit good collaborative research by the fellow 
in the centre visited. Alternatively, the fellowships 
might be used for shorter periods of time, of one to 
three months, for visits between laboratories and 
hospitals to exchange information and techniques and 
to set up collaboration between the two centres. 
Several such short-term fellowships could then collec-
tively represent one man-year. 
These fellowships are available to scientists, clinicians 
and epidemiologists from the 12 Member States to 
work in another Community State. In addition, Swe-
den and Switzerland with their associate status are also 
eligible. Emphasis has been placed on the importance 
of encouraging young applicants as part of a pro-
gramme of career development. There is a real need to 
bring good scientists and clinicians into cancer research 
and it is hoped that this programme within the Com-
munity will facilitate this. 
It is pleasing to report that many good applications 
have been received for these fellowships. Their award 
has been carried out critically by peer assessment. The 
short award of term fellowships may be carried out 
rapidly by a selected panel of experts using post and 
telephone. The one-year fellowships are reviewed 
twice a year by a committee of experts. Applications 
have been received and awards made over a very wide 
range of disciplines. 
This programme is particularly appreciated by the 
young scientists and clinicians. For example, from my 
own laboratories a pharmacologist who was recently 
successful in obtaining her PhD whilst working on 
mechanisms of tumour drug resistance, has gone to 
work in a department in Italy to gain new experience in 
another related area. 
We have also received in our laboratories three 
recently graduated medical scientists who have come 
from Spain, Portugal and Germany to work on pro-
grammes relating to hyperthermia, drug resistance and 
the molecular biology of lung cancer. Each one of these 
fellows is now gaining further experience and oppor-
tunities which would not have necessarily been avail-
able in their own country. When they return home, we 
have little doubt that they will be able to communicate 
their training and experience to the benefit of their 
parent countries and institutions. 
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Treatment research: 
encouragement 
at a supranational level 
The second priority is related to treatment research. 
This is an extremely important area of work as most 
new treatments need to be tested and validated in 
clinical trials. It is very easy to gain a clinical impression 
that a treatment works, which, as a result of undue 
optimism, is spurious. Well-structured and organized 
studies are needed before unequivocal assessment is 
possible. Many such clinical studies are carried out by 
large oncology centres and national organizations. 
However, the European Community is fortunate in 
having a supranational collaborative organization, the 
European Organization for Research and Treatment of 
Cancer (EORTC), which has for many years now been 
running numerous cooperative clinical trials. These 
investigate new drugs, other new and old modalities of 
treatment, such as radiotherapy, hyperthermia and 
combinations of these, both in early clinical trials and 
formal randomized studies. The funding of the 
EORTC has until recently been from a variety of 
sources which lacked an element of continuity. 
Early in the discussions of the Experts' Committee 
relating to the goals of the European cancer initiative, 
it seemed appropriate that a high priority should also 
be given to providing at least part of the funding of the 
EORTC. Currently the European Community funds 
ECU 750 000 per year towards this work. This money 
is earmarked for several different aspects, largely 
related to trial management. The data centre, currently 
situated in Brussels, employs many statisticians and 
data managers. 
One interesting aspect of the funding is that a specified 
sum of ECU 100 000 per year has been allocated to the 
EuroCode project. This project is designed to provide a 
computer link-up between key trial centres so that 
patient details, randomizations, treatment protocols, 
etc. can be exchanged rapidly, without the need for 
involving post and all the consequent delays. This 
EuroCode project is now in its third year of operation. 
Centres in many of the Community's countries are now 
participating and more are hoping to join in, provided 
enough money is available. The seed money of ECU 
20 000 available to individual centres can be extremely 
productive. Thus the designated centre in England, the 
MRC Cancer Trials Office in Cambridge has, as a 
result of this seed money, subsequently been given a 
VAX computer to ensure that the EuroCode project is 
implemented optimally in the UK. 
Between 40 to 50% of all patients with cancer survive 
five years, most of whom we may then regard as cured. 
There are many methods used for the treatment of 
cancer. The commonest and best known is that of 
surgery which is probably responsible for about half of 
all the cures. Thus around 22% of all patients with 
cancer will be cured by surgery alone. 
Each year, 50 grants are 
awarded to European 
scientists wanting to 
specialize in cancer research. 
Photo: CEC 
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Research makes a significant 
contribution to improving the 
effectiveness of cancer 
treatment. 
Photo: Colothèque. 
Support for research 
to improve results 
from chemotherapy and radiotherapy 
The next most important treatment modality is 
radiotherapy, with 12% cured by radiotherapy alone. 
That is, a quarter of the total of those who are cured. 
Chemotherapy alone, unfortunately, is only curative in 
a relatively small percentage of patients, probably less 
than 2% of all cancers. It is very effective in some of 
the uncommon ones such as children's malignancies, 
some leukaemias, testicular tumours and lymphomas. 
Various combinations of surgery, radiotherapy and 
chemotherapy provide the remaining cures. 
Much emphasis has therefore been placed on the 
funding of clinical research in trying to improve the 
results of chemotherapy treatment by identifying new 
and more effective agents. There is also the need to 
improve the results of radiotherapy by the investigation 
of newer modalities of treatment. Some research is also 
being carried out on surgical managements but these 
are usually combined with other treatment modalities. 
Encouragement of concertation 
in other research 
The other support within the Community for cancer 
research is very varied and is largely mediated by a 
number of concerted actions. These do not provide 
large sums of money for funding individual research 
projects but assist collaborative groups to meet 
together. They may then define research programmes, 
allocate amongst themselves various projects within the 
main one, exchange information about techniques and 
finally jointly assess the results. This is a well-defined 
path for coordination within the Community. 
Recently, following an advertisement for further con-
certed action applications, a very large number of 
excellent collaborative projects were suggested by brief 
declarations of intent. After further exploration by 
requesting more detailed specifications, the successful 
ones will be funded individually in their own right or 
combined together in group actions. 
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It is not possible to give extensive details of these 
projects, but a few illustrate the broad range of this 
work. They include projects such as studies of cytoki-
nes in the treatment of haematogical malignancies, 
gene expression and growth factors in leukaemias, pre-
clinical diagnosis and prevention of colo-rectal cancer 
in familial polyposis. Other studies are on various 
aspects of bone marrow transplantation, drug target-
ing, malignant melanomas, thyroid cancer, the genetics 
of solid tumours, cellular properties relating to invasion 
and metastasis, oncogene growth factors and their 
receptors, and papilloma virus. 
This list does illustrate that the European Community 
is very active in supporting basic clinical and laboratory 
research not only by funding large projects and fellow-
ships, but assisting in the coordination of groups of 
workers to make the maximum use of their own 
resources. 
There is little question that the sums of money that the 
Community can put into such research is inadequate if 
considered on its own. However, it must be remem-
bered that each of the Member States finances its own 
internal research programmes. One should, therefore, 
regard the Community's research effort as being one of 
bringing our supranational groups together. There is 
every indication that the 'Europe against cancer' pro-
gramme has started to do this very successfully. Pro-
vided that funding continues to be available, hopefully 
at an increased amount, this goal will continue to be 
achieved. 
Prof. Norman Bleehen 
Member of the Committee of Cancer Experts 
of the European Community 
'Europe against cancer' programme 
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Future cancer management will continue to involve surgery, radiotherapy, 
chemotherapy and immunotherapy working together in a more important fashion than 
ever before. Local approaches such as surgery and radiotherapy will be needed to get 
rid of as much as possible of the macroscopically visible tumour tissue so as to leave a 
minimal tumour burden. In this way the effect of the systematic treatments available 
can be maximized. As a consequence, more effective methods of local control and of 
systematic treatments are required in order to achieve rapid improvement in overall 
survival. It is estimated that selectivity of radiotherapy can be further improved using 
light ion therapy and boron neutron capture therapy, with direct consequences for the 
survival rate of cancer patients in the immediate future. 
T he European cancer experts have defined their strategy for research on cancer therapy up to the 
year 2000 in the context of the 'Europe against cancer' 
programme. 
There are at present various approaches to cancer 
treatment: 
D surgical removal of the tumour tissue; 
D radiotherapy; 
D chemotherapy; 
□ immunotherapy. 
It is the lack of specificity which limits most existing 
therapeutic approaches, and research in most fields is 
therefore directed towards increasing this specificity. 
Surgery generally produces 
the best results 
Surgery, usually applied to relatively limited tumours, 
is at present the most general successful mode of cancer 
treatment. About half of all cancer patients have a 
survival exceeding five years. Half of these may be 
attributed to surgery alone, and half either to a 
combination of surgery and radiotherapy or 
chemotherapy or either of these latter treatment mo­
dalities alone. 
Surgery is quite specific since it removes mainly dis­
eased tissues; its applicability is, however, normally 
limited to tumours which have not yet metastasized. 
For that reason, research in the field of early diagnosis 
is important and it therefore forms the strategic 
approach I: Research on early detection and diagnosis. 
The techniques of surgery have already reached a very 
high level and they can be combined with other 
treatment modalities. Progress in this field could result 
in further improvement in functional and cosmetic 
outcome. Improvement of surgery is therefore part of 
strategic approach II: Research in improvement of 
local treatment. 
Radiotherapy: 
given to two patients in three 
Radiotherapy is the most widely used form of cancer 
treatment, being given to two out of every three 
patients. Approximately one quarter of cured cancer 
patients owe their five­year survival to radiotherapy 
alone, and another eighth are cured by combined 
treatment with surgery and/or chemotherapy. 
Radiotherapy is therefore involved in almost half of 
curative cancer treatment. Moreover, radiotherapy is 
involved in the palliative treatment of many other 
patients. 
Although in principle radiation is not selective for a 
cancer cell, the selective destruction of a tumour is 
achieved to some extent by the fact that considerable 
efforts are made to concentrate the dose in the tumour 
tissue and so spare the surrounding normal tissue as 
much as possible. 
There are now new approaches which appear promis­
ing for further increases in selectivity of radiotherapy. 
Radiotherapy with ions 
of light atoms (light ions) 
Beams of light ions such as those of carbon, oxygen and 
neon travel in virtually straight lines with negligible 
sideways spreading and they deposit a large fraction of 
their energy at the end of their range. This allows a 
well­defined distribution of the dose in depth better 
even than that of protons. In addition, because of their 
intense local ionization, light ions could be effective 
against radioresistant tumours. 
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Light ion beam therapy has 
given excellent results for 
certain types of cancer. 
Pnofo: CEC. 
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Boron neutron capture therapy 
For various reasons, some boron compounds may 
accumulate in some tumours, and particularly in brain 
tumours where a reduction in the tumour blood-brain 
barrier encourages their selectivity. 
Upon irradiation with neutrons the boron atoms cap-
ture the neutrons and give rise to alpha and lithium 
particles. These have a high energy and their track is 
less than a fraction of a millimetre in tissue, so that they 
do not leave the tumour. It is estimated that in this 
way, with the same dose to surrounding normal tissue, 
the dose to the tumour can be increased by about one 
third. 
The first clinical trials in Japan indicate that this 
treatment could be beneficial for treatment of certain 
brain tumours such as gliomas, and trials for other 
tumour types are being initiated. 
Chemotherapy: 
palliative in most cases 
Chemotherapy has been employed mostly when 
tumour metastases are already present. Up to now, 
however, noteworthy successes have been limited pre-
dominantly to haematopoietic malignancies, malignan-
cies of embryonal origin (e.g. testicular tumours) and 
paediatric malignancies. At the present time, unfortu-
nately these only make up approximately 4% of total 
tumour incidence, although in about two-thirds of 
these cases cure is indeed achieved. The early adjuvant 
use of chemotherapy with surgery and/or radiotherapy 
in the more common cancers (e.g. breast carcinoma) is 
encouraging, but in all other situations chemotherapy 
serves mainly as palliation. 
Immunotherapy: 
used in conjunction 
with other treatments 
Active immunotherapy by vaccination with tumour cell 
extracts has been successful in experimental systems 
and recently some success has been reported in 
humans. There are now some preliminary indications, 
that progress along these same lines is to be expected in 
the future. As an example, the histo-compatibility 
antigens hold a key position in cellular interactions with 
the immune system. In animal models reintroduction of 
missing histo-compatibility antigens (neo-antigens) into 
tumour cells renders these cells more sensitive to 
immune rejection processes. It has also been shown 
that introduction of new transplantation antigens by in 
vitro mutagenesis induces a response against the 
tumour cells. Both approaches may become extremely 
useful in cancer treatment; they will however only be 
effective against relatively small numbers of cells and 
they will thus need to be used in conjunction with other 
anti-cancer modalities such as surgery, radiotherapy 
and chemotherapy. 
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Current status of treatment techniques 
Situation now at moment of diagnosis 
Treatment used 
Surgery alone 
Radiotherapy alone 
Both combined 
All other treatments 
and combinations 
including chemotherapy 
Patients curable now 
Strategic approach 
(see table below) 
No cure available 
Primary 
tumour 
(58% oteases) 
22% 
12% 
6% 
40% 
Metastasized 
tumour 
(42% oteases) 
5% 
5% 
a^tì 
1 8 % 3 7 % 
4 5 % 
5 5 % 
Strategy 
Problem 
I Late diagnosis 
11 (a) Poor treatment 
(b) Tumours with 
difficult localization 
(c) Tumours currently 
radioresistant 
III Conventional 
treatments not 
effective 
Remedy 
Screening 
Quality control 
Improved 
L | 8 ' 1 1 l o n s local 
and BNCT t r e a t m e n t s 
Light ions 
and BNCT 
Improved local treatments 
combined with improved 
systemic treatments 
Research on improvement of chemotherapy and 
immunotherapy therefore forms the strategic approach 
III. 
New approaches 
to improving radiotherapy 
Radiotherapy is the most widely used form of cancer 
treatment at the moment. Two new approaches: light 
ion treatment and boron neutron capture therapy 
appear promising vis-à-vis further increases in selectiv-
ity in radiotherapy. Accelerators will play a key role in 
their design. For boron neutron capture therapy an 
alternative exists: neutron sources emerging from nucl-
ear power plants. If results of clinical trials are promis-
ing, hospital-based, high intensity accelerators will 
have to be developed. For light ion treatment the 
design of a high-energy accelerator is a prerequisite. In 
both the USA and Japan facilities for light ion treat-
ment are either at design stage, under construction or 
in part-time use. 
Fons Vermorken 
Administrator, 
Medical research Unit 
Directorate-General for Science, 
Research and Development 
Commission of the European Communities 
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EORTC 
European Organization for Research 
and Treatment of Cancer 
Cancer is probably one of the most complex problems that medicine has had to deal 
with and a victory over it represents, without any doubt, one of the most challenging 
goals to be achieved by human beings. 
W hilst for a long time the first answer of modern medicine to cancer was surgery (the first radical 
mastectomy for a breast cancer was described in a 
scientific paper by Halsted almost 100 years ago), after 
World War II new successes were obtained by 
chemotherapy, i.e. treatment of tumours with chemi-
cals which were discovered for use in war time and, 
subsequently, found to be active in impeding the 
growth of malignant cells. 
In the late 1970s and during the 1980s, the main effort 
of oncology has been to correlate our increasing 
biological knowledge of cancer with the treatment of 
our patients, thus progressively approaching the goal of 
optimum knowledge of every single human tumour. 
For example, when a breast cancer was removed in a 
surgical theatre 10 years ago, it was simply sent to the 
pathology department for histological diagnosis and 
classification: today, in every cancer research centre it 
will also be sent to the laboratory of molecular biology 
for testing oncogenes, to the laboratory of endocrinolo-
gy to test its hormonal receptors, to the cell kinetics 
department to evaluate its growth rate and chemosen-
sitivity, etc. 
One of the protagonists of these developments has 
been the EORTC, the European Organization for 
Research and Treatment of Cancer with its more than 
25-year contribution to the fight against cancer. The 
idea of a European organization for the fight against 
cancer was born in 1962 when the Groupe européen de 
chimiothérapie anticancereuse (GECA) was founded; 
in 1963 the European Journal of Cancer and Clinical 
Oncology became the official organ of the Organiza-
tion which changed its name to the EORTC; in 1972 
the National Cancer Institute (USA) set up a liaison 
office in Brussels to collaborate with the EORTC in the 
new anti-cancer drug research; in 1984 the EORTC 
New Drug Development Office was set up in Am-
sterdam. 
Due to the rapid development of the EORTC and in 
order to meet the many requirements of research and 
education the following four branches were instituted: 
Epidemiology and Prevention; Research; Treatment; 
Education. 
The Epidemiology and Prevention branch has, apart 
from establishing contacts with EORTC clinical groups 
such as the Lymphoma, the Genito-Urinary, the Breast 
Cancer and the Melanoma Cooperative Groups, 
developed studies in two main areas. They are: aetio-
logy of childhood leukaemia and late effects of anti-
cancer therapies. The latter is crucial and now possible 
since children successfully treated 15 or 20 years ago 
are now grown-up youths and the effects of anti-cancer 
treatment on growth, fertility, blood cell count etc. can 
be evaluated. 
The basic aim of the Research branch is to provide 
every year all clinical groups with a highly specialized, 
updated report on developing areas of experimental 
research. It is of extreme importance that conceptual 
and methodological innovations in the basic sciences 
which are potentially applicable to clinical oncology be 
exploited without needless delay. The New Drug 
Development Office (NDDO) aims at reducing the 
time-lag between drug synthesis and early clinical 
studies and develops guidelines for the conduct of 
preclinical and early clinical studies. 
The Treatment branch deals with the research in 
patient management and encompasses the assessment 
of new drugs, combinations of drugs and biological 
response modifiers, as well as the investigation of new 
radiotherapeutic and surgical techniques and the 
development of new combined treatment strategies. 
The basic work is done by 30 groups which centre their 
work either on specific tumour types or on a particular 
discipline. The groups are setting up controlled clinical 
trials (phase II or phase III) and are publishing results. 
The EORTC data centre provides the necessary know-
how in data-processing and statistical analysis and has 
also developed a system called EuroCode (The Euro-
pean Computerized Oncology Data Exchange) to 
speed up communication among European oncologists. 
The main concern of the Education branch is to address 
the issue of cancer education in Europe and to attempt 
to set up several projects. As a result of meetings in 
Venice and Bonn in 1988 agreement was reached on 
SOCIAL EUROPE 1/91 105 
Chapter 6 
the major components of an undergraduate curriculum 
in oncology and its implementation is a part of the EC 
action programme for 1990-94. A list of courses suit-
able for international participation in Europe is pub-
lished annually within the quarterly journal Review in 
Oncology providing updated information on key topics 
in experimental and clinical cancer research. Other 
educational activities of the Education branch are the 
European Journal of Cancer and Clinical Oncology, the 
programmes for fellowships and personnel exchange. 
The EORTC and the European School of Oncology 
common initiatives are also coordinated by the Educa-
tion branch. 
The EORTC is today one of the most established 
models of international integration in cancer medicine 
and as such it offers a guarantee for a brighter future. 
Thanks to a donation of the Belgian Government, the 
EORTC Central Office is now based in new headquar-
ters in Woluwe, 83 Avenue E. Mounier, B-1200 
Brussels. 
Prof. Umberto Veronesi 
Past President EORTC 
Vice-President of the EC 
Committee of Cancer Experts 
of the 'Europe against cancer' programme 
106 SOCIAL EUROPE 1/91 
Conclusion 
SOCIAL EUROPE 1/91 107 
Europe against cancer 
Only the beginning 
Building on the satisfactory results achieved so far, especially in the context of the first 
action plan of the 'Europe against cancer' programme, the European Community will 
extend its campaign from 1990 to 1994, on the basis of the decision adopted by the 
Council and representatives of the Member States meeting in the Council on 17 May 
1990. 
^ H his decision covers the following fields: 
D With regard to prevention, the Community will 
pursue its legislative activities in the fight against 
smoking (restrictions on the tar content of cigar-
ettes, strict controls on advertising, etc.). 
Particular importance will be given to studies and 
pilot actions concerning the links between nutrition 
and cancer, given that diet could be responsible for 
a third of cancer deaths. Prospective studies will 
allow large population samples across the Commun-
ity to be monitored for many years. The diversity of 
diets in the Member States should enable clearer 
links to be established between certain foods and 
cancer of the breast or digestive system. 
D As regards screening, further progress is expected to 
be made at European level with the setting up of 
European networks of breast and cervical cancer 
pilot screening programmes. In addition, evaluation 
studies on the effectiveness of screening program-
mes for colo-rectal cancer will be completed and 
should enable national and regional health 
authorities to reach precise conclusions by the end 
of 1994. 
D On the question of information and health educa-
tion, the 'Europe against cancer' programme will 
continue the work of promoting public awareness of 
the 10 European commandments for cancer preven-
tion. The second action plan will place special 
emphasis on health education in schools, based on 
the conclusions of the studies and the European 
conferences conducted between 1987 and 1989. 
D With regard to training of health personnel, special 
efforts will be made to encourage implementation of 
the recommendations produced during the first 
action plan. Also, on the basis of the experience 
acquired in 1988 and 1989, financial support will be 
forthcoming for numerous further training 
initiatives for doctors and nurses. 
D Additionally, the first results of the joint medical 
research actions undertaken since 1987 should find 
practical applications, notably in the form of pilot 
installations for treating patients by improved 
radiotherapy. Naturally, endeavours to coordinate 
medical research will be continued and streng-
thened. 
Finally, I cannot conclude this review of the positive 
results already achieved, or expected to be achieved 
between now and 1994, without mentioning the crucial 
role played in each of the 12 Member States by the 
public and private bodies involved in the fight against 
cancer. In particular, the cancer associations and 
leagues, which have more than 10 million families in 
their ranks, have given wholehearted and enthusiastic 
support to the 'Europe against cancer' programme. 
Without these partners the European Community 
would never have been able to progress so far in a field 
which concerns so many of its citizens. 
Steffen Smidt 
Deputy Director-General 
Directorate-General for Employment. 
Industrial Relations and Social Affairs 
Commission of the European Communities 
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COMMUNICATION 
from the Commission to the Council 
of 13 December 1985 
regarding the action against cancer 
Introductory statement 
1. The European Council in Milan (28 and 29 June 1985) 
expressed interest in a French memorandum calling 
for, and emphasizing the value of, a coordinated Euro-
pean action against cancer, making full use of existing 
structures. 
A letter was subsequently sent on the same subject by 
the President of the Council of Ministers of Italy to 
the Heads of State or Government and to the President 
of the Commission of the European Communities. 
The European Council in Luxembourg (2 and 3 De-
cember 1985) took note of a French-Italian communi-
cation on this subject and asked that the Ministers for 
Foreign Affairs should examine at their next meeting 
the best way of giving a rapid and effective follow-up 
to this initiative. 
The Commission welcomes these initiatives and fully 
shares the views expressed in the abovementioned 
documents. 
Community actions 
2. The Commission has so far undertaken a series of 
actions which, in various ways, contribute to the fight 
against cancer. 
3. As regards prevention, Directives have been adopted 
by the Council which have a direct bearing on cancer 
induction by physical and chemical agents. The 'Basic 
safety standards for the health protection of the general 
public and workers against the dangers of ionizing 
radiation' and the 'Protection of workers from risks 
relating to exposure to chemical, physical and biologi-
cal agents', including protection from asbestos and 
vinyl chloride, are examples of such Directives. 
4. In the light of the conclusions of the European Council 
in Milan, the Commission has submitted to the Coun-
cil a proposal for a resolution on a programme of 
action of the European Communities on cancer pre-
vention. This programme aims at improving the health 
and quality of life of the citizens within the Commu-
nity and at providing a setting in which existing actions 
and future initiatives in the field of prevention can be 
made more coherent. The objectives of the programme 
are to halt the increase of cancer, to establish health 
strategies for those factors to which cancer is attribu-
ted, to facilitate development of population screening 
and treatment, to improve the monitoring of the health 
and specific groups of the population in order to 
identify risk factors for cancer, and to collaborate with 
international and national organizations to these ends 
and to the application of the results of cancer research. 
Prevention and therapy of cancer must undoubtedly 
contain an important element of public and professio-
nal information and education. The draft resolution 
therefore proposes that due attention be given to these. 
The Commission will seek to act jointly with national 
authorities. 
This proposal is currently under discussion in the 
Council. 
5. In the field of research, a series of actions in the areas 
of cancerogenesis and cancer therapy have been sup-
ported in Community research programmes, mainly 
the environmental protection, radiation protection and 
medical research programmes of the EEC and the 
ECSC. In this context, the coordinating and data 
centre of the European Organization for Research on 
Treatment of Cancer (EORTC) has been given finan-
cial support. 
6. The Commission has announced to the Council that 'a 
coordination action on cancer, m agreement with the 
conclusions of the Milan Summit'1 will be embodied 
into the proposal for a renewal of its medical research 
programme, to be presented to the Council in early 
19S6. This clearly identifies a 'cancer' action which will 
focus on three areas: early detection and diagnosis, 
multi-modality treatment (including the development 
and improvement of clinical trials in organ-oriented 
projects) and transfer of research results. In conducting 
this programme, the Commission will seek to make an 
optimal use of existing structures. 
Conclusions 
7. Important national and international efforts are under 
way at present. Community actions have been de-
scribed above. New initiatives have been proposed at 
the recent European Councils. Given the desirabilitv, 
therefore, of appropriate consultation and coordination 
between all the parties concerned, it appears that the 
Community framework offers a possibility for the 
development of a coherent 'Europe against cancer' 
action which would optimize the benefits of the va-
rious efforts already being undertaken, without 
interfering in their efficient functioning or duplicating 
existing work. 
COM(S5) 530 final. 
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As a first step, the Commission intends to host an ad 
hoc expert committee, composed of high-level scien-
tists and cancer specialists, in order to make recom-
mendations on the ways and means of implementing a 
European action against cancer. 
The Council is therefore requested: 
(i) to decide on the launching of an action to be known 
as 'Europe against cancer', aimed at ensuring the 
optimum coordination of all initiatives currently 
being taken in Europe as well as the study of new 
initiatives in the fields of prevention and research 
(including therapy); 
(ii) to take note of the Commission's intention to 
convene the abovementioned ad hoc expert commit-
tee and to report back to the Council with specific 
proposals based on the recommendations of the 
Committee within a period of three months; 
(iii) to undertake to examine as a matter of priority the 
existing Commission proposals on prevention as 
well as the forthcoming proposals on research with 
a view to their rapid adoption. 
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R E S O L U T I O N 
of the Council and the representatives of the Governments of the Member States, meeting 
within the Council, 
of 7 July 1986 
on a p rogramme of action of the European Communities against cancer 
( 8 6 / C 184/05) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE REPRESENTATIVES OF THE GOVERN-
MENTS OF THE MEMBER STATES, MEETING WITHIN 
THE COUNCIL, 
Having regard to the Treaties establishing the European 
Communit ies , 
Having regard to the draft resolution submitted by the 
Commission, 
Having regard to the opinion of the European Par-
liament ('), 
Having regard to the opinion of the Economic and 
Social Commit tee (2), 
Whereas , pursuant to the Treaty establishing the 
European Economic Communi ty , the Communi ty has 
inter alia as its task, by establishing a common market 
and progressively approximating the economic policies of 
Member States, to promote throughout the Communi ty 
a harmonious development of economic activities, a 
continuous and balanced expansion and an accelerated 
raising of the standard of living; 
Whereas the European Council ¡n Milan on 28 and 29 
June 1985 emphasized the importance of launching a 
European programme of action against cancer; 
Whereas that European Council also approved the 
proposals of the ad hoc Commit tee on a People's Europe 
calling for an appropriate follow-up to the Commission 
communicat ion on cooperat ion at Communi ty level on 
health problems; 
Whereas various Communi ty actions to prevent cancers 
arising from exposure to ionizing radiation or exposure 
to chemical carcinogens are already being carried out 
under the Treaties establishing the European Economic 
Communi ty and the European Atomic Energy 
Communi ty ; 
Whereas actions to reduce the risk of cancer from 
exposure to carcinogenic substances are included in a 
number of existing Communi ty programmes on the 
environment, worker protection, consumer protection, 
nutrition, agriculture and the internal market ; 
(') Opinion delivered on 12 May 1986 (not yet published in the 
Official Journal). 
(') OJ No C 101, 28. 4. 1986, p. 22. 
Whereas the present p rogramme would increase 
knowledge about the causes of the cancer and the 
possible means of preventing and treating it; 
Whereas by ensuring a wider dissemination of 
knowledge of the causes, prevention and treatment of 
cancer, and an improvement in the comparabili ty of 
information about those matters, in particular concerning 
the nature and degree of risk of cancer arising from 
exposure to given substances or processes, the 
programme will contr ibute to the achievement of 
Communi ty objectives, in particular the removal of non-
tariff barriers to t rade, while contributing to the overall 
reduction of risks of cancer; 
Whereas research into cancer and carcinogenic effects of 
physical and chemical agents is being under taken in a 
number of Communi ty research programmes; 
Whereas the coordinat ion of national research activities 
relating to the early detection and t reatment of cancer is 
not the specific purpose of this resolution; whereas 
research should take place in the context of the 
promotion of research organized by the Commission and 
of the relevant medical and public health research 
programmes; whereas it is desirable to provide the 
necessary coordinat ion and liaison between those 
activities and the activities under taken pursuant to this 
resolution; 
Whereas cooperat ion with international and national 
organizat ions carrying out work in this field will ensure 
a wider dissemination of knowledge of cancer and help 
to avoid duplication of effort, 
1. take note of lhe conclusions of the ad hoc Commit tee 
of cancer experts (which met in Paris on 19 and 20 
February 1986), forwarded to the Council by the 
Commission in its report of 10 March 1986; 
2. express the political will to implement a five-year 
action programme of the European Communit ies 
against cancer; 
3. set for this p rogramme the objective of contributing to 
an improvement of the health and quality of life of 
citizens within the Communi ty by: 
— reducing the number of illnesses due to cancer and 
the related mortality and 
— decreasing the potential years of life lost because 
of cancer ; 
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4. call on the Commission to examine systematically 
whether and to what extent, Community legislation, 
measures and other activities are likely to constitute a 
hindrance to cancer prevention; 
5. take note of the action programme proposed by the 
Commission and consider the following priority 
actions to be necessary: 
(a) Tobacco 
As a first priority, development of measures to 
limit and reduce the use of tobacco. 
These measures should be based on the practical 
experience gained in the various Member States 
and should contribute to increasing the 
effectiveness of national programmes and actions. 
Systematic examination of the various ways and 
means of limiting and reducing the use of 
tobacco, such as rules on advertising, rules on 
labelling, tax legislation, sponsorship, enforcement 
of no-smoking rules, extension of no-smoking 
areas and, if appropriate, the drafting of proposals 
for actions at Community level. 
(b) Chemical substances 
Development of harmonized criteria and pro-
cedures for evaluating the carcinogenic nature of 
chemical substances. 
Identification and quantification of the 
carcinogens to which 'workers and/or the popu-
lation are exposed and, if appropriate, drafting of 
new legislation and amendment of existing 
legislation in order to reduce exposure of workers 
and/or the population to carcinogens. 
(c) Nutrition and alcohol 
Assessment of the results of research and, where 
appropriate, preparation of measures, taking 
account of differing circumstances and habits in 
the Member States. 
Attention should also be paid to abuses in the 
consumption of alcohol. 
(d) Prevention/early diagnosis 
Exchange of information and experience, parti-
cularly on Member 'States ' preventive and early 
diagnosis programmes (type of examination, 
numbers participating, effectiveness, cost/benefit 
analysis excluding resources directly allocated to 
research) and, on this basis, the preparation of 
any appropriate measures. 
(e) Epidemiological data 
Exchange of information on Member States' 
structures and procedures for cancer 
epidemiology (inter alia through exchanges of 
experts) and evaluation of those structures and 
procedures with a view to improving them. 
Improvement in the collection, availability and 
comparability of epidemiological data on cancer 
and factors causing cancer and, if appropriate, 
preparation of measures in this field taking 
particular account of the problems of data 
protection to assist in and help increase the 
effectiveness of epidemiological research. 
(f) Health education 
Exchange of information and experience, parti-
cularly on Member States' health education and 
information programmes and, on this basis, the 
preparation of any appropriate measures. 
(g) International collaboration 
Collaboration with international and national 
organizations active in the field covered by these 
actions to achieve maximum possible 
effectiveness ; 
6. consider that a high degree of cohesion between 
current and future actions at national and Community 
level would help achieve the objective referred to in 
point 3 and therefore advocate the strengthening of 
cancer prevention measures already initiated at 
Community level and the coordination of such actions 
with those referred to in point 5; 
7. call on the Commission to submit within 12 months of 
the adoption of this resolution, and thereafter 
annually, in close collaboration with the Member 
States, a work programme detailing the work it 
intends to carry out in order to implement this 
resolution and, if necessary, to submit proposals to 
the Council to this effect. 
The annual work programmes, together with a report 
on results achieved and activities carried out, will be 
forwarded to the European Parliament, the Council 
and the Economic and Social Committee; 
8. take note of the Commission's intention to: 
— submit proposals on research and on a European 
Cancer Information Campaign and 
— intensify work relating to cancer in all other 
Community programmes with a view to submitting 
appropriate proposals. 
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II 
(Preparatory Acts) 
COMMISSION 
'EUROPE AGAINST CANCER' P R O G R A M M E 
Proposal for a plan of action, 1987 to 1989 
including a proposal for a Council Decision on informing the general public and the training of 
members of the health professions 
COM(86) 717 final 
(Submitted by the Commission to the Council on 17 December 1986) 
( 8 7 / C 50 /01 ) 
PRELIMINARY REMARKS 
In June 1985, in Milan, and in December 1985, in Luxembourg, the Heads of State and of 
Government of the 12 Member States of the European Community stressed the importance of 
launching a European programme in the fight against cancer, so that the construction of Europe could 
make the necessary contribution to combatting this scourge, but also take on a new dimension, closer 
to the concerns of citizens. 
In order to implement that conclusion of the European Council and prepare a proposal for a 'Europe 
against cancer' programme, a committee of leading cancer experts (') was set up in January 1986 
under the auspices of the Commission of the European Communities. The following proposals cover 
the first three years of implementation of the programme. They are based to a large extent on the 
conclusions of that committee, whose readiness and commitment, and the high calibre of its work 
should be stressed. 
In addit ion, this work has benefited significantly by the studies and research carried out or underway 
in the World Health Organization, and in its International Agency for Research on Cancer. 
Four areas are covered by this proposal for a plan of action for the period 1987 to 1989: 
— cancer prevention: O n 7 July 1986, a resolution was adopted by the Council and the 
representatives of the Governments of the Member States meeting within the Council which lays 
down the main lines for the preventive part of the European programme of action against 
cancer (2). The present communication completes this programme by identifying about 30 
Community actions, 
— information and health education of the general population and training of health care workers in 
cancer, for which a proposed Council Decision is attached to the present communication, 
(>) The committee consists of the following figures: Prof. C. de Duve, substitute, Prof. Boon (Belgium), Prof. C. 
Schmidt (Federal Republic of Germany), Prof. E. Grundmann (Federal Republic of Germany), Dr O. Moeller 
Jensen (Denmark), Prof. J. Estape (Spain), Prof. M. Tubiana (France), Dr S. Vassilaros (Greece), Dr M. 
Moriarty (Ireland), Prof. U. Veronesi (Italy ), Prof. M. Dicato (Luxembourg), Dr R. Kroes (Netherlands), Prof. 
J. Conde (Porrugal) and Prof. N. Bleehen (United Kingdom). From January 1987 Sweden will be represented 
by Prof. J. Einhorn, as an observer. 
(J) OJ No C 184, 23. 7. 1986, p. 19. 
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— cancer research: In November 1986 the Commission forwarded to the Council of Ministers of the 
European Communities a proposed Regulation (') on a fourth programme for coordination in 
medical research (1987 to 1989). The present communication clarifies and details the cancer 
research dimension. 
Some of the actions which are foreseen come directly under the Commission's management powers. 
They will be carried out as such in that manner, beginning in 1987 for the majority of them. This 
communication also contains many proposed actions which the Commission intends to send, in 1987 
to 1989 to the European Parliament, for consultation, and the Council of Ministers of the European 
Communities, for approval. They are therefore liable to be amended at a later stage. 
(') Doc. COM(86) 549 final, 29. 10. 1986. 
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GENERAL INTRODUCTION 
Going back probably to the origins of man (the Kanam jawbone, which is some 500 000 years old, 
already shows signs of the disease (')), varied in its manifestations (several hundred different types are 
observed today), extremely widespread in our developed societies (one European in four today has 
been, is being or will be affected), cancer is still considered as a mysterious disease characterized by the 
disorganization of certain cells and their anarchical proliferation, for reasons about which more and 
more is being learned but that have not so far been totally elucidated. Moreover, if the increase 
observed in recent years were to continue, by the year 2000 one European in three would be stricken 
by cancer at some time in his life. 
Although worrying, the picture is not, however, altogether sombre. Clearly, the rise in the number of 
cancer cases can be accounted for by the increase in the average lifespan, since the incidence of cancer 
increases rapidly with age. Moreover, cancer is only the second largest cause of death in man, after 
cardiovascular diseases. 
All the same, like the infectious diseases in previous centuries, cancers are the most feared form of 
illness today, probably because treatment is still too often at the cost of surgical mutilation or 
undesirable side effects, and probably also because, until the recent invention of effective 
pain-suppressant drugs, cancer frequently caused prolonged and unbearable suffering. 
Nevertheless, we no longer have to accept that cancer is a fatal disease. It is a fact that the frequency of 
cancer should be reduced by prevention, and treatment improved through therapeutic research. The 
current state of our resources renders long-term survival, if not complete cure, possible in nearly half 
the cases, whereas scarcely one-quarter of patients were cured in 1950 (2). Above all, cancer is often 
avoidable, as can be seen from the considerable successes registered in certain countries in combating 
three common types of cancer. 
The spectacular reduction in the number of stomach cancers in the developed countries can thus 
probably be ascribed to more wholesome food, free from microbial proliferation (thanks to 
refrigerators and probably also thanks to antioxidant food additives). The fall in the frequency of 
cervical cancer, a disease that is increasingly thought to be sexually transmitted cah, for its part, 
probably be attributed to more regular gynaecological screening and improved standards of hygiene in 
both sexes. Lastly,, in countries such as the United States and the United Kingdom, a drop in the 
frequency of lung cancer is being observed today, such countries having begun anti-smoking 
campaigns earlier than others. 
Through better prevention and through more effective treatment, improved by research, Europeans 
can in future hope to achieve a further big reduction in the death rate due to cancer and the number of 
persons afflicted. The struggle against cancer concerns everyone at all levels. For its part, European 
agriculture and industry can harmonize its regulations and techniques so that the day-to-day 
environment in which Europeans live is improved and rid of cancer-inducing factors. As regards 
European research and technology, it can boost the effectiveness of private and public research efforts 
through a more efficient coordination of its human and financial resources. 
(') Origine et l'évolution de l'homme, National Museum of Natural History, Paris, 1984. 
(2) M. Tubiana, Le cancer. Presses Universitaires de France, Paris, 1985. 
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DECISION OF THE COUNCIL A N D OF REPRESENTATIVES OF THE 
GOVERNMENTS OF THE MEMBER STATES, MEETING WITHIN THE 
COUNCIL 
of 21 June 1988 
adopting a 1988 to 1989 plan of action for an information and public awareness 
campaign in the context of the 'Europe against cancer' p rog ramme 
(88/351/EEC) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES AND 
THE REPRESENTATIVES OF THE GOVERNMENTS OF 
THE MEMBER STATES, MEETING WITHIN THE COUNCIL, 
Having regard to the Treaty establishing the European 
Economic Community, 
Having regard to the proposal from the Commission, 
Having regard to the opinion of the European Parli-
ament ('), 
Having regard to the opinion of the Economic and Social 
Committee (2), 
Whereas in June 1985 in Milan and in December 1985 in 
Luxembourg the European Council underlined the advan-
tages of launching a European programme against cancer ; 
Whereas in December 1986 in London the European 
Council decided that 1989 should be designated 'Euro-
pean Cancer Information Year' and specified that the aim 
would be to develop a sustained and concerted informa-
tion campaign in all the Member States on the preven-
tion, early screening and treatment of cancer ; 
Whereas the prevention and reserach measures already 
undertaken in the context of the 'Europe against cancer' 
programme should be supplemented by measures to 
increase awareness among members of the health profes-
sions and by an information campaign ; 
Whereas this campaign should be especially designed to 
increase the awareness of the public, teachers and 
members of the health professions regarding the fight 
against cancer, which includes in particular the fight 
against tobacco, protection against carcinogenic agents 
and, for the purposes of health promotion in general, 
improvement in nutrition ; 
Whereas information campaigns against cancer are a 
matter for the competent private organizations and public 
authorities of the Member States, but Community action 
may give a major boost towards success in the fight 
against cancer ; 
Whereas duplication of effort should be avoided by deve-
loping common basic material for the information of the 
public and for the training of members of the health 
professions, as well as by promoting exchanges of experi-
ence, 
HAVE DECIDED AS FOLLOWS : 
Article 1 
1. The Commission and the Member States shall 
implement, in the period 1988 to 1989, the measures set 
out in the Annex. 
2. The estimated amount of the Community distribu-
tion necessary for these measures is 10 million ECU. 
Article 2 
1. At intervals, and at least once a year, the Commis-
sion shall consult the competent authorities of the 
Member States during the various stages of implementa-
tion of the measures provided for in this Decision. 
2. The Commission shall keep the European Parli-
ament and the Council informed of progress. 
Done at Luxembourg, 21 June 1988. 
For the Council 
The President 
J. WARNK.E 
(') OJ No C 68, 14. 3. 1988, p. 84. 
(2) OJ No C 105, 21. 4. 1987, p. 18 
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C O M M U N I C A T I O N 
from the European Commission to the Counci l , t he European Par l iament 
and the Economic and Social C o m m i t t e e 
of 8 M a y 1990 
regarding the 'Europe against cancer ' p r o g r a m m e : 
Repor t on the implementat ion of the first plan of action 1987-89 
The 'Europe against cancer' programme was launched on 
the initiative of the Heads of State or Government of the 
European Communi ty meeting in Milan in June 1985. 
Acting on proposals from the European Commission, 
and following favourable opinions from the European 
Parliament, the Council adopted three basic texts defining 
the overall framework and financial provisions for the 
programme: 
(a) Resolution of 7 July 1986 (OJ C 184, 23. 7. 1986), 
which concentrated on prevention and health educa-
tion; 
(b) Decision of 7 November 1987 ( O J L 334, 24. 11. 1987) 
on medical research; 
(c) Decision of 17 May 1988 (OJ L 160, 28. 6. 1988) on 
informing the public and training medical personnel. 
Also in 1986, the Commission prepared a detailed plan of 
action for the period 1987-89. This 75-point plan was 
published in the Official Journal (C 50, 26. 2. 1987, pp. 
1-55). It constitutes the first stage of the programme, the 
objective of which is to reduce the expected number of 
deaths due to cancer by 15% (from 1 000 000 to 850 000) 
by the year 2000. To achieve this ambitious goal, the 
European Commission adopted a 'partnership approach' 
aimed at involving everyone concerned with the fight 
against cancer at national level: 
(i) the Committee of Cancer Experts, the scientific soul 
of the programme; 
(ii) the cancer associations and leagues and anti-smoking 
organizations in the European Community, the 
spearheads of the programme; 
(iii) the producers of television medical programmes, who 
have helped to spread the message of cancer preven-
tion; 
(iv) the representatives of general practitioners, who play 
a central role in early detection and systematic screen-
ing for cancer; 
(v) senior officials in the health, education and research 
ministries. 
Of course, it is much too early to identify any possible 
fall-off in the growing number of cancer deaths in the 
European Communi ty . It is, however, no problem at all 
to take stock of achievements under each of the 75 actions 
announced at the beginning of 1987. An overall assess-
ment is contained in the conclusion on page 135. 
Chapter 1 : Cancer prevention 
I — CAMPAIGN AGAINST TOBACCO 
Action 1: Upward a l ignment of t axa t ion on tobacco 
manufac tured in the European C o m m u n i t y 
(a) O n 7 August 1987, as part of the process towards 
completing the internal market, the Commission pre-
sented two proposals for Directives (COM(87) 325 and 
COM(87) 326) on the approximation of taxes on cigarettes 
and on manufactured tobacco other than cigarettes. 
The proposal on cigarettes required the tax burden in the 
European Community to be increased by more than 30% 
before 1 January 1993. In at least nine of the 12 Member 
States, this meant very sharp increases in taxes and prices 
(more than 150% in some cases), but in three countries 
prices would have fallen. 
The price and tax increases for manufactured tobacco 
other than cigarettes (cigars, cigarillos, pipe tobacco, snuff 
and chewing tobacco) would, generally speaking, have 
affected the countries with the highest consumption. 
The 1987 proposals, which required the unanimous ap-
proval of the Member States if they were to become law, 
gave rise to fervent discussions with·n the Council and 
European Parliament, but were not adopted. The Member 
States and the European Parliament took the view that the 
introduction of an element of flexibility in the rates 
proposed was the only way of progressing towards har-
monization. 
(b) Consequently, on 19 December 1989, the Commis-
sion officially presented its amended proposal for a Coun-
cil Directive on the approximation of taxes on cigarettes 
and manufactured tobacco other than cigarettes 
(COM(89) 525 final). According to the amended propo-
sal: 
(i) on 1 January 1993, each Member State will be required 
to apply rates higher than, or equal to, minimum rates 
set for each product category (in the Member States 
as a whole, this approach will allow the maintenance 
or the increase of the fiscal burden to a level more 
compatible with the requirements of public health). 
This flexibility must under no circumstances jeopardi-
ze the fundamental principle of abolition of customs 
and tax frontiers by 1 January 1993; 
(ii) after 1 January 1993, this initial flexibility must gradu-
ally give way to a movement towards target rates 
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compatible with essential public health requirements. 
To this end, the target rates have been significantly 
increased compared to those proposed in 1987. 
Action 2: Financing of preventive actions at national 
level by the use of increased fiscal measures on tobacco 
No action of this type was taken by the Member States 
under the first plan of action 1987-89. However, discus-
sions have started in some countries, e.g. France, between 
the authorities and both sides of industry, with a view to 
removing tobacco from the price index (see action 3) in 
return for an increased effort by the authorities in the 
field of cancer screening. Exemplary measures have been 
taken in certain non-Community countries such as Aus-
tralia, where the state of South Australia increased tax on 
tobacco products to finance health promotion publicity -
thus helping to compensate for the loss to advertising 
agencies caused by the total ban on tobacco advertising. 
Action 3: Publication of indices excluding tobacco by 
the Statistical Office of the European Communities 
Since July 1989 a price index excluding tobacco has been 
published monthly by the Statistical Office of the Euro-
pean Communities. Comparing price index trends with 
and without tobacco reveals that the price of tobacco in 
real terms - calculated on the general consumption price 
index - fell during the period covered by the first plan of 
action (December 1989 compared with December 1986) 
in four countries, namely the United Kingdom (-9.4%), 
Denmark (-8.9%), Spain (-5.2%) and the Netherlands 
(-0.2%). This contrasts with an increase in real terms in 
the other eight countries: Federal Republic of Germany 
(+0.6%), Ireland (+1.3%), Luxembourg (+2.6%), Portu-
gal (+4%), France (+6.9%), Italy (+7.5%), Belgium 
(+10.3%) and Greece (+27.1%). 
Action 4: Harmonization of cigarette labelling in the 
European Communities 
On 4 February 1988, the Commission submitted a propo-
sal for a Council Directive, on the basis of Article 100a of 
the EEC Treaty (qualified majority), concerning harmoni-
zation of the labelling of tobacco products (OJ C 48, 
20. 2. 1988). The opinion of the Economic and Social 
Committee was delivered on 7 July 1988 (OJ C 237, 
12. 9. 1988), followed by the first reading of the European 
Parliament on 14 December 1988 (OJ C 12, 16. 1. 1989). 
The Commission generally took account of both institu-
tions' opinions in its amended proposal (OJ C 62, 
11.3. 1989), which served as a basis for the Council's 
common position of 16 May 1989. Following a favourable 
vote at the second reading by the European Parliament, 
the Council adopted this Directive on 13 November 1989 
(OJ L 359, 8. 12. 1989). Article 4 states that: 
(i) all unit packets of tobacco products shall carry, 
on the most visible surface, the following general 
warning in the official language or languages 
of the country of final marketing: 'Tobacco seriously 
damages health' (Article 4 (1)); 
(ii) with regard to cigarette packets (Article 4 (2), (3) and 
(4) and Annex), the other large surface shall carry 
alternating specific warnings. For this purpose each 
Member State shall draw up a list of warnings taken 
exclusively from those listed in the Annex to the 
Directive. 
The following warnings must be included in each 
Member State's list: 
'Smoking causes cancer'; 
'Smoking causes heart disease'; 
(iii) the tar and nicotine contents of cigarettes must also 
be printed on the side of packets (Article 2). 
The Member States must bring into force the laws, 
regulations and administrative provisions needed to com-
ply with this Directive before 31 December 1991. 
Action 5: Prohibition of cigarettes with a high tar 
content 
On 1 February 1988, the Commission presented apropo-
sal for a Council Directive (OJ C 48, 20. 2. 1988), on the 
basis of Article 100a of the EEC Treaty, to limit the 
maximum tar content of cigarettes to 15 mg by 31 
December 1992 and 12 mg by 31 December 1995. On 7 
July 1988, the Economic and Social Committee adopted a 
favourable opinion (OJ C 237, 12. 9. 1988). The European 
Parliament expressed its opinion on 25 May 1989 (OJ C 
158, 26. 6. 1989), diverging considerably from the Com-
mission's proposal by recommending an initial limit of 
20 mg tar by 31 December 1989, with the possibility of a 
further reduction to 15 mg by a second, unspecified date, 
after approval of a report on the socio-economic repercus-
sions of these limits. The Commission did not see fit to 
amend its initial timetable in its amended proposal (OJ 
C 228, 5. 9. 1989, and OJ C 237, 15. 9. 1989 - corrigen-
dum). 
On 13 November 1989, the Council of Health Ministers 
adopted a common position maintaining the date of 31 
December 1992 for the 15 mg limit and differing the date 
of application for the 12 mg limit until 31 December 1997. 
A special temporary exemption was granted to Greece 
(20 mg by 31 December 1992, 18 mg by 31 December 
1998, 15 mg by 31 December 2000 and 12 mg by 31 
December 2006). 
On 14 March 1990, the European Parliament adopted the 
common position of the Council at its second reading, 
which meant that the Directive should be adopted finally 
by the Council of Health Ministers on 17 May 1990. 
Action 6: Harmonization of the standards for 
measuring the components of tobacco smoke 
The Council Directives on the labelling of tobacco pro-
ducts and the maximum tar content of cigarettes require 
the nicotine and tar contents of cigarettes to be measured 
on the basis of standards ISO 4387 and ISO 3400 and 
verified in accordance with ISO 8243. 
The national and European standardization institutes are 
currently working on ISO standards for measuring the tar 
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and nicotine yields of tobacco products other than ciga-
rettes (rolling tobacco, cigars, etc). 
Action 7: Prohibition of tax-free sales of tobacco in the 
European Community 
Proposals will be drawn up under the second plan of 
action, 1990-94. 
Action 8: Protection of children from tobacco sales 
After consulting experts, the European Commission deci-
ded not to draw up a proposal for a Directive prohibiting 
the selling of tobacco products to minors. In several 
countries, particularly in southern Europe, such a ban 
could encourage young people to smoke for the sheer 
thrill of breaking the law. 
The European Commission felt that is was better to 
increase protection of young people through a campaign 
against tobacco. Its proposal on limiting advertising for 
tobacco products in youth magazines therefore provides 
for a total ban on tobacco advertising (see action 12). 
Action 9: Reorientation of tobacco production towards 
less toxic varieties and study of the possibilities of 
reconversion 
The common agricultural policy has taken account of 
concern about public health by encouraging the reorienta-
tion of tobacco production towards less toxic varieties 
(which are also the most popular) and promoting conver-
sion to other products. The following measures have been 
implemented: 
(a) The prices and premiums paid in 1987-89 for the 
most toxic varieties were reduced by 8 to 18%. The 
maximum quantities for which the guaranteed prices 
and premiums were payable, introduced in 1988, has 
been reduced by 2 5 % for the period 1988-90. 
(b) The structural Funds set up in connection with the 
C A P have been used to finance investments, e.g. 
irrigation, necessary for conversion to less toxic varie-
ties or other crops. The technological research and 
development programme for agriculture has also fi-
nanced research into the creation of tobacco varieties 
which are less toxic as a result of a lower tar content 
or, by way of diversification, tobacco plants contain-
ing proteins which can be used for pharmaceutical 
purposes. The integrated Mediterranean programmes 
budget has also been used, to the amount of E C U 
2.33 million over the period 1986-92, to finance 
changes to less toxic varieties and for conversion of 
4 030 ha of land used for tobacco growing in Greece. 
Action 10: Information and public awareness campaign 
in the struggle against tobacco 
The Commission has subsidized a large number of activi-
ties in the campaign against tobacco, most of them carried 
out by anti-cancer associations and leagues and anti-
smoking organizations in the 12 Member States. A special 
effort was made during the European Cancer Information 
Year to promote the first commandment of the European 
Code against cancer: ' D o not smoke. Smokers, stop as 
quickly as possible and do not smoke in the presence of 
others' (see report, published separately, on the European 
Cancer Information Year). 
The graph on the next page shows that encouraging 
results have been achieved during the first action plan in 
seven of the 12 Member States. 
The 'Europe against cancer' programme also financed an 
assessment of the effectiveness of legislation and the 
anti-smoking campaigns in the European Community 
over the past 40 years. The results of this study were 
published in 1990 in the journal Scandinavian oncology. 
Action 11: Study of national provisions, and develop-
ment of proposed Community regulations on tobacco 
smoking in public places 
O n 16 May 1989, the Council and the Health Ministers 
of the Member States adopted a resolution based on a 
proposal from the Commission (OJ C 32, 8. 2. 1989), to 
ban smoking in places open to the public (OJ C 189, 
26. 7. 1989). The Member States have to inform the Euro-
pean Commission every two years of action taken in 
response to this resolution. 
Action 12: Study of national provisions, and 
development of proposed Community regulations on 
the limitation of tobacco publicity 
In September 1989, the Council (Internal Market Minis-
ters) adopted the proposal for a Directive on the pursuit 
of television broadcasting activities (OJ L 298, 
17. 10. 1989). Article 13 of this Directive states that 'All 
forms of television advertising for cigarettes and other 
tobacco products shall be prohibited'. This ban must be 
effective by 3 October 1991 at the latest and covers both 
direct and indirect advertising, the latter being defined in 
the 29th recital as 'forms of advertising which, whilst not 
directly mentioning the tobacco product, seek to circum-
vent the ban on advertising by using brand names, sym-
bols or other distinctive features of tobacco products or 
of undertakings whose known or main activities include 
the production or sale of such products ' . 
O n 30 March 1989, the European Commission presented 
a proposal for a Council Directive on the advertising of 
tobacco products in the press and by means of bills and 
posters (OJ C 124, 18. 5. 1989). This proposal places strict 
controls on direct advertising, for example by imposing 
compulsory health warnings identical to those annexed to 
the Directive on labelling. Indirect advertising is totally 
banned, and both direct and indirect advertising are 
prohibited in publications mainly intended for young 
people. Finally, the proposal does not prevent the Mem-
ber States from placing a total ban on the advertising of 
tobacco products, should they so wish. 
Action 13: Comparative analysis of anti-smoking 
campaigns 
In cooperation with the World Health Organization and 
the British Medical Association, the European Commis-
sion has helped to finance a report on helping smokers to 
give up smoking (available in French, English and 
Spanish). 
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Changes in the percentage of non­smokers during the action plan 1987­89 
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Significant changes (4% or more) have been recorded in seven of the 12 Member States 
Action 14: Information exchange in the struggle 
against smoking 
In the course of the first plan of action 1987­89, the 
European Commission set up the following three infor­
mation exchange structures: 
(i) a European group of non­governmental organizations 
against tobacco, which met four times between 1987 
and 1989; 
(ii) a group of senior officials responsible for the cam­
paign against tobacco, which also met four times; 
(iii) the European Bureau for Action on Smoking Preven­
tion (BASP), which was established in 1988 and 
published six information brochures in 19SS and 
1989. 
Finally, the European Commission joined forces with the 
World Health Organization and the Spanish Health Min­
istry to organize the first European conference on anti­
tobacco policy, held in Madrid from 7 to 11 November 
19S8 and marked by the publication in French, English 
and Spanish of a set of 10 brochures which were then 
widely distributed in 1989, in particular to the 300 partici­
pants in the 'Europe against cancer' programme in the 12 
Member States. 
II — IMPROVEMENT IN NUTRITION 
Action 15: Analysis of existing information on 'Nutri­
tion and cancer' 
Several studies aimed at improving knowledge on the 
possible links between nutrition and cancer were subsi­
dized under the first plan of action 1987­89: 
(a) Feasibility phase of prospective studies of the links 
between nutrition, health and cancer. Seven studies 
were launched in the Federal Republic of Germany, 
United Kingdom, Netherlands, France, Italy, Spain 
and Greece in order to explore the possibility of 
undertaking a very wide study of these links in the 
seven countries mentioned as from 1990. This would 
involve monitoring a group of around 350 000 persons 
over a period of several years, through nutrition 
surveys carried out every two or three years and 
correlated with the subjects' state of health. The 
European Commission and the WHO's International 
Agency for Research on Cancer are jointly responsible 
for overall coordination. 
(b) Prospective study of the anti­promoting role of sel­
enium. Conducted by the University of Limburg 
between 1986 and 1989, this study monitored 120 000 
subjects aged between 55 and 69 to assess the possible 
protective role of selenium, a mineral salt present in 
foodstuffs. The results will be published in October 
1990. 
(c) Feasibility phase of a case control study relating to the 
links between nutrition, lifestyle and the incidence of 
breast and colon cancer in the European Community. 
The separate studies carried out in nine Member 
States, namely the United Kingdom, Netherlands, 
Federal Republic oi Genn.inv, Ireland, Belgium, 1 ux­
embourg, Greece, Italy and Spain, were coordinated 
by the IARC, and the results should be available in 
mid­1990. 
(d) Case control study of patients with adenomatous 
polyps or cancer of the colon. 450 persons from 
Belgium, France, the United Kingdom, Federal Repu­
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blic of Germany, Italy and Portugal were monitored 
for three years to evaluate the possible role of diet on 
the development of the polyps and their degeneration 
into cancer of the colon. The study was coordinated 
by the European Organization for Cooperation in 
Cancer Prevention Studies (ECP), and the results will 
be published towards the end of 1990. 
(e) Case control study of the link between lifestyle, 
especially diet, and cancers of the pancreas and bile 
ducts. This study was undertaken in the Netherlands, 
between 1984 and 1989, by the Institute for Health, 
and involved a group comprising 189 persons with 
cancer of the pancreas, 127 persons with cancer of the 
bile ducts and 487 persons not suffering from either. 
All subjects were interviewed twice to establish their 
lifestyles and dietary habits. The results will be 
published in 1990. 
(f) Case control study of nutrition, alcohol consumption 
and breast cancer. Carried out under the auspices of 
the Nutrition Department at the Athens School of 
Public Health, this study, which began in 1988, is 
monitoring 600 women with breast cancer and a 
1 200-strong control group. It will be completed by 
the end of 1990. 
(g) Case control study of nutrition and precancerous 
intestinal lesions. This was carried out in five Member 
States, covering 180 persons with precancerous intesti-
nal lesions and a control group of 500 persons. The 
aim was to identify possible links between dietary 
habits and the appearance of precancerous lesions. 
The work was coordinated by the ECP, and the 
preliminary results will be published towards the end 
of 1990. 
(h) Intervention study of the anti-promoting role of cal-
cium. Launched in 1989 by the University of Notting-
ham (United Kingdom), this study will monitor a 
group of 200 persons with colorectal adenomas and a 
200-strong control group for a period of five years. 
Each group is divided into two subgroups, one of 
which receives a daily supplement of 1.5 g of calcium, 
whilst the other does not. The results will be available 
in 1994. 
Avoid becoming overweight and limit your intake of fatty 
foods.' 
These two rules have been publicized by the governmental 
and non-governmental programme participants in each 
Member State, in most cases with financial support from 
the European Commission. 
Action 17: Harmoniza t ion of nutr i t ional labelling of 
foodstuffs in the European Communi ty 
The European Commission's proposal dated 5 October 
1988 (COM(88) 489 final) was revised following consulta-
tion of the European Parliament (COM(89) 420 final), 
resulting in a common position dated 21 December 1989. 
Article 2 of this common position states that 'Nutrition 
labelling shall be compulsory when a nutrition claim is 
made in labelling or advertising. Nutrition labelling is 
optional in all other cases.' (OJ C 66, 16. 3. 1990). 
Action 18: Consumer protection against certain agents 
in foodstuffs 
In 1988, the European Commission drew up a new 
proposal for a Directive on pesticide residues in fruit and 
vegetables (OJ C 46, 25. 2. 1989), on the basis of Article 
43 of the EEC Treaty. This consolidates existing legisla-
tion and in addition makes it compulsory to provide clear 
information for the consumer. The Council will reach a 
decision on this proposal once the European Parliament 
has delivered its opinion at the May 1990 part-session. 
Action 19: Improvement of existing information 
campaigns concerning nutr i t ion 
All the participants in the 'Europe against cancer' pro-
gramme in the 12 Member States realigned their informa-
tion campaigns aimed at the general public to take account 
of the two European cancer prevention rules on nutrition 
and the results of epidemiological studies which had 
become available. New brochures were published with 
financial assistance from the European Commission, in-
cluding 'Diet and cancer' from the UK Health Education 
Authority, 'Eet wijzer' from the Nederlandse Kanker 
Bestrijding, and '100 recettes santé' from the Association 
contre le Cancer (Belgium). 
Action 16: Development of nutri t ional recommenda-
tions against cancer adapted to each of the categories 
of participants concerned 
Despite the numerous uncertainties affecting current 
knowledge of the links between nutrition and cancer, the 
European Committee of Cancer Experts has formulated 
two recommendations on nutrition, introduced by a gen-
eral warning: 
'Your general health will benefit from the following two 
commandments which may also reduce the risks of some 
cancers: 
Frequently eat fresh fruit and vegetables and cereals with 
a high fibre content. 
Action 20: Initiation of information campaigns for 
recommended foodstuffs 
Numerous campaigns were conducted, particularly during 
European Cancer Information Year, including the free 
distribution of fresh fruit and vegetables through non-
governmental associations — in Italy during the European 
Cancer Prevention Week in May 1988, and in Luxem-
bourg and Denmark during the European Week in Octo-
ber 1989. 
Action 21: Promotion of appropriate foodstuffs and 
techniques 
Community-level activities of this nature may be included 
in the second plan of action, 1990-94. 
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Action 22: Evaluation of pilot experiments in nutrition 
An assessment of the strategies used to provide the 
general public with nutrition information and education 
was started in 1989, and the results will be published in 
1990. 
Action 23: Exchange of information on 'nutrition and 
cancer' 
In 1988 and 1989 several symposia were organized, with 
the financial support of the 'Europe against cancer' pro-
gramme. 
(a) European seminar on 'Fighting cancer with preven-
tion, education and research' for 60 scientific journa-
lists. (Organized by the European School of Onco-
logy, Venice, 11 and 12 May 1989.) 
Two of the papers dealt with nutrition, namely 
'Ingestion of fats and the risk of cancer' and 'Vegetable 
fibres and the risk of cancer'. All the papers presented 
are available in a booklet, and the most important 
ones will be published in French and English by 
Springer Verlag in mid-1990. 
(b) EEC workshop on the important components of food 
and nutrition policy in the EEC. (Organized by the 
Athens School of Public Health, Corfu, 6 to 8 Octo-
ber 1988.) 
This workshop looked at current knowledge of links 
between nutrition and health and examined existing 
legislation on foodstuffs, especially nutritional label-
ling. The proceedings have been summarized in a 
brochure (in English), several thousand of which have 
been distributed. 
(c) EEC workshop on recommended dietary intakes. 
(Organized by the Athens School of Public Health, 
23 to 25 November 1989.) 
This workshop examined the similarities and differen-
ces between the dietary intakes recommended in the 
European Community Member States and Scandina-
via. The objective was to study the possibility of 
harmonizing the nutritional standards recommended 
in Europe. The proceedings have been summarized in 
a brochure and will be published as a supplement to 
the European journal of clinical nutrition in 1990. 
Ill — PROTECTION AGAINST 
CARCINOGENIC AGENTS 
Action 24: Protection against ionizing radiation and 
follow-up to Chernobyl 
On 14 December 1987, the Council adopted Regulation 
No 87/3954/Euratom laying down maximum permitted 
levels of radioactive contamination of foodstuffs and of 
feedingstuffs following a nuclear accident or any other 
case of radiological emergency (OJ L 371, 30. 12. 1987). 
In 1989, the Council adopted Regulation (EEC) No 
2219/89 on the conditions governing exports of foodstuffs 
and of feedingstuffs following a nuclear accident or any 
other case of radiological emergency (OJ L 371, 
30. 12. 1987), and Directive (Euratom) No 618/89 on 
informing the population of health protection measures 
and behaviour in the case of a radiological emergency (OJ 
L 357, 7. 12. 1989, p. 31). 
Action 25: Creation of an observation antenna and 
establishment of a list of chemical substances suspected 
of being carcinogenic 
Owing to a shortage of staff, it was not possible to create 
such an antenna within the European Commission. How-
ever, the following studies habe been financed under the 
'Europe against cancer' programme: 
(a) Study of occupational cancers among workers in-
volved in the manufacture of certain types of herbi-
cides. The purpose of this'study, by the National 
Institute for Public Health and Protection of the 
Environment in the Netherlands, is to compare the 
frequency of deaths caused by the various types of 
cancer among persons exposed and persons not ex-
posed to the suspected substances (phenoxy acids and 
chlorophenols). The results should be available to-
wards the end of 1990. 
(b) Study of the carcinogenic risks of certain pesticides 
used in agriculture. The objective of this case-control 
study is to identify the possible links between cancers 
observed among certain farmers and chemicals used in 
farming. This study was launched in 1989 by the 
Italian Health Institute. 
(c) Preliminary study of the cancer risk among biology 
laboratory workers in Europe. The need for such a 
study became apparent in 1986 when several cases of 
rare cancers occurred at the Institut Pasteur in Paris. 
The feasibility study, carried out in 1988 and 1989 by 
the International Agency for Research on Cancer, 
recommends a large-scale European study. 
(d) Preliminary study of the prevention of secondary' 
cancers caused by chemotherapy. This study is cur-
rently being carried out by the International Agency 
for Research on Cancer and aims to identify the 
possibilities of improving certain types of chemo-
therapy treatment in order to reduce the long-term 
risks of secondary cancer. 
(e) Study of the role played in lung cancer by exposure 
to radon in houses and flats. This study is currently 
being carried out by the Department of Hygiene and 
Medicine at the University of Ghent. It may be 
extended to France and the Federal Republic of Ger-
many. 
Action 26: Speeding up of the work at Community 
level, and creation of a special group on classification 
and labelling of carcinogenic substances 
In 1987 a working party on carcinogenic substances was 
created within the 'Classification and labelling of carcino-
genic substances' group created by Directive 67/548/EEC. 
Several suspected substances have been examined during 
the past three years. Eighty carcinogenic substances or 
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groups of substances have already been classified, and at 
the beginning of 1990 a further 150 substances were being 
examined. 
Action 27: Adoption of Directives currently being 
discussed by the Council for the protection of workers 
On 9 June 1988, the Council adopted Directive 88/364/ 
EEC on the protection of workers by the banning of 
certain specified agents (OJ L 179, 9. 7. 1988). Apart from 
a number of exemptions which may be granted by the 
Member States for clearly specified purposes under clearly 
established conditions, the production and use of the 
following substances, responsible for cancers of the blad-
der, are banned: 2-naphthylamine and its salts, 4-aminobi-
phenyl and its salts, benzidine and its salts, and 4-nitrodi-
phenyl. The Directive also states that the Council, acting 
by a qualified majority on a proposal from the Commis-
sion, in cooperation with the European Parliament and 
after consulting the Economic and Social Committee, 
may amend the Annex, in particular to include further 
agents or activities. 
Action 28: New Directives for the protection of 
workers against carcinogenic substances 
On 21 December 1987, the Commission, acting on the 
basis of Article 118a of the EEC Treaty, presented a 
proposal for a Council Directive on the protection of 
workers from the risks related to exposure to carcinogens 
at work (OJ C 34, 8. 2. 1988). Where exposure of workers 
is inevitable, the proposal calls on employers to take 
various supplementary measures, including the design of 
work processes, early detection of abnormal exposures, 
information for workers, surveillance of workers' health, 
emergency measures, and arrangements for safe storage of 
substances and safe disposal of waste. The Economic and 
Social Committee delivered its opinion on 2 June 1988 
(OJ C 208, 8. 8. 1988), followed on 24 May 1989 by the 
European Parliament (OJ C 158, 26. 6. 1989). On 31 July 
1989, the European Commission transmitted to the Coun-
cil a revised proposal taking account of most of the 
European Parliament's amendments (OJ C 229, 
6. 9. 1989). 
On 30 November 1989, the Council on Social Affairs 
adopted a common position including most of the amend-
ments contained in this latter proposal. The proposal 
covers 52 chemical agents already classified as carcino-
genic and will automatically be extended to cover any 
substances classified as such in the future (see action 26). 
The Directive should be adopted finally in 1990, after the 
European Parliament has given its opinion on the Coun-
cil's common position at the part-session in May 1990. 
Action 29: Prevention of occupational cancers by im-
proving the practical organization in undertakings, 
including information to employers and workers 
On 18 March 1988, the Commission presented a proposal 
for a Council Directive on the introduction of measures 
to encourage improvements in the safety and health of 
workers at work (COM(87) 73 final). It requires employ-
ers to assess the health risks to their workers, decide on 
the protective measures to be taken, and make information 
accessible to workers and their representatives. The Direc-
tive (EEC/89/391) was adopted in June 1989 (OJ L 183, 
29 .6 . 1989). 
Action 30: New measures for public protection against 
carcinogenic substances 
On 28 January 1988, the European Commission, acting 
on the basis of Article 100a of the EEC Treaty, presented 
to the Council a proposal for a Directive amending 
Directive 76/769/EEC relating to restrictions on the mar-
keting and use of certain dangerous substances and prepa-
rations. The substances covered include the four product 
families mentioned under Action 27, plus benzene. The 
Directive was adopted by the Council on 21 December 
1989 (OJ L 398, 30. 12. 1989). 
IV — SYSTEMATIC SCREENING AND 
EARLY DIAGNOSIS 
Action 31: Promotion of a policy for systematic screen-
ing and early diagnosis of cancer of the uterine cervix 
and cancer of the breast 
In 1988, the Committee of Cancer Experts set up under 
the 'Europe against cancer' programme created two sub-
committees on screening for breast cancer and cervical 
cancer respectively. Each of these subcommittees drew up 
a strict protocol to be respected by all projects to be taken 
under the wing of and receive financial support from the 
'Europe against cancer' programme. For example, syste-
matic screening for breast cancer is recommended between 
the ages of 50 and 65 (every 2 to 3 years) and for cervical 
cancer every 3 to 5 years from the age of 25. 
A European network of pilot projects for breast cancer 
screening was established in 1989. Every project must 
monitor a group of at least 10 000 women, each of whom 
must be invited by a personal letter, with an automatic 
reminder if necessary, in order to achieve high rates of 
participation. In four regions — Pirgos (Greece), Navarra 
(Spain), Porto (Portugal) and Limburg (Belgium) — mo-
bile units are used for screening. In the Dublin area, 
screening takes place in a mobile unit and at a permanent 
centre (Mater Hospital). In the department of Bas-Rhin 
(France), it is done by approved radiologists. In 1990, the 
network will be extended to the Florence region and to 
Luxembourg. The staff involved in pilot operations are 
being invited for further training at one of the most 
advanced screening centres, that in Utrecht (Netherlands). 
Finally, the 'Europe against cancer' programme budget 
permitting, a start could be made in 1991 on setting up a 
European network of pilot projects for cervical cancer 
screening. 
Action 32: Evaluation and improvement of the policy 
for the systematic screening and early diagnosis of 
other common cancers 
There are still many uncertainties about the usefulness of 
policies for systematic screening for colo-rectal cancers 
by detection of blood in the faeces, which is why the 
'Europe against cancer' programme has not given financial 
support to the many projects submitted. On the other 
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hand, three studies on the subject have been financed 
under the first plan of action 1987-89: 
(a) A report on the efficiency of haemoculture for early 
detection of colo-rectal cancers. Carried out by ex-
perts of international standing under Professor Hard-
castle (United Kingdom), this study was described at 
the European Conference in Venice on 11 and 12 May 
1989. Publication in French and English by Springer 
Verlag will follow in 1990 (see action 23). 
(b) A study to assess the efficiency of colo-rectal cancer 
screening in the Federal Republic of Germany. Con-
ducted in the Saarland by the University of Heidel-
berg, it will provide an assessment of the effectiveness 
of colo-rectal cancer screening, which was introduced 
on a large scale in 1977. The results should be available 
early in 1991. 
(c) A controlled experiment on the efficiency of colo-rec-
tal cancer screening in the Dijon region (France). This 
experiment, comparable in principle with those car-
ried out in the United Kingdom and Denmark, covers 
45 000 persons aged between 47 and 55. Initial results 
should be available as from 1991. 
V — E U R O P E A N C O D E A G A I N S T C A N C E R 
Action 33: Transformation into layman's language of 
the European Code against cancer 
The European Code against cancer was adopted by the 
Committee of Cancer Experts set up under the 'Europe 
against cancer' programme in May 1987 following wide 
consultation of the health ministries and non-governmen-
tal organizations involved in the fight against cancer. 
Chapter 2: Information and health education 
I — I N F O R M I N G T H E G E N E R A L P U B L I C 
Action 34: Establishment of a directory of the private 
organizations against cancer in Europe 
This directory was prepared in 1987 and is available in 
French, English and German. It will be updated in 1990. 
Action 35: Comparative survey of private and public 
cancer prevention information campaigns 
At the start of the plan of action 1987-89, a general study 
was undertaken to establish what had been accomplished 
in the various Member States. The creation of the group 
of organizations against cancer led to a broad exchange of 
experience and permitted continuous assessment of ac-
tions (dissemination of the European Code through 
various channels, organization of open days, travelling 
exhibitions, etc.). On 25 January 1990, a symposium was 
held in Athens to assess the efficiency of actions (see 
special report on the European Cancer Information Year). 
Action 36: Bringing cancer prevention and the 'Europe 
against cancer' programme to the attention of the 
media 
Following an invitation to tender, a public relations 
agency network was set up at the beginning of 1987, and 
as from 1989 a 'Europe against cancer' programme corres-
pondent was assigned to each of the European Commis-
sion's offices in the Member States. Every year, two press 
conferences are organized simultaneously in the 12 Mem-
ber States, and three or four press releases are sent out. In 
some countries (e.g. Denmark), the press releases have, 
since 1989, been backed up by a bi-monthly newsletter. 
This will be practised in all countries as from 1990. 
Action 37: Eurobarometer survey of Europeans' 
attitudes to cancer and its prevention 
Between 1987 and 1989 several surveys were carried out 
simultaneously in the 12 Member States of the European 
Community to assess the extent of knowledge and appli-
cation of the European Code against cancer by the general 
public, doctors and teachers. The survey reports are 
available in French and English, and a book containing 
the full results will be published in French, English and 
German towards the end of 1990. 
Action 38: Financial contribution to television cancer 
prevention broadcasts for the general public 
Ten television programmes on cancer prevention and 
treatment were financed in 1988 and 1989 by the 'Europe 
against cancer' programme. Two of them received interna-
tional awards. The European Cancer Information Year 
ended on 9 January 1990 with a major Eurovision broad-
cast (see special report on the European Year). 
Action 39: Dissemination of the European Code against 
cancer at sports and cultural events sponsored by the 
European Community 
Two of these events deserve special mention. First of all, 
the special concerts given in 1987 to mark the 30th 
anniversary of the Treaty of Rome, when around ECU 
100 000 was collected and donated to the European Orga-
nization for Research on Treatment of Cancer, and 
secondly, the 1989 Tour de France across Luxembourg, 
Belgium and France, when the 'Europe against cancer' 
programme was represented in the accompanying convoy 
by two vehicles in the programme colours, which distri-
buted information in several languages on the European 
Code against cancer. This action was coordinated by a 
Netherlands anti-cancer association, the LOK. 
Action 40: Public meeting to mark the end of the first 
year of the 'Europe against cancer' programme 
During the European Council in Copenhagen on 5 De-
cember 1987, a brief official ceremony was held, and a 
prestige version of the European Code against cancer was 
presented to the Danish Prime Minister, the President-in-
Office of the Council. Each Head of State or Government 
received a similar copy in his or her own language. 
Action 41: Preparation of the actions to be carried out 
in 1989, European Cancer Information Year 
This involved the various networks of partners set up 
since the end of 1986: cancer prevention, anti-smoking 
and general practitioners' organizations; producers of 
medical programmes for the European television stations; 
public relations agencies; senior health and education 
ministry officials. A total of nearly 100 non-governmental 
organizations took part. 
128 SOCIAL EUROPE 1/91 
'Europe against cancer' programme 
Evolution of the notoriety of the European Code during the European Year of Information on Cancer 
Have heard about the European Code against cancer 
The objective of the European Year of Information on Cancer was to increase the notoriety of the European Code against 
cancer. This objective was attained in 9 of the 12 countries, and most spectacularly in Portugal (from 29% to 56%). O n 
the contrary, in the Netherlands and the United Kingdom the level of notoriety remained stationary and fell slightly in 
Germany (from 15% to 12%) and in Denmark (from 15% to 11%). 
Action 42: Organization of a European week against 
cancer as a test for the 1989 campaign (European 
Cancer Information Year) 
The purpose of this week (1 to 8 May 1988) was to 
prepare for the European Cancer Information Year. Three 
European television broadcasts were produced by the 
European Commission, and numerous activities were 
organized by the programme participants. 
Action 43: Increase in 1988 of the campaigns carried 
out in 1987 to inform the public and increase public 
awareness of the campaign against cancer 
The objective was achieved despite a very limited budget, 
thanks above all to the non-governmental organizations, 
which invested substantial human and financial resources 
in the dissemination of the European Code against cancer. 
Polls in the 12 Member States measured changes in the 
degree of awareness of this Code, and the excellent results 
recorded in certain southern European countries show 
that it is possible to increase Europeans' awareness on 
matters of such paramount importance as their health. 
Action 44: Interesting teachers and the health 
professions in dissemination of the European cancer 
prevention commandments 
The European Commission was able to involve these vital 
groups despite a lack of financial resources, thanks to the 
representatives of general practitioners and senior health 
education officials whom it met twice a year in Brussels. 
In many countries, the European Code against cancer was 
displayed in general practitioners' waiting-rooms, and 
there were numerous campaigns aimed at schools (see 
special report on the European Year). 
Action 45: Organization in 1989 of a media campaign 
aimed at the general public: '12 nations, 12 days of 
action against cancer' 
This action was not carried out owing to a lack of funds. 
Action 46: Intensification in 1989 of the campaigns 
carried out in 1987 and 1988 to inform the public and 
increase public awareness of the fight against cancer 
See special report on the European Cancer Information 
Year. The graph illustrates the encouraging results reached 
in most of the Member States. 
II — HEALTH EDUCATION 
Action 47: Establishment of a comparative survey of 
health education programmes in European schools 
Two comparative studies of health education in the 12 
Member States of the European Communi ty were carried 
out in 1988 and 1989. The first, by Professor Trevor 
Williams (Head of the Health Education Department at 
the University of Southampton and consultant to the 
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'Europe against cancer' programme) looked at the existing 
situation. The second took the form of a survey of 2 750 
teachers in the European Community. Both studies, 
together with other reports, were presented at the first 
European conference on 'Health education and cancer 
prevention in schools', held in Dublin from 7 to 9 
February 1990, the proceedings of which will be published 
in the nine official languages of the European Community 
in mid-1990. 
Action 48: Drawing-up of proposals to improve health 
education programmes in schools 
On 31 May 1988, the Council and the Ministers for 
Health meeting within the Council adopted a Decision on 
a plan of action for 1988-89 on information and health 
education in the context of the 'Europe against cancer' 
programme (OJ L 160, 26.6. 1988). On 23 November 
1988, the Council and the Ministers for Education meet-
ing within the Council adopted a general resolution on 
health education in schools. Finally, on 13 November 
1989, the Council and the Ministers for Health meeting 
within the Council adopted in principle — whilst awaiting 
the opinion of the European Parliament — a Decision on 
the second plan of action 1990-94 under the 'Europe 
against cancer' programme. The planned health education 
campaigns aimed at preventing cancer will benefit from a 
budget averaging close to ECU 2 million per annum. 
Action 49: Provision of teaching material relating to 
health education 
Three types of European audiovisual material were produ-
ced by the European Commission in the nine official 
languages of the European Community and distributed 
free of charge via the governmental and non-governmental 
programme participants: 
(i) a booklet aimed at the general public about the 
'Europe against cancer' programme; 
(ii) a set of six posters containing the European Code 
against cancer and five maps showing cancer deaths 
in Europe (lung-tobacco; oesophagus-alcohol; mela-
nomas-sun; stomach-fruit and vegetables; breast-
fats); 
(¡ii) a cartoon video for children (Euro-Jim against Crah 
Cancer), illustrating the European commandments 
relating to tobacco, alcohol, sun, fruit and vegetables, 
and fats) and two films for older teenagers and adults 
(Man and cancer and Lifestyle and cancer in Europe). 
Action 50: Contribution to the financing of television 
health education broadcasts on the prevention and 
treatment of cancer 
In addition to the television programmes aimed at the 
general public and mentioned under Action 38, the Euro-
pean Commission produced a special health education 
film entitled Prevention and early detection of cancer, 
which was awarded the first prize for films on cancer at 
the international medical film festival in Parma (Italy) in 
1989. This film is particularly suitable for health education 
teachers and will be available on video to programme 
participants free of charge as from mid-1990. 
Chapter 3: Training of the health professions 
Action 51: Comparative study of the systems of 
university training for health-care workers 
On the basis of the general recommendations drawn up 
in 1986 by the Committee of Cancer Experts set up under 
the 'Europe against cancer' programme and specific re-
ports by four European experts in 1987, the three Advi-
sory Committees on the training of nurses, dentists and 
doctors delivered their opinions and recommendations in 
1988 and 1989 (Documents III/D/248/3/88 of 20 Decem-
ber 1988, III/D/886/3/88 of 22 November 1988 and 
III/D/890/3/89 of 20 April 1989). These opinions and 
recommendations were sent officially to the Member 
States' Ambassadors (Permanent Representatives) in 1989 
to ensure maximum publicity. 
On 8 November 1989, the European Commission formal-
ly adopted a Recommendation concerning the training of 
health personnel in the matter of cancer. It 'recommends 
that the Member States, their competent authorities and 
their establishments responsible for professional training 
make every effort to ensure, in accordance with their 
respective competence, that [the recommendations of the 
three Advisory Committees on the training of health 
personnel] are widely distributed, discussed and imple-
mented' (OJ L 346, 27. 11. 1989). 
Action 52: Formulation of proposals for improving the 
organization of studies in the cancer field 
In May 1988, a first European conference on cancer 
training as part of basic medical studies was held in Bonn. 
Organized jointly by the European Commission and the 
European Organization for Research on Treatment of 
Cancer, it was attended by around 40 faculty of medicine 
deans and cancer experts. Consensus was reached on the 
minimum amount of cancer training in basic medical 
studies and on the procedures for implementation. Three 
further 'consensus' conferences of this type were prepared 
in 1989, covering cancer training for dentists, nurses and 
general practitioners. 
Action 53: Stimulation of mobility of medical and 
nursing students 
Fifty grants were awarded in 1989 to doctors and nurses 
wishing to undergo further training in cancer at the 
European School of Oncology in Venice. Another 20 
grants were awarded in 1989 to persons involved in the 
European network of pilot projects for breast cancer 
screening to allow them to receive further training at the 
Prevention Centre in Utrecht. Grants were also awarded 
to medical students and student nurses under the Erasmus 
programme. 
Action 54: Joint preparation and exchange of teaching 
materials and testing of this during the European 
Cancer Information Year 
Teams of international experts prepared handbooks for 
the European School of Oncology on lung cancer (1988) 
and breast cancer (1989) to be used for initial or further 
training of general practitioners. These were distributed 
to a sample of general practitioners for trial use and will 
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be published as from September 1990 in the nine official 
languages of the European Community, by Springer 
Verlag. 
Action 55: Exchange of experience on cont inuous 
t ra in ing 
The European Commission has limited its activity in this 
field to further training for general practitioners, given 
their central role in a policy of cancer prevention and 
screening. Apart from the handbooks mentioned above, 
an ad hoc working party was set up to prepare the 
consensus conference on the training of general practitio­
ners, which should take place early in 1991. 
Action 56: Development of common compute r 
p rog rams for expert medical systems for cancer 
This action was not carried out owing to lack of funds. 
C h a p t e r 4 : C a n c e r r e s e a r c h 
Action 57: European grants to encourage mobility of 
cancer research workers 
The cancer research training scheme became fully opera­
tional in 1988. More than 100 fellowships were allocated 
to young scientists wanting to spend up to two years in 
another Member State, or in Switzerland or Austria 
(countries participating in the cancer target). In 1988, 25 
post­doctoral and 21 post­graduate long­term fellowships 
were allocated (for one year and, in exceptional cases, two 
years). Moreover, 10 short­term fellowships were alloca­
ted (up to four months). In 1989, 21 post­doctoral and 17 
post­graduate long­term fellowships as well as 18 short­
term fellowships were allocated. 
Action 58: Compar i son of existing cancer registers and 
recommenda t ion for their m in imum contents and 
condit ions of access to them 
During the first action plan, a study was carried out by 
the International Agency for Research on Cancer (IARC) 
in Lyons on the existing cancer registries in Europe. This 
study shows several different approaches towards data 
collection and data management. 
In 1989, the first phase of a feasibility study for setting up 
a European network of cancer registries was carried out, 
coordinated by the IARC and the Danish Cancer Regis­
try. The aim of the study is to fix a minimum of data 
collection in order to enhance comparability. During the 
second action plan 1990­94, this network will be set up 
and gradually be extended to permit the implementation 
of a monitoring system on cancer incidence in the EC. 
Action 59: Launch ing European coordinat ion of 
medical research on food and cancer 
This action, which is partially under way within the 
framework of the joint Euronut ­ECP (European Organi­
zation for Cooperation in Cancer Prevention Studies) 
project, has seen the launching of a pilot study on the role 
of dietary factors in the development of type Β atrophic 
gastritis, a pre­cancerous stomach lesion. Data are collec­
ted in seven countries, and in a few months, the centres 
will stop collecting cases and controls. The next step is the 
data set analysis. The total number of cases and controls 
will be around 450 instead of the planned 600. 
A collaborative research project on the geographic corre­
lation between biological risk factors for gastritis and 
gastric cancer has been financed by the Commission from 
January 1989 for a period of two years. A first meeting, 
organized in collaboration with the International Agency 
for Research on Cancer (IARC) in Lyons, permitted the 
finalization of the study protocol. 
Action 60: Stepping­up of European research on 
occupational cancers 
Following up a seminar held in Paris in December 1987 
on methodologies for evaluating the links between occu­
pational exposure and the risk of developing cancer, a 
workshop was organized in 1988 to prepare a joint action 
on this subject within the framework of the fourth 
medical and health research programme (1987­91). A 
proposal for a concerted action was approved in June 
1989 and will be financed by the Commission from 
January 1990 onwards for a duration of 2Vi years. 
The objectives of the concerted action are: 
(i) to improve the ways of measuring occupational expo­
sures in epidemiological investigation of cancer; 
(ii) to compare the performance of different methods on 
a large number of epidemiological surveys in a stan­
dardized way, to make conclusions and recommenda­
tions. 
Action 61 : C o n t i n u a t i o n of the co­financing by the 
European C o m m u n i t y of research on the prevent ion of 
radiat ion­induced cancers 
The current (1985­89) and future (1990­91) radiation 
protection research programmes support, on a cost­shared 
basis, projects designed to improve the understanding of 
how radiation induces cancer and the dependence on dose 
and exposure conditions. 
(1) Cell transformation and molecular biology studies 
investigate the mechanisms by which radiation con­
verts a normal cell to malignancy. 
(2) Animal studies investigate the effect of dose, dose rate 
and radiation quality on the induction of cancer. 
(3) Epidemiological studies on human populations expo­
sed to radium and thorotrast in previous medical 
treatments and to radon in homes attempt to deter­
mine the risk of cancer induction from these sources 
of radiation. 
A meeting on 'Cell transformation systems relevant tö 
radiation­induced cancer in man' was jointly organized 
by the Commission, the US Department of Energy and 
the Nuclear Energy Board of Ireland, and the proceedings 
of the meeting have been published. A report 'Feasibility 
of studies on health effects in Western Europe due to the 
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reactor accident at Chernobyl and recommendations for 
research' has been finalized. The report concludes that it 
will be virtually impossible to detect the relatively few 
cancers resulting from the accident but recommends that 
an epidemiological study of childhood leukaemia inci-
dence be made using existing cancer registries. 
Action 62: Continuation of co-financing by the Euro-
pean Community of research on environmental factors 
and cancer 
The coordinated projects in this area are intended to 
provide a scientific basis for early identification and 
assessment of cancer risks to the general population from 
environmental factors. There are a number of substantial 
projects currently under way: 
(1) Genetic effects of environmental chemicals, which 
include the following research topics: 
Mechanisms of mutagenesis; 
Quantitative mutagenesis (molecular dosimetry); 
Development and validation of predictive tests for 
chromosome non-disjunction; 
Development and validation of tests for detection of 
epigenetic (promoter) substances. 
(2) Biomonitoring of human populations exposed to 
genotoxic environmental chemicals: the aim of this 
project is to develop monitoring techniques for the 
determination of chemically-induced D N A damage 
in man. 
(3) The EC environmental R&D programme has been 
requested by the O E C D to prepare a review of the 
O E C D guidelines for genetic toxicity tests. 
Action 63: Continuation of European coordination of 
medical research on cancer and reproduction 
In 1988, two studies were carried out as a part of the 
Eurocat project for birth surveillance in order to assess 
the mutagenic and teratogenic consequences of the Cher-
nobyl accident. The preliminary results do not suggest an 
increase in frequency of chromosomal syndromes or of 
central nervous system anomalies among conceptuses in 
women exposed to radiation in May to August 1986. The 
results have been published (De Wals P. et al., Int. J. 
Epidemio. 17: 230-231, 1988; Eurocat Working Group, 
Paed. Perinat. Epidemio. 45: 369-382, 1988). A re-analysis 
of the data collected in 1988 and 1989 is foreseen. 
Other studies are needed to assess the long-term carcino-
genic effect of the contamination. 
Action 64: Launching of European coordination of 
medical research on passive smoking 
A seminar on 'Passive smoking and health' was held from 
30 November to 1 December 1987. On the basis of the 
participants' recommendations, a proposal for a project 
on the effects of passive smoking on health was submitted 
to the Commission for examination. 
The objectives of the concerted action are: 
(i) to estimate the overall impact of passive smoking on 
the EC population; 
(ii) to substantiate and quantify the effects of exposure to 
environmental tobacco smoke on the occurrence of 
lung cancer. 
This proposal has been approved, and has been financed 
from January 1989 by the EC for a duration of 2Vi years. 
Action 65: Continuation of European coordination of 
medical research of automated tissue analysis 
1. The first project relates to clinically-applied analytical 
cytometry. A new proposal has been approved in Novem-
ber 1988, with two main lines. The first one is the further 
development, adaptation to the users, and clinical and 
technical evaluation of devices for automated, quantitative 
and analytical cytology and histology; the second one is 
directly relevant to cancer, in particular breast cancer, 
with multicentre clinical studies on the use of cytometric 
analysis of cytological and histological specimens for 
early detection, diagnosis, prognosis, and treatment man-
agement. 
Several instruments have been developed by industries, in 
collaboration with participants in the previous concerted 
action; they are in the phase of prototype development 
for clinical testing. It is now planned to participate, in 
particular, in screening programmes for cervical cancer 
using automated pre-screening systems. 
2. The second project relates to automation of cytogen-
etics. The progress achieved so far is presented in a 
publication entitled Automation of cytogenetics — Advan-
ces in systems and techniques (Springer, 1989). This inclu-
des the evaluation of complete image-based chromosome 
analysis, the development of new image techniques and of 
systems for chromosome aberration scoring, automatic 
specimen preparation, and the use of flow systems for 
chromosome measurement and analysis. 
Action 66: Continued European coordination of 
research on imaging in medicine 
A new project on tissue characterization by magnetic 
resonance spectroscopy (MRS) and imaging (MRI) was 
approved in June 1988. Its main objectives are, on the one 
hand, to extend the scope and usage of standardized 
methods in the fields of MRS tissue characterization by 
nuclear magnetic resonance (NMR) and of performance 
assessment of MRS and MRI; and, on the other hand, to 
gather more complete and reliable data on magnetic 
resonance properties of tissues. 
It follows a project on identification and characterization 
of biological tissues by NMR which included works on 
NMR standardization, methodology for in vitro measure-
ment of relaxation times, test substances for calibration, 
test procedures and test objects, etc. The activities and 
results are reported in a series of six papers in Magnetic 
resonance imaging, Vol. 6, No. 2, 198S, pp. 173-222. List 
of the activities held in 1989: 
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Workshop on 'The uses of an in-vivo N M R relaxation 
time data bank — Acquisition and accumulation', Dun-
dee, 13 to 15 March 1989; 
Workshop on 'Quantification in N M R spectroscopy and 
its medical implications', Rome, 16 and 17 June 1988. 
Another project was approved in November 1988 on 
positron emission tomography (PET) in investigation of 
cellular regeneration and degeneration. Its main objective 
is to improve the understanding of major diseases and the 
follow-up of treatment, PET being the only method 
allowing non-traumatic estimation of cell degeneration, 
regeneration and proliferation, and special attention is 
envisaged to be given to pharmacology since PET allows 
pharmacokinetic studies, estimation of interaction of 
drugs with their specific receptors, and consequently 
improvement in drug design and administration. List of 
activities in 1989: 
First modelling expert panel meeting, London, 13 and 14 
April 1989; 
First radiochemistry workshop, Jülich, 11 and 12 May 
1989; 
First cardiology workshop, Pisa, 22 and 23 May 1989; 
Oncology symposium and workshop, London, 6 and 7 
July 1989. 
Action 67: S t reng then ing of European coordinat ion of 
research on clinical t r ea tmen t and of control of mul t i -
centre therapeut ic trials 
1. Under the fourth medical and health research program-
me, support for the E O R T C , as well as for its data centre, 
has been reinforced. Moreover, the improvement of the 
Eurocode informatics network, which facilitates direct 
communication between oncologists and their participa-
tion in the E O R T C ' s clinical trials, has been achieved by 
installing peripheral nodes in Britain, France and the 
Netherlands. 
2. It was agreed to make use of the high flux reactor at 
Petten (EC Joint Research Centre, Netherlands) to esta-
blish a centre for the treatment of malignant brain tu-
mours by boron neutron capture therapy. For reasons not 
yet fully understood, boron compounds are selectively 
accumulated in tumour cells. Subsequent irradiation with 
neutrons results in the capture of neutrons by the boron 
atoms, giving rise to alpha-particles. These have a high 
cell-destructing capacity and do not leave the tumour 
since they move only 5 micrometres in tissue. The results 
obtained in Japan with this treatment are promising. A 
concerted action was approved and started in July 1989. 
About 30 institutes will assure the scientific backing of 
the treatment facility under construction at Petten. It is 
expected that the first patients can be treated in early 1992. 
3. There are both biological as well as physical reasons to 
assume a potential value of light ion beam therapy for 
cancer. Light ion beam treatment allows a more accurate 
irradiation of the tumours, thereby preserving the sur-
rounding healthy tissue. The clinical trials performed in 
the USA so far indicate that there is a clear value for this 
type of treatment for certain tumour types. A feasibility 
study to investigate the possibility of installing a light ion 
medical accelerator in Europe started in 1988. A final 
report is expected at the end of 1991. 
4. A concerted action on the role of cell surface properties 
and tumour specific antigens in metastasis and host immu-
ne response was approved and started in July 1989. 
The general aim is to improve knowledge of the tumour 
cell properties that influence the specific immune response 
of the host and the ability of tumour cells to invade 
surrounding tissues and to metastasize, in order to deve-
lop new forms of cancer treatment by increasing the 
specific host immune response and by inhibiting the 
invasive potential of tumour cells. 
5. A concerted action on treatment of haematological 
malignancies by bone marrow transplantation from vol-
unteer donors was approved in 1989 and will start in early 
1990. 
The general aim of the project is to create in the respective 
areas of donor pool and search coordination, the necessary 
conditions to increase the number of patients with haema-
tological malignancies who can be treated by unrelated 
volunteer bone marrow transplantation and therefore be 
cured of their cancer of the bone marrow. 
If successful, unrelated bone marrow transplantation will 
have a major impact. Until now, the vast majority of 
patients who could be cured by bone marrow transplanta-
tion lack a donor. Bone marrow transplantation would 
then become a possibility available for all patients with 
haematological diseases which cannot be cured by means 
other than transplantation of healthy normal bone mar-
row. It is estimated that this would quadruple the number 
of leukaemic patients being cured within the next decade. 
6. A concerted action on the pathogenesis, diagnosis and 
therapy of tumour progression in human melanomas and 
precursor lesions was approved in 1989 and will start in 
early 1990. 
The objectives are: 
(i) to identify the organization and function of the genes 
coding for progression antigens and their products, 
and to prepare (monoclonal) antibodies recognizing 
these progression antigens; 
(ii) to identify antigens that predict the susceptibility and 
effect of immunotherapy in melanoma patients and 
to study the mechanisms of escape from immune 
response as a manifestation of tumour progression in 
melanoma patients; 
(iii) to prepare vaccines, useful for immunotherapy; 
(iv) to perform dose-response studies on the induction of 
cutaneous melanoma in the opossum (Monodelphis 
domestica) by UV radiation. 
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7. A concerted action on the molecular and cellular 
strategies for immunotherapy of cancer was approved in 
1989 and will start in early 1990. The purpose of the 
project is to elucidate the complex immunologic interrela-
tionship between the host and the tumour, and to manipu-
late this relationship for the purpose of diagnosis, preven-
tion and treatment of cancer. 
8. A concerted action on the molecular genetics of human 
thyroid cancer was approved in 1989 and will start in 
early 1990. 
The objectives are: 
(i) to increase our understanding of the causes of cancer 
through a cooperative project on an uncommon 
group of tumours with well-defined inherited and 
environmental causative factors; 
(ii) to identify the somatic and hereditary genetic abnor-
malities which occur at each stage in the development 
of sporadic (follicular cell) and familial (C cell) thy-
roid cancer; 
(iii) to use results on thyroid as a simple model for 
understanding the basic mechanisms of tumourigene-
sis in human epithelia in general, and hence to provide 
insight into cancers of more complex epithelia such 
as breast. 
9. A concerted action on genetics in cancer families with 
primary regard to familial adenomatous polyposis (FAP) 
was approved in 1989 and will start in early 1990. 
The aim of this concerted action is to optimize the 
possibilities of prevention and management of the disease 
(or diseases) in the EC. This requires efficient identifica-
tion and registration of FAP-cases. 
For those families who choose to make use of efficient 
diagnostic methods under further development in this 
programme, such cases could be prevented if this were in 
accordance with the wishes and norms of the families 
involved. A successful implementation of such measures 
for polyposis could eventually serve as a model for other 
hereditary cancers. 
10. A concerted action on the relation between DNA 
repair and cancer was approved in 1989 and will start in 
early 1990. 
It aims at a better understanding of mechanisms of DNA 
repair and their relationship to cancer, in particular (i) 
mechanisms of action of carcinogens, (ii) variation in 
response to carcinogens in the population, (iii) basis of 
cancer-prone DNA repair disorders, (iv) interaction of 
carcinogens with DNA and short-term tests, (v) mecha-
nisms of chemotherapeutic drugs. 
11. A concerted action on molecular cytogenetics of solid 
tumours was approved in 1989 and will start in early 
1990. It aims at: development of totally new diagnostic 
protocols and reagents to type reliably and easily the 
major forms of solid tumours. The diagnostic protocols 
will be based upon molecular cytogenetics. 
12. A concerted action on optimization of hyperthermia 
technology and the assessment of its clinical efficacy was 
approved in 1989 and it will start in early 1990. 
The objectives are: 
(i) to improve hyperthermia technologies and determine 
guidelines for improving the quality of treatment; 
(ii) to assess the efficacy of hyperthermia in combination 
with radiotherapy in cancer treatment. 
13. The Commission finances a concerted action on deve-
lopment of medical laser applications. The aims are to 
improve and to standardize the knowledge and practice of 
the use of lasers in medicine and surgery. It concentrates 
on safety and tumour therapy. 
Action 68: Co-financing of a European network of 
data banks for hybridomas (cells producing monoclonal 
antibodies) 
The Community has co-financed, from November 1985 
to date, the development of the European centre of the 
hybridoma and immunoclone data bank of Codata (the 
International Council of Scientific Unions' Committee on 
Data for Science and Technology). Codata relies on three 
centres, located in Europe (Centre for R&D in Immuno-
clones in the Faculty of Medicine in Nice), the United 
States (American Type Culture Collection, Rockville, 
Md) and Japan (Tokyo). The data collected by each centre 
are made available to all three. 
The present European centre is extending its dissemina-
tion/collection/publication activities through other forms 
of European collaboration, in particular electronic net-
works, starting with an experiment using France's Minitel 
network. The database is also now mounted on DIMDI, 
Cologne, the German Institute for Medical Documenta-
tion and Information. For further details, contact Dr 
Louis Rechaussât, Cerdic, Nice (Tel. 33/93.20.01.80). 
Action 69: Co-financing by the European Community 
of research into genetic engineering and protein engi-
neering, techniques potentially useful for the develop-
ment of anti-cancer drugs 
A number of projects under the biotechnology action 
programme (1985-89) are aimed at achieving a better 
understanding of the relationship between structure and 
function of cellular proteins. This fundamental approach 
will eventually allow the study of proteins specific for 
tumour cells (such as mutated receptors for growth hor-
mones) and their function in the oncogenic process. In 
one particular project, the elongation factor Tu (EF-Tu) 
was studied, a protein closely related to oncogene pro-
ducts such as p21. The work done by the three laborato-
ries involved has given much more insight into the struc-
ture/function relationship of EF-Tu. The biotechnologv 
action programme will be followed by the Brigde pro-
gramme (1990-93), in which these areas of research will 
continue to be covered. 
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Action 70: Co-financing by the European C o m m u n i t y 
of research on the ta rge t ing of cancer-killing drugs 
The project on cancer treatment by drug targeting with 
neocarzinostatin, which was started in 1988, has now 
developed into a concerted action entitled 'Drug targeting: 
immunoconjugates for cancer therapy'. It is the intention 
to develop monoclonal antibody-neocarzinostatin conju­
gates and to test them for their tumour specificity both in 
vitro and in vivo. 
A second concerted action on drug targeting was also 
started in 1989: 'Targeting systems in cancer chemothera­
py: Drug carrier systems'. 
During the period of funding, it is expected that candidate 
carrier systems containing mitomycin C or biological 
response modifiers for each of three target areas (liver, 
lymph nodes and bone marrow) will have been evaluated 
in animal models. Limited clinical studies with promising 
systems will either have been planned or even conducted 
before the end of 1992. 
Action 71 : Co-financing by the European C o m m u n i t y 
of research on the pharmacology of a n t i - t u m o u r 
substances 
The biotechnology action programme (1985-89) has in­
cluded a pharmacotoxicology research project in the area 
of cancer. Many of the results are already published (a list 
of publications is available from D G XII/F/2); further­
more, some of the newly developed systems are already 
used for pharmacotoxicological studies by industry. 
Action 72: Ha rmon iza t i on of testing s tandards for 
ant i-cancer drugs 
The EEC Committee for Proprietary Medicinal Products 
(CPMP) has, in accordance with the concerted procedure 
for the authorization before marketing of a medicinal 
product foreseen in Directive 87/22/EEC, given a favour­
able opinion for interleukin-2, indicated in treatment of 
renal cancer. The CPMP has also pursued its work in the 
field of harmonization by elaborating explanatory notes 
for applicants for marketing authorization. These explana­
tory notes deal in particular with good clinical practice for 
trials with medicinal products, with clinical trials for 
anti-cancer drugs, and with radiolabelled monoclonal 
antibodies. The drafts of these explanatory notes were 
circulated for consultation and will be finalized in 1990. 
Proposed action 73: Co-financing by the European 
C o m m u n i t y of research into the h u m a n genome 
This project may be carried out under the human genome 
analysis programme proposal. Final discussions of this 
proposal will take place in 1990 in the European Parlia­
ment and in the Council of Ministers. 
Proposed action 74: Co-financing by the European 
C o m m u n i t y of research on nuclear acid probes 
This project may be carried out under the human genome 
analysis programme proposal. Final discussions of this 
proposal will take place in 1990 in the European Parlia­
ment and in the Council of Ministers. 
Action 75: Co-f inancing by the European C o m m u n i t y 
of research on cancer in developing countries 
In tropical areas, there is a relatively high incidence of 
cancers for which viral infections are suspected of playing 
a role in their aetiology. 
Liver cancer is frequent in tropical areas, probably due to 
the high prevalence of hepatitis. The Commission current­
ly finances four research projects on liver cancer. The aim 
of two of these projects is to study the role at the 
molecular level of the hepatitis Β virus on hepatic onco­
genesis. The goals of the third project are: (a) to detect 
and characterize hepatitis Β virus variants and to analyse 
their role in primary liver cancer in Senegal; (b) to 
identify and analyse chromosomal deletions in liver can­
cer, as well as genetic predisposition to this type of cancer. 
The basic objective of the fourth project is to develop the 
analysis of the control mechanisms of the alpha-foetopro-
tein gene expression, so as to understand how and why 
this gene is only expressed in hepatoma cells. The applied 
objective of this study is to create the basis of a new-
approach to hepatoma therapy. 
Other studies indicate a high percentage of spumaretrovi-
rus (HSRV) infections among nasopharyngeal carcinoma 
patients from East Africa. The Commission finances a 
studyr which plans to develop a reliable, rapid HSRV-spe-
cific test system (Elisa), in order to screen for the presence 
of HSRV in African patients suffering from degenerative 
or lymphoproliferative diseases such as nasopharyngeal 
carcinoma. The results of this study are expected to make 
it possible to correlate and study the prevalence of an 
HSRV infection in certain human diseases. 
The Commission is also financing a project whose aim is 
to identify putative tumour viruses in AIDS-associated 
malignancies such as Kaposi's sarcoma and non-Hodgkin 
lymphoma, and to analyse an association of further speci­
fic tumours with human immunodeficiency virus (HIV) 
infection. 
C o n c l u s i o n 
Over the past three years, the European Community has 
demonstrated its ability to make its own major contribu­
tion to the fight against cancer, by no longer restricting 
itself to its conventional activities — measures to combat 
carcinogenic chemicals (ECSC and E E C Treaties) or 
ionizing radiation (Euratom Treaty) — but by extending 
its sphere of action to new areas such as discouraging the 
use of tobacco, improving nutrition, cancer screening, 
training of medical personnel, health information and 
education, and medical research. O n the whole, the results 
have been most satisfactory. 
(a) Legislation: Several pieces of Community legislation 
were announced, concerning the discouragement of tobac­
co use, improvement of nutrition, and measures to combat 
carcinogenic chemicals and ionizing radiation. Ou t of 13 
proposals, only one (on the prohibition of tax-free tobac-
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co sales) was not drawn up on schedule. Seven out of the 
other twelve have already been adopted by the Council 
(labelling of tobacco products, ban on smoking in public 
places, protection against ionizing radiation, protection 
against carcinogenic chemicals). The Council has adopted 
common positions on three others (prohibition of cigaret-
tes with a high tar content, nutritional labelling, protec-
tion of workers). The other two are still being discussed 
by the Council (tax burden on tobacco, limitation of 
advertising of tobacco products in the press and by means 
of bills and posters). 
(b) Actions financed by the Community budget: An aver-
age of around ECU 9 million was available from 1987 to 
1989 to help finance actions in the fields of research, 
prevention, training, information and health education. 
Although on the low side, this budget still enabled 
progress to be made in each of the four sections of the 
programme. However, as far as information is concerned, 
the European Year would not have been possible without 
the much larger amounts invested by the non-governmen-
tal cancer organizations and the active cooperation of 
major television stations in most Member States of the 
European Community. 
This European-scale action will be continued and exten-
ded under the second plan of action 1990-94, which the 
Council will adopt on 17 May 1990. A complete assess-
ment of the programme, particularly its scientific compo-
nents, will be made public early in 1992. 
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II 
(Acts whose publication is not obligatory) 
COUNCIL 
DECISION OF THE COUNCIL A N D THE REPRESENTATIVES OF THE 
GOVERNMENTS OF THE MEMBER STATES MEETING W I T H I N THE 
COUNCIL, 
on 17 May 1990 
adopting a 1990 to 1994 ac t ion p lan in the con tex t of the 'Europe aga ins t Cancer ' 
p r o g r a m m e 
(90/238/Euratom, ECSC, EEC) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES AND 
THE REPRESENTATIVES OF THE GOVERNMENTS OF 
THE MEMBER STATES, MEETING WITHIN THE COUNCIL, 
Having regard to the Treaties establishing the European 
Communities, 
Having regard to the draft resolution submitted by the 
Commission, 
against cancer (3) which is concerned principally with 
cancer prevention ; 
Whereas the Council and the representatives of the 
Governments of the Member States, meeting within the 
Council, adopted on 21 June 1988 Decision 88/351/EEC 
on a 1988 to 1989 action plan for an information and 
public awareness campaign in the context of the 'Europe 
against Cancer' programme (*) ; 
Having regard to the opinion of the European 
Parliament ('), 
Having regard to the opinion of the Economic and Social 
Committee (2), 
Whereas various Community measures to prevent cancers 
arising from exposure to ionizing radiation or to chemical 
carcinogens are already being implemented under the 
Treaties establishing the European Economic Community 
and the European Atomic Energy Community ; 
Whereas, at its meetings in June 1985 in Milan and in 
December 1985 in Luxembourg, the European Council 
underlined the advantages of launching a European 
programme against cancer ; 
Whereas, at its meeting in December 1986 in London, 
the European Council decided that 1989 should be 
designated 'European Cancer Information Year' and 
specified that the aim would be to develop a sustained 
and concerted information campaign in all the Member 
States on the prevention, early screening and treatment of 
cancer ; 
Whereas the Council and the representatives of the 
Governments of the Member States, meeting within the 
Council, adopted on 7 July 1986 a resolution on a 
programme of action of the European Communities 
Whereas measures to reduce the risk of cancer from 
exposure to carcinogens are included in a number of 
existing Community programmes on the environment, 
worker protection, consumer protection, nutrition, 
agriculture and the internal market ; 
Whereas the right to health is a natural right and every 
European citizen has the right to the most appropriate 
treatment, regardless of social position ; 
Whereas the purpose of this action plan is to increase 
knowledge of the causes of cancer and the possible means 
of preventing and treating it ; 
Whereas occupational cancers account for 4 % of all 
cancers and cause 30 000 deaths per year ; 
(') OJ No C 96, 17. 4. 1990. 
(!) OJ No C 329, 30. 12. 1989, p. 60. 
O OJ No C 184, 23. 7. 1986, p. 19. 
(") OJ No L 160, 28. 6. 1988, p. 52. 
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Whereas, by ensuring wider dissemination of knowledge 
of the causes, prevention, screening and treatment of 
cancer, as well as an improvement in the comparability of 
information about those matters, in particular concerning 
the nature and degree of risk of cancer arising from 
exposure to given substances or processes, the programme 
will contribute to the achievement of Community 
objectives while contributing to the overall reduction of 
risks of cancer ; 
Whereas it is advisable to promote the dissemination and 
the implementation of recommendations on the oncology 
content of training programmes which were approved in 
1988 by the three advisory committees on the training of 
members of the health professions ; 
Whereas recognition must be given to the crucial role of 
members of the health professions and whereas 
theoretical and practical training for all professions and 
individuals involved in the prevention of cancer and the 
treatment of cancer sufferers must be encouraged in 
accordance with the conclusions of the European 
Organization for Research on Treatment of Cancer ; 
Whereas it is the view of the World Health Organization 
that palliative care can provide extremely valuable support 
both for patients for whom all treatment has failed and 
for their families ; whereas such care should therefore be 
given recognition and assistance ; 
Whereas it is advisable to support training actions in 
respect of cancer for members of the health professions of 
one Member State in centres of excellence in another 
Member State ; 
Whereas encouragement should be given to information 
campaigns, in schools as well as elsewhere, on cancer and 
its prevention ; 
Whereas duplication of effort should be avoided by the 
promotion of exchanges of experience and by the joint 
development of basic information modules for the public, 
for health education and for training members of the 
health professions ; 
Whereas efforts should be made to achieve advances in 
treatment through controlled clinical tests ; 
Whereas public health policy as such, except in cases 
where the Treaties provide otherwise, is the responsibility 
of Member States but whereas promoting cooperation and 
the coordination of national activities as well as the 
stimulation of Community activities in this field makes a 
valuable contribution to the fight against cancer ; 
Whereas it is advisable to continue and strengthen, from 
1990 to 1994, the action undertaken between 1987 and 
1989 in the fields of prevention, information and health 
education, and training of members of the health 
professions, 
HAVE DECIDED AS FOLLOWS : 
Article 1 
1. The Commission shall implement the 1990 to 1994 
action plan set out in the Annex in close coordination 
with the competent authorities of the Member States. 
2. The Commission shall be assisted by an advisory 
committee consisting of representatives of the Member 
States and chaired by the Commission representative. 
The duties of the committee shall be : 
— to examine projects and measures involving 
cofinancing from public funds, 
— to coordinate at national level projects partly financed 
by non-governmental organizations. 
3. The Commission representative shall submit to the 
committee a draft of the measures to be taken. The 
committee shall deliver its opinion on the draft, within a 
time limit which the chairman may lay down according 
to the urgency of the matter, if necessary by taking a vote. 
The opinion shall be recorded in the minutes ; in 
addition, each Member State shall have the right to ask to 
have its position recorded in the minutes. 
The Commission shall-take the utmost account of the 
opinion delivered by the committee. It shall inform the 
committee of the manner in which its opinion has been 
taken into account. 
4. Furthermore, the Commission will involve the 
high-level Committee of Cancer Experts and the private 
bodies active in the fight against cancer closely in 
implementing the action plan. It will cooperate with both 
the World Health Organization and the International 
Agency for Research on Cancer. 
5. The Commission will regularly publish technical 
information on the progress of the action plan and on 
potential Community financing in the various fields of 
action. 
Article 2 
1. The Community contribution estimated necessary 
for implementing the 1990 to 1994 action plan is ECU 
50 million. 
2. The Council and the Ministers for Health, meeting 
within the Council, will review this total amount in the 
light of the evaluation report referred to in Article 3 (2), 
with the possibility of increasing it to a total amount of 
ECU 55 million, if necessary, from 1 January 1993. 
Article 3 
1. The Commission will continously assess the action 
undertaken. 
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2. The Council and the Ministers of Health will carry 
out a scientific evaluation of the effectiveness of the 
action undertaken. To this end the Commission will 
submit a report on the subject during the second half of 
1992. 
3 . The Commission will keep the European 
Parliament, the Council and the Economic and Social 
Committee regularly informed of progress. 
4. The Commission is also requested to encourage 
every kind of exchange with third countries in connection 
with the activities set out in the Annex. 
Done at Brussels, 17 May 1990. 
For the Council 
The President 
R. O'HANLON 
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ANNEX 
MEASURES TO BE IMPLEMENTED IN THE PERIOD 1990 TO 1994 
I. CANCER PREVENTION (including screening) 
In addition to the legislative action under way : 
A. Prevention of tobacco consumpt ion 
— Stimulation of projects of European interest concerning the prevention of nicotine addiction, 
especially amongst such target groups as young people, women, teachers and members of the 
health professions. 
— Stimulation of pilot projects to teach methods of breaking nicotine addiction to members of the 
health professions and to teachers. 
— Stimulation of innovative information campaigns to prevent the use of tobacco among the 
general public and in the workplace. 
— Financing of a study on the possibilities for putting tobacco-growing areas to other uses. 
B. Diet and cancer (including alcohol) 
— Stimulation of studies into eating habits and cancer in close conjunction with the Community 
medical research programme (meta-analyses, case studies, prospective studies, intervention studies 
on 'anti-promoting' agents). 
— Drafting and publication of guidelines on nutrition aimed at improving cancer prevention. 
C. Campaign against carcinogenic agents 
— Continuation of all Community action concerning protection against ionizing radiation. 
— Support for comparative studies of European interest aimed at improving protection against ultra-
violet radiation. 
— Support for European studies on the possible carcinogenic risks of certain chemicals. 
— Continuation of the classification and labelling, at European level, of carcinogens and continua-
tion of the information campaign by means of specialized annual publications. 
D. Systematic screening and early diagnosis 
— Continuation of comparative studies to improve the organization of cancer screening 
programmes. 
— Extension and monitoring of the European network of breast cancer screening pilot programmes 
to help the Member States determine a general screening policy. 
— Evaluation of existing cervical cancer screening programmes and setting up of a European 
network of regional or local pilot programmes. 
— Continuation of evaluation studies on screening programmes for colorectal cancer and possible 
setting up of a European network. 
— Promotion of studies of European interest on the effectiveness and feasibility of early screening 
for other cancers. 
— Promotion of, and support for, screening programmes where the results of exploratory studies 
have proved positive, in close coordination with the AIM and RACE programmes. 
E. Cancer registers and similar measures 
— Support for exchanges of experience in establishing cancer registers in the Community and for 
setting up a European network in cooperation with the International Agency for Research on 
Cancer and in close coordination with the AIM and RACE programmes. 
F. Other aspects 
1. Evaluation of the operation of the various bone marrow banks. 
2. Feasibility study on cooperation between such banks and, if appropriate, support for existing 
European cooperation. 
3. Exchanging experience regarding the quality control of care given. 
4. Establishing an up-to-date list of treatments recognized as worthwhile by the international scien-
tific community. 
II. HEALTH INFORMATION AND-EDUCATION 
A. Information of the public 
— Possible updating of the European Code against Cancer. 
— Repeat of European compaigns of cancer information, if possible during the second week of 
October. Encouraging, within this context, private and public television stations to run spots free 
of charge on the subject of the fight against cancer. 
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— Production of European information modules on the prevention, screening and treatment of 
cancers, adaptable to national requirements 
— Publicizing of the European Code among the general public by the partners in the action plan. 
— Support for innovative information compaigns on cancer prevention among targeted groups. 
— Informing workers, and migrant workers in particular, under existing Community Directives, of 
the fight against job-related cancers. 
B. Health educa t ion and c ance r 
— Support for efforts to inform and increase the awareness of schoolteachers of the European Code 
against Cancer. 
— Dissemination of European teaching material for health education. 
— Promotion of pilot projects to promote awareness of the European Code among young people. 
— Encouragement at school of a change in dietary habits and, in particular, encouragement of the 
consumption of fruit and vegetables during break and at mealtimes. 
III. TRAINING OF THE HEALTH PROFESSIONS 
— Support for the organization of national or regional meetings to promote the 1989 European recom-
mendations on the cancerology content of basic training programmes for members of the health 
professions. 
— Support for setting up three European pilot networks of medical schools, nursing colleges and dental 
schools implementing the recommendations on training in cancer formulated in 1988 by the three 
European advisory committees on the training of the health professions. 
— Promotion of cancerology training projects. 
— Support for the mobility of the health professions between Member States in order to improve their 
specialized training in cancerology. 
— Collection and exchange of teaching material of European interest for the training of members of 
the health professions. 
— Exchange of experience and support for the organization of European seminars on the continuing 
education of members of the health professions. 
— Exchange of experience between Member States in the area of pain-relieving treatments, palliative 
and continuing care and the role of the health professions. 
IV. RESEARCH A N D CANCER 
— Contribution towards the preparation of a Fifth European Medical and Health Research Coordina-
tion Programme and a Sixth ECSC Medical Research Programme. 
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I 
(Information) 
COUNCIL 
RESOLUTION 
OF THE COUNCIL AND THE MINISTERS FOR HEALTH OF THE MEMBER 
STATES, MEETING WITHIN THE COUNCIL 
of 18 July 1989 
on banning smoking in places open to the public 
(89/C 189/01) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE MINISTERS FOR HEALTH OF THE MEMBER 
STATES, MEETING WITHIN THE COUNCIL, 
Having regard to the Treaty establishing the European 
Economic Community, 
Having regard to the draft recommendation from the 
Commission, 
Having regard to the opinion of the Economic and 
Social Committee ('), 
Whereas the European Council held in Milan on 28 and 
29 June 1985 stressed the importance of launching a 
European action programme against cancer; 
Whereas the Council and the Representatives of the 
Governments of the Member States, meeting within the 
Council, in their resolution of 7 July 1986 on a 
programme of action of the European Communities 
against cancer, set the objective of contributing to an 
improvement in the health and quality of life of citizens 
within the Community by reducing the number of cases 
of cancer and under this heading gave priority to 
measures against smoking; 
Whereas, in addition to the potential encouragement to 
smoke and the unpleasant physical effects and the 
nuisance which smoke causes for non-smokers, there is 
an increased risk of respiratory illnesses for non-smokers 
involuntarily exposed to the smoke of tobacco products; 
whereas consequently, it is appropriate to protect the 
right to health of non-smokers against involuntary 
smoking; 
Whereas, to ensure respect for the right to health of 
non-smokers, it is essential to ban smoking in public 
places in certain establishments and in forms of 
transport; 
(') Opinion delivered on 26 April 1989 (not yet published in the 
Official Journal). 
Whereas, however, in view of the extent of tobacco 
addiction affecting part of the population, it is appro-
priate to make provision to permit smoking in part of 
these establishments and forms of transpon; 
Whereas it is necessary to extend to the citizens of all 
Member States the protection they are afforded in some 
Member States against the damage caused by involuntary 
smoking; 
Whereas, finally, the initiative set out in this resolution 
will have an even more beneficial effect on public health, 
particularly for the workers directly concerned, when 
coupled with health education programmes during the 
years of compulsory education and with information and 
public awareness campaigns, 
INVITES THE MEMBER STATES: 
to take the following measures by introducing legislation 
or by other methods in accordance with national 
practices and conditions: 
1. Ban smoking in enclosed premises open to the public 
which form part of the public or private estab-
lishments listed in the Annex. Member States may add 
to the said list; 
2. Extend the ban on smoking to all forms of public 
transport; 
3. Provide, where necessary, for clearly defined areas to 
be reserved for smokers in the above establishments 
and, if possible, in public transport, particularly for 
long journeys; 
4. Ensure that in the event of a conflict, in areas other 
than those reserved for smokers, the right to health of 
non-smokers prevails over the right of smokers to 
smoke; 
to inform the Commission every two years of action 
taken in response to this resolution. 
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Public and private establishments referred to in point 1 of the resolution 
(non-exhaustive list) 
1. Establishments where services are provided to the public, whether for a charge or free, including the 
sale of goods; 
2. Hospitals, establishments where health care is given and all other medical establishments; 
3. Establishments where elderly persons are received; 
4. Schools and other premises where children or young people are received or housed; 
5. Establishments where higher education and vocational training are given; 
6. Enclosed establishments used for entertainment (cinemas, theatres, etc.); radio and television studios 
open to the public; 
7. Enclosed establishments where exhibitions are held; 
8. Establishments and enclosed places where sports are practised; 
9. Enclosed premises of underground and railway stations, ports and airports. 
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II 
(Acts whose publication is not obligatory) 
COUNCIL 
COUNCIL DIRECTIVE 
of 13 November 1989 
on the approximation of the laws, regulations and administrative provisions of the Member 
States concerning the labelling of tobacco products 
(89/622/EEC) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European 
Economic Community, and in particular Article 100a 
thereof, 
Having regard to the proposal from the Commission (]), 
In cooperation with the European Parliament (2), 
Having regard to the opinion of the Economic and Social 
Committee (3), 
Whereas there are differences between the laws, regulations 
and administrative provisions of the Member States on the 
labelling of tobacco products; whereas these differences are 
likely to constitute barriers to trade and to impede the 
establishment and operation of the internal market; 
Whereas these possible barriers should be eliminated and 
whereas, to that end, the marketing and free movement of 
tobacco products should be made subject to common rules 
concerning labelling; 
Whereas such common rules must take due account of 
public health protection; 
(') OJ No C 48, 20. 2. 1988, p. 8, and 
OJ No C 62, 11. 3. 1989, p. 12. 
(2) OJ No C 12, 16. 1. 1989, p. 106 and 
OJ No C 291, 20. 11. 1989. 
(3) OJ No C 237, 12. 9. 1980, p. 43. 
Whereas the European Council meeting held in Milan on 
28 and 29 June 1985 stressed the importance of launching 
a European action programme against cancer; 
Whereas the Council and the representatives of the 
Governments of the Member States, meeting within the 
Council, in their resolution of 7 July 1986 on a programme 
of action of the European Communities against cancer (4) 
set for this programme the objective of contributing to an 
improvement of the health and quality of life of citizens 
within the Community by reducing the number of cancers 
and whereas they have for this purpose identified a fight 
against the use of tobacco products as their prime 
objective; 
Whereas the printing of health warnings on the unit 
packaging of all tobacco products concerning the risks of 
use of such products is a vital factor in the protection of 
public health; 
Whereas, for the purpose of improving public health 
protection, the indication of the tar and nicotine yield on 
cigarette packets is essential for the health information and 
education of the general public; 
Whereas this Directive contains provisions which will be 
reviewed on the basis of experience gained and the 
development of medical knowledge in this area, the 
objective being to achieve greater protection of 
individuals; 
(4) OJ No C 184, 23. 7. 1986, p. 19. 
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Whereas, finally, the initiatives set in this Directive will 
have an even more beneficial effect on public health if they 
are coupled with health education programmes during the 
years of compulsory education and with information and 
public awareness campaigns, 
Article 4 
1. All unit packets of tobacco products shall carry, on the 
most visible surface, the following general warning in the 
official language or languages of the country of final 
marketing: 'Tobacco seriously damages health'. 
HAS ADOPTED THIS DIRECTIVE: 
Article 1 
The objective of this Directive is the harmonization of the 
laws, regulations and administrative provisions of the 
Member States concerning the warnings regarding health to 
appear on the unit packet of tobacco products and the 
indication of the tar and nicotine yield to appear on 
cigarette packets, taking as a base a high level of health 
protection by reducing the harm done to health by tobacco 
addiction. 
2. With regard to cigarette packets, the other large surface 
of the packet shall carry, in the official language or 
languages of the country of final marketing, specific 
warnings alternating in accordance with the following 
rule: 
— each Member State shall draw up a list of warnings 
taken exclusively from those listed in the Annex, 
— the specific warnings selected shall be printed on the 
unit packets so as to guarantee the appearance of each 
warning on an equal quantity of unit packets, with a 
tolerance of around 5 %. 
Article 2 
For the purposes of this Directive: 
(1) 'tobacco products' means products for the purpose of 
smoking, sniffing, sucking or chewing, inasmuch as 
they are, even partly, made of tobacco; 
(2) 'tar' means the raw anhydrous nicotine-free condensate 
of smoke; 
(3) 'nicotine' means nicotinic alkaloids. 
3 . Member States may stipulate that the warnings referred 
to in paragraphs 1 and 2 be combined with the indication 
of the authority that is their author. 
4. On cigarette packets the warnings provided for in 
paragraphs 1 and 2 shall cover at least 4 % of each large 
surface of the unit packet, excluding the indication of the 
authority provided for in paragraph 3. This percentage 
shall be increased to 6 % for countries with two official 
languages and to 8 % for countries with three official 
languages. 
Article 3 
1. The tar and nicotine yields that must be indicated on 
cigarette packets shall be measured on the basis of the ISO 
4387 and ISO 3400 methods. 
2. The accuracy of the indications on packets shall be 
verified in accordance with ISO standard 8243. 
3. The indications concerned shall be printed on the side 
of cigarette packets, in the official language or languages of 
the country of final marketing in clearly legible print on a 
contrasting background so that at least 4 % of the 
corresponding surface is covered. This percentage shall be 
raised to 6 % for countries with two official languages and 
to 8 % for countries with three official languages. 
4. In January each year the Member States shall forward 
to the Commission lists of the tar and nicotine contents of 
the cigarettes sold on their markets. The Commission shall 
publish this information in the Official Journal of the 
European Communities. 
The required warnings on the two largest surfaces of each 
cigarette packet: 
(a) shall be clear and legible; 
(b) shall be printed in bold letters; 
(c) shall be printed on a contrasting background; 
(d) shall not be printed in a place where they may be 
damaged when the package is opened; 
(e) shall not be printed on the transparent wrapper or any 
other external wrapping. 
5. In the case of tobacco products other than cigarettes, 
the general warning laid down in paragraph 1 shall be 
printed in, or irremoveably affixed to, a conspicuous place 
on a contrasting background and in such a way as to be 
easilyvisible, clearly legible and indelible. It shall not in any 
way be hidden, obscured or interrupted by other written or 
pictorial matter. 
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Article 5 
Adaptation to technical progress of the provisions of this 
Directive shall be limited to the measurement and 
verification methods referred to in Article 3 (1) and (2). 
Article 9 
1. Member States shall adopt the laws, regulations and 
administrative provisions necessary to comply with this 
Directive before 1 July 1990. 
Article 6 
With a view to the adaptation to technical progress referred 
to in Article 5, the Commission shall be assisted by an 
advisory Committee, composed of representatives of the 
Member States and chaired by the Commission 
representative. 
Article 7 
The Commission representative shall submit to the 
Committee a draft of the measures to be taken. The 
Committee shall deliver its opinion on the draft, within a 
time limit which the chairman may lay down according to 
the urgency of the matter, if necessary by taking a vote. 
The opinion shall be recorded in the minutes; in addition, 
each Member State may ask to have its position recorded in 
the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the Committee. It shall inform the 
Committee of the manner in which its opinion has been 
taken into account. 
They shall forthwith inform the Commission thereof and 
communicate to it the provisions of national law which 
they adopt in the field governed by this Directive. 
The Commission shall publish in the Official Journal of the 
European Communities the national warning lists drawn 
up in accordance with the first indent of Article 4 (2). 
2. Member States shall bring into force the above laws, 
regulations and adminsitrative provisions before 31 
December 1991. 
However, 
— until 31 December 1992 cigarettes, and 
— until 31 December 1993 other tobacco products 
existing on 31 December 1991 which do not comply 
with this Directive may still be put on sale. 
3. Member States which, after 31 December 1991, amend 
their warning lists drawn up in accordance with the first 
indent of Article 4 (2) shall notify the Commission of that 
amendment eighteen months before its application. The 
Commission shall publish it in the Official Journal of the 
European Communities. 
Article 8 
1. Member States may not, for reasons of labelling, 
prohibit or restrict the sale of products which comply with 
this Directive. 
Article 10 
This Directive is addressed to the Member States. 
2. The provisions of this Directive do not affect the right 
of the Member States to lay down, in compliance with the 
Treaty, requirements concerning the import, sale and 
consumption of tobacco products which they deem 
necessary in order to protect public health, provided such 
requirements do not imply any changes to labelling as laid 
down in this Directive. 
Done at Brussels, 13 November 1989. 
For the Council 
The President 
C. EVIN 
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ANNEX 
List of health warnings referred to in the first indent of Article 4 (2) 
A. Warnings which must be included on the national lists 
1. Smoking causes cancer. 
2. Smoking causes heart disease. 
B. Warnings from amongst which Member States may choose 
1. Smoking causes fatal diseases. 
2. Smoking kills. 
3 . Smoking can kill. 
4 . Smoking when pregnant harms your baby. 
5. Protect children: don't make them breathe your smoke. 
6. Smoking damages the health of those around you. 
7. Stopping smoking reduces the risk of serious disease.· 
8. Smoking causes cancer, chronic bronchitis and other chest diseases. 
9. More than ( . . . . ) people die each year in (name of the country) from lung cancer. 
10. Every year, . . . people are killed in road accidents in (name of the country) — . . . times more die 
from their addiction to smoking. 
11. Every year, addiction to smoking claims more victims than road accidents. 
12. Smokers die younger. 
13. Don't smoke if you want to stay healthy. 
14. Save money: stop smoking. 
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COUNCIL DIRECTIVE 
of 17 May 1990 
on the approximation of the laws, regulations and administrative provisions of 
the Member States concerning the maximum tar yield of cigarettes 
(90/239/EEC) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European 
Economic Community, and in particular Article 100a 
thereof, 
Having regard to the proposal from the Commission ('), 
In cooperation with the European Parliament (2), 
Having regard to the opinion of the Economic and Social 
Committee (3), 
Whereas there are differences between the laws, regula-
tions and administrative provisions of the Member States 
on the limitation of the maximum tar yield of cigarettes ; 
whereas such differences are liable to constitute barriers to 
trade and to impede the establishment and operation of 
the internal market ; 
Whereas those obstacles should accordingly be eliminated 
and whereas to that end the marketing and free move-
ment of cigarettes must be made subject to common rules 
concerning maximum tar yields ; 
Whereas such common nales must take due account of 
public health protection ; 
Whereas the higher the tar content of smoked tobacco, 
the greater the risk of lung cancer and whereas the Euro-
pean Council held in Milan on 28 and 29 June 1985 
stressed the importance of launching a European action 
programme against cancer; 
Whereas, in their resolution of 7 July 1986 (4), the 
Council and the representatives of the Governments of 
the Member States meeting within the Council consi-
dered that measures to combat smoking were a priority ; 
Whereas in applying this Directive provision should be 
made for establishing deadlines which allow, on the one 
hand, completion to a minimum degree of efficiency of 
the process of conversion to other varieties which has 
already begun, and, on the other, consumers and manu-
facturers to adapt to products with a lower tar yield ; 
Whereas this Directive contains provisions, which will be 
reviewed on the basis of experience gained, the develop-
ment of techniques and medical knowledge in this area, 
(') OJ No C 48, 20. 2. 1988, p. 10. 
O OJ No C 158, 26. 6. 1989, p. 229 and 
OJ No C 96, 17. 4. 1990. 
(3) OJ No C 237, 12. 9. 1988, p. 49. 
{') OJ No C 184, 23. 7. 1986, p. 19. 
the objective being to achieve greater protection of indivi-
duals ; 
Whereas smokers must always be aware that all cigarettes 
are harmful to health ; whereas it is much more desirable 
for them to stop smoking rather than to switch to low-tar 
cigarettes ; 
Whereas the initiative set out in this Directive will have 
an even more beneficial effect on public health if it is 
coupled with health education programmes during the 
years of compulsory education and with information and 
public awareness campaigns ; 
Whereas the introduction of maximum tar yields would 
result in particular socioeconomic difficulties for the 
Hellenic Republic ; whereas that Member State should be 
granted, exceptionally, a derogation with regard to the 
implementation dates laid down for the other Member 
States, 
HAS ADOPTED THIS DIRECTIVE : 
Article 1 
The objective of this Directive is the harmonization of the 
laws, regulations and administrative provisions of the 
Member States concerning the maximum tar yield of 
cigarettes, taking as a basis a high level of public health 
protection by the reduction of the health damage caused 
by tar. 
Article 2 
1. For the purposes of this Directive, 'tar' means the 
raw anhydrous nicotine-free condensate of smoke. 
2. The tar yield of cigarettes marketed in the Member 
States shall not be greater than : 
— 15 mg per cigarette as from 31 December 1992, and 
— 12 mg per cigarette as from 31 December 1997. 
3. For the Hellenic Republic, as a temporary deroga-
tion, the limit values and dates of implementation shall 
be as follows : 
— 20 mg until 31 December 1992, 
— 18 mg until 31 December 1998, 
— 15 mg until 31 December 2000, 
— 12 mg until 31 December 2006. 
However, this derogation may not be used to justify 
controls at the Community's internal frontiers. 
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Article 3 
The tar yield of cigarettes shall be measured according to 
ISO standards 4387 and 3400. Verification must be 
carried out according to ISO standard 8243. 
Article 4 
Adaptation of this Directive to technical progress shall be 
limited to the method of measuring tar yields and the 
method of verification referred to in Article 3. 
Article 7 
1. The Member States may not, for considerations of 
limitation of the tar yield of cigarettes, prohibit or restrict 
the sale of products which comply with this Directive. 
2. This Directive shall not otherwise affect the right of 
the Member States to adopt, in accordance with the 
Treaty, rules concerning the import, sale and consump-
tion of tobacco products which they deem necessary in 
order to protect public health, provided such rules do not 
imply any changes to limits on the tar yield of cigarettes 
as laid down in this Directive. 
Article 5 
With a view to the adaptation to technical progress 
referred to in Article 4, the Commission shall be assisted 
by a committee of an advisory nature composed of repre-
sentatives of the Member States and chaired by the 
Commission representative. 
Article 6 
The representative of the Commission shall submit to the 
committee a draft of the measures to be taken. The 
committee shall deliver its opinion on the draft within a 
time limit which the chairman may lay down according 
to the urgency of the matter, if necessary by taking a vote. 
The opinion shall be recorded in the minutes ; in addi-
tion, each Member State may ask to have its position 
recorded in the minutes. 
The Commission shall take the utmost account of the 
opinion delivered by the committee. It shall inform the 
committee of the manner in which its opinion has been 
taken into account. 
Article 8 
1. Member States shall bring into force the laws, regu-
lations and administrative provisions necessary to comply 
with this Directive within 18 months of its notification ('). 
They shall forthwith inform the Commission thereof. 
2. Products existing at the dates referred to in Article 2 
(2) which do not comply with this Directive may continue 
to be marketed for two years thereafter. 
3. Member States shall communicate to the Commis-
sion provisions of national law which they adopt in the 
field governed by this Directive. 
Article 9 
This Directive is addressed to the Member States. 
Done at Brussels, 17 May 1990. 
For the Council 
The President 
R. O'HANLON 
This Directive was notified to the Member Stattes on 18 May 
1990. 
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II 
(Preparatory Acts) 
COMMISSION 
Amended proposal for a Council Directive on the authorized advertising of tobacco products in 
the press and by means of bills and posters (') 
COM(90) 147 final — SYN 194 
(Submitted by the Commission pursuant to Article 149 (3) of the EEC Treaty on 19 April 1990) 
(90/C 116/05) 
(') OJ No C 124, 19. 5. 1989, p. 5 (COM(89) 163 final 12 — SYN 194). 
ORIGINAL TEXT AMENDED PROPOSAL 
Proposal for a Council Directive on the advertising of 
tobacco products in the press and by means of bills and 
posters 
Amended proposal for a Council Directive on the auth-
orized advertising of tobacco products in the press and by 
means of bills and posters 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European 
Economic Community, and in particular Article 100a 
thereof, 
Having regard to the proposal from the Commission ('), 
In cooperation with the European Parliament ('), 
Having regard to the opinion of the Economic and 
Social Committee ('), 
Whereas there are differences between the laws, regu-
lations and administrative provisions of the Member 
States on tobacco advertising in the press and by means 
of bills and posters; whereas advertising by these means 
transcends the borders of the Member States and 
whereas such differences are likely to constitute barriers 
to trade, distort competition and thus impede the estab-
lishment and operation of the internal market; 
Whereas obstacles should be eliminated and, to this end, 
the rules relating to tobacco advertising by the above 
means should be harmonized, leaving Member States the 
possibility of introducing, under certain conditions, the 
measures they consider necessary to guarantee the health 
protection of their citizens; 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Unchanged 
Unchanged 
Unchanged 
Unchanged 
Whereas there are differences between the laws, regu-
lations and administrative provisions of the Member 
States on authorized tobacco advertising in the press and 
by means of bills and posters; whereas authorized adver-
tising by these means transcends the barriers of the 
Member States and whereas such differences are likely to 
constitute barriers to trade, distort competition and thus 
impede the establishment and operation of the internal 
market; 
Whereas obstacles should be eliminated and, to this end, 
the rules relating to authorized tobacco advertising by 
the above means should be harmonized, leaving Member 
States the possibility of introducing, under certain 
conditions, the measures they consider necessary to 
guarantee the health protection of their citizens. 
(') OJ No C 124, 19. 5. 1989. 
(') Sitting of 14. 3. 1990. 
(J) OJ No C 62, 12. 3. 1990. 
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ORIGINAL TEXT AMENDED PROPOSAL 
Whereas these rules must take due account of public 
health protection, in particular in relation to young 
people ; 
Whereas the European Council held on 28 and 29 June 
in Milan stressed the importance of launching a 
European action programme against cancer; 
Whereas the Council and the representatives of the 
Governments of the Member States, meeting within the 
Council, in their resolution of 7 July 1986 on a 
programme of action of the European Communities 
against cancer (') set for this programme the objective of 
contributing to an improvement in the health and quality 
of life of citizens within the Community by reducing the 
number of illnesses due to cancer and, accordingly, 
regarded measures to counter the use of tobacco as their 
prime objective; 
Whereas the incorporation in tobacco advertising inserts 
in the press and by means of bills and posters of a 
warning of the health risks entailed in the use of these 
products is important for health protection; 
Whereas it is necessary to prohibit all indirect forms of 
advertising which, whilst not directly mentioning tobacco 
products, seek to promote, tobacco products by using 
trade marks, emblems, symbols or other distinctive 
features associated with tobacco products; 
Whereas special provisions should ensure the protection 
of young people against the advertising of tobacco 
products; 
Whereas one of the main objectives of the Member 
States of the European Commission is to bring about 
steady improvements in the living and working 
conditions of their citizens; 
Whereas Article 100a (3) of the EEC Treaty stipulates 
that the Commission, in its proposals concerning health, 
safety, environmental protection and consumer 
protection, should take as a base a high level of 
protection; 
Whereas it is advisable to ensure that authorized adver-
tising in the press and by means of bills and posters 
provides information on the main features of the 
products which meets the essential requirements 
concerning the health protection of consumers and the 
fairness of commercial transactions; 
Unchanged 
Unchanged 
Unchanged 
Unchanged 
Whereas it has been shown that young people are ready-
made victims of advertising and that dependency on 
tobacco begins at a young age; 
Unchanged 
Whereas these common rules relating only to authorized 
tobacco advertising in the press and by means of bills 
and posters shall not apply in the event of a complete 
ban; 
Whereas this Directive represents the first stage in a 
harmonization which should guarantee the free circu-
lation of goods aimed at for 31 December 1992, 
(') OJ No C 184, 23. 7. 1986, p. 19. 
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ORIGINAL TEXT 
HAS ADOPTED THIS DIRECTIVE: 
Article 1 
For the purposes of this Directive, 'tobacco products' 
means products intended to be smoked, sniffed, sucked 
or chewed, in as much as they are, even partly, made of 
tobacco. 
Article 2 
1. Advertisements for cigarettes in the press and by 
means of bills and posters shall carry specific warnings 
alternating according to the following rules: 
— each Member State shall draw up a list of warnings 
based on those listed in the Annex, 
— the specific warnings so adopted shall be printed 
against a contrasting background on inserts and in 
such a way as to guarantee an equal frequency of 
display for each warning, allowing for a 5 % margin. 
2. Advertising in the press and by means of bills and 
posters of tobacco products other than cigarettes shall 
carry the general warning: 'Tobacco seriously damages 
your health'. 
3. Member States may stipulate that the warnings 
referred to in paragraphs 1 and 2 shall bear the name of 
the issuing authority. 
4. . The text of the warnings mentioned in paragraphs 
1 and 2 shall cover a minimum of 10 % of the total 
advertising insert, excluding the name of any authority as 
referred to in paragraph 3. The percentage shall be 
raised to at least 15 % where the warning is in two 
languages and to at least 20 % where it is in three or 
more languages. 
Article 3 
1. The content of advertisements in the press and on 
bills and posters shall be restricted solely to the presen-
tation of the packaging of the tobacco products, possibly 
with the addition of information on the features of the 
product. 
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AMENDED PROPOSAL 
HAS ADOPTED THIS DIRECTIVE: 
Article 1 
This Directive concerns the harmonization of the laws, 
regulations and administrative provisions of the Member 
States on authorized tobacco advertising in the press and 
by means of bills and posters. 
Unchanged 
^4rri'c/e 2 
1. Advertisements for cigarettes in the press and by 
means of bills and posters shall carry specific warnings 
alternating according to the following rules: 
— each Member State shall draw up a list of warnings 
based solely on those listed in the Annex, 
— the specific warnings so adopted shall be printed 
horizontally against a contrasting background on 
inserts and in such a way as to guarantee an equal 
frequency of display for each warning, allowing for a 
5 % margin. 
2. Advertising in the press and by means of bills and 
posters of tobacco products other than cigarettes shall 
carry the general warning 'Tobacco seriously damages 
your health', printed horizontally against a contrasting 
background. 
3. The warnings referred to in paragraphs 1 and 2 
shall, when appearing in the press, be in the same 
language as that used in the publication and, in the case 
of bills and posters, shall be in the language or languages 
of the country in which such bills and posters are shown. 
4. Member States may stipulate that the warnings 
referred to in paragraphs 1 and 2 shall bear the name of 
the issuing authority. 
5. The text of the warnings mentioned in paragraphs 
1 and 2 shall cover a minimum of 10 % of the total 
advertising insert, excluding the name of any authority as 
referred to in paragraph 3. The percentage shall be 
raised to at least 15 % where the warning is in two 
languages and to at least 20 °/o where it is in three or 
more languages. 
Article 3 
Unchanged 
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ORIGINAL TEXT AMENDED PROPOSAL 
2. Advertising in the press and by means of bills and 
posters which, whilst not directly mentioning the tobacco 
product, refers to a trade mark, emblem, symbol or other 
distinctive feature mainly used in connection with 
tobacco products shall be prohibited. 
2. T o prevent the provision in paragraph 1 of this 
Article from being circumvented, advertising in the press 
and by means of bills and posters which, whilst not 
directly mentioning the tobacco product, refers to a 
trade mark, emblem, symbol or other distinctive feature 
mainly used in connection with tobacco products shall be 
prohibited. 
3. The preceding paragraph shall not apply when the 
identity of a tobacco trade mark with the trade mark of 
a product other than tobacco which is marketed by 
undertakings that are legally and financially distinct from 
one another is purely fortuitous. 
Article 4 
Member States shall prohibit all advertising for tobacco 
products in publications mainly intended for people 
under 18. 
Article 4 
Unchanged 
Article 5 
1. The Member States may not cite tobacco adver-
tising as the reason for prohibiting or restricting the sale 
of newspapers, magazines and publications of a similar 
kind or the display of bills and posters which comply 
with this Directive. 
Article 5 
Unchanged 
2. The provisions of this Directive shall not affect the 
right of Member States to introduce measures 
concerning tobacco advertising, in accordance with the 
Treaty, which they deem necessary to guarantee the 
health protection of their citizens provided that such 
measures do not imply modifications of the content or of 
the form of advertisements as provided by this Directive. 
2. The Commission will report to the Council, before 
31 December 1991, on the evolution of the situation in 
the Member States, notably following the implemen-
tation of this Directive, and at the same time will 
propose the necessary measures to guarantee the free 
circulation of goods aimed at for 31 December 1992. 
Article 6 
1. Member States shall adopt the laws, regulations 
and administrative provisions necessary to comply with 
this Directive by 31 December 1991. They shall 
forthwith inform the Commission thereof. 
The provisions adopted pursuant to the first paragraph 
shall make express reference to this Directive. 
Article 6 
Unchanged 
2. Member States shall communicate to the 
Commission the text of the main provisions of national 
law which they adopt in the fields governed by this 
Directive. 
Article 7 
This Directive is addressed to the Member States. 
Article 7 
Unchanged 
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ANNEX 
LIST OF HEALTH WARNINGS, AS REFERRED TO IN ARTICLE 2 (1) 
(a) Warnings which must appear in the national lists: 
1. Smoking causes cancer 
2. Smoking causes heart disease 
(b) Warnings from which the Member States may choose: 
1. Smoking causes fatal diseases 
2. Smoking kills 
3. Pregnant women: smoking harms your baby 
4. Protect children from tobacco smoke 
5. Smoking damages the health of those around you 
6. Stopping smoking reduces the risk of serious diseases 
7. Smoking causes lung cancer, chronic bronchitis and other chest diseases 
8. More than . . . people die each year in . . . (name of the country) from lung cancer 
9. Every year . . . (name of nationals of a country) die in road accidents: . . . times more die from 
smoking 
10. Smokers die before their time 
11. Don't smoke if you want to stay healthy 
12. Save money: stop smoking 
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Proposal for a Council Directive amending Directive 89/622/EEC on the approximation of the 
laws, regulations and administrative provisions of the Member States concerning the labelling of 
tobacco products 
COM(90) 538 final — SYN 314 
(Submitted by the Commission on 16 November 1990) 
(91/C 29/06) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European 
Economic Community, and in particular Article 100a 
thereof, 
Having regard to the proposal from the Commission, 
In cooperation with the European Parliament, 
Having regard to the opinion of the Economic and 
Social Committee, 
Whereas there are differences between the laws, regu-
lations and administrative provisions of the Member 
States on the labelling of tobacco products; whereas 
these differences are likely to constitute barriers to trade 
and to impede the establishment and operation of the 
internal market; 
Whereas these possible barriers should be eliminated; 
whereas, to that end, the marketing and free movement 
of tobacco products should be made subject to common 
rules concerning labelling; 
Whereas such common rules must take due account of 
public health protection, and of the protection of young 
persons in particular, taking as a base a high level of 
protection, according to Article 100a (3) of the Treaty; 
warning to be carried on the unit packaging of all 
tobacco products, together with additional warnings 
exclusively for cigarettes; 
Whereas the Commission, at the request of the Council, 
undertook to propose an amendment to Directive 
89 /622 /EEC so as to establish additional warnings to be 
carried on the unit packaging of tobacco products other 
than cigarettes; 
Whereas scientific experts are of the opinion that all 
tobacco products carry health risks; 
Whereas, in relation to their effects on health and for the 
purposes of their labelling, a distinction needs to be 
made between smoking tobacco products and smokeless 
tobacco products; 
Whereas rolling tobaccos carry the same health risks as 
cigarettes and it is therefore appropriate that the specific 
warnings selected for cigarettes should also apply to 
rolling tobaccos; 
Whereas other smoking tobacco products carry similar 
health risks to those carried by cigarettes, but there are 
still reservations concerning their contribution to heart 
disease; whereas these products should therefore be 
required to carry the specific warnings selected for ciga-
rettes and rolling tobacco, with the exception of the 
warning concerning heart disease; 
Whereas the Council and the representatives of the 
Governments of the Member States, meeting within the 
Council, in their resolution of 7 July 1986 on a 
programme of action of the European Communities 
against cancer ('), set for this programme the objective of 
contributing to an improvement of the health and quality 
of life of citizens within the Community by reducing the 
number of cancers; whereas they have for this purpose 
identified a fight against the use of tobacco products as 
their prime objective; 
Whereas, for the purposes of providing objective infor-
mation on the risks entailed in tobacco consumption, 
Council Directive 89/622/EEC (2) established a general 
(') OJ No C 184, 23. 7. 1986, p. 19. 
O OJ No L 359, 8. 12. 1989, p. 1. 
Whereas it has been proved that smokeless tobacco 
products can provoke cancer and that, consequently, 
they must be subject to a specific warning on tobacco 
products; 
Whereas scientific experts are of the opinion that the 
addiction caused by tobacco consumption constitutes a 
danger meriting a specific warning on every tobacco 
product; 
Whereas, moreover, new smokeless tobacco products — 
moist snuff — designed for oral use, which have 
appeared recently on the market in certain Member 
States, exercise a particular attraction for young persons; 
whereas the Member States most exposed to this 
problem have already placed total bans on these new 
tobacco products or are about to do so; 
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Whereas there are differences between the laws, regu-
lations and administrative provisions of the Member 
States in respect of oral moist snuff tobaccos; whereas 
these products therefore need to be made subject to 
common rules; 
Whereas there is a real risk that oral moist snuff 
tobaccos could be used, particularly by young persons, as 
substitutes for smoking tobacco products, causing 
nicotine addiction, if restrictive measures are not taken 
in time; 
Whereas, in accordance with the conclusions of the 
studies conducted by the International Agency for 
Research on Cancer, oral moist snuff tobaccos contain 
particularly large quantities of carcinogenic substances; 
whereas these new products cause cancer of the mouth 
in particular; 
Whereas, the sales bans for moist oral snuff already 
adopted by two Member States have a direct impact on 
the establishment and operation of the internal market, 
hence the necessity to approximate the laws of Member 
States in this subject taking as a base a high level of 
protection, the only appropriate measure being a total 
ban, 
HAS ADOPTED THIS DIRECTIVE: 
Article 1 
Directive 89/622/EEC is hereby amended as follows: 
1. Article 2 is amended as follows: 
(a) point 1 is replaced by the following: 
'1 . "tobacco products" means products for the 
purpose of smoking, sniffing, sucking or 
chewing, with the exception of oral moist 
snuff tobaccos, inasmuch as they are, even 
partly, made of tobacco;' 
(b) the following point 4 is added: 
'4. "oral moist snuff tobaccos" means all products 
made wholly or partly of moistened tobaccos, 
in fine-cut, ground or particulate form or in 
any combination of these forms, which are for 
oral use other than smoking;' 
(b) the unit packets of cigars, cigarillos, pipe 
tobacco or other smoking tobacco products 
with the exception of cigarettes and rolling 
tobacco shall carry, in addition to the general 
warning provided for in paragraph 1, a 
specific warning. To this end, each Member 
State shall draw up a list of warnings taken 
exclusively from those listed in the Annex, 
with the exception of warning No 2 in part A 
of the Annex; 
(c) unit packets of smokeless tobacco products 
shall carry, in addition to the warning 
provided for in paragraph 1, the following 
specific warning: "Can cause cancer". 
The specific warnings provided for in this 
paragraph shall be printed or irremovably 
affixed on the unit packets in the official 
language or languages of the country of final 
marketing, in such a way as to guarantee, in 
the cases referred to in points (a) and (b), the 
appearance in rotation of each warning on an 
equal quantity of unit packets, with a 
tolerance of 5 %' ; 
(b) paragraph 5 is replaced by the following: 
'5. Without prejudice to paragraph 4, the 
general warning provided for in paragraph 1 and 
the specific warning provided for in paragraph 2 
shall be printed in, or irremovably affixed to, a 
conspicuous place on a contrasting background 
and in such a way as to be easily visible, clearly 
legible and indelible. The warnings shall not in 
any way be hidden, obscured or interrupted by 
other written or pictorial matter.'; 
3. Article 5 is replaced by the following: 
'Article 5 
The Commission shall adopt the measurement and 
verification methods referred to in Article 3 (1) and 
(2) in accordance with the procedure provided for in 
Articles 6 and 7.'; 
4. the following Article 8a is inserted: 
'Article 8a 
Member States shall prohibit the release on the 
market of moist snuff tobacco products for oral use.' 
2. Article 4 is amended as follows: 
(a) paragraph 2 is replaced by the following: 
'2. Apart from the general warning referred to 
in paragraph 1, tobacco product packaging shall 
carry specific warnings as follows: 
(a) with regard to cigarette packets and rolling 
tobacco, the other large surface of the packet 
shall carry specific warnings. To this end, 
each Member State shall draw up a list of 
warnings taken exclusively from those listed 
in the Annex; 
5. the Annex is amended as set out in the Annex to this 
Directive. 
Article 2 
1. The prohibition of moist snuff tobacco products 
shall enter into force before 1 July 1992. 
2. For the other amendments made by this Directive 
to Directive 89/622/EEC, Member States shall take the 
necessary steps to comply before 1 July 1992. They shall 
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immediately inform the Commission thereof and shall 
send to it the provisions they have adopted. 
When Member States adopt these provisions, they shall 
contain a reference to this Directive or shall be ac­
companied by such reference at the time of their official 
publication. The procedure for such reference shall be 
adopted by Member States. 
3. Member States shall bring into force the provisions 
referred to in paragraph 2 before 31 December 1992. 
Nevertheless, products existing at that date which do not 
comply with Article 1 (2) (a) may still be marketed until 
31 December 1993. 
rolling tobaccos and point (b) for other smoking 
tobaccos in the Official Journal of the European 
Communities. 
2. Member States which, after 31 December 1992, 
modify their lists of warnings as provided for in Article 4 
(2) (a) and (b) shall notify this modification 18 months 
before its application to the Commission, which shall 
publish it in the Official Journal of the European 
Communities. 
Article 4 
This Directive is addressed to the Member States. 
Article 3 
1. The Commission shall publish the national lists of 
warnings provided for in Article 4 (2), point (a) for 
ANNEX 
1. The title of the Annex to the Directive shall be worded as follows: 
'List of health warnings referred to in points (a) and (b) of Article 4 (2)'. 
2. In pan Β of the Annex, the following new warning, No 15, shall be added after warning No 14: 
'15. Smoking causes addiction.' 
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II 
(Acts whose publication is not obligatory) 
COMMISSION 
COMMISSION RECOMMENDATION 
of 8 November 1989 
concerning the training of health personnel in the matter of cancer 
(89/601/EEC) 
I. Cancer is a disease on which there has been a great 
deal of action, both public and private, for many years. 
This action has covered many aspects, including research, 
prevention, screening, treatment, and the counselling of 
patients and their families. Our knowledge about the 
disease and its management has advanced considerably, 
but cancer remains one of the biggest causes of death in 
modern society. 
is taught to members of their professions, at all levels in 
their training, and to make recommendations for 
improving such training. The Advisory Committees 
carried out their reviews during 1987/88, and have now 
adopted the enclosed recommendations which constitute 
the practical application of the first action programme 
(1987 to 1989) on the training of health personnel 
(measures 51 and 52) (4). 
The initiative taken at the European Councils of June 
1985 in Milan and December 1985 in Luxembourg was 
innovative in that it was the first time that a specific 
disease had been singled out for a broad attack at 
European Community level. The results already obtained 
in pursuit of the 'Europe against cancer' programme have 
confirmed that the initiative was justified, in particular in 
the field of the training of health personnel. 
II. In order to facilitate the mutual recognition of 
diplomas, certificates and other qualifications between 
Member States, as provided for in Article 57 of the EEC 
Treaty, the Council, by successive Decisions, set up the 
Advisory Committee on Medical Training ('), the Advisory 
Committee on Training in Nursing (2) and the Advisory 
Committee on the Training of Dental Practitioners (3). 
The Advisory Committees are the authoritative sources of 
advice on professional training of health personnel to the 
Commission and to the Member States at Community 
level. 
At the request of the Commission and on the basis of the 
recommendations of the committee of cancer experts, 
their contribution to the 'Europe against cancer" 
programme has been to review how the subject of cancer 
III. The Commission attaches considerable importance 
to the recommendations of the three Advisory 
Committees, which have underlined the value of looking 
at training collectively at Community level, and of 
generating ideas for bringing about improvements while 
respecting national competences and academic freedom. 
All the specific recommendations by these advisory 
committees should be the subject of wide-ranging debate 
among those responsible at national and regional level in 
each Member State. 
For its part, within the framework of its responsibilities 
and the available funds, the Commission intends to 
propose as part of the second 'Europe against cancer' 
programme (1990 to 1994) measures which can contribute 
at Community level to improving training in cancer of 
those belonging to the health professions. 
In particular, measures should be undertaken to 
encourage the mobility between the Member States of 
such persons, the exchange of experience in the area of 
prevention, treatment and terminal care, the collection 
and exchange of teaching materials of interest at 
Community level and the establishment of pilot 
European networks of medical, nursing and dentistry 
schools. 
(') Decision 75/364/EEC (OJ No L 167, 30. 6. 1975, p. 17). 
(2) Decision 77/454/EEC (OJ No L 176, 15. 7. 1977, p. 11). 
(ή Decision 78/688/EEC (OJ No L 233, 24. 8. 1978, p. 15). (') OJ No C 50, 26. 2. 1987, p. 1. 
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IV. The Commission intends to work together with the 
responsible authorities and training establishments in the 
Member States in the future development of ideas and 
recommendations relating to the training of health 
personnel in matters concerning cancer. In this context, 
the Commission will encourage from 1990 an 
examination of progress recorded in the Member States as 
regards the practical implementation of the 
recommendations. 
The Commission, believing that the attached 
recommendations on training in cancer adopted by the 
Advisory Committee on Medical Training, the Advisory 
Committee on Training in Nursing, and the Advisory 
Committee on the Training of Dental Practitioners, 
constitute a good basis for the widest possible discussion 
in the Member States, makes the following 
recommendation pursuant to the EEC Treaty, and in 
particular the second indent of Article 155 thereof: 
The Commission recommends that the Member 
States, their competent authorities and their 
establishments responsible for professional training 
make every effort to ensure, in accordance with their 
respective competence, that these recommendations 
are widely distributed, discussed and implemented. 
This recommendation is addressed to the Member States. 
Done at Brussels, 8 November 1989. 
For the Commission 
Vasso PAPANDREOU 
Member of the Commission 
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ANNEX I 
RECOMMENDATIONS 
of the Advisory Commit tee on Medical Training 
1. The training of doctors in cancer should be vigorously advanced by both teaching and research in the 
subject. 
2. Each medical school should have an undergraduate teaching programme in cancer. Coordination of this 
programme is of critical importance, and should be implemented. 
3. The vital role of the general practitioner both in the prevention and early diagnosis of cancer should be 
recognized and developed in all possible ways. 
4. General practitioners should receive specific training in those aspects of the care of cancer patients parti-
cularly relevant to general practice, such as screening methods, counselling, appropriate methods of 
treatment, rehabilitation and terminal care. 
5. Trainees in all relevant disciplines should receive appropriate teaching in the biology of neoplastic 
disease and in the scientific and clinical basis of treatment. 
6. In those countries where oncologists are recognized, agreement should be reached on minimal objectives 
and requirements for the training of such specialists. 
7. The principles of epidemiology should be taught at all levels of training. 
8. All postgraduate trainees should have opportunities for gaining experience in both basic and clinical 
research. 
9. The importance of inter-disciplinary cooperation in the care of patients with cancer should be recog-
nized and encouraged in all relevant disciplines. 
10. Efforts should be made to coordinate the activities of cancer institutes, specialist and scientific societies, 
universities and all types of hospital both in regard to clinical training and cancer research. 
11. Modern teaching techniques should be used whenever appropriate at all levels of training. 
12. More advantage should be taken of existing opportunities for promoting the interchange within the 
European Community of teachers, undergraduate students, postgraduate students and research workers. 
13. All those responsible for planning programmes of continuing medical education should ensure that the 
subject of oncology receives appropriate emphasis. Particular attention should be given to the needs of 
doctors who, by nature of their isolated practice, do not have easy access to institutions providing conti-
nuing education programmes. 
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ANNEX II 
R E C O M M E N D A T I O N S 
of t he Advisory C o m m i t t e e on T ra in ing in N u r s i n g 
I. BASIC TRAINING 
1. Basic training of nurses should include in a systematic and global way the prevention of cancer, participa-
tion in detection and diagnosis, identification of the problems of cancer patients and responding to their 
specific needs, the administration of anti-cancer therapy programmes, participation in rehabilitation as 
well as the care of patients in the terminal stage of their illness, and the care of the family of cancer 
patients. 
2. The training of nurses in the care of cancer patients should be based upon a nursing model adapted to the 
situation of such patients. It should serve as a framework for organising the actual training in accordance 
with clearly established teaching objectives. The objectives of nursing care are identifying and interpreta-
ting the needs of the individual, and responding to them in an appropriate and personalized manner. 
Nurse training should react to these objectives and should prepare the nurse to practice his or her profes-
sion in a responsible manner. Nurses should therefore have the capacity to take decisions, resolve 
problems, assess their actions and to adapt themselves to the particular situations of patients and to the 
evolution of knowledge. 
3. Together with the other professionals concerned, nurses should participate actively in action programmes 
against cancer, collaborate in informing and educating the general public about the positive benefits of 
prevention, screening and detection, and the early treatment of cancerous conditions. To fulfill this task 
nurses through their own training must acquire a positive attitude towards this very real social problem 
and should equip themselves, with a sound base of knowledge which they can use in their clinical trai-
ning. 
4. Given the speed of developments and discoveries, as much in the level of understanding of physio-
pathological processes and mechanisms as in diagnostic and therapeutic techniques, basic training must 
provide nurses with the substantial tools to enable them to make use of their knowledge and practical 
skills, and to reinforce their ability. It is a question of a dynamic process, in a constant state of evolution. 
5. The teaching materials that cover the prevention, screening and treatment of cancer, the fruit of work 
carried out in teaching establishments and cancer research and treatment centres, must be developed and 
a European Community network set up for the exchange of information so as to make the best possible 
use of human, material and financial resources. 
6. The basic training must prepare nurses for interdisciplinary tasks, for team work is essential in patient 
care and even more so in the case of cancer patients. 
II. POST BASIC TRAINING 
A. C o n t i n u i n g educa t ion 
1. Continuing training courses that deal with cancer care should be made available to as many nurses as 
possible by setting up organizational procedures that can adjust to personal and professional constraints. 
The organization of these activities should be encouraged and the resources necessary for their realization 
should be found. 
2. Continuing education in the field of cancer care must not be developed as a way of making up for gaps in 
basic training ; it must be an extension of basic training, taking account of prerequisites and exploiting 
acquired experience. The courses must comply with adult education principles. 
3. In the context of cancer care the objectives of the continuing training programmes are to update acquired 
knowledge, reinforce it on specific aspects and stimulate and promote reflection on nurses' actual profes-
sional experience with cancer patients. The course content must not therefore be limited to passing on 
theoretical information on pathology and diagnostic and therapeutic methods, but must also cover rela-
tionships and personal and ethical question which nurses have to face in their daily work with cancer 
patients. 
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4. Both the conditions of access to continuing training courses and the structures used must be very flexible. 
Distance learning should be promoted, and the Committee recommend that the exchange of knowledge, 
experience and teaching materials be encouraged at Community level. It is in fact complementary to 
group sessions and leads to a more effective use of the knowledge acquired. 
5. The requirements and expectations of the nurses concerned must be carefully analysed before any conti-
nuing education programme is set up. Common training courses drawn up by nurses having special expe-
rience of caring for cancer patients and 'fighting cancer in cooperation with other professionals could be 
developed and distributed in the various Member States. Such programmes would not constitute sets of 
rules, but serve as scientific references for the national authorities wishing to introduce such training. 
Such training courses should make the maximum use of modern teaching technology. 
B. Advanced training 
1. Improving the quality of the care provided for cancer patients is a priority. It is therefore essential that 
nurses who have completed high level training in cancer care should take part in the research carried out 
in this field, fulfilling an advisory role in the departments concerned and providing special training for 
nursing staff. 
2. This advanced training in cancer care should be at the highest appropriate level. The general and specific 
objectives of such a training programme and its contents should be drawn up by a group of expert nurses 
in cooperation with other professionals and form a common core for the Member States. Specialized 
centres should be associated in the implementation of these high level programmes. 
3. The content of the training should not concentrate only on the acquiring of theoretical medical know-
ledge ; it must also incorporate human relations and the acquiring of skills in managing teams of nurses 
responsible for cancer patients. The theoretical teaching must be supplemented by suitable clinical 
teaching, preferably in hospital departments or other centres specialized in cancer care. 
4. In the course of the advanced training the student should take part in research work in the field of cancer 
nursing. Publication of work in this area should be promoted and stimulated. 
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ANNEX III 
R E C O M M E N D A T I O N S 
of the Advisory C o m m i t t e e o n the T r a i n i n g of Den ta l P rac t i t i one r s 
1. Objectives and guidelines should be drawn up at European Community level on the content of a core 
curriculum upon oral precancer and cancer for undergraduate dental students ('). 
2. Consideration should be given to the use (in whole or part) of these objectives and guidelines for the 
teaching of these same subjects to undergraduate medical students. 
3. The basic dental curriculum must equip the general dental practitioner to play a major role in prevention, 
and in the early detection and diagnosis of oral malignancies so that treatment may be initiated at as early 
a stage as possible. 
4. Emphasis should be placed upon clinical experience during basic training. To this end, where necessary, 
dental faculties should collaborate closely with medical services to ensure that dental students obtain 
access to a wide range of patients with malignant disease. At all major centres for the treatment of cancer 
there should be a dentally qualified specialist with particular knowledge of oral oncology. 
5. There should be developed urgently at European Community level continuing dental education courses 
on oral precancer and cancer. 
6. Similarly, consideration should be given to developing at Community level common teaching material in 
oral precancer and cancer, possibly in association with the medical profession. 
7. The three action programmes set out in the Appendix should be implemented as early as possible in all 
Member States. 
(') The Advisory Committee has made explicit proposals for such objectives and guidelines (Doc. III /D/ 
886/3/88). 
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Appendix 
Action Programme N o 1 
National dental associations in all Member States should give consideration to the desirability and feasibility 
that on one day or more in 1989 citizens in accepted risk groups for oral precancer and oral cancer should 
be offered a free examination of the oral cavity and associated regions by general dental practitioners. 
Action Programme N o 2 
The national bodies in the individual Member States responsible for continuing dental education should in 
1989/90 arrange a national meeting upon oral precancer and oral cancer with emphasis on early diagnosis 
and prevention as the main theme of the meeting. The meeting should be open to all dental practitioners. 
National dental journals should be fully involved in propulgating to the profession current knowledge on 
oral precancer and cancer. 
Action Programme No 3 
The national dental associations of the different Member States in cooperation with national cancer organiza-
tions and dental school's should prepare informative material for the general public with emphasis on early 
signs of oral precancer and oral cancer and prevention of oral precancer and oral cancer. 
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Detailed summary 
Public health: initiatives and texts adopted in 1990 
AIDS 
Conclusions of the Council and of the Ministers 
for Health meeting within the Council of 3 
December 1990 on AIDS (90/C/329/07) . . . . 168 
Proposal for a decision of the Council and the 
Ministers for Health of the Member States meet-
ing within the Council adopting a plan of action 
in the framework of the 1991 to 1993 'Europe 
against AIDS' programme, submitted by the 
Commission on 11 December 1990 (91/C 13/06) . 169 
Nutrition 
Resolution of the Council and of the representa-
tives of the Governments of the Member States 
meeting within the Council of 3 December 1990 
concerning an action programme on nutrition 
and health (90/C 329/01) 175 
Conclusions of the Council and the Ministers for 
Health meeting within the Council of 3 Decem-
ber 1990 on the safety of food and drink and 
water intended for human consumption (90/C 
329/05) 178 
Fight against cardiovascular diseases 
Conclusion of the Council and of the Ministers for 
Health meeting within the Council of 3 December 
1990 concerning cardiovascular disease in the 
Community (90/C 329/04) 179 
Fight against the use of drugs 
Resolution of the Council and of the representa-
tives of the Governments of the Member States 
meeting within the Council of 3 December 1990 
on Community action to combat the use of 
drugs, including the abuse of medicinal products, 
particularly in sport (90/C 329/02) 180 
Acute poisoning 
Resolution of the Council and of the representa-
tives of the Governments of the Member States 
meeting within the Council of 3 December 1990 
on improving the prevention and treatment of 
acute human poisoning (90/C 329/03) 182 
Amendment to the draft Council resolution on 
improving the prevention and treatment of acute 
human poisoning, submitted by the Commission 
on 14 December 1990 (91/C 5/03) 195 
Fight against drugs 
Communication from the Commission to the 
Council of 8 November 1990 regarding the re-
port on national programmes for drug demand 
reduction in the European Community . . . 
Conclusions of the Council and the Ministers for 
Health meeting within the Council of 3 Decem-
ber 1990 on reducing the demand for narcotic 
and psychotropic substances (90/C 329/06) . . . 
199 
215 
Occupational diseases 
Commission recommendation of 22 May 1990 
concerning the adoption of a European schedule 
of occupational diseases (90/326/EEC) 
OJ L 160, 26.6.1990 - see Social Europe No 2/90 
Apart from the texts regarding the 'Europe against cancer' pro-
gramme which can be found in the Annex to Part One of this issue. 
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CONCLUSIONS OF THE COUNCIL AND OF THE MINISTERS FOR HEALTH, 
MEETING WITHIN THE COUNCIL 
of 3 December 1990 
on AIDS 
(90/C 329/07) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE MINISTERS FOR HEALTH, MEETING 
WITHIN THE COUNCIL, 
to foster within these structures, respecting confiden-
tiality, a psychological and social climate which is 
sensitive to the needs of the individuals concerned, 
Having considered the epidemiological development and 
the medical and social consequences of the spread of 
HIV infection in Europe, 
Having considered in particular the growing link 
between drug addiction, infection from HIV (Human 
Immunodeficiency Virus) and the development of 
HIV-related diseases in many of the European countries, 
Having regard to the conclusions of the Council and the 
Ministers for Health, meeting within the Council, on 
16 May 1989 regarding the prevention of AIDS in 
parenteral drug users ('), in particular the section on 
pregnant women drug users, and to the increase in the 
number of children born sero-positive, 
to the intermediate report and the 
a European plan to combat drugs 
Having regard 
guidelines for 
approved by the European Council in Dublin on 25 and 
26 June 1990 and to the draft European plan to combat 
drugs to be submitted by the European Committee for 
the fight against drugs (Celad) to the next European 
Council on 13 and 14 December 1990, and in particular 
the paragraph on drug addiction and AIDS, 
INVITE THE MEMBER STATES: 
1. to promote, in drug addiction services and reception 
centres, access to early intervention and, where 
appropriate to treatment for sero-positive drug addicts 
and for those with clinical signs of HIV infection; 
INVITE THE COMMISSION: 
1. to step up exchanges of information, experience and 
experts : 
(a) on medical and social assistance to sero-positive 
pregnant women and newborn babies; 
(b) on the organization of home care for people 
suffering from HIV/AIDS and other forms of 
health care for HIV-infected persons; 
(c) for assessing the measures implemented in the 
Member States to supply safer injecting materials; 
this assessment with also cover new types of 
disposable syringes and needles; 
2. to inform the Council of the results of the exchange 
of experience referred to in point 1 and to submit an 
appropriate assessment and, if necessary, proposals 
for action; 
In addition, repeat the call made to the Member States 
in the conclusions of the Council and the Ministers for 
Health, meeting within the Council, on 17 May 1990 to 
continue with active policies to avoid any discrimination 
against sero-positive persons and people suffering from 
HIV/AIDS and to encourage the social acceptance of 
such persons; 
Finally invite the Member States to extend the 
commitment to non-discrimination and social acceptance 
to those living with sero-positive persons and people 
suffering from HIV/AIDS or to those who have contact 
with such persons. 
(') OJ No C 185, 22. 7. 1989, p. 3. 
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Proposal for a decision of the Council and the Ministers for Health of the Member States 
meeting within the Council adopting a plan of action in the framework of the 1991 to 1993 
'Europe against AIDS' programme 
COM(90) 601 final 
(Submitted by the Commission on 11 December 1990) 
(91/C 13/06) 
THE COUNCIL AND THE MINISTERS FOR HEALTH OF 
THE MEMBER STATES, MEETING WITHIN THE 
COUNCIL, 
Having regard to the Treaty establishing the European 
Economic Community, 
Whereas the conclusions of the Council and Ministers 
for Health of the Member States, meeting within the 
Council of 16 May 1989, regarding the prevention of 
AIDS in intravenous drug users, requested the 
Commission to prepare and submit to the Council a 
programme in this area; 
Having regard to the proposed decision submitted by the 
Commission, 
Having regard to the opinion of the European 
Parliament, 
Having regard to the opinion of the Economic and 
Social Committee, 
Whereas, the increase in the AIDS epidemic is of major 
concern to Member States and the Community; 
Whereas the conclusions of the Council and the 
Ministers for Health of the Member States, meeting 
within the Council of 16 May 1989, on the improvement 
of the general system for collecting epidemiological data, 
including the application of the new definition of AIDS 
cases, asked the Commission to compare the system for 
recording notifications of AIDS cases at national and 
Community level in order to pinpoint where the 
improvement of coverage can take place, as well as the 
reliability and the comparability of the data used; 
Whereas the resolution of the European Parliament of 
30 March 1989 on the fight against AIDS called on the 
Commission for action in particular in the fields of infor-
mation and training of health professionals; 
Whereas the resolution of the representatives of the 
governments of the Member States, meeting within the 
Council, of 29 May 1986, on AIDS, requested the 
Commission to organize an exchange of information and 
experience; 
Whereas the resolution of the Council and of the 
Ministers of Education meeting within the Council of 23 
November 1988, concerning health education in schools, 
expressed concern about the high incidence of AIDS, 
and invited the Commission to undertake a series of 
actions at Community level; 
Whereas the conclusions of the Council and the 
Ministers for Health of the Member States, meeting 
within the Council of 16 May 1989, regarding future 
activities on AIDS prevention and control at Community 
level called upon the Commission to examine the possi-
bilities for harmonization with regard to condoms and 
H I V self-testing kits; 
Whereas the resolution of the Council and Ministers for 
Health of the Member States, meeting within the 
Council of 22 December 1989, on the fight against 
AIDS, requested the Commission to develop exchanges 
of information and experience defining in priority the 
details and contents of an action plan integrating appro-
priate measures to prevent and control AIDS; 
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Whereas the conclusions of the Council and the 
Ministers for Hea l th of the Member States, meeting 
within the Counci l , of 17 M a y 1990, on medical and 
psycho-social care services in relation to the A I D S 
epidemic, requested the Commission to examine the 
feasibility of developing a consistent approach to costing 
the management of care for HfV-seroposit ive persons; 
Whereas the present plan of action for the programme 
'Europe against A I D S ' contains the aforementioned 
requests; whereas it also contains other measures 
intended to contain the A I D S epidemic, 
HAVE DECIDED AS FOLLOWS: 
Article 1 
1. T h e Commission shall implement the 1991 to 1993 
action plan set out in the Annex in close coordinat ion 
with the competent authorities of M e m b e r States. 
2. T h e Commission will cooperate with International 
Organiza t ions active in this field such as the W H O and 
the Council of Europe . 
3. T h e Commission will regularly publish technical 
information on the progress of the action plan. 
Article 2 
1. T h e Communi ty funds required for the w o r k to be 
under taken under this Decision shall be determined by 
the budget authori ty within the context of the appropri-
ations available for each year. 
Article 3 
1. T h e Commission will continuously assess the action 
under taken and the priorities taking into account 
emerging urgencies. 
2. T h e Council and the Ministers for Heal th of the 
M e m b e r States meeting within the Council will carry out 
an evaluation of the effectiveness of the ac t ions . 
under taken . T o this end the Commission will submit a 
report on the subject during the second half of 1992. 
ANNEX 
CHAPTER I 
INFORMATION AND HEALTH EDUCATION IN T H E PREVENTION OF HIV INFECTION 
The importance of prevention cannot be stressed enough as there is no vaccine nor effective treatment 
available. The Member States have been active for several years in promoting information and health 
education for the general public in this field. It is of fundamental importance to continue this work in 
order to ensure the success of prevention efforts. 
Different approaches are used in the Member States in preventive strategies and prevention intervention 
methods are under development and evaluation. This diversity of approach can be used to maximum 
benefit if there is an interactive knowledge of what is being done. Therefore, exchanges of information are 
necessary and need to be promoted. 
A key role at Community level is to facilitate exchanges of experience, to evaluate results and to promote 
new approaches, so that the most effective approaches can be promoted taking into account local needs 
and characteristics. 
Health education in schools is an essential part of health promotion, and within the limits of specific 
national educational policies and structures, appropriate arrangements should be made for coordinating 
health-promotion measures, so that health education can be seen by children as a practical pan of their 
lives. 
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Repeated efforts are necessary for prevention messages to be retained by the public and relevant target 
groups. This will help them develop a real understanding of AIDS problems and their consequences, in 
order to contribute to a change in their attitudes. 
Simple messages can increase the general public's awareness, and can improve the efficiency of an AIDS 
prevention information campaign, in particular by the use of a European code against AIDS which will 
take into account the work already carried out in the Council of Europe ('). 
Objectives: 
— to prevent the spread of the epidemic by providing information on HIV risk factors, and therefore to 
avoid discrimination and stigmatization of HIV seropositive persons, 
— to monitor attitudes towards AIDS in the general population of the Community. 
Action 1 : Informing the public about AIDS prevention campaigns 
Member States have already gained valuable experience in the use of publicity campaigns to inform the 
public about AIDS. A survey of current AIDS prevention campaigns will be carried out with a view to 
improving the existing campaigns and to designing more effective ones in the future. 
At Community level, a publicity campaign will need to take into account the experience of the Member 
States in order to ensure maximum impact on the general public, resulting in increased awareness. This 
campaign will also aim at providing information to prevent discrimination against HIV seropositive persons 
and AIDS sufferers. 
The public and private organizations involved in the fight against AIDS will be closely associated with the 
preparation and implementation of this action. Broad coverage will be given to the results of the actions. 
With the help of appropriate experts, the Commission will establish a European code against AIDS and 
ensure its transformation into layman's language. Dissemination of the code will be made in all appropriate 
fora, including schools and the workplace. 
Action 2 : Prevention of HIV infection and health education in schools 
Exchanges of information will be encouraged and supported within the framework of health education in 
schools. Specific seminars for teachers from the Member States will provide not only an opportunity for 
exchanging experiences and knowledge but also lay down the foundations for broader cooperation. 
Where appropriate, exchanges of teaching materials produced in Member States on health education 
related to AIDS and HIV infection wjll be promoted and supported. 
Action 3: Eurobarometer surveys on AIDS and its prevention 
Repeated monitoring of public opinion and attitudes is necessary in order to assess the effectiveness of 
prevention efforts. 
Regular updating of Eurobarometer surveys will be carried out in close cooperation with European 
specialists in this field so as to determine to what extent Europeans are informed about AIDS issues and 
prevention. 
(') In particular recommendation No R(87) 25 of the Committee of Ministers concerning a common European public 
health policy to fight the Acquired Immunodeficiency Syndrome (AIDS) adopted on 26 November 1987 and recom-
mendation No R(89) 14 of the Committee of Ministers on the ethical issues of HIV infection in the health care and 
social settings adopted by the Committee of Ministers on 24 October 1989. 
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CHAPTER 2 
PREVENTION AND TREATMENT, SOCIAL CARE AND COUNSELLING 
Clinical trials have shown that the available treatments do not cure the disease although they do appear to 
delay its onset. New approaches are under development and evaluation. Persons with AIDS need specific 
care, in particular the rapid treatment of multiple infections due to immunodeficiency. 
Counselling is an important element in both care and preventive strategies. Intravenous drug users are a 
high-risk group for which treatment and social care are of particular importance. 
Objectives: 
— to improve medical and psycho-social support to HIV-positive and AIDS symptomatic drug users, 
— to make counselling more accessible to all HIV-positive people, 
— to prevent the spread of HIV infection among drug users, their sexual partners and offspring, 
— to reduce HIV transmission in blood and blood based products. 
Action 4: Exchanges of experience on counselling and treatment services 
Accessibility to counselling services, as well as telephone directories and other telephone information 
systems, are necessary to assist both HIV seropositive persons and AIDS sufferers. 
Crisis intervention helplines are increasingly available in Member States. The first European Conference on 
AIDS hotlines, which took place in Amsterdam (April 1989), has demonstrated their effectiveness not only 
in providing support in cases of crisis but also to serve as an anonymous personalized information system. 
This could lead to the establishment of a Community-wide directory of helplines. This should be done in 
close coordination with drug helplines, since HIV-seropositive and AIDS symptomatic drug users may have 
recourse to both systems. 
With the growing mobility of people in the European Community, there is a need to promote exchanges of 
experience between health care professionals on treatment services and medical care, so that they can cope 
better with an increasing number of patients coming from different cultural backgrounds. 
Appropriate means will be established for exchanges of experience, and to develop effective treatment 
methodologies. That could lead to a European guide of medical care and treatment facilities, which can be 
used further by Member States and the Commission to promote exchange visits. 
Action 5: Development of models for the costing of the management of AIDS 
It is foreseen that there could be 150 000 persons with AIDS in the European Community in 1992. The 
average yearly cost for an AIDS patient has been estimated as being of the order of ECU 20 000 for 
medication, hospitalization, home care and psycho-social support. Thus ECU 3 billion will be required in 
1992 to cover these costs, and this amount could be expected to increase yearly as the number of AIDS 
victims rises. 
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The Commission will examine the feasibility of developing models for the costing of the management of 
AIDS, taking account of the available findings of the W H O report on costs, and the conclusions of the 
European Health Committee with regard to the impact of AIDS on the organization of health care. 
Action 6: Reduction of HIV transmission in blood and blood based products 
In the past, a cause of AIDS was the transmission of HIV in blood and blood derived products. Several 
measures have now significantly reduced the risk of transmission. 
Selection of blood and plasma donors and screening of their donation for HIV antibodies is now systemat-
ically carried out, in accordance with the recommendations of the Council of Europe. Also, Directive 
89/381/EEC relating to medicinal products derived from human blood and plasma lays down requirements 
for manufacturing and purification processes to ensure, insofar as technology permits, the absence of 
specific viral contamination. 
However, the risk of transmission can be reduced still further. The attainment of European self-sufficiency 
in blood and blood derived products has become a Community objective, through the promotion of 
voluntary unpaid blood donations. The Commission will examine carefully the current situation and 
evaluate how best these objectives can be achieved, bearing in mind its current cooperation with the 
Council of Europe in this field. 
CHAPTER 3 
EPIDEMIOLOGICAL ASSESSMENTS 
Although statistics are available on the numbers of AIDS cases, there are no reliable statistics for HIV 
seroprevalence. 
Prevention, treatment and risk reduction strategies and the corresponding allocation of resources require 
knowledge of the patterns and trends of the AIDS epidemic. 
Objectives: 
— to ensure and improve the availability and comparability of data on AIDS, and H I V seroprevalence, 
— to provide through epidemiological studies on A I D S / H I V , appropriate information for preventive 
policies. 
Action 7: Improvements to the system for gathering the data on AIDS 
The European Centre for the Epidemiological Monitoring of AIDS ( W H O - E C Collaborative Centre in 
Paris) is playing a major role in gathering and analysing epidemiological data on AIDS. 
In order to improve the quality of the data, support will be given to national monitoring systems; to the 
accessibility of the Paris Centre's data base; and to improving epidemiological information on the disease. 
Proposals will be made on the establishment of a Community-wide system, with a view to facilitating 
exchanges of information. 
Action 8: Common methodological approaches to ensure the availability and comparability of epidemio-
logical data on HPV seroprevalence 
HIV seroprevalence is becoming a central issue in developing strategies for prevention and care. The 
present lack of knowledge is not a sufficient basis on which to establish sound health policies. 
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As a first step, a methodology should be agreed at Community level. 
A survey will be made on current approaches determining HIV seroprevalence in the European 
Community, in order to provide information on the epidemiological situation regarding HIV transmission. 
CHAPTER 4 
MANPOWER TRAINING AND DEVELOPMENT 
The development of the actions contained in this programme in terms of prevention, treatment, risk 
reduction, socioeconomic integration, as well as epidemiological data collection and evaluation, requires 
the presence of adequately trained personnel. 
Adaptation and improvement of träning for health and social care professionals can be ensured through 
exchanges of experience. 
Objectives: 
— to provide health and social care professionals with an adequate knowledge of AIDS prevention and 
primary care of AIDS patients and HIV seropositive persons, 
— to develop an adequate core of specialists in AIDS prevention, treatment and psycho-social care of 
people with HIV or AIDS. 
Action 9: Systems of university training for health care workers; mobility of medical and nursing students 
Universities and bodies involved with professional training courses for health and social care should 
become more involved in the fight against AIDS with adequate information and training on AIDS issues 
being provided. 
To accelerate the education and continuous training of professionals, the development of appropriate 
teaching materials and supports is necessary. 
A survey will be made on the training and instruction given in university education and training, and 
exchanges of experience will be organized. 
A survey on existing teaching materials will be carried out, and if appropriate, the promotion of exchanges 
of materials, as well as the development of additional training material. 
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(Information) 
COUNCIL 
RESOLUTION OF T H E COUNCIL A N D OF T H E REPRESENTATIVES OF THE 
GOVERNMENTS OF T H E MEMBER STATES, MEETING WITHIN T H E COUNCIL 
of 3 December 1990 
concerning an action programme on nutrition and health 
(90/C 329/01) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE REPRESENTATIVES OF THE GOVERN-
MENTS OF THE MEMBER STATES OF THE EUROPEAN 
ECONOMIC COMMUNITY, MEETING WITHIN THE 
COUNCIL, 
Having regard to the Treaty establishing the European 
Economic Community, 
Considering that proper, balanced eating habits, 
combined with other factors, efficiently prevent a series 
of diseases which are currently the main causes of death 
and morbidity in Europe; 
Considering that, although the nutritional situation 
varies greatly between different Community Member 
States, between different regions of one and the same 
State and between different groups of people in the same 
region, there are still problems linked with both excessive 
consumption of food and imbalances in the intake of the 
various nutrients; 
Considering that the Community has dealt on various 
occasions with nutritional problems and related measures 
in sectoral contexts, such as the fight against cancer 
(resolution of 7 July 1986 ('), Decision of 21 June 
1988 (2) and Decision of 17 May 1990 (3) or alcohol 
abuse and the problems of young people (resolution of 
29 May 1986 (4) and conclusions of 17 May 1990) or 
health education (resolution of 23 November 1988 (5)), 
but has not given overall consideration to aspects of 
nutritional education and consumer information taken as 
a whole with the aim of promoting eating habits in 
keeping with individual needs; 
Considering that, on the basis of the above, it is clearly 
important to find more effective ways of providing all 
Community citizens with the vital knowledge and 
education which will enable them, within the framework 
of their lifestyle, to make the necessary choices for 
ensuring appropriate nutrition in keeping with individual 
needs; 
Considering that these advances require active support 
not only from governments and parliaments but also 
from society as a whole; 
Considering the importance of looking at nutritional 
aspects in relation to various physiological states such as 
those peculiar to pregnant women, nursing mothers, 
children, adolescents and the elderly; 
Considering that it is important to organize and promote 
a programme of events and activities aimed primarily at 
increasing public awareness of the role of a proper diet 
in maintaining health, 
Considering that access to sufficient quantities of healthy 
food is a determining factor for human health; 
Considering the existing high level of protection as 
regards the wholesomeness of food and drink and the 
general availability of good-quality food on the 
Community market; 
Invite the Commission to submit to the Council a 
proposal for an action programme, together with the 
budget proposals necessary under the usual procedures, 
(') OJ No C 184, 23. 7. 1986, p. 19. 
(') OJ No L 160, 28. 6. 1988, p. 52. 
(>) OJ No L 137, 30. 5. 1990, p. 31. 
O OJ No C 184, 23. 7. 1986, p. 3. 
(') OJ No C 3, 5. 1. 1989, p. 1. 
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which provides in particular that 1994 will be 'European 
Nutr i t ion Year ' . W h e n drafting this p rogramme, the 
Commission is invited to use as a basis the aims and 
guidelines set out in the Annex. 
Invite the competent authorities in the Member States to 
take appropriate measures, on the basis of any decisions 
taken by the Council , to carry out the programme, and 
to set up the necessary coordinat ion arrangements . 
Recommend that Communi ty activities in this sector be 
conducted while taking into account the activities of the 
W H O and FAO and, as far as possible, in cooperat ion 
with them. 
Invite the Commission to call meetings of senior officials 
appointed by the competent national authorities on a 
regular basis at least every two years from 1992 onwards 
to evaluate progress in the programmes on nutritional 
education and consumer information. 
Ask the Commission to keep the Council regularly 
informed of progress and to submit a final report to the 
Council on the work done. 
ANNEX 
OBJECTIVES AND GUIDELINES FOR THE ACTION PROGRAMME ON NUTRITION AND 
HEALTH 
1. OBJECTIVES 
The objectives of the action programme are: 
(a) to disseminate knowledge about the decisive role for health and well-being of a correct diet in relation 
to various diseases and risk factors; 
(b) to disseminate knowledge about the serious public health problems and social evils associated with 
alcohol abuse; 
(c) to prepare and disseminate information and recommendations promoting eating habits which, while 
reflecting each community's own traditions and habits, help to promote good health and enable 
everyone to adopt eating habits suited to his/her personal physiology; 
(d) to promote consumer understanding of the type of information given on labels for general and nutri-
tional purposes and of the ways in which such information can be used to protect one's health; 
(e) to foster awareness among those concerned of the need to observe the rules of hygiene throughout the 
various stages of the food cycle, i.e. during agricultural and industrial production, storage, transport, 
wholesale and retail sale and the preparation of food in the home; 
(f) to encourage to a greater extent consideration of nutritional and health aspects in the measures in the 
various relevant sectors of the Community and its Member States; 
(g) to promote studies and investigations, in close coordination with the Community medical research 
programme, including epidemiological research, into the relationships between nutrition and disease or 
risk factors and the best ways of protecting health and preventing disease by means of a sensible and 
balanced diet; 
(h) to disseminate knowledge about the important results which European policies in the nutrition sector 
have obtained to date. 
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2. MEASURES T O BE T A K E N 
From a Community angle, and in order to achieve the objectives set out in Section 1, the Community and 
the Member States, according to their respective competences will take the following measures, acting in 
close cooperation: 
(a) European Nutrition Year 
Decision to declare and implement a European Nutrition Year, in 1994. 
(b) General measures to heighten awareness 
Activities focused on a limited number of aspects geared to different sectors of society, particularly to 
schools and scientific and industrial circles and mass catering as well as to typically national, regional 
or local aspects. Such activities will include, amongst others, information programmes via television, 
radio and the press as well as conferences and the distribution of educational and informative material 
and, possibly, prizes. 
(c) Pilot projects on nutrition 
Ad hoc projects aimed at improving the nutritional standards of select groups of people at risk and the 
nutritional quality of food and at assessing the levels currently achieved in the Community. Such 
projects will be directed, inter alia, at the methods of disseminating such knowledge. 
(d) Research and studies 
Research and studies on nutrition and health and in particular on: 
— factors affecting choice of food by consumers and the effect of foods on metabolic rates, 
— the consequences of changes in eating habits, 
— the consequences of rapid changes in methods of food manufacture, preservation and distribution, 
— the formulation of information for consumers, 
— studies on eating habits in the various regions of the Community. 
(e) Work of the Scientific Committee for Food 
Stepping up and diversifying the work of the Scientific Committee for Food in the nutritional field 
and, if need be, examination of setting up a Scientific Committee for Nutrition, attached to the 
Commission. 
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CONCLUSIONS OF THE COUNCIL AND THE MINISTERS FOR HEALTH, 
MEETING WITHIN THE COUNCIL 
of 3 December 1990 
on the safety of food and drink and water intended for human consumption 
(90/C 329/05) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE MINISTERS FOR HEALTH, MEETING 
WITHIN THE COUNCIL, 
Whereas, with the single market in prospect, the regu-
latory innovations so far introduced into Community 
rules under the Single European Act must be developed 
further to ensure the reasonable protection of public 
health in a system based on free movement of foodstuffs; 
Whereas, whenever Community harmonization is lacking 
or inadequate, the diversity of national legislation 
frequently gives rise to difficulties in trade and, at any 
rate, to an increase in disputes and may have adverse 
repercussions on public health protection; 
Recognize that the chief task of the Community in this 
situation is to take coordinated and thorough action to 
adopt as soon as possible, and at all events by the end of 
1992, effective rules, particularly in priority sectors 
where a high level of health protection has to be 
attained; 
Consider that the implementation of such action must 
take account of the fact that the protection of public 
health has long been the basic aim of Community food-
stuffs and water regulations and is not merely a question 
of adopting new rules but also of coordinating, updating 
and amplifying existing ones and guaranteeing, through 
effective, uniform application, that they are actually 
complied with; 
Recognize that the Commission must play an important 
role in the success of such action and that the 
Commission needs to take the necessary steps to bring 
unity to the differing approaches within the Commission 
itself, with precedence being given to the aim of 
protecting public health; 
Emphasize that, in order to ensure more effective health 
protection, uniform legislative principles and approaches 
should be adopted for the foodstuffs, agricultural and 
veterinary sectors as well as for the environment and the 
safety of water intended for human consumption; 
Emphasize the need for the involvement of the Council 
and of the Ministers for Health, inter alia adequate 
information, enabling a contribution to be made, in 
particular, by formulating general health objectives and 
criteria, to decisions in the foodstuffs and water sector 
on matters involving the protection of public health. 
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C O N C L U S I O N S O F T H E C O U N C I L A N D O F T H E MINISTERS FOR H E A L T H , 
M E E T I N G W I T H I N T H E C O U N C I L 
of 3 December 1990 
concerning cardio-vascular disease in the Community 
(90/C 329/04) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES AND THE MINISTERS FOR HEALTH 
OF THE MEMBER STATES, MEETING WITHIN THE COUNCIL, 
1. note that cardio-vascular disease is one of the main causes of death in all the Member States 
of the Community, particularly in the working population; 
2. consider that a number of preventive measures have already been, put in hand for cancer and 
that these measures have an effect in preventing cardio-vascular disease; 
3. consider that further measures should be identified and implemented; 
4. call upon the Commission to investigate the best way of facilitating exchange of information 
and cooperation on national measures, including in the field of research and means of 
diagnosis, obtaining to that end the assistance of experts and of representatives appointed by 
the Member States and to report to the Council on the outcome of that investigation. 
In carrying out this work the Commission should, in order to avoid duplication, take account 
of the work of other bodies in this area, particularly the W H O . 
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RESOLUTION OF T H E COUNCIL AND OF T H E REPRESENTATIVES OF THE 
GOVERNMENTS OF THE MEMBER STATES, MEETING WITHIN THE COUNCIL 
of 3 December 1990 
on Community action to combat the use of drugs, including the abuse of medicinal products, 
particularly in sport 
(90/C 329/02) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE REPRESENTATIVES OF THE 
GOVERNMENTS OF THE MEMBER STATES OF THE 
EUROPEAN ECONOMIC COMMUNITY, MEETING 
WITHIN THE COUNCIL, 
Having regard to the Treaty establishing the European 
Economic Community, 
Whereas the use of drugs, including the abuse of 
medicinal products, which is damaging to health, is 
increasingly prevalent in Europe, particularly in sport; 
whereas sport has a considerable impact on society, in 
particular on young persons, given the substantial 
publicity given to it in the media; whereas, as a result, 
vigorous action against drug use in sport may serve as an 
example to show that, generally, it can and must be 
possible to win without recourse to stimulants and 
medicinal substances which endanger health; 
Whereas, in view of the above, one important objective 
of the fight against the use of drugs in sport should be 
the protection of the health of those taking part in 
sporting activities; 
Having regard to the Council of Europe Convention, its 
importance and the advisability of close cooperation 
between the Member States of the Community and the 
Council of Europe in this sphere, in a spirit of 
complementarity, 
Whereas the use of drugs in sport contravenes health 
regulations in a number of ways, in particular to the 
extent that it implies: 
(a) the use of substances authorized by the Community 
as medicinal products (Directive 65/65/EEC) (') for 
purposes other than those for which authorization 
was given (the diagnosis or treatment of recognized 
pathological states); 
(b) the use of such substances in forms and dosages not 
covered by the authorization (Directive 
65/65/EEC); 
(c) failure to comply with rules on distribution 
(Directive 75/319/EEC — black market and/or sale 
to non-authorized persons) (2), prescription (sale 
without a doctor's prescription — Directive 
75/319/EEC, as amended by Directive 
89/341/EEC) and advertising of such products 
(Directive 84/450/EEC) (3); 
Whereas an educational and preventive approach should 
prevail and extend to cover all persons taking part in 
sporting activities, in particular young people and the 
circles in which they move; 
Whereas it would be opportune for a European code of 
conduct to combat the use of drugs in sport to be 
publicized at the 1992 Olympic Games in order to take 
advantage of the impact of that event on public opinion, 
Invite the Commission, assisted by a Group of Experts 
appointed by the Member States: 
— to draft and circulate, in close conjunction with the 
Member States, by the end of 1991, with a view to 
the Olympic Games in 1992, a code of conduct to 
combat the use of drugs in sport, based on the 
guidelines set out in Annex I, 
— to propose to the Council measures of Community 
interest based on the guidelines set out in Annex II, 
taking into account the measures already initiated by 
government sporting authorities, the Council of 
Europe and international sporting organizations. 
(') OJ No 22, 9. 2. 1965, p. 369/65, as last amended by 
Directive 89/341/EEC (OJ No L 142, 25. 5. 1989, p. 11). 
(') OJ No L 147, 9. 6. 1975, p. 13, as last amended by Directive 
89/381/EEC (OJ No L 181, 28. 6. 1989, p. 44). 
(') OJ No L 250, 19. 9. 1984, p. 17. 
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DRAFTING, CIRCULATION AND USE OF A CODE OF CONDUCT TO COMBAT THE USE OF 
DRUGS IN SPORT 
The code should constitute an important instrument of information and education against the use of drugs 
in sport. Denouncing the use of drugs in sport as contravening the rules of health protection and in any 
case as constituting unsporting behaviour, it should be submitted for joint discussion by medical and 
sporting circles operating in the Community. 
ANNEX II 
MEASURES OF COMMUNITY INTEREST 
(guidelines) 
(a) Stepping-up training information and health education initiatives against the use of drugs in sport. 
(b) Study of most common current drug-use practices. 
(c) Drug-testing methods and cooperation between laboratories. 
(d) Research on effects of drug-taking on health within the Community biomedical research framework 
programme. 
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RESOLUTION OF THE COUNCIL AND OF THE REPRESENTATIVES OF THE 
GOVERNMENTS OF THE MEMBER STATES, MEETING WITHIN THE COUNCIL 
of 3 December 1990 
on improving the prevention and treatment of acute human poisoning 
' (90/C 329/03) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE REPRESENTATIVES OF THE 
GOVERNMENTS OF THE MEMBER STATES OF THE 
EUROPEAN COMMUNITIES, MEETING WITHIN THE 
COUNCIL, 
Having regard to the Treaty establishing the European 
Economic Community, 
Having regard to the draft resolution submitted by the 
Commission ('), 
Having regard to the opinion of the European 
Parliament (2), 
Having regard to the opinion of the Economic and 
Social Committee ('), 
Whereas, for a policy aimed at preventing the risks of 
acute poisoning in the population and, in particular, 
among workers, it is desirable to have the maximum 
amount of comparable data on clinical toxicology at 
Community level; 
Whereas harmonized annual reports would be of value 
in the context of the Ehlass project subject of Council 
Directive 86/138/EEC of 22 April 1986 concerning a 
demonstration project with a view to introducing a 
Community system of information on accidents involving 
consumer products (5); whereas Annex I (Section 2, third 
paragraph) of that Decision stipulates that additional 
information may be obtained from poison centres to 
supplement the basic information obtained from the 
casualty departments of hospitals; 
Whereas, with a view to the free movement of persons 
and goods, it is important to improve the availability of 
antidotes by facilitating exchanges of information on 
their availability, in particular in areas adjacent to other 
Member States; 
Whereas this resolution would help to develop the use of 
clinical toxicology data in overall assessments of the 
impact of chemical products and preparations on the 
health of the public in general and, more particularly, on 
the health of workers exposed to dangerous substances 
liable to cause acute poisoning; 
Whereas poison centres in the Community, by virtue of 
their informative therapeutic and analytical functions, are 
amongst those bodies in the best position to collect 
clinical toxicology data in their geographical areas of 
activity and to process this information; 
Whereas it is important to ensure access to information 
on the chemical composition of preparations in order to 
ensure the correct advice and treatment in connection 
with poisoning; 
Whereas harmonization of the procedures for collecting 
clinical toxicology data for all the poison centres in the 
Community would facilitate the development of a policy 
for toxic risk prevention; 
Whereas, by fostering the integration of clinical and 
analytical data, the Community wishes to achieve one of 
the main objectives of its programme of action on toxi-
cology for health protection ('), namely to help ensure 
the quality and comparability of data and encourage the 
exchange of experience and information in the field of 
clinical toxicology; 
(') OJ No C 294, 22. 11. 1989, p. 10. 
(!) Opinion delivered on 23 November 1990 (not yet published 
in the Official Journal). 
O OJ No C 124, 21. 5. 1990, p. 1. 
C) OJ No C 184, 23. 7. 1986, p. 1. 
Whereas this resolution should contribute to the devel-
opment of health data with respect to the unlawful use 
of drugs with reference to the resolution of the Council 
of the Ministers for Health of the Member States, 
meeting within the Council of 16 May 1989, concerning 
a European network of health data on drug abuse (6); 
Whereas the information obtained in the event of 
poisoning by medicinal products may constitute a factor 
in the assessment of their safety in use; whereas it is 
desirable for the information collected in this connection 
by poison centres to be forwarded to the authorities 
responsible for medicinal products and drug monitoring; 
(s) OJ No L 109, 26. 4. 1986, p. 23. 
(') OJ No C 185, 22. 7. 1989, p. 1. 
182 SOCIAL EUROPE 1/91 
31. 12. 90 
Acute poisoning 
Official Journal of the European Communities N o C 329/7 
Whereas continued close cooperation with the various 
international agencies active in this area, in particular the 
World Health Organization (WHO) , the United 
Nations Environment Programme (UNEP) and the 
International Labour Organization (ILO) through their 
joint International Programme on Chemical Safety 
(IPCS), and where appropriate the implementation of 
joint measures with those agencies, would be beneficial 
and is necessary to avoid duplication of effort, 
between the poison centres or, where appropriate, 
other competent services a Community system of 
information and collaboration concerning the avail-
ability of antidotes; 
5. to arrange for the competent authority to produce a 
summary of the harmonized annual reports of the 
poison centres and, where appropriate, of other 
competent services; 
EXPRESS THE WILL to take the necessary steps to 
improve the prevention and treatment of acute human 
poisoning. 
This summary will deal in particular with records of 
acute poisoning, with a note on the measures taken or 
planned to improve the prevention of acute poisoning 
and will, if possible, also take account of available 
anonymous data on poisoning resulting from the 
taking of illegal drugs. 
II 
INVITE THE MEMBER STATES: 
to designate a competent authority to take the 
necessary measures to ensure that the collection of 
call data and the annual reports on the work of the 
poison centres or, where appropriate, other competent 
services operating in the territory of the Member 
State concerned are based essentially on the indi-
cations set out in Annexes I and II; 
2. to ensure that antidotes i.e. the substances and prep-
arations used specifically in cases of acute poisoning, 
are as widely available as possible in their respective 
territories ; 
3. to increase the practical scope for using antidotes in 
their respective territories. 
The summary will be forwarded to the Commission 
before 15 May of the following year, together with a 
list of the poison centres or, where appropriate, other 
competent services operating in the territory of the 
Member State, showing the areas which they cover, 
and the list of available antidotes. 
The Commission may, where necessary, arrange for 
all or part of the harmonized annual reports referred 
to in Annex II to be forwarded to it. 
T o help improve the safety of use of medicinal 
products, it would be desirable for the annual report 
on cases of poisoning involving them to be forwarded 
also to the authorities responsible for the safety of 
those products. The poison centres or, where appro-
priate, other competent services would be encouraged 
to give the drug-monitoring authorities every 
assistance possible and should in particular respond, 
on the basis of the legislation in force, to any specific 
request for informtion from those authorities. 
T o that end, the competent authority will have drawn 
up and distributed to the poison centres and, where 
appropriate, to other competent services, information, 
based on the indicative list in Annex III, on the avail-
ability of antidotes for treating acute poisoning cases 
and on the sources of supply. That information 
should enable the recipients to obtain these antidotes 
within the requisite period for administering them 
effectively; 
4. to provide better emergency services in areas adjacent 
to other Member States. 
I l l 
INVITE THE COMMISSION TO: 
prepare regular summary reports for the Community 
indicating, in particular, the measures required at 
Community level for the prevention of acute 
poisoning, 
T o that end, the relevant competent authorities, in 
cooperation with the Commission, will set up 
expand on specific topics based on the information 
received from the Member States on the prevention 
and treatment of acute poisoning. 
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IV — to invite the Commission to review the technical 
Annexes to this resolution at least every two years 
AGREE: and, if necessary, update them regularly in the light 
— to review the provisions of this resolution within five o f t h e experience acquired, 
years of their adoption on the basis of a Commission — that in the preparation of the above report and in the 
report. That review will take account of the need to updating of the Annexes the Commission will be 
step up prevention by means of the activities provided assisted by a working party of experts appointed by 
for in this resolution, the Member States. 
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ANNEX I 
HARMONI2ED CASE DATA RECORD SHEET 
(to be completed in so far as the data are available, at the time of consultation or at a later stage, provided 
this is compatible with national laws and policies) (') 
Further call: 
N o C 3 2 9 / 9 
Method of call: 
3. 3.1. Date (yymmdd) (J): 3.2. Time (hhmm) ('): 
Address: 
Tel. N o : 
4.2. Type of enquirer: 
4.2.1. Not identified 
4.2.2. Hospital: 4.2.3. Outside hospital: 
Accident and emergency (Casualty) LJ Physicians 
Internal medicine LZI Nurses 
Intensive care, resuscitation IZI Pharmacists 
Paediatrics □ Veterinary surgeons 
Psychiatry LJ Occupational health services 
Other poison centre □ Industry/manufacturers 
General public 
Mass media 
Authorities 
Others 
** 5. Type of enquiry: 
Call related to a case LZI Information only LJ 
Request for antidotes IZI Other LJ Unknown Ll 
(') The headings of particular relevance for the purpose of prevention are marked by a double asterisk. 
(') yymmdd = abbreviation corresponding to year/month/day. 
(') hhmm = abbreviation corresponding to hour/minute. 
D 
D 
D 
D 
D 
D 
D 
D 
α 
π 
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** 6. Patient 6.1. Multipe cases : Yes fZI Number: 
6.2. Human: Name (optional): 
6.2.1. Age (yymmdd): ; if estimated LJ 
Foetus LJ Unknown Child LJ Unknown Adult LJ Unknown LJ 
6.2.2. Sex: Male D Female Π 
6.2.3. Weight (kg): ; if estimated Π 
6.2.4. Pregnant: Duration (weeks): 
6.2.5. Lactating: yes LJ 
6.3. Animal species: 
** 7. Agents 
Information to be repeated where poisoning is by more than one agent 
7.1. Name (given by enquirer): 
Composition of product: 
Manufacturer (if applicable): 
Quantity: No: ; Vol: ; Wt: , if estimated LJ 
Unknown LJ 
Exposure: Single LJ/Repeated/Chronic LJ 
— duration: — frequency: 
— duration: 
7.2. Time elapsed since exposure: (yymmdd hhmm) 
** 8. Location 
8.1. Home and surroundings LJ 
8.2. Workplace: 
Factory/workshop LJ Laboratory LJ Agriculture/horticulture LJ 
Other D 
8.3. Community: 
Nursery or primary school LJ Other school, university, educational establishment LJ 
Hospital, clinic, nursing home LJ Institution: prison, military, etc LJ Other LJ 
8.4. Enclosed public places (e.g.: bars, discotheques, restaurants, shopping centres, department stores, etc.) LJ 
8.5. Open places (e.g.: sports grounds, children's playgrounds, etc.) LJ 
8.6. Other Π 
8.7. Unknown D 
186 SOCIAL EUROPE 1/91 
31. 12. 90 
Acute poisoning 
Official Journal of the European Communities N o C 329/11 
** 9. Circumstances 
9.1. Accidental/unintentional 
Household Q 
Occupational LJ 
Environmental IZI 
Transport accident LJ 
Fire D 
Therapeutic error LJ 
Misuse LZI 
Other D 
Unknown LJ 
9.2. Intentional 
Suicide IZI 
Misuse LJ 
Abuse LZI 
Malicious/criminal LJ 
Other D 
Unknown LJ 
9.3. Adverse reaction 
Drug D 
Food D 
Other D 
9.4. Unknown D 
10. Route of exposure 
10.1. Ingestion IZI 
10.2. Inhalation D 
10.3. Cutaneous LJ 
10.4. Eye contact LJ 
10.5. Bite D 
10.6. Sting D 
10.7. Injection: 
Subcutaneous LJ 
Intramuscular Π 
Intravenous LJ 
Intra­arterial Ö 
10.8. Mucosal: 
Buccal Π 
Nasal D 
Rectal Π 
Vaginal LJ 
10.9. Placental D 
10.10. Other D 
10.11. Unknown IZI 
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11. Signs and symptoms 
11.1. Signs and symptoms present 
11.2. Signs and symptoms not present 
11.3. Unknown 
Comments in free text: 
12. Identification and/or quantification of the toxic agent: yes LJ 
13. Other investigations requested: yes LJ 
14. Treatment: 
14.1. None 
Prevention of absorption : 
Gastric emptying: Emesis 
Lavage 
Activated charcoal 
Activated charcoal 
Elimination 
Antidote therapy 
Other 
14.2. Place of treatment 
Treatment at home or at place of poisoning, not by physician LJ 
Treatment outside hospital by a physician LJ 
Treatment in hospital LJ 
Other D 
15. Estimated risk: 
Non-toxic LJ 
Probably non-toxic (low toxicity/minimal exposure) LJ 
Poisoning possible LJ Confirmed poisoning LJ 
Symptoms unrelated to exposure LJ 
16. Outcome: 
Hospitalization LJ — I f yes, number of days: 
Complete recovery LJ Sequelae LJ Death LJ Unknown LJ 
Treatment carried out before 
enquiry 
D 
Π 
Π 
D 
D 
Π 
Π 
D 
Treatment recommended by first 
poison centre 
D 
Π 
Π 
D 
D 
D 
Π 
D 
Signature : 
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ANNEX II 
LAYOUT O F T H E H A R M O N I Z E D ANNUAL REPORTS (') 
1. Identification of the body drafting the report 
Name; full address (indicating country); telephone, telex and fax numbers (if any); name of person 
in charge of centre. 
2. Year 
The year covered by the annual report in question. 
3. Administrative information on the centre 
Description of staff at centre (medical and administrative personnel); a brief description of the 
centre's work; the size of the population served. 
** 4. Calls to the centre 
The total number of calls, their monthly variation, their distribution according to the person making 
the enquiry, the way in which the call is made (telephone, letter, etc.), the reasons (actual or 
presumed poisoning, simple request for information, etc.). 
** 5. Poisoning cases 
— the number of cases and the frequency should be indicated for each category or sub-category, 
— if the centre has the necessary resources, it would be desirable to break down the data in terms of 
the classes of aetiological agents listed below. 
5.1. Cases involving human beings 
— males, females (including pregnant women, nursing mothers), unspecified 
— age groups (in years): 
1 -
5 -
10 -
15 -
20 -
50 -
> 
unknown 
< 1 
4 
9 
14 
19 
49 
69 
70 
Aetiological agents: 
— non-pharmaceutical chemical substances (simple or compound, natural or synthetic): 
— industrial 
— pesticides 
— household products 
— cosmetics and personal hygiene products 
— drugs which may lead to dependence 
— others 
(') The headings of particular relevance for the purpose of prevention arc marked by a double asterisk. 
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— pharmaceutical substances (human or veterinary) 
— animals as such (whether by their venom or through consumption of poisonous meat — 
e.g. ichthyosarcotoxism — where chemical products, bacteria or putrefaction are not the 
cause) 
— plants as such (including poisonous mushrooms and plants which may lead to 
dependence) 
— others (including toxins of bacterial origin, e.g. botulism) 
— not identified 
Location : 
Home and surroundings LJ 
Workplace: 
Factory/workshop LJ Laboratory LJ Agriculture/horticulture LJ Other LJ 
Community: 
Nursery or primary school LJ 
Other school, university, educational establishment Q 
Hospital, clinic, nursing home LJ 
Institution: prison, military, etc. LJ 
Other D 
Enclosed public places (e.g.: bars, discotheques, restaurants, shopping centres, department 
stores, etc.) 
Open places (e.g.: spons grounds, children's playgrounds, etc.) 
Other 
Unknown 
Circumstances: 
(a) Accidental/ 
unintentional 
Household 
Occupational 
Environmental 
Transport accident 
Fire 
Therapeutic error 
Misuse 
Other 
Unknown 
D 
D 
D 
D 
D 
Π 
Π 
D 
Π 
(b) Intentional 
Suicide 
Misuse 
Abuse 
Malicious/criminal 
Other 
Unknown 
D 
D 
D 
D 
D 
D 
(c) Adverse 
reaction 
Drug 
Food 
Other 
α 
D 
D 
(d) Unknown LJ 
Estimated risk: 
Non-toxic LJ 
Probably non-toxic (low toxicity/minimal exposure) LJ 
Poisoning possible LJ Confirmed poisoning LJ 
Symptoms unrelated to exposure LJ 
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— Treatment: 
— none 
— symptomatic only 
— specific (antidote therapy) 
— elimination of the toxic substance 
— Outcome 
— complete recovery 
— hospitalization (number of days) 
— sequelae 
— death 
— unknown 
5.2. Animals 
** 6. Record of poisoning cases 
Draw up a list of the 15 most frequent causes of poisoning in decreasing order of frequency 
(indicating the number of calls) with a breakdown by age group, if the centre has the necessary 
resources. 
7. Record of requests for information 
Draw up a list of the 15 reasons for 'which most requests for information are received. 
8. Record of toxicological analyses 
Draw up a list of the 15 toxicological analyses which are most frequently requested by the centre. 
9. Comments in free text 
O n all treatment given and information provided; on particularly interesting cases which may have 
been encountered, on other activities (teaching, research, etc.) and on any other aspect not included 
elsewhere. 
10. Conclusions 
These are to deal mainly with the impact of the centre's activities on prevention. 
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ANNEX III 
INDICATIVE LIST OF ANTIDOTES 
A. SPECIFIC ANTIDOTES 
Antidote 
Acetylcysteine 
Amylnitrite 
Antivenins and antitoxins 
Atropine 
Benzylpenicillin 
Calcium gluconate 
Calcium disodium edetate 
(Ca Na2 EDTA) 
Dantrolene 
Deferoxamine 
Diazepam 
Dicobalt Edetate 
Digoxin-specific (Fab) 
antibody fragments 
Dimercaprol (BAL) 
4-Dimethylaminophenol 
(4-DMAP) 
Diphenhydramine 
Ethanol 
Etybenzatropine 
Flumazenil 
Folinic acid 
Glucagon 
Hydroxocobalamin 
(Vitamin Β 12a) 
Methionine 
4-Methylpyrazole 
Methylthioninium 
chloride 
(Methylene blue) 
N-Acetyl penicillamine 
Naloxone 
Neostigmine 
Oximes 
Oxygen 
Main indications 
Paracetamol 
Carbon tetrachloride 
Cyanide 
Cholinergic syndrome 
Amanitotoxins 
Hydrofluoric acid 
Fluorides 
Oxalates 
Lead 
Malignant hyperthermia 
Malignant neuroleptic syndrome 
Iron 
Aluminium 
Seizures 
Chloroquine 
Cyanide 
Digoxin 
Digitoxin 
Digitalis glycosides 
Arsenic 
Gold, inorganic mercury 
Lead encephalopathy 
Cyanide 
Drug-induced dystonias 
Methanol 
Ethylene glycol 
Drug-induced dystonias 
Benzodiazepines 
Folic acid antagonists 
Beta-blockers 
Cyanide 
Paracetamol 
Ethylene glycol 
Methanol 
Methaemoglobinaemia 
Mercury (organic and metallic) 
Opiates 
Neuromuscular block (curare type) 
Peripheral anticholinergic poisoning 
Organophosphates 
Carbon monoxide 
Cyanide 
Hydrogen sulphide 
Availability in terms of 
urgency of use in 
treatment 
Β 
Β 
A 
A-C 
A 
Β 
A 
A 
A 
A 
A 
A 
Β 
Β 
A 
A 
A 
A 
A 
A 
Β 
Β 
Β 
A 
A 
A 
A 
A 
Β 
A 
A 
A 
Β 
A 
A 
A 
C 
A 
A 
A 
Β 
A 
A 
A 
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Antidote 
Oxygen hyperbaric 
D­Penicillamine 
Pentetic acid (DTPA) 
Diethylenetriamine pentaacetic 
acid 
Phentolamine 
Physostigmine 
Phytomenadione 
(Vitamin K l ) 
Potassium ferric 
hexacyanoferrate 
(Prussian Blue) 
Prenalterol 
Protamine sulphate 
Pyridoxine 
(Vitamin B6) 
Silibinin 
Sodium nitrate 
Sodium thiosulphate 
Succimer (DMSA) 
2.3­Dimercaptosuccinic acid 
Tolonium chloride 
(Toluidine Blue) 
Trientine 
(Triethylene tetramine) 
Unithiol (DMPS) 2.3 Dimer­
capto­1­propanesulphonic acid 
Main indications 
Carbon monoxide 
Cyanide 
Hydrogen sulphide 
Copper 
Gold, lead, mercury 
(elemental), zinc 
Plutonium, actinides 
Alpha­adrenergic poisoning 
Central anticholinergic syndrome from 
— atropine and derivatives 
— other drugs 
Coumarin and ¡ndanedione anticoagulants 
Thallium 
Beta­blockers 
Heparin 
Isoni azid 
Crimidine 
Gyromitrin 
Hydrazines 
Amanitotoxins 
Cyanide 
Cyanide 
Lead 
Mercury (inorganic and organic) 
Arsenic 
Methaemoglobinaemia 
Copper 
Mercury (methyl­ and inorganic) 
Lead 
Availability in terms of 
urgency of use in 
treatment 
C c c 
c c c 
A 
A 
A 
A 
Β 
Β 
A 
A 
A 
Β 
Β 
Β 
Β 
Α 
Α 
Β 
Β 
Β 
Α 
Β 
Β 
Β 
Β. AGENTS TO PREVENT ABSORPTION OF TOXIC SUBSTANCES IN THE GASTRO­INTESTINAL TRACT 
Antidote 
Activated charcoal (') 
Cholestyramine 
Fullers earth 
Potassium ferrocyanide 
Sodium bicarbonate 
Sodium sulphate 
Starch 
Main indications 
For most poisonings 
Digitalis, coumarin, chlordecone 
Paraquat, diqu.it 
Copper 
Iron 
Organophosphates 
Barium 
Iodine 
Availability in terms of 
urgency of use in 
treatment 
A 
Β 
A 
A 
A 
A 
A 
A 
(') Can also be used to enhance elimination of some toxic substances. 
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C. AGENTS TO PREVENT ABSORPTION AND/OR DAMAGE ON THE SKIN 
Antidote 
Calcium gluconate gel 
Macrogo l 400 (PEG) 
C o p p e r sulphate, 
sodium bicarbonate , 
hydroxy-ethylcellulose 
Main indications 
Hydrof luor ic acid 
Phenol 
Whi te phosphorus 
Availability in terms of 
urgency of use in 
treatment 
A 
A 
A 
D. EMETICS 
Antidote 
Ipecacuanha 
Main indications 
Availability in terms of 
urgency of use in 
treatment 
A 
E. CATHARTICS AND SOLUTIONS USED FOR WHOLE GUT LAVAGE 
Antidote 
Magnes ium citrate 
Magnes ium sulphate 
Manni to l 
Sodium sulphate 
Sorbitol 
Polyethylene glycol electrolyte 
(lavage solution) 
Main indications 
Availability in terms of 
urgency of use in 
treatment 
Β 
Β 
Β 
Β 
Β 
Β 
F. AGENTS TO MODIFY URINARY pH 
Antidote 
A m m o n i u m chloride 
Agrinine hydrochlor ide 
Hydroch lo r i c acid (0,1 Ν ) 
Sodium bicarbonate 
Main indications 
Availability in terms of 
urgency of use in 
treatment 
Β 
Β 
Β 
A 
A: required to be immediately available (within 30 minutes). 
B: required to be available within two hours. 
C: required to be available within six hours. 
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II 
(Preparatory Acts) 
COMMISSION 
Amendment to the draft Council resolution on improving the prevention and treatment of acute 
human poisoning (') 
COM(90) 598 final 
(Submitted by the Commission pursuant to Article 149 (3) of the EEC Treaty on 14 December 
1990) 
(91/C 5/03) 
(') OJ No C 294, 22. 11. 1989, p. 10. 
ORIGINAL PROPOSAL AMENDED PROPOSAL 
C i t a t i o n s a n d r e c i t a l s 1 t o 4 u n c h a n g e d 
Recital 5 
Whereas harmonized annual reports will also be of value 
in the context of the Council Decision of 22 April 1986 
(86/138/EEC) (2) concerning a demonstration project 
with a view to introducing a Community system of infor-
mation on accidents involving consumer products, which 
stipulates in Annex I (sub-section 2, paragraph 3) that 
additional information may be obtained from poison 
centres to supplement the basic information obtained 
from the casualty departments of hospitals; 
Recital 5 
"Whereas harmonized annual reports will also be of value 
in the context of the Council Decision of 22 April 1986 
(86/138/EEC) concerning a demonstration project with 
a view to introducing a Community system of infor-
mation on accidents involving consumer products (Ehlass 
project), which, stipulates in Annex I (subsection 2, 
paragraph 3) that additional information may be 
obtained from poison centres to supplement the basic 
information obtained from the casualty departments of 
hospitals; 
R e c i t a l 6 u n c h a n g e d 
Recital 7 
Whereas this resolution should help to develop the use of 
clinical toxicology data in overall assessments of the 
impact of chemical products and preparations on the 
health of the public in general and, more particularly, of 
workers exposed to dangerous substances liable to cause 
acute poisoning; 
Recital 7 
Whereas this resolution should help to develop the use of 
clinical toxicology data in overall assessments of the 
impact of chemical products and preparations, principally 
on workers exposed to dangerous substances liable to 
cause acute poisoning, and more generally on the health 
of the public in general; 
(') OJ No L 109, 26. 4. 1986, p. 23. 
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ANNEX 2 
Layout of the harmonized annual reports 
P o i n t s 1 t o 5.1 ( i n d e n t s 1 t o 3) u n c h a n g e d 
Indent 4 
— Location: 
— home and immediate surroundings 
— workplace: 
— industry 
— agriculture/horticulture 
— other 
— public establishment 
(e. g. schools or training centres, government offices, 
post offices, libraries, public transport — trains, buses, 
underground railways, etc.) 
— enclosed public spaces 
(e. g. bars, discotheques, restaurants, shopping centres, 
department stores, etc.) 
— open places (e. g. sports grounds, children's playgrounds, 
etc.) 
— other or unknown 
I n d e n t s 5 t o 
Points 5.2 and 6 
Indent 4 
Location: 
home and surroundings ( ) 
workplace: 
— factory /workshop ( ) 
laboratory ( ) 
— agriculture/horticulture ( ) 
— other ( ) 
community: 
— nursery or primary school ( ) 
other school, university, educational establishment ( ) 
— hospital, clinic, nursing home ( ) 
— institution: prison, military, etc. ( ) 
other ( ) 
— enclosed public spaces 
(e. g. bars, discotheques, restaurants, shopping centres, 
department stores, etc.) ( ) 
— open places (e. g. sports grounds, children's playgrounds, 
etc.)( ) 
— other ( ) 
— unknown ( ) 
8 u n c h a n g e d 
to 10 unchanged 
ANNEX 3 
u n c h a n g e d 
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8. Location: 
8.1. Home and surroundings ( ) 
8.2. Workplace: 
— Factory/workshop ( ) 
Laboratory ( ) 
Agriculture/horticulture ( ) 
— Other ( ) 
8.3. Community: 
— Nursery or primary school ( ) 
Other school, university, educational establishment 
( ) 
Hospital, clinic, nursing home ( ) 
— Institution: prison, military, etc. ( ) 
Other ( ) 
8.4. Enclosed public spaces ( ) 
8.5. Open places ( ) 
8.6. Other ( ) 
8.7. Unknown ( ) 
ANNEX 1 (') 
Harmonized case data record sheet 
P o i n t s 1 t o 7 u n c h a n g e d 
8. unchanged 
8.4. Enclosed public spaces (e. g. bars, discotheques, 
restaurants, shopping centres, department stores, etc.) 
( ) 
8.5. Open places (e. g. sports grounds, children's play-
grounds, etc.) ( ) 
unchanged 
P o i n t s 9 t o 16 u n c h a n g e d 
(') The nomenclature for poisoning locations to be harmonized 
in Annexes 1 and 2. 
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Recital 8 
(new) 
Whereas the current fruitful collaboration with the 
W H O , the poison centres of the Member States, and of 
non-Community countries must be continued and 
developed; 
P a r a g r a p h I u n c h a n g e d 
P a r a g r a p h II u n c h a n g e d in inden t s 1 to 4 
Indent 5 
to arrange for the competent authority to produce a 
summary of the harmonized annual reports of the 
poison centres and the associated toxicology services. 
This summary will deal in particular with records of 
poisoning, with a note on the measures taken or 
planned by the competent authority to improve the 
prevention of acute poisoning, and shall be 
forwarded to the Commission before 31 March of 
the following year, together with a list of the poison 
centres operating on their territory showing the areas 
which they cover, and the list of available antidotes. 
The Commission may, where necessary, arrange for 
all or part of the harmonized annual reports to be 
forwarded to it; 
Indent 5 
to arrange for the competent authority to produce a 
summary of the harmonized annual reports of the 
poison centres and the associated toxicology services. 
This summary will deal in particular with records of 
poisoning, in particular those due to illicit use of 
drugs, with a note on the measures taken or planned 
by the competent authority to improve the prevention 
of acute poisoning, and shall be forwarded to the 
Commission before 21 March of the following year, 
together with a list of the poison centres operating on 
their territory showing the areas which they cover, 
and the list of available antidotes. The Commission 
may, where necessary, arrange for all or part of the 
harmonized annual reports to be forwarded to it; 
Paragraph IV 
P a r a g r a p h II I u n c h a n g e d 
Paragraph IV 
AGREES to review the provisions of this resolution 
within a maximum period of five years following its 
adoption, on the basis of a report from the Commission. 
AGREES to review the provisions of this resolution 
within a maximum period of three years following its 
adoption, on the basis of a report from the Commission, 
taking into account the need for the Annexes to be 
updated. 
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C O M M U N I C A T I O N FROM THE COMMISSION TO THE C O U N C I L 
of 8 November 1990 
regarding 
the report o n n a t i o n a l p r o g r a m m e s for drug d e m a n d r e d u c t i o n in the E u r o p e a n C o m m u n i t y 
(COM(90) 527 final) 
Background 
The European Council on 25 and 26 June 1990 in Dublin 
invited the Commission to present on a regular basis to 
the Council and the Ministers for Health a report on 
work done on drug demand reduction in the Member 
States. At its meeting on 19 and 20 July 1990 in Rome, 
the Celad expressed an interest in receiving the first of 
these reports in time for the Rome Summit in December. 
O n 30 July 1990, the Commission, following discussions 
with experts from Member States (meeting in Luxem-
bourg on 16 July 1990), requested, through the Permanent 
Representations, the relevant authorities to forward by 
mid-September national reports on the programmes for 
the reduction of drug demand, giving the following infor-
mation: 
(i) The introduction should contain details of the scale of 
and trends in drug demand, policies for reducing drug 
demand and whether these are regional or national, 
and the role of central organizations in financing 
action; 
(ii) The other sections of the report should cover the 
following points: 
legal aspects of drug demand, 
information and instruction, 
treatment and reduction of risk, 
social and vocational rehabilitation, 
education, 
statistics and epidemiology — population studies, 
public opinion surveys, 
promotion of research. 
For each of these fields it was considered useful to have 
details of: 
national, regional and local structures, 
the level and sources of aid, 
what action has been taken and the main results to date, 
any future measures planned. 
The reports transmitted by a number of Member States 
departed considerably from the above outline. This over-
view report, which has been prepared in consultation 
with national experts (meeting in Luxembourg on 2 and 
3 October 1990) provides a comprehensive synthesis of 
the situation in the European Community regarding drug 
demand reduction in Member States (a summary of the 
national reports is annexed). 
I n t r o d u c t i o n 
The definition of drug policies and the setting up of 
appropriate actions reflect the socio-cultural and political 
context at various levels. In this respect in each Member 
State, national, regional and local levels have their own 
competence in the field of drug demand reduction. Most 
of the Member States involve each level with specific 
responsibilities. 
In most Member States policies and general guidelines for 
drug demand reduction are established at national level, 
while the implementation of actions in prevention, treat-
ment and rehabilitation is the responsibility of regional or 
local bodies. There is a trend towards decentralization 
even in Member States where such responsibilities are not 
clearly distributed. 
National support and coordination are often considered 
essential for the establishment of general policies. There 
¡s a willingness to keep a balance between local innovative 
activities and the necessity to have a minimum coordina-
tion of policies. 
The sources of funding and their allocation reflect the 
distribution of responsibilities between the national, re-
gional and local levels. In some Member States levels of 
government funding are enhanced by the substantial con-
tribution by the non-government sector. In several of 
them the levels of funding have shown a substantial 
increase in recent years, in a number of cases due to the 
additional threat of AIDS. 
The levels and trends of drug use, when looked at in 
comparative terms, must be considered with caution, 
since each Member State uses different methodologies and 
definitions for data collection. In some cases, trends 
cannot be ascertained within some Member States, since 
no consistent data collection effort has been implemented 
over a period of time. 
Member States stressed the difficulty of estimating the 
total number of drug users since many do not seek help 
nor do they come into contact with the authorities. On 
the basis of the limited available data on the number of 
known drug users, many Member States have experienced 
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an increase in their number in recent years. In some 
Member States there are reports of a stabilization in the 
overall number of users, in particular for heroin. This 
probably reflects the overall changing pattern of supply 
and demand and the type of drug used. Health-based 
indicators on drug users applying for treatment and 
drug-related deaths show an increasing trend of drug-rela-
ted problems in most Member States. In a number of 
Member States, there is a clear indication that the average 
age of the drug-using population is increasing. Heroin 
and polydrug use remain the main problems; there is 
evidence in some Member States that the use of cocaine 
and new drugs is increasing; however, this is not substan-
tiated at present by health data. 
Legal aspects 
Regarding the legal framework of drug demand reduction 
in Member States, four aspects are to be pointed out: legal 
provisions regarding drug possession or use and the 
consequences for drug users; regulations and practices 
concerning compulsory detoxification and treatment; vol-
untary detoxification and treatment and substitution treat-
ments; and special provisions related to the prevention of 
HIV transmission and AIDS. 
There is a constant adaptation of legislation and regula-
tions in response to a complex and changing situation. In 
most Member States the legal provisions favour the thera-
peutic approach for drug users. This may be voluntary or 
compulsory, and it is, when compulsory, an alternative to 
prison. There is, however, in certain Member States a 
tendency to increase the penalties for drug possession for 
personal use. 
More recently, the awareness of the role of intravenous 
drug use as a risk behaviour for HIV infection has 
emphasized, in the legislation of many Member States, the 
public health aspects of drug misuse. Two examples can 
be mentioned in this respect: the substitution treatments 
on one hand, in particular involving methadone, which 
are increasingly approved in some Member States for 
pilot experiments where methadone was not available for 
normal medical treatments; and on the other hand, the 
liberalization of the sales of syringes to take into account 
the new risk of HIV transmission and AIDS. Needle-ex-
change programmes still remain limited. 
Prevention 
Member States have made numerous efforts to deal with 
the drug abuse problem. As a common factor for most 
Member States the increasing recognition of the need to 
develop coordinated, continuous and structured preven-
tive actions can be highlighted responding to a rapidly 
evolving situation. Guidelines mentioned for prevention 
activities include: 
(i) the importance of a broader framework of preven-
tion measures in which various cultural, health and 
social problems are addressed; 
(ii) the need for a comprehensive approach to drug 
abuse problems, covering a range of different envi-
ronments simultaneously, taking into account risk 
factors and including illicit and licit drugs; 
(iii) the importance of adapting interventions to local 
needs and circumstances; 
(iv) the integration of drug education in general health 
education school programmes; 
(v) the emphasis on the promotion of a healthy life-
style and avoiding risk behaviours; 
(vi) the need for factual, objective, non-dramatized and 
non-fear-raising information; 
(vii) the importance of the responsibility of parents and 
leading figures as positive role models; 
(viii) the training of educators, youth workers, and health 
professionals. 
There are two approaches concerning the use of mass 
media in information campaigns. Some countries consider 
them not a very effective way to carry out prevention 
interventions while others have recently launched cam-
paigns. 
Treatment and rehabilitation 
Most Member States have treatment structures with ser-
vices ranging from hospital and community-based medical 
facilities, outpatient centres, and therapeutic communities 
to self-help groups. The coverage, diversification and 
decentralization of services varies considerably between 
them; both formally structured institutions with profes-
sional staff, and loosely organized voluntary assistance 
provide these services. 
Member States report the need to continue to strive for 
better, more diversified and an increased number of 
treatment possibilities. An important factor conditioning 
treatment policies is the role of intravenous drug use as a 
risk factor for HIV transmission. This fact has prompted 
many Member States to have flexible approaches to sub-
stitution treatments and syringe availability, as well as to 
try to reach drug users in their environments, and to make 
help available to them without the requirement of a 
drug-free lifestyle as a first goal. 
The balance between health and social sendees in the 
approaches to the care of drug users is different between 
the Member States; while in some of them the emphasis 
is on the social approach, with the collaboration of health 
care when needed, in others the trend is to include the 
treatment of substance abuse in the general health-care 
system with the collaboration of social services. Finally, 
in some Member States the mental health care system also 
plays an important role. Most Member States report a 
need for better adapted services aimed at individuals with 
specific problems: prisoners, AIDS patients and HIV-
positive persons, drug-using pregnant women, children of 
drug users, etc. 
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Statistics and epidemiology 
As a whole, health-based data collection at national level 
is recent, scarce and generally not consistent. The data 
sources at national level most commonly used among 
Member States are treatment-based reporting systems, 
drug-related deaths and school surveys. In some instances 
national general population surveys on drug use and 
specific population surveys have been carried out using 
different methodologies. Member States mention the need 
for more systematized, coordinated, comparable and in-
depth data collection. A number of Member States parti-
cipate in the work of the Pompidou Group on health-
based indicators and collection of data in pilot cities. 
At a regional/local level the picture is similar. Most 
countries have carried out isolated regional and local data 
collection efforts, which although very valuable in their 
specific contexts, do not permit trend assessments or the 
establishment of comparisons between regions due to a 
lack of consistent methodology. 
Specific research-oriented studies have been carried out at 
local and/or regional levels with a psychosocial/sociologi-
cal/anthropological perspective to provide a more in-
depth view of different aspects of substance abuse. 
Manpower training 
Most Member States report a recent increase in awareness 
on the urgent need for adequately trained personnel for 
the prevention and treatment of drug use. U p to the 
present, the most common approach to manpower train-
ing has been sporadic and/or of short duration and 
sometimes outside normal structures. Interdisciplinary 
courses for professionals and, in a few cases, continuous 
training has been provided. Some Member States have 
produced resource information/training materials for 
physicians, pharmacists, teachers and parents. Several 
Member States have structured, regular university and 
postgraduate studies for training and specialization in 
substance abuse. 
The need to develop permanent programmes is recognized 
by a number of Member States, and in some instances, the 
planning is well under way. Examples of such plans are: 
the integration of substance abuse training in university 
curricula of teachers, health professionals and psycholo-
gists; university and postgraduate training on substance 
abuse; and continuing education systems for professionals 
involved in prevention and treatment. 
R e s e a r c h 
There seems to have been, up to very recently, only minor 
attention given to research, with a lack of coordination at 
national level (mostly isolated research initiatives at some 
universities). This highlights the need for an increase of 
funding and coordination in substance abuse research. 
Some Member States have already started responding to 
this need by creating new research coordinating bodies 
and/or specific funding for substance abuse research. 
C o n c l u s i o n s 
Member States are deeply aware of the importance of 
drug demand reduction programmes and the need to 
develop them as an essential element in an overall drug 
policy. The approaches to drug demand reduction are 
continually and often rapidly evolving in Member States; 
furthermore a large variety of approaches is being ex-
plored. Member States consider it important to introduce 
and improve evaluation programmes. They emphasize the 
importance of a broader framework of prevention 
measures in which various cultural, health and social 
problems are addressed and for a comprehensive approach 
to drug abuse problems, covering a range of environments 
simultaneously, taking into account risk factors and inclu-
ding illicit and licit drugs. Member States stress the need 
to have available a variety of different treatment methods 
for drug users. They consider that there is a clear need for 
developing comparable data collection systems on drug 
demand reduction. They recognize the need for increased 
support and coordination of research efforts. Adequate 
funding and manpower resources are fundamental to 
ensuring that drug demand reduction (prevention, treat-
ment and rehabilitation) is carried out effectively. 
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Annex 
Summary of the national reports 
Introduct ion 
1. Definition of drug policies 
1.1. National level 
Belgium 
Everything to do with drug trafficking is a matter for the 
national authorities (i.e. the Ministries of the Interior, 
Justice and Finance and the Department of Health). As 
regards demand reduction, the Ministry of the Interior is 
responsible for the crime prevention aspect, mainly taking 
the form of training the police force with a view to 
enhancing their capacity to meet the specific demand issue 
of such 'drugs issue adult target groups' as parents, 
teachers, educators, etc. The legal and criminal aspects of 
drug demand reduction come under the Ministry of 
Justice, while drugs prescription monitoring duties fall to 
the Health Department's pharmacy inspectorate. 
Denmark 
The national level establishes statutes and other regula-
tions, all control measures and general coordination. 
France 
Responsibility for policies regarding prevention, care and 
rehabilitation and for financing special addict care struc-
tures lies entirely with the national authorities. There is a 
General Delegation for combating drugs and drug abuse 
which is responsible for the overall coordination of drugs 
policies. 
Greece 
There is an interministerial body operating since the 
beginning of 1988 which determines national policy 
against the misuse of drugs. The Ministry of Health, 
Welfare and Social Security is currently expanding a 
network of institutions for prevention, treatment and 
rehabilitation and financially supports a non-governmen-
tal national programme based on the therapeutic commu-
nity concept. 
Ireland 
The Department of Health plays a key role at the national 
level in a concerted effort with other government depart-
ments and agencies to monitor the position and to stimu-
late corrective action regarding the abuse of drugs covered 
by the Misuse of Drugs Act. There is a National Coordi-
nating Committee on Drug Abuse which is chaired by the 
Minister of State at the Department of Health and is 
representative of all the relevant government departments 
and agencies (i.e. Justice, Education, Foreign Affairs, 
Police, Customs, etc.). This Committee is currently draf-
ting a national plan to combat drug abuse. 
Italy 
The new law on drug dependence which entered into 
force on 26 June 1990 has redefined the institutional 
instruments for the formulation of policies and action 
programmes for the fight against drugs. The President of 
the Council of Ministers chairs the National Coordinating 
Committee for the Fight against Drugs, which comprises 
the competent Ministers (Health, Defence, Internal Af-
fairs, Education, Social Affairs, Justice and External Af-
fairs) and is supported by a Committee of Experts and the 
Permanent Observatory for the Drugs Phenomenon (res-
ponsible for the collection of data needed to prepare 
action policies). The Permanent Conference on Relations 
between the State, Regions and Autonomous Provinces is 
responsible for coordination between the central and 
regional governments in respect of programme implemen-
tation. 
Luxembourg 
Action to be taken in the fight against drugs is decided at 
national level by the Ministries of Health, Justice, Educa-
tion, Family Affairs and Youth. A Coordinating Commit-
tee chaired by a senior official of the Ministry of Justice 
was set up in 1980 to facilitate interministerial coopera-
tion. 
Netherlands 
Drug policy is defined at national level in close coopera-
tion between the Ministry of Justice and the Ministry of 
Welfare, Health and Cultural Affairs. 
Portugal 
There is an interministerial and interinstitutional integra-
ted plan against drugs, called 'Project Life', in effect since 
March 1987, coordinated in each specific area by the 
following Ministries: Internal Affairs, Justice, Education, 
Health, Employment and Social Security, Youth and 
Adjunct Minister Cabinet. Their aim is to decentralize the 
response to drugs and reinforce community initiatives. 
The areas covered are: information, treatment, rehabilita-
tion, social reinsertion and supply reduction. 
Spain 
There is a national plan on drugs since 1985. It coordinates 
all governmental and non-governmental organizations, as 
well as citizens in general on actions against drugs. This 
plan is implemented through two bodies: an Interminis-
terial Group, which coordinates the Central Administra-
tion (Health and Consumer Affairs; Employment and 
Social Security; Justice; Interior; Education and Science; 
and Social Affairs), and a Sectorial Conference, with 
representations from the autonomous communities (re-
gions). They take decisions and actions related both to 
offer and demand reduction. The N G O National Assem-
bly acts as a consultative body. The fight against drugs 
demand is seen as a collective, participative and integrative 
task, based on specific and unspecific prevention, treat-
ment, rehabilitation and training of professionals. The 
basic objective is to normalize the social perception and 
response to the problem, therefore providing care through 
the general health and social resources and minimizing 
specific resources. 
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United Kingdom 
Responsibility for implementing the Government 's stra-
tegy rests 'with a number of Departments. Their activities 
are coordinated by Ministers. An Advisory Council on 
the Misuse of Drugs has also been established. 
The UK drug demand reduction strategy has two main 
components. One is a programme of publicity and educa-
tion aimed at discouraging people, in particular young 
people, from trying drugs. The other is to bring existing 
misusers into contact with a range of services intended to 
facilitate their adoption of less dangerous habits of misuse 
and, ultimately, to lead to total abstinence from drugs. 
1.2. Regional and local levels 
Belgium 
Drug demand reduction, including prevention and treat-
ment, is essentially a matter for the three regional (i.e. 
Flemish, French and German-speaking) communities. 
Some provinces have their own structure for organizing 
the coordination and development of specific programmes 
in conjunction with the national authorities and the 
regional communities. 
Denmark 
The regional level is responsible for treatment matters, 
regional coordination and expert counselling; the local 
level is responsible for prevention and early intervention. 
France 
The departements are responsible for adolescent 
maladjustment matters, and to this end run and finance 
clubs and drug advisory units active in this area, which is 
clearly linked with drug dependency. The prevention of 
delinquency is a matter for the local mayors under their 
overall responsibility for the maintenance of public order, 
and it is in this light and in the context of urban social 
development policies that local authorities are concerning 
themselves increasingly with matters relating to drug 
addiction, particularly in the fields of prevention and 
rehabilitation (before and after the event). The General 
Delegation has the task of developing activities involving 
the various levels of jurisdiction and financing, as well as 
central government. 
Germany 
Public health, including the care of drug addicts, is the 
responsibility of individual Lander. 
Greece 
Several regional and local consulting and therapeutic 
centres are currently in operation or will operate shortly. 
The centres are under the auspices of the public or the 
private sectors, the local authorities or the church. 
Ireland 
Details of the organizations providing services for drug 
abusers are set out in the Department of Health's publica-
tion Directory of organizations dealing with substance 
abuse. The Health Promotion Unit of the Department of 
Health seeks to encourage community-based responses to 
local drug problems. Coordination of regional services is 
the responsibility of the eight Regional Health Boards. 
Italy 
The law makes the regions and autonomous provinces 
responsible for drawing up (on the basis of guidelines 
issued by the Ministry of Health) and implementing plans 
of action relating to prevention, health treatment and 
social rehabilitation of drug addicts. The local and moun-
tain-community authorities take action to prevent social 
deprivation and facilitate educational, occupational and 
social reintegration of addicts. 
Netherlands 
The major 23 municipalities are responsible for the devel-
opment of ambulatory treatment and prevention policy. 
The 12 provinces are responsible for hospital-based treat-
ment services (residential addiction clinics). 
Portugal 
Regional and local initiatives have recently been encour-
aged in order to develop and coordinate local partners. 
Spain 
There is a progressive development of autonomous plans 
on drugs (17 autonomous communities). These plans 
implement prevention, treatment and rehabilitation in 
each community, setting out the national plan on drugs. 
United Kingdom 
Regional Health Authorities (RHA) are responsible, with 
the help of their Drug Advisory Committee and Regional 
Drug Problem Team, for developing and coordinating 
local drug misuse treatment services. 
Local services for drug misusers are provided by a diverse 
range of statutory and voluntary services, general practi-
tioners (GPs) and health authorities themselves. Proper 
coordination of service delivery should be provided by 
District Drug Advisory Committees, whose members 
should include representatives of the health service, social 
services, the police, the probation service, the local educa-
tion authority and the voluntary sector (including parents 
and self-helf groups). Their role is to monitor the preva-
lence of drug misuse, to assess the effectiveness of local 
services and make proposals for their improvement, and 
to coordinate, at working level, the efforts of different 
agencies involved in preventive measures and in service 
provision. 
2. Level and sources of funding 
Belgium 
The system of demand reduction — ranging from preven-
tion to care and treatment — is financed in whole or in 
part by the regional authorities (institutions resulting 
from public or private, governmental or non-governmen-
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tal initiatives). One exception here concerning some pri-
mary prevention educational projects consists of very 
fragmentary sponsoring of such projects by private com-
mercial institutions. The Ministry of the Interior finances 
its own prevention activities. The current level of preven-
tion financing — especially primary prevention — is on 
the whole inadequate to meet the needs of the regional 
communities. 
Denmark 
Denmark has distinguished the respective parts of fun-
dings from municipalities, counties and national authori-
ties; for instance, treatment expenses are provided both 
by municipalities (50%) and counties (50%); social assis-
tance support by municipalities (50%) and the State 
(50%); reception centres and shelters by counties (25%) 
and the State (75%). 
France 
Over recent years, central government has substantially 
increased its financial involvement. Taking a look just at 
the Ministry of Solidarity, Health and Social Protection, 
expenditure on addiction prevention and the care of 
addicts in special centres, hospitals and the social system 
increased from FF 235 million (ECU 33.6 million) in 1984 
to FF 428 million (ECU 61 million) in 1990. In addition, 
an annual allocation of FF 250 million (ECU 35.7 million) 
has, for a number of years, been divided by the General 
Delegation among the various ministries, with some FF 
150 million (ECU 21.4 million) allocated for demand 
reduction work to the Ministries of Education, Solidarity 
and Health, Justice, Youth and Sport. 
Germany 
Germany has pointed out that the national authorities 
have increased their funding by DM 11 million (ECU 5.3 
million), from DM 1.8 million (ECU 870 000) to 12.8 
million (ECU 6.2 million). 
Greece 
The Ministry of Health, Welfare and Social Security has 
allocated DR 582 million (ECU 2.9 million) for the public 
sector and DR 450 million (ECU 2.2 million) for the 
non-governmental programme of therapeutic communi-
ties for the year 1990. For the year 1991, the respective 
sums are DR 2 000 million (ECU 10 million) for the 
public and DR 450 million (ECU 2.2 million) for the 
non-governmental sectors. 
Ireland 
Over UKL 1 million (ECU 1.3 million) has been allocated 
from national lottery funds to a number of statutory and 
voluntary agencies dealing with intravenous drug abusers, 
who are at risk of contracting and transmitting HlV. The 
National Drug Treatment and Advisory Centre is funded 
by the State at a cost of UKL 1 million per annum 
(approximately). 
Italy 
The new drugs law and other recent legislation provide 
for the funding of the following activities over the period 
1990-92: 
(i) LIT 360 million (ECU 230 000) per annum for the 
creation and operation of the Central Service for 
Alcohol, Narcotic and Psychotropic Substance De-
pendence attached to the Health Ministry; 
(ii) LIT 6.05 billion (ECU 3.9 million) per annum from 
1991 for the employment of 200 social assistants 
within the Ministry of Internal Affairs; 
(iii) LIT 4 billion (ECU 2.6 million) per annum for the 
operation of Ministry of Public Education commit-
tees, whose main task is to prevent drug addiction in 
schools; 
(iv) LIT 176 040 billion (ECU 114 million) for 1990, 
including LIT 30 billion (ECU 20 million) for expan-
ding the State drug addiction services, and LIT 180 
billion (ECU 120 million) per annum for 1991 to 
finance anti-drug projects presented by the mini-
stries, regions and local authorities; 
(v) LIT 150 billion (ECU 97 million) per annum to 
finance help for drug-addicted and AIDS-infected 
prisoners; 
(vi) LIT 10 billion (ECU 6.5 million) for the marketing 
of non-reusable ('self-blocking') syringes; 
(vii) LIT 20 billion (ECU 13 million) for 1990 and LIT 
38 billion (ECU 25 million) from 1991 for employ-
ment of State services staff to work on the prevention 
of AIDS among drug addicts. 
Netherlands 
All aid and treatment facilities — except for the metha-
done programmes of some municipal health services — 
are autonomous non-governmental institutions. The me-
dical consultation bureaux for alcohol and drug problems 
(CAD) with a multidisciplinary orientation have a total 
budget of HFL 79 million (ECU 34 million) for 1990; the 
budget for social welfare services directed to drug users is 
HFL 55 million (ECU 23.6 million) in 1990, the budget 
of the methadone programmes of municipal health ser-
vices is approximately HFL 7 million (ECU 3 million). 
Approximately 95% of the funds is dependent on the 
Ministry of Welfare, Health and Cultural Affairs that 
distributes these funds among the major municipalities. 
Residential treatment facilities are financed by the public 
health insurance funds (HFL 100 million, i.e. ECU 43 
million). Furthermore, the Ministry of Welfare, Health 
and Cultural Affairs provides HFL 6 million (ECU 2.5 
million) for AIDS prevention among drug users and HFL 
4 million (ECU 1.7 million) for specialized national 
residential treatment facilities and experimental projects. 
The total cost of addiction treatment and prevention is 
approximately HFL 250 million (ECU 107 million). These 
costs include the treatments for alcohol dependency. 
United Kingdom 
The Government has allocated specific funds since 1986/ 
87 to all Regional Health Authorities for the expansion of 
services for drug misusers; further additional funds have 
been allocated since 1987/8S to help prevent the spread of 
HIV among and from injecting drug users; in 1990/91, 
this funding totalled over UKL 15.5 million (ECU 22.6 
million), and this money is distributed on the basis of the 
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proportion of the population between the ages of 15 and 
34 within each region. 
3 . Levels and t rends of d r u g use 
Belgium 
Estimates put the number of users and addicts at between 
10 000 and 20 000, half of whom are regarded as problem 
cases. These figures are for the whole of the country. It is 
not possible to give reliable and significant figures, given 
that nothing is known of the number of users outside the 
specialized care and treatment network. 
Denmark 
It is estimated that the total number of drug abusers is 
about 10 000, with a substantial increase of drug abusers 
in methadone substitution treatment in recent years. 
France 
The number of drug users is put at some 100 000, a figure 
which has remained stable since 1980. 
Germany 
The number of regular hard drug users is estimated at 
60 000 to 80 000, with a shift towards older age groups. 
Greece 
The number of regular hard drug users as judged by the 
commonly used indicators is currently estimated at bet-
ween 9 000 and 13 000 users. 
Ireland 
The number of patients who attended the Dublin drug 
advisory and treatment centre was 1 052 in 1988, decreas-
ing steadily from 1 514 in 1983, as compared with the 
number of persons charged with drug offences — 1 422 
in 1989 and regularly increasing. There is evidence to 
suggest, however, that polydrug use in particular and new 
drug use are increasing. 
Italy 
The information available at present is not sufficient to 
allow an estimate of the total number of users of illegal 
substances. Figures are available for the number of per-
sons who turn to the State help services and social 
rehabilitation structures. The Ministry of Health has 
estimated the number of drug addicts who at least started 
treatment under the State health services during the 12 
months of 1989 at around 6 000, an increase of almost 
18% over the previous year. O n 30 June 1990, according 
to data compiled by the Obse rva to ry ' operated by the 
Ministry of Internal Affairs, some 38 000 persons were 
currently being treated on that specific day by the State 
structures, plus 11 000 in residential therapy communities. 
The average age of new users is increasing. 30 to 40% of 
persons receiving treatment were found to be HIV-sero-
positive. Almost 90% of new subjects starting treatment 
over the past two years have been addicted to heroin as 
the primary substance, with 5 to 6% addicted to canna-
binoids. 
Luxembourg 
Department of Toxicological and Pharmaceutical Chemis-
try statistics show that 1 799 analyses were carried out on 
samples from drug addicts in 1989, These figures reflect 
the level of activity of the service rather than trends in 
drug addiction in Luxembourg. Of the 1 799 analyses 
requested in 1989, around 700 samples had been collected 
under the new methadone maintenance treatment pro-
gramme (two compulsory urine analyses per week for 
each person participating in the programme). 
Netherlands 
Reliable estimates for 1989 put the number of heroin 
addicts in the country as a whole at approximately 20 000, 
with stabilization of the overall problems but an increase 
in socio-economically disadvantaged populations. The 
mean age and the age of first use of heroin users are rising. 
Multiple drug use among heroin addicts is common. 
There are no indications that the use of cocaine has 
increased in recent years and has presented problems 
comparable to the nature and size of heroin problems. 
According to some local reports, the pattern of the misuse 
of other drugs, such as benzodiazepines and M D M A 
(Extacy), changes rapidly. 
Portugal 
The estimate of the total number of addicts in Portugal is 
40 000 to 50 000, one third of them concentrated in the 
greater Lisbon area. There are around 3 000 first treatment 
admissions every year, mostly because of intravenous 
heroin use. It is estimated that there are 4 000 addicts in 
treatment and 350 in methadone substitution. Users seek-
ing treatment are getting younger, and there are indica-
tions that heroin is increasing on the streets. Cocaine use 
is low but increasing, frequently combined with heroin. 
Polydrug use is also increasing. 
Spain 
In the last three years, there has been an increase in offer 
indicators, as well as an increase in acute deaths and 
treatment admissions; this seems to indicate an increase of 
drug use associated problems. There is also an age increase 
among addicts in treatment centres, emergency rooms 
and acute deaths. Problems are concentrated around 
heroin, although an increase of cocaine consumption is 
pointed out. 
United Kingdom 
It is difficult to measure the extent of an illegal activity 
such as drug-taking. O n e indicator is the number of 
addicts formally notified to the H o m e Office by doctors. 
This shows an increase in notifications of some 30% a 
year between 1980 and 1985, a fall between 1985 and 
1987, and a renewed rise from 1987. However, this does 
not represent a complete picture of the scale of drug 
misuse. It has been estimated that the Addicts ' Index 
underestimates addicts of notifiable drugs by a factor of 
at least 5, though these proportions, too, may be changing 
as a result of efforts to attract clients to drug services. 
There are also perhaps as many misusers of non-notifiable 
drugs, excluding those who use cannabis. Other indicators 
of the changing scale of the drug misuse problem are 
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statistics for the seizure of drugs and for persons involved 
in drug-related offences. This corroborates the evidence 
from the Home Office Addicts' Index of a respite in the 
increase in the number of misusers during the mid-1980s, 
although changes in statistics for seizures can, of course, 
be influenced by a range of other factors. The figures for 
drug-related offences show a similar correlation with the 
general trend. 
Legal aspects 
Belgium 
The problem of drug abuse is generally covered by laws 
relating to public order and the protection of young 
people. However, there are a number of measures in 
certain districts at the instigation of public prosecutors 
seeking an alternative to the penal sanctioning of illicit 
drug-taking and requiring the drug abuser to consult a 
mental health service run by the aid network or to seek 
aid under a methadone programme. 
Denmark 
Treatment programmes for drug abuse are authorized 
under the Social Assistance Act, and treatment has always 
been voluntary. As regards the prevention of HIV trans-
mission, specific recommendations have been added as 
amendments to treatment programmes. 
France 
The law of 31 December 1970 authorizes compulsory 
treatment of drug users on the basis of a court decision. 
It also allows the public prosecutor to suspend legal 
proceedings if the addict agrees to undergo treatment. 
3 800 addicts benefited from this provision in 1988. The 
1970 law also encourages spontaneous requests for treat-
ment by making such treatment anonymous and free of 
charge. In order to prevent the spread of AIDS, legislation 
was introduced in 1988 to liberalize the sale of syringes. 
Pilot needle exchange programmes were set up, although 
without specific legal provisions. 
Germany 
There is disagreement in the Federal Republic of Germany 
as to the form drug substitution treatment should take, as 
reflected in the resolution passed by the special conference 
of the Länder of 30 March 1990. The current situation is 
that the Länder apply different criteria (medical and 
otherwise). A decision clarifying the legality of substitute 
drug treatment was taken by the Bundesrat (Second 
Chamber) on 11 May 1990. The Government endorses 
the position adopted by the Chamber of Physicians on 9 
February 1990, setting out the various circumstances in 
which L-Polamidon can be dispensed to drug addicts. 
The Chamber of Physicians' view is that substitute drugs 
should be made available to addicts only in very specific 
(medically determined) cases under strict medical supervi-
sion and in conjunction with intensive psychosocial care. 
Drug substitution treatment should take place only in 
special institutions. 
Greece 
Arrested drug users are separated into two categories: 
non-dependent users arrested for personal use are obliged 
to follow a counselling programme, and they are impri-
soned if recidivists in detoxification units; dependent 
users arrested for personal use follow either a voluntary 
detoxification programme or a compulsory confinement 
in a prison detoxification unit for therapy without any 
penalty: if these dependent users are arrested for drug 
trafficking, penalties are reduced with the same two above 
options (voluntary detoxification or compulsory confine-
ment). Extensive modifications of the current law are 
being advanced for approval by the Greek Parliament. 
These modifications provide for extended authorities for 
the interministerial policy-making body and institute 
measures for the materialization of the public sector 
programme. They also provide alternate solutions to 
punishment to encourage convicted drug users to attend 
treatment and rehabilitation programmes. 
Ireland 
The previous Regulations (1979), relating in particular to 
the possession of controlled drugs, have been updated by 
the new Misuse of Drugs Regulations (1988), and the 
Minister for Health has established an out-patient drug 
treatment centre in the city centre of Dublin which has 
statutory responsibility for organizing and administering 
out-patient drug treatment services. 
Italy 
The law confirms the illicitness of the personal use of 
illegal substances, but punishes only possession. 
Possession of a quantity of an illegal substance below the 
average daily dose, fixed by the Health Ministry, is 
punishable by administrative penalties, with criminal pen-
alties commensurate with the offence of drug-pushing for 
larger quantities. Both administrative and criminal penal-
ties may be suspended if the subject agrees to undergo 
treatment. Persons requesting voluntary treatment are 
guaranteed anonymity. The use of methadone is subject 
to ministerial regulations and must be available at State 
help centres. The sale of syringes by pharmacies has been 
liberalized. 
Luxembourg 
The law of 19 February 1973 on the sale of medicinal 
substances and the fight against drug addiction offers 
addicts the option of withdrawal treatment in a specialized 
establishment. 
Netherlands 
There is a clear-cut distinction between drug users and 
traffickers, in order to avoid classifying the possession of 
drugs by users as a serious crime, and to allow easy access 
to prevention and voluntary interventions. As a conse-
quence of prosecution policy, no special action is taken 
by the police to detect offences involving possession of 
drugs for personal use except in practice in the course of 
finding evidence against drug dealers, or in cases of public 
order disturbances. The selling or possessing of up to 30 
grams of hemp products is illegal, but has lowest priority 
in prosecution policy, except in cases where minors are 
involved or (illegal) advertising takes place. There are no 
legal restrictions on the distribution of methadone in 
addiction treatment or the sale and free distribution of 
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syringes in AIDS prevention. All medical treatment of 
addicts takes place within the framework of the ordinary 
legislation concerning medical practice. For drug addicts 
who commit drug-related crimes the Penal Code provides 
for different measures to divert the suspects or convicts 
from the criminal justice system to the treatment system. 
Portugal 
Both traffic and use are punished with prison and/or 
fines. In the case of addicts, prison can be commuted to 
treatment. The sale of syringes is free, but there are no 
exchange programmes or free availability. Methadone is 
not commercially available. 
Spain 
The use of drugs has never been penalized in Spain. 
Possession for personal use is not penalized, but there is 
an open clause which allows to consider as an offence the 
invitation to use or the donation for use. A regulation on 
public use is under study, which foresees administrative 
sanctions (not penal). In 1990, a new law made substitu-
tive treatments more flexible and less restrictive, due to 
the risk of HIV transmission. The sale of syringes has 
always been free in Spain. As to what concerns the 
workplace, there is a lack of legislation to allow drugs 
intake detection among employees. 
United Kingdom 
The principal legislation concerned with the control of 
drugs in the UK is the Misuse of Drugs Act 1971 and the 
various regulations made under it. The Act defines illegal 
drugs, placing them in three categories according to their 
degree of harmfulness. It is designed to be flexible, 
allowing new drugs to be added to the lists of illegal 
substances by secondary legislation. The Act prohibits 
the import and export, production and supply and posses-
sion of controlled drugs and sets out a range of penalties 
relating to its infringement. The Act also established the 
Advisory Council on the Misuse of Drugs. 
Other relevant legislation includes the Medicines Act 
1968, which provides for the control of medicinal pro-
ducts and certain other substances and articles, for exam-
ple syringes and sterile water for injecting, through a 
system of product licences and clinical trial certificates, 
licences for manufacturers, and, where appropriate, re-
strictions on methods of sale. The Customs and Excise 
Management Act 1979 and the Drug Trafficking Offences 
Act 1986 broadened the range of drug-related offences 
and set out penalties. 
Prevention 
Belgium 
The French and German-speaking regional communities 
place the emphasis on coordinated and global approaches 
with fieldworkers, organized by the Coordinating Com-
mittee on Alcohol and Other Drugs in the French-speak-
ing community and the Working Party for the Prevention 
of Drug Addiction and Coping with Life in the German-
speaking community. These approaches are centred on 
such centre-of-interest groupings as the family, the 
school, the working environment, the local communities, 
etc. They cover training for people with a 'relay' function 
and the organization of ongoing activity programmes 
addressed to young people and adults. In the Flemish-
speaking community, information and education respon-
sibilities lie with the Association for Alcohol and other 
Drug-related Problems, whose prevention staff work to 
strengthen the existing cooperation within and between 
such groupings as education, young people, adult educa-
tion, health care and law enforcement agencies. 
Denmark 
Denmark bases its prevention interventions on two main 
paths: general social preventive measures to provide good 
conditions of life, and specific information given through 
two-way communication activities rather than mass 
media. Their emphasis is on harm-reduction rather than 
abstinence. 
The implementation is based on national delineation of 
basic principles together with the publication of resource 
materials and a local planning and implementation of 
specific prevention interventions. 
France 
In 1990, France set up a major prevention programme . 
based on three lines of attack: mass communication 
largely based on the media; the school and the family as 
role-leaders for young people; local initiatives bringing 
together a wide variety of people and organizations in 
towns and neighbourhoods. 
Germany 
Germany puts an emphasis on the concept of vulnerability 
and the need for protecting those at risk, as well as of 
including secondary prevention. Its aim is to develop 
targeted information campaigns to make people aware of 
the danger and legal implications of drug abuse, pointing 
towards total abstinence. Its plan of action encompasses a 
broad-based range of interventions aimed at reaching 
multiple target groups: publicity campaigns using the 
mass media for the general public work with media 
representatives, community figures and staff in schools; 
youth in their natural environments and institutional 
group situations (military and civilian national service-
men); young adults and parents. 
Greece 
There are no systematic primary prevention programmes, 
but several actions oriented towards secondary preven-
tion: a network of consulting and drop-in centres, and 
groups of immediate intervention with high-risk popula-
tions. A national programme based on the 'health careers' 
concept is under approval for immediate implementation. 
Ireland 
Ireland has actions mostly oriented towards the informa-
tion and training of professionals: teachers, workers in 
local communities, doctors, pharmacists, and specialists 
in drug abuse. 
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Italy 
A publicity campaign to prevent drug abuse, aimed prima-
rily at young people aged between 12 and 16, is currently 
being carried out through the mass media, parallel to the 
AIDS campaign. The Ministry of Health has promoted 
the expansion of educational initiatives which have proved 
effective (school team approach) and is to support initia-
tives of other agencies (the Unicri's 'Stop droga' pro-
gramme), which will be coordinated with the measures 
implemented by the Ministry of Public Education. The 
Ministry of Defence has introduced an information pro-
gramme for military service conscripts. 
Luxembourg 
Efforts are concentrated on supplying information to the 
population, parents, teachers and youth. The police parti-
cipates in these information activities. Another focus is 
the promotion of alternative activities. 
Netherlands 
Drug prevention is part of general health education in 
schools as well as prevention programmes in the field of 
youth, mental health and social welfare. Specific drug 
information campaigns are found to be effective only with 
specific at-risk groups; therefore, mass media campaigns 
are not found to be appropriate. On the basis of local risk 
assessments (in a community, a school, a youth service, 
etc.) emphasis is given to substance abuse in general, 
specific licit or illicit substances, primary or secondary 
prevention. On a national level special funds are made 
available for prevention-workers and the development of 
technical support. However, priority is given to alcohol, 
smoking, and AIDS prevention among drug users. 
Portugal 
Portugal uses in its prevention efforts an array of initia-
tives, through a variety of channels: information and 
awareness campaigns to motivate social groups to become 
involved in prevention; production and distribution of 
informative materials for specific target groups, mass 
media campaigns and collaboration with the media; a 
telephone help line; information and education pro-
grammes for specific groups (school environment, parent-
to-parent, youth-to-youth, professionals); and leisure-
time activities with the collaboration of NGOs . 
Spain 
In recent years, there has been a progressive increase of 
resources allocated to prevention by the autonomous 
communities in relation to the total budget allocated to 
drug abuse control (from 14% in 1986 to 28.6% in 1989). 
The three main areas of intervention for prevention are: 
schools, communities and the workplace. A school pre-
vention programme was launched by the Education 
Ministry in 1987-88. It created the post of provincial 
coordinator and entails teacher training, creation of re-
source materials, the incorporation of school health edu-
cation in curricula and training for parent associations. 
Pilot projects are planned to evaluate the integrated curri-
culum. According to the priorities set up in community 
prevention, special support is given to programmes deal-
ing with: high-risk youth, the improvement of the social 
image of drug abusers, the support of community social 
and health services, a technical information network, 
ongoing prevention programmes 'IDEA-prevención', and 
the training of local professionals. These community 
programmes are based on the knowledge of the current 
situation regarding drug abuse in each municipality in 
which they are to be implemented, and are drawn up with 
the coordinated participation of representatives from the 
various levels of power and the community sectors con-
cerned. Pilot programmes at the workplace are starting to 
develop in Spain, some of them with the support of the 
main trade unions. 
United Kingdom 
The twin-pronged strategy of seeking to discourage peo-
ple from using drugs in the first place and bringing those 
who use drugs into touch with a range of services reflects 
the Government's overriding priority of eliminating com-
pletely the misuse of drugs. But it also recognizes the 
important role of risk minimization among people who 
continue to misuse drugs. This emphasis is in large 
measure the product of recognition of drug misusers' role 
as a channel by which the HIV virus can spread into the 
general population. 
In 1985, the Government launched a major health educa-
tion and information campaign to discourage drug misuse. 
The campaign was developed in the wider context of 
Government action, begun in 1983, to improve treatment 
facilities, encourage professional interest and improve 
training. It was also a preliminary step in the fuller 
development of other preventive measures, which are 
now under way, such as advice and counselling services 
for parents and young people and educational material for 
use in schools. An extension of the Government's strategy 
on prevention was the introduction of needle exchange 
schemes in 1987. 
Treatment and rehabilitation 
Belgium 
In the French-speaking community, there is a special 
network of out-patient, reception and residential facilities 
in addition to the conventional hospital and psychiatric 
services. The German-speaking community uses addic-
tion-treatment professionals operating within the mental 
health care system. There is a scheme (in the French-
speaking community) in day centres for rehabilitation and 
for helping people to readjust to working life, while the 
Flemish-speaking community also has a substantial net-
work of addict-aid associations. 
Over recent years, there has been a definite trend towards 
making evaluation of the types of treatment available and 
their results more uniform. This applies also to the other 
regional communities, who are trying to move in the same 
direction. The various self-help groups also have a specific 
role to play in the rehabilitation system throughout the 
country. 
Denmark 
Denmark reports an important revision of aims and 
methods in the last five years. The importance of offering 
different treatment options, including low-threshold ones 
in order to meet the needs of individual abusers, is 
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stressed. There is an emphasis on out-patient treatment, 
rather than in-patient; an increasing use of reception and 
shelter centres and a decreasing use of psychiatric hospi-
tals. The majority of professional staff are social peda-
gogues and social workers. Prescription of methadone 
should be only a part of the treatment, accompanying 
continued control and assistance in the different areas; the 
improvement of methadone prescription practices by 
general practitioners is stressed. There are insufficient 
programmes, and their geographical distribution is irregu-
lar, not always covering the needs of the different types 
of abusers. There are special services for pregnant women 
and abusers with children. Special HIV/AIDS prevention 
interventions have been developed: information, easy 
access to needles and syringes and distribution of con-
doms. A clinic for HIV patients and drug abusers has 
been set up, and the collaboration between treatment 
centres and hospitals promoted. 
France 
A system specifically designed for drug addicts was set up 
in the 1970s, characterized by a wide range of schemes: 
reception centres (including out-patient, psychotherapy, 
and reintegration services), special hospital units, after-
care centres and foster families. The aim here is to provide 
an optimum response to the wide range of individual 
needs, leaving plenty of leeway for multiple therapeutic 
models. The role of general health services is growing in 
importance, and general practitioners have received train-
ing in drug abuse since 1988. In the main prisons, specific 
services have been set up to prepare prisoners for release, 
putting them in touch with sources of aid. Steps have been 
taken to limit the risk of transmission of infectious 
diseases, particularly HIV, with the deregulation of syr-
inge sales and a syringe exchange programme. These are 
seen as an important source of prevention work thanks to 
the information on HIV transmission and contact with 
addicts who are not registered with a care centre. Im-
proved job access is also a part of the overall reintegration 
programme for young people. 
Germany 
Germany has set up some prerequisites for treatment: 
accessibility, availability and diversification to cater for 
specific needs, long-term addicts being one main target 
group. They stress the need to supplement treatment with 
a fully integrated range of follow-up services and, within 
treatment, to provide for many stages (although it may 
entail a risk to prolong addiction). There is controversy 
about drug substitution, without uniformity between 
Länder. The Federal position is to administer it in special 
cases, under medical and psychosocial supervision. There 
is a comprehensive system which, nevertheless, needs to 
be extended in quantitative and qualitative terms, especial-
ly to rural areas; outreach work; confidence-building 
facilities (to reach more addicts); provision of special 
accommodation; women and addicts with children; easy-
access hospital detoxification; and, in some Länder, drug 
substitution. 
Greece 
There is a network of services operating within the 
National Health System (public sector) and a variety of 
services operating within the private sector which include 
a national programme based on the therapeutic com-
munity concept. Both sectors are being substantially 
financed by the Ministry of Health, Welfare and Social 
Security and are currently expanding their services. The 
services available are several counselling and evaluation 
centres, a physical detoxification centre, a drug therapy 
unit within a hospital psychiatric section, therapeutic 
communities, day hospital, a hot-line for emergencies and 
mobile units for action in the community. The therapeutic 
communities include a rehabilitation and social reintegra-
tion programme as well as a programme for vocational 
training. 
Ireland 
Ireland has an out-patient treatment centre which coordi-
nates comprehensive services: out-patient treatment; toxi-
cology laboratory service; referral for in-patient treat-
ment; counselling services; ante-natal and post-natal ad-
vice and methadone maintenance. There is also a drop-in 
centre for IVDU, offering counselling, medical services, 
needle exchange services, methadone maintenance, welfare 
advice and link with housing. Statutory and voluntary 
agencies are funded to facilitate the expansion of special' 
services and AIDS preventionprogrammes, in particular 
outreach research and services, and a community-based 
information programme. 
Italy 
In the various regions of Italy, there are 517 State help 
centres for drug addicts, which operate as part of the State 
Health Service. Addicts may also be admitted into hospi-
tals providing detoxification treatment. There are around 
11 000 drug addicts in the 433 residential therapy commu-
nities, almost all of which are run by voluntary non-
governmental organizations, although financed by the 
State or regions. The interdisciplinary teams of the State 
help services practise programmes of treatment with sub-
stitute products, psychotherapy and social rehabilitation 
programmes. They also cooperate with the AIDS unit to 
care for HIV-seropositive subjects. 
Luxembourg 
There is a system of decentralized reception and informa-
tion centres, including psychology guidance departments 
in schools and street workers' networks. The therapeutic 
facilities include out-patient treatment centres, specialized 
psychiatric services, in-patient detoxification, therapeutic 
community and a post-treatment centre. The AIDS and 
drugs programme aims at reaching as many addicts as 
possible, and includes a network of street workers (inclu-
ding visits to hospitals and prisons), a pilot project on 
methadone substitution, a pilot project in the prison, and 
the preparation of a system for syringe exchange and free 
distribution of condoms. 
Netherlands 
The Netherlands has the following principles for the 
treatment and rehabilitation of addicts: a multifunctional 
network of medical and social services built up at local or 
regional level; easily accessible aid; the maximum use of 
unspecific services and the promotion of social rehabilita-
tion of present and former drug abusers. The regional 
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networks include non-residential services (field work, 
social counselling, therapy, methadone supply and rehab-
ilitation); semi-residential services (day/night centres, 
day-care treatment, employment and recreation); and 
residential services (crises and detoxification drug depen-
dence units and therapeutic communities). 
In this network there are forms of assistance not primarily 
intended to end addiction, but geared to 'harm reduction': 
field work, initial reception, supply of substitute drugs, 
material support and opportunities for social rehabilita-
tion. The AIDS prevention measures provide information 
on safe sex and safe drug use, offer new-for-old syringes 
exchange programmes and distribute condoms. These 
networks are based on various types of centres: medical 
consultation bureaux for alcohol and drug problems; 
municipal methadone programmes; social welfare services 
and residential facilities. The consultation bureaux also 
have a probation task in relation to the criminal justice 
system. 
Portugal 
There are insufficient treatment (out-patient, methadone 
substitution, therapeutic community) facilities, and the 
existing ones are concentrated on the coast. More coope-
ration with social services is needed. The government 
coordinates eight out-patient centres and two therapeutic 
communities. Methadone is administered in only one 
centre in Oporto. One centre attached to 'Project Life' 
(Taipas) is a specialized unit with an array of services 
(out-patient, in-patient detoxification, emergency service 
and day-care centre). NGOs have an important role in the 
implementation of treatment and rehabilitation. There are 
plans to create penitentiary units. There is an agreement 
with a maternity clinic for the care of pregnant addicts, 
although insufficient. Care of addicts with AIDS is assu-
med from drug abuse treatment centres. 
Spain 
In 1989, there were in Spain more than 300 out-patient 
treatment centres, 120 therapeutic communities and more 
than 200 hospital beds for detoxification. Most out-patient 
services and half of the therapeutic communities are 
funded with public resources. The general services of 
health, in special primary care, have progressively more 
active participation in drug users' attention. Although 
there has been an important increase of resources in 
recent years, there are still waiting lists. There is a special 
programme for care of drug abusers in prison. Special 
risk-reduction activities have been developed to combat 
HIV transmission (including education programmes for 
high-risk groups and methadone maintenance). The pri-
orities are the following: increased coverage; diversifica-
tion of treatment services; improvement of care program-
mes for drug abusers having legal problems; and program-
me evaluation. Rehabilitation efforts are concentrated 
around the promotion of the reinsertion in the socio-labo-
ral environment. The participation of general social servi-
ces in this process is potentiated. Occupational promotion 
is sought through training and support for youth coopera-
tives' initiatives, and general promotion of employment 
alternatives. 
United Kingdom 
Government guidelines state that all DHAs should have 
access to the following services: 
(i) advice and counselling; 
(ii) in-patient and out-patient facilities for detoxification; 
(iii) short-term residential rehabilitation facilities, inclu-
ding re-entry houses; 
(iv) hostel or other housing provision. 
In addition to developing, coordinating and monitoring 
the provision of drug treatment services locally, RHAs 
provide at least one specialist drug service; an expert 
regional drug problem team (RDPT) made up of profes-
sional medical, nursing and social care staff. 
They are based at a Drug Dependency Unit, with full 
in-patient and laboratory facilities. 
The RDPT also gives expert advice, support and training 
for district services. 
In Scotland and Wales, detailed arrangements differ to 
take account of the different organizational and adminis-
trative structure of the National Health Service and local 
government; but overall policy relating to the provision 
of drug misuse services is the same as in England. Primary 
responsibility for the planning and provision of services 
lies with Health Boards and local authorities in consulta-
tion with the voluntary sector. Inter-agency Drug Liaison 
Committees have been established in all mainland Health 
Board areas to coordinate local action. In addition to their 
allocations, some UKL 2.2 million per annum is currently 
being made available to Health Boards in Scotland, speci-
fically for the support and development of drug misuse 
services. A wide range of services for drug misusers has 
developed from a low base over the last six years, but 
some gaps remain, particularly in relation to residential 
crisis intervention and rehabilitation facilities. 
Statistics and epidemiology 
Belgium 
A variety of regional studies, mostly among schoolchil-
dren and other target populations, have been conducted 
over the past 10 years. With such a variety of survey 
methods, it is impossible to make any comparison at 
present between times and regions. No estimate has been 
made of the total number of addicts or drug users. A 
one-day prevalence survey was carried out in 1986, 1987 
and 1988 in all treatment institutions in all three regional 
communities. An inter-community coordinating com-
mittee has been set up, along with a permanent observa-
tion unit on drug and alcohol-related problems. 
A summary report for the three communities is now 
being drawn up, including national data from the various 
departments concerned. The German-speaking com-
munity has set up a 'permanent measuring instrument', 
while the Flemish-speaking community has an epidemio-
logy working party. The three units are organized differ-
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ently in the three regional communities, but work toget-
her with the Hygiene and the Epidemiology Institute 
nationally. 
Denmark 
Denmark has annual reports from the counties based on 
drug abusers in treatment, as well as estimates of the 
prevalence of drug abuse and the characteristics of drug 
abusers in contact with service providers. The National 
Board of Health collects information on methadone pre-
scriptions and the Institute of Psychiatry on drug-related 
admissions to hospitals. School surveys have been conduc-
ted in local areas, but there are no long-term observations. 
A project under way is a national substance abuse profile, 
which will provide more complete nation-wide informa-
tion. 
France 
France conducts an annual national statistical survey (by 
the Ministry of Solidarity and Health) at special consulta-
tion and treatment centres, and an epidemiological survey 
on drug addiction in prisons (conducted by Inserm - the 
national institute of health and medical research). At 
regional level, there is a monitoring network which col-
lects and analyses indicators on drug abuse. Demographic 
studies are mostly related to licit drugs, but since 1978, 
other surveys have been carried out (by the Inserm) in 
schools on illicit drugs. Several sociological and anthropo-
logical, as well as evaluation, studies have been carried 
out. A permanent drug and drug addiction observatory is 
now being set up by the General Delegation and all the 
ministries concerned. 
Germany 
Under the Establishment-based information system 
(EBIS), information is collected on addicts in some 300 
out-patient centres. A survey is conducted every three 
years by the Centre for Youth Education on susceptibility 
to drugs among young people. Other studies have been 
conducted, e.g. extensive interviewing and HIV testing of 
drug addicts. The Ministry of Youth, the Family, Women 
and Health has for many years now conducted representa-
tive surveys on the nature and extent of drug use in 
particular age-groups. The survey currently in progress 
uses a sample of 19 000 people aged between 12 and 39, 
and for the first time includes what used to be the 
territory of the GDR. In-depth analysis of the survey 
results should reveal what factors operate on individuals 
in triggering and stabilizing drug abuse. 
Greece 
The Department of Psychiatry of Athens University, in 
connection with the Department of Youth, has conducted 
several nation-wide and local studies: a retrospective 
study of recorded drug addicts (1973-83); a nation-wide 
general population survey (1984); a nation-wide high-
school student survey (1984); other high-school surveys 
in Athens and in other major cities; and psychosocial 
studies on drug addicts. 
Ireland 
Ireland collects treatment-based data. 
Italy 
Help centres and doctors send information on subjects 
receiving treatment to the Regional Epidemiological O b -
servatories. The data are processed on a central basis by 
the Ministry of Health and cover the following aspects: 
(i) Number of subjects taken into care during the year; 
(ii) Substances to which they are addicted; 
(iii) Type of treatment (in 1989, 33 000 subjects were 
treated with substitute drugs, around half of them 
with methadone; a total of 55% of subjects received 
substitute drug treatment, whilst 45% received only 
psychosocial treatment); 
(iv) Age and sex of persons receiving treatment. 
These data are published (also in English) in the Ministry 
of Health's Bollettino per le Farmacodipendenze. 
The Permanent Observatory for the Drug Phenomenon, 
which is an instrument of the National Coordinating 
Committee for the Fight against Drugs and operates 
under the Ministry of Internal Affairs, carries out regular 
systematic surveys covering the whole country, in col-
laboration with State and local authorities. These surveys 
involve the collection of epidemiological data on social 
and health aspects and the prevention and suppression of 
illicit drug traffic. 
The main data published by the Observatory are as 
follows: 
(i) the number, distribution and characteristics of drug 
addicts who have turned to the State health structures 
and residential therapy communities (situation on 
four specific days of the year); 
(ii) the number, distribution and characteristics of the 
State services and social rehabilitation structures. 
Luxembourg 
Luxembourg has statistics from the toxicological and 
pharmaceutical chemical division on forensic toxicology. 
Netherlands 
The Netherlands has a reporting system based on drug 
treatment services, which, at this point, includes the 
Ambulatory Consultation Bureau for Alcohol and Drugs 
and the residential addiction clinics; and in 1991, it will 
be expanded to municipal methadone programmes and 
local rehabilitation services. The Central Bureau of Stat-
istics reports on drug deaths and AIDS data are also 
collected. A study on 'Acute death after misuse' was 
conducted in Amsterdam (1990). Surveys have been car-
ried out both at national (National school survey 1988) 
and regional/local level (Household survey City of Am-
sterdam 1989-90), and several sociological (qualitative/ 
descriptive) studies have been conducted. After positive 
experiences with anthropological techniques in several 
local studies on drug abuse, a continuous nation-wide 
drug abuse monitoring programme is now under 
consideration. The Netherlands participates in the epide-
SOCIAL EUROPE 1/91 211 
Events and documents 
miology programmes of the Pompidou Group, directed 
to school surveys and city-based studies. 
Portugal 
The development of a systematic drug abuse data collec-
tion network is under way. This network is to be'integra-
ted in the European network called for in Resolution 
89/C 185/01 of the Council of Health (EEC). 
Spain 
Spain has an ongoing reporting system based on three 
indicators: out-patient treatment admissions, acute deaths, 
and non-fatal emergency room episodes (State informa-
tion system on drug addiction: SEIT). This system provi-
des information on opiate and cocaine use at national and 
regional levels. 
A retrospective study on drug-related deaths was conduc-
ted in six Spanish cities (1983-89). Several surveys, mostly 
regional, have been conducted between 1984 and 1989, 
but, since there was no standardized multiwave survey, 
trend assessment is not possible. Indirect indicators 
regarding drugs on offer are also available. 
United Kingdom 
Wales and all Regional Health Authorities in England 
have been asked to set up a database which collects 
. anonymous data about clients attending both voluntary 
and statutory services and will enable regions to monitor 
trends in drug misuse and the use of drug misuse services 
in their own region, and to plan future services. 
A similar database has been established in Scotland. This 
information will be submitted to the Department of 
Health at six-monthly intervals and used to monitor and 
evaluate the expenditure by health authorities and boards 
of earmarked moneys, and to develop future policies. The 
database will also provide information required by the 
Home Office for the Addicts' Index. 
Manpower training 
Belgium 
There is no specific curriculum at university level on drug 
abuse. A number of universities have developed training 
modules for health, social work and education profession-
als to provide knowledge on treatment and prevention. 
One of them now offers a full second-level course, while 
even more recently, a new, more intensive programme 
(160 hours) has been organized by the provincial authori-
ties, aimed at graduates in paramedical and social studies. 
Denmark 
Manpower training had a low priority at national level 
until recently. In July 1990, a model training programme 
was established. This programme is addressed at post-
graduate training of staff dealing with substance abusers, 
with the long-term aim to reform local treatment in 
general. 
France 
France has continuous national drug misuse training for 
general practitioners, organized by the Ministry of Soli-
darity, Health and Social Protection; practical organiza-
tion is up to the regional authorities. There is also a 
national training scheme for professionals in after-care 
centres on problems related to HIV and a programme for 
pharmacists similar to the one for physicians. An informa-
tion brochure for pharmacists has been published, to be 
followed shortly by another for local politicians. 
Germany 
Germany reports a need for general improvement in 
manpower training. This improvement means the exten-
sion of the range of multidisciplinary further training 
courses available (for judges, public prosecutors, and 
social services connected to the courts and the police). 
Greece 
A few sporadic actions have been carried out up to now. 
Meetings and short training programmes for health work-
ers have been conducted with the aim of forming small 
expert groups in the different regions. 
Ireland 
There is a programme for interdisciplinary training for 
people working in local communities which seeks to 
encourage community-based responses. 
One college offers a diploma course on addiction studies 
which provides specialized training for workers in direct 
contact with drug abusers and their families. Information 
resources, such as a document for doctors and pharmacists 
with recommendations on the prescribing and dispensing 
of controlled drugs, and an information booklet on sub-
stance abuse, have been produced. 
Italy 
At the moment, there are no post-university training 
courses for doctors and psychologists working with drug 
addicts. Occasional initiatives by individual universities 
are limited to short, non-permanent courses. Staff training 
is currently entrusted to the regional authorities. Non-
government agencies provide for a national staff training 
plan specific to the needs of health service personnel and 
therapy community staff, together with permanent train-
ing structures. Special training programmes are also 
planned for staff involved in prevention. These will form 
part of a series of training actions promoted by the 
Ministry of Health through its recent financing of around 
50 courses at national level to be organized according to 
guidelines drawn up by the Ministry itself for the follow-
ing programmes: attitude training, training for staff in-
volved in preventing the spread of AIDS among drug 
addicts, training for drugs workers and counsellors, etc. 
Netherlands 
Several projects have been funded in order to stimulate 
manpower training in universities and professional educa-
tion, post-graduate training and in-service training. These 
projects were meant for addiction treatment personnel 
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and for personnel in general health care and social work 
facilities. The Netherlands Institute on Alcohol and Drugs 
provides many training programmes, which cover the 
whole range of treatment and prevention modalities. 
Portugal 
At this point, generalists start getting some specific infor-
mation on drug abuse. It is considered to be of great 
importance and need to integrate training on drug abuse 
within medicine, psychology and nursing schools. 
Spain 
In 1987, the national plan funded postgraduate university 
studies on drug abuse in five Spanish universities. N o w -
adays, three Spanish universities offer a Masters in Drug 
Abuse. Other higher-education institutions have included 
drug abuse education for their students. Schools of Public 
Health in the autonomous communities offer specialized 
training. Training packs are being produced to support 
courses for health professionals, teachers and parents. The 
Ministry of Education promotes training of teachers and 
parents. 
United Kingdom 
The Advisory Council on the Misuse of Drugs (ACMD) 
made a number of recommendations regarding the train-
ing of professional staff who (may) work with drug 
misusers, but also of health-care staff, teachers, youth 
workers, health service managers and residential care 
staff. The Government has itself initiated a range of 
activities and supported others to help meet the financing 
needs identified in the A C M D ' s report. Teachers play a 
crucial role in making young people aware of the risks 
involved in drug-taking. The Government also provides 
funds for a number of training activities. For example, it 
has provided pump-priming money for training courses 
run by the English National Board for Nurses, and by the 
National Association for the Care and Resettlement of 
Offenders. 
Research 
Belgium 
A number of universities have ongoing research covering 
different aspects of drug abuse (prevention, treatment and 
training) looked at from different angles: psychiatry, 
social psychology, medical sociology, hygiene and peda-
gogics, legal aspects, etc. Generally speaking, these p ro-
jects tend to be isolated, apart from two coordinated 
projects involving a number of universities in the two 
main regional communities, centring on use habits and 
activities undertaken in the two communities. The inter-
community coordinating committee and its ad hoc work-
ing party on epidemiology want to start work in 1991 on 
epidemiological research using a standard method 
throughout Belgium. 
Denmark 
A review on research from 1986 reported the existence of 
few integrated environments for substance abuse research, 
mostly by medical doctors, few by social scientists, and 
virtually none by humanists. There is a need for increased 
priority to be given to substance abuse research, especially 
aspects of prevention and control policy. In 1988, and for 
a trial period of five years, an organization and funding 
project to promote substance abuse research was initiated. 
It intends to promote educational possibilities for young 
researchers and the establishment of integrated environ-
ments for substance abuse research. 
France 
Research into drug addiction has always had an important 
place in France. The main areas covered are basic neuro-
scientific research, epidemiological, ethnographic and psy-
chosocial research and, to a lesser degree, historical and 
legal research. 
Germany 
There are problems in research, since substance abuse 
professionals do not have, in general, adequate research 
training, and researchers in universities, on the other 
hand, have not given enough attention to the subject. The 
areas needing improvement are: basic biological research, 
medicament development, interlinking available data sys-
tems, family background and drug use, and different 
prevention aspects. 
There is a need for coordination between the federal 
government and other bodies, as well as more commit-
ment from research institutions and their collaboration 
with treatment centres. At a national level, an analysis of 
research requirements and potentials is under way. 
Greece 
Several epidemiological research studies have been carried 
out primarily by the University of Athens. In addition, 
Greece is participating in the development of method-
ology for reporting and survey systems in connection 
with the Pompidou Group (ECU 2.2 million). 
Ireland 
Ireland is participating in the setting up of a drug repor-
ting system under the aegis of the Pompidou Group. 
Italy 
A considerable amount of drug dependence research is 
financed by the various Ministries (Health, Internal Af-
fairs, Universities, etc.) and the regional authorities. The 
new drugs law includes provisions on coordination bet-
ween the research promoted by the mentioned industries. 
Increased funding is needed if more in-depth research and 
monitoring of the phenomenon are to be made possible. 
Netherlands 
The Netherlands has different lines of research: epidemio-
logical studies (including methodology development for 
surveys and reporting systems in connection with the 
Pompidou Group) , treatment evaluation studies, qualita-
tive and descriptive sociological studies. There is p romo-
tion of research through funds from the Ministry of 
Welfare, Health and Cultural Affairs, the Ministry of 
SOCIAL EUROPE 1/91 213 
Events and documents 
Justice and the Ministry of Education and Science; also, 
non-governmental funds are involved. 
Portugal 
Research carried out up to the present is very insufficient 
and with no specific support, although there is'scientific 
potential to develop it. Some epidemiology studies in the 
school environment have been carried out in connection 
with the Pompidou Group. 
Spain 
There has been an important increase in funding for 
research in fields associated with drug use. A specific line 
of funding for drug abuse research within the main 
Spanish research agency in the area of health is to be 
created. There have been some epidemiological and socio-
logical studies and other research initiatives funded by the 
national and autonomic plans on drugs. There is a need 
to define priority areas for research in the field of drugs. 
An information and documentation centre was created in 
1987 by the national plan on drugs. Its documentation 
(over 7 000 titles) constitutes a database named Eleusis 
that is fully computerized. 
United Kingdom 
The Department of Health and the Scottish Office have 
funded or commissioned a number of research projects 
and other studies relevant to the prevention of misuse, 
and the treatment and rehabilitation of misusers. Research 
is carried out by a variety of people or bodies — indepen-
dent researchers, university departments, and specialist 
units. 
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Official Journal of the European Communities 31. 12.90 
C O N C L U S I O N S O F T H E C O U N C I L A N D T H E MINISTERS FOR H E A L T H , 
M E E T I N G W I T H I N T H E C O U N C I L 
of 3 December 1990 
on reducing the demand for narcotic and psychotropic substances 
(90/C 329/06) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES 
AND THE MINISTERS FOR HEALTH, MEETING 
WITHIN THE COUNCIL, 
on demand reduction policies in the Member States, 
requested of the Commission by the European Council 
in Dublin on 25 and 26 June 1990; 
Having regard to the interim report and the guidelines 
for a European plan to combat drugs approved by the 
European Council in Dublin on 25 and 26 June 1990, Express their appreciation of the work carried out by the ad hoc Working Party and the Commission; 
Having noted the task which the European Committee 
for the fight against drugs (Celad) assigned to the ad hoc 
Working Party on Drug Abuse, namely to examine the 
aspects relating to drug demand reduction contained in 
the preliminary draft European plan to combat drugs, 
drawn up by the current Presidency of Celad, and to 
prepare a document on the subject; 
Suggest that the European Council, at its meeting of 
13 and 14 December 1990, approves the paragraph on 
demand reduction in the draft European plan to combat 
drugs proposed by Celad, in view of the important 
health-related objectives which it contains and which the 
Council supports; 
In the light of the thorough work carried out by the ad 
hoc Working Party on Drug Abuse in preparing that 
document; 
Having noted that at its meeting of 19 and 20 November 
1990 Celad used the findings of that work in its 
European plan to combat drugs, to be submitted by 
Celad to the Rome European Council on 13 and 14 
December 1990; 
Having examined, furthermore, the report drawn up by 
the Commission in conjunction with the Member States 
Take note of the conclusions of the report on demand 
reduction policies, which the Commission forwarded to 
the Council; 
Identify, amongst social and health measures, the 
following as the most urgent of the measures defined by 
Celad in the European plan to combat drugs and as 
being in keeping with the needs emphasized by the 
Commission in its report on demand reduction policies 
in the Member States: 
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1. The intensification of prevention measures in each 
Member State, aimed at the general population and 
high-risk groups. 
2. The intensification of measures in the Member States, 
to extend the range of effective methods for treating 
drug addiction by: 
(a) developing services providing the main therapeutic 
options, where appropriate in an integrated 
fashion, with special emphasis on those groups 
among which the continued use of drugs entails 
serious subsequent risks to their health; 
INVITE THE COMMISSION: 
(a) to promote the Community-wide exchange of infor-
mation, concerning in particular information and 
educational material on prevention, approaches to 
treatment and measures taken on social and occupa-
tional integration; 
(b) to promote the exchange of information on the 
methods used to evaluate the efficacy of the different 
measures taken and, in close cooperation with the 
Member States, to explore the possibility of 
improving methods of evaluation, enabling the 
Member States to use compatible and comparable 
evaluation methods; 
(b) analysing, updating and applying the various 
methods of treatment assessment. 
3. The intensification of intervention in the Member 
States of proven efficacy in obtaining and maintaining 
the social and occupational integration of addicts. 
(c) to draw up regular reports, in collaboration with the 
Member States, on demand reduction policies; 
(d) to carry out a feasibility study on the organization 
within the Community of regular training and 
update courses for qualified staff on themes which, 
because of their novelty and/or special nature, have 
not yet been sufficiently developed and studied; 
4. The intensification in the Member States of those 
activities and in-service training of qualified staff in 
the prevention, treatment and social integration 
sectors, 
Invite finally the ad hoc Working Party on Drug Abuse 
to act on any requests from Celad to examine the social 
and health aspects of studies concerning a Drugs Moni-
toring Centre and to report to the Council. 
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